
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.e22e79d5a578.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.f012d399c229.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.4455260d4345.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Oral delivery of proteins and peptides: Challenges, status quo and future perspectives - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939B2EEA04BEA4E500004010684F3992.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="1.6.0.post2+24fead6" />

<meta name="ncbi_domain" content="apsb" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC8424290/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424290/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Acta Pharmaceutica Sinica. B" /><meta name="citation_title" content="Oral delivery of proteins and peptides: Challenges, status quo and future perspectives" /><meta name="citation_author" content="Quangang Zhu" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author" content="Zhongjian Chen" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author" content="Pijush Kumar Paul" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author_institution" content="Department of Pharmacy, Gono Bishwabidyalay (University), Mirzanagar Savar, Dhaka 1344, Bangladesh" /><meta name="citation_author" content="Yi Lu" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author_institution" content="Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China" /><meta name="citation_author" content="Wei Wu" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author_institution" content="Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China" /><meta name="citation_author" content="Jianping Qi" /><meta name="citation_author_institution" content="Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China" /><meta name="citation_author_institution" content="Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China" /><meta name="citation_publication_date" content="2021/08" /><meta name="citation_issue" content="8" /><meta name="citation_volume" content="11" /><meta name="citation_firstpage" content="2416" /><meta name="citation_doi" content="10.1016/j.apsb.2021.04.001" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8424290/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8424290/" /><meta name="citation_pmid" content="34522593" /><meta name="DC.Title" content="Oral delivery of proteins and peptides: Challenges, status quo and future perspectives" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Elsevier" /><meta name="DC.Contributor" content="Quangang Zhu" /><meta name="DC.Contributor" content="Zhongjian Chen" /><meta name="DC.Contributor" content="Pijush Kumar Paul" /><meta name="DC.Contributor" content="Yi Lu" /><meta name="DC.Contributor" content="Wei Wu" /><meta name="DC.Contributor" content="Jianping Qi" /><meta name="DC.Date" content="2021 Aug" /><meta name="DC.Identifier" content="10.1016/j.apsb.2021.04.001" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Oral delivery of proteins and peptides: Challenges, status quo and future perspectives" /><meta property="og:type" content="article" /><meta property="og:description" content="Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastrointestinal ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424290/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2814/">Acta Pharm Sin B</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/389664/">v.11(8); 2021 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8424290
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8424290/pdf/main.pdf" class="int-view">PDF (4.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8424290/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8424290/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8424290" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="qIMFynVeF4sBPSW1uECGDKHihzByzoNqZ3koBK60J04D7WmhESNivSfhc9t9O7uf">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F&amp;text=Oral%20delivery%20of%20proteins%20and%20peptides%3A%20Challenges%2C%20status%20quo%20and%20future%20perspectives" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424290/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34522593/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34522593/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8424290/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2814/">Acta Pharm Sin B</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/389664/">v.11(8); 2021 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8424290
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-apsb.gif" alt="Logo of apsb" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="6,31,115,50" alt="Guide for Authors" title="Guide for Authors" href="http://www.elsevier.com/journals/acta-pharmaceutica-sinica-b/2211-3835/guide-for-authors" ref="reftype=publisher&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="121,32,162,50" alt="About this journal" title="About this journal" href="http://www.journals.elsevier.com/acta-pharmaceutica-sinica-b" ref="reftype=publisher&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="169,32,284,51" alt="Explore this journal" title="Explore this journal" href="http://www.sciencedirect.com/science/journal/22113835" ref="reftype=publisher&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,499,74" alt="Acta Pharmaceutica Sinica. B" title="Acta Pharmaceutica Sinica. B" href="http://www.sciencedirect.com/science/journal/22113835" ref="reftype=publisher&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Acta Pharm Sin B.</span> 2021 Aug; 11(8): 2416–2448. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2021 Apr 29. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.apsb.2021.04.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.apsb.2021.04.001</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8424290</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34522593">34522593</a></div></div></div><h1 class="content-title">Oral delivery of proteins and peptides: Challenges, status quo and future perspectives</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhu%20Q%5BAuthor%5D" id="au1" class="affpopup" co-rid="_co_idm140232410915136" co-class="co-affbox">Quangang Zhu</a>,<sup>a,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D" id="au2" class="affpopup" co-rid="_co_idm140232415725728" co-class="co-affbox">Zhongjian Chen</a>,<sup>a,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Paul%20PK%5BAuthor%5D" id="au3" class="affpopup" co-rid="_co_idm140232421348336" co-class="co-affbox">Pijush Kumar Paul</a>,<sup>a,</sup><sup>c,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lu%20Y%5BAuthor%5D" id="au4" class="affpopup" co-rid="_co_idm140232411027200" co-class="co-affbox">Yi Lu</a>,<sup>a,</sup><sup>b</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20W%5BAuthor%5D" id="au5" class="affpopup" co-rid="_co_idm140232465155472" co-class="co-affbox">Wei Wu</a>,<sup>a,</sup><sup>b,</sup><sup>&#x02217;</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Qi%20J%5BAuthor%5D" id="au6" class="affpopup" co-rid="_co_idm140232416138288" co-class="co-affbox">Jianping Qi</a><sup>a,</sup><sup>b,</sup><sup>&#x02217;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140232410915136"><h3 class="no_margin">Quangang Zhu</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhu%20Q%5BAuthor%5D">Quangang Zhu</a></div></div><div id="_co_idm140232415725728"><h3 class="no_margin">Zhongjian Chen</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D">Zhongjian Chen</a></div></div><div id="_co_idm140232421348336"><h3 class="no_margin">Pijush Kumar Paul</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><p><sup>c</sup>Department of Pharmacy, Gono Bishwabidyalay (University), Mirzanagar Savar, Dhaka 1344, Bangladesh</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Paul%20PK%5BAuthor%5D">Pijush Kumar Paul</a></div></div><div id="_co_idm140232411027200"><h3 class="no_margin">Yi Lu</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><p><sup>b</sup>Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lu%20Y%5BAuthor%5D">Yi Lu</a></div></div><div id="_co_idm140232465155472"><h3 class="no_margin">Wei Wu</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><p><sup>b</sup>Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20W%5BAuthor%5D">Wei Wu</a></div></div><div id="_co_idm140232416138288"><h3 class="no_margin">Jianping Qi</h3><p><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</p><p><sup>b</sup>Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Qi%20J%5BAuthor%5D">Jianping Qi</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140232427733472_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140232427733472_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140232427733472_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140232427733472_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>a</sup>Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China</div><div class="fm-affl" id="aff2"><sup>b</sup>Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China</div><div class="fm-affl" id="aff3"><sup>c</sup>Department of Pharmacy, Gono Bishwabidyalay (University), Mirzanagar Savar, Dhaka 1344, Bangladesh</div><div><span class="contrib-email" id="au5">Wei Wu: <a href="mailto:dev@null" data-email="nc.ude.umhs@iewuw" class="oemail">nc.ude.umhs@iewuw</a>; </span> <span class="contrib-email" id="au6">Jianping Qi: <a href="mailto:dev@null" data-email="nc.ude.naduf@gnipnaijiq" class="oemail">nc.ude.naduf@gnipnaijiq</a></span> </div><div id="cor1"><sup>&#x02217;</sup>Corresponding authors. <a href="mailto:dev@null" data-email="nc.ude.umhs@iewuw" class="oemail">nc.ude.umhs@iewuw</a><span style="unicode-bidi:bidi-override">, </span><a href="mailto:dev@null" data-email="nc.ude.naduf@gnipnaijiq" class="oemail">nc.ude.naduf@gnipnaijiq</a></div><div id="fn1"><sup>&#x02020;</sup>These authors made equal contributions to this work.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140232427733472_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2020 Nov 28; Revised 2021 Jan 29; Accepted 2021 Feb 12.</div></div><div class="permissions half_rhythm hide" id="idm140232427733472_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.</div><div class="license half_rhythm">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abs0010" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0010title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastrointestinal (GI) tract and epithelia, the therapeutic PPs are usually administered by parenteral route. Given the big demand for oral administration in clinical use, a variety of researches focused on developing new technologies to overcome GI barriers of PPs, such as enteric coating, enzyme inhibitors, permeation enhancers, nanoparticles, as well as intestinal microdevices. Some new technologies have been developed under clinical trials and even on the market. This review summarizes the history, the physiological barriers and the overcoming approaches, current clinical and preclinical technologies, and future prospects of oral delivery of PPs.</p></div><div class="sec"><strong class="kwd-title">Key words: </strong><span class="kwd-text">Proteins, Peptides, Oral delivery, Permeation enhancer, Enzyme inhibitor, Stability, Clinical</span></div><div class="sec"><strong class="kwd-title">Abbreviations: </strong><span class="kwd-text">ASBT, apical sodium-dependent bile acid transporter; BSA, bovine serum albumin; CAGR, compound annual growth; CaP, calcium phosphate; CD, Crohn's disease; COPD, chronic obstructive pulmonary disease; CPP, cell penetrating peptide; DCs, dendritic cells; DDVAP, desmopressin acetate; DTPA, diethylene triamine pentaacetic acid; EDTA, ethylene diamine tetraacetic acid; EPD, empirical phase diagrams; EPR, electron paramagnetic resonance; FA, folic acid; FcRn, Fc receptor; FDA, U.S. Food and Drug Administration; GALT, gut-associated lymphoid tissue; GI, gastrointestinal; GIPET, gastrointestinal permeation enhancement technology; GLP-1, glucagon-like peptide 1; GRAS, generally recognized as safe; HBsAg, hepatitis B surface antigen; HPMCP, hydroxypropyl methylcellulose phthalate; IBD, inflammatory bowel disease; ILs, ionic liquids; LBNs, lipid-based nanoparticles; LMWP, low molecular weight protamine; MCT-1, monocarborxylate transporter 1; MSNs, mesoporous silica nanoparticles; NAC, <em>N</em>-acetyl-<span class="small-caps">l</span>-cysteine; NLCs, nanostructured lipid carriers; PAA, polyacrylic acid; PBPK, physiologically based pharmacokinetics; PCA, principal component analysis; PCL, polycarprolacton; PGA, poly-<em>&#x003b3;</em>-glutamic acid; pHPMA, <em>N-</em>(2-hydroxypropyl)methacrylamide; p<em>I</em>, isoelectric point; PLA, poly(latic acid); PLGA, poly(lactic<em>-co-</em>glycolic acid); PPs, proteins and peptides; PVA, poly vinyl alcohol; RGD, Arg-Gly-Asp; RTILs, room temperature ionic liquids; SAR, structure&#x02013;activity relationship; sc, subcutaneous; sCT, salmon calcitonin; SDC, sodium deoxycholate; SGF, simulated gastric fluids; SGC, sodium glycocholate; STC, sodium taurocholate; SIF, simulated intestinal fluids; SLNs, solid lipid nanoparticles; SNAC, sodium <em>N-</em>[8-(2-hydroxybenzoyl)amino]caprylate; SNEDDS, self-nanoemulsifying drug delivery systems; TAT, <em>trans-</em>activating transcriptional peptide; Tf, transferrin; TfR, transferrin receptors; TMC, <em>N-</em>trimethyl chitosan; UC, ulcerative colitis; UEA1, ulex europaeus agglutinin 1; VB12, vitamin B12; WGA, wheat germ agglutinin</span></div></div><div id="abs0015" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0015title">Graphical abstract</h2><!--article-meta--><div><p class="p p-first-last">The current strategies for improving oral absorption of proteins and peptides (PPs) include stabilization, absorption enhancement and mucus-related technologies. Most of marketed oral PP products employ two or more strategies.<!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--></p><div class="fig  iconblock anchored whole_rhythm" id="undfig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232431286544"><img loading="lazy" class="fig-image" alt="Image 1" title="Image 1" src="/pmc/articles/PMC8424290/bin/ga1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140232431286544"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/undfig1/?report=objectonly">Open in a separate window</a></div></div><p></p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">1. Introduction</h2><p id="p0010" class="p p-first">With rapid advancement of biotechnology, more and more proteins and peptides (PPs) have been developed for treatment of various diseases<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a>. The PPs have become one of alternatives of small molecular drugs because they are highly selective and effective, but low toxicity<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a>, which stimulates interests of pharmaceutical industry. The statistical data of <em>Coherent Market Insights</em> revealed the global biologics market was approximately US $ 255.19 billion in 2019 and was expected to be increasing over the forecast period (2019&#x02013;2027) with a compound annual growth rate (CAGR) of 7.6%<a href="#bib3" rid="bib3" class=" bibr popnode"><sup>3</sup></a>. Similarly, biologics, including nucleotides and PPs, account for nearly 30% of all drugs approved by the U.S. Food and Drug Administration (FDA) between 2015 and 2018<a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a>. In addition, more than 90% of the recently approved biologics were monoclonal antibodies (mAbs) based drugs<a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a>.</p><p id="p0015">PPs are constituted of lots of amino acids linked by peptide bonds. Generally, the short chains between two and fifty amino acids are defined as peptides. There are oligopeptides which have less than ten or fifteen amino acids, and polypeptides which have more than fifteen amino acids. It is known as a protein when the chains longer than fifty amino acids<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a>. However, there is still controversy with respect to the use of proteins or peptides, for example, mature human insulin with 51 amino acid is confused to define as proteins or peptides<a href="#bib6" rid="bib6" class=" bibr popnode"><sup>6</sup></a>. Some references have also regarded the peptides as the smaller proteins with molecular mass less than 9000&#x000a0;Da<a href="#bib7" rid="bib7" class=" bibr popnode"><sup>7</sup></a><sup>,</sup><a href="#bib8" rid="bib8" class=" bibr popnode"><sup>8</sup></a>. Therefore, PPs have large variations in molecular size and structure (<a href="/pmc/articles/PMC8424290/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). Besides, PPs have big differences in physicochemical characteristics with chemical drugs. Most of PPs are highly hydrophilic<a href="#bib9" rid="bib9" class=" bibr popnode"><sup>9</sup></a>, but some cyclic peptides exert hydrophobic properties, such as cyclosporine<a href="#bib10" rid="bib10" class=" bibr popnode"><sup>10</sup></a>. Owing to the ionization of amino and carboxyl groups, PPs have isoelectric point (p<em>I</em>) which leads to different charges under different pHs<a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a>. The largest difference with chemical drugs is that the conformation is able to affect the pharmacological activity of PPs absolutely<a href="#bib12" rid="bib12" class=" bibr popnode"><sup>12</sup></a>. Hence, unlike conventional small molecular drugs, it is impossible to develop clinical use of PPs without some sort of sophisticated pharmaceutical technology<a href="#bib13" rid="bib13" class=" bibr popnode"><sup>13</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC8424290/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232423946608"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 1" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232423946608"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Schematic illustration of the molecular size and chemical structures of typical proteins and peptides (the conformational structures of leptin, interferon and ovalbumin are from Wikipedia). The spheres represent the relative size of PPs molecules.</p></div></div></div><p id="p0020">Appropriate administration routes enable not only the therapeutic efficacy of drugs but also patient compliance. However, the administration route of PPs is usually parenteral injection due to their poor oral bioavailability<a href="#bib14" rid="bib14" class=" bibr popnode"><sup>14</sup></a>. The long-term continuous injection could pose a big challenge of medication adherence, including pain, aversion to injections, concerns about needle size and local irritation. Consequently, many scientific groups attempted to develop the alternative routes to deliver the PPs, such as oral, nasal, ophthalmic, buccal and transdermal administration<a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a><sup>,</sup><a href="#bib15" rid="bib15" class=" bibr popnode"><sup>15</sup></a>, among which oral route is the most attractive alternative due to the higher safety and compliance<a href="#bib16" rid="bib16" class=" bibr popnode">16</a>, <a href="#bib17" rid="bib17" class=" bibr popnode">17</a>, <a href="#bib18" rid="bib18" class=" bibr popnode">18</a>. Furthermore, the oral route is able to mimic the physiological fate of the endogenous insulin which could achieve better glucose homeostasis than subcutaneous (sc) injection<a href="#bib6" rid="bib6" class=" bibr popnode"><sup>6</sup></a>. The oral route would enhance the health outcomes for the treatment of certain chronic conditions by improving the living conditions of patients. According to the recent report from allied market research, the global market of oral PPs is expected to grow from US$ 643 million in 2016 to 8.23 billion in 2028<a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a>. In addition, academic efforts are also focused on develop some novel technologies to improve the oral absorption of PPs<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a>. Since 1995, the number of publication about oral delivery of PPs was increasing exponentially (<a href="/pmc/articles/PMC8424290/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>). However, the commercial products of oral proteins and peptides are very limited to some special peptides, such as Neoral&#x000ae; for cyclosporin A and Rybelsus&#x000ae; for semaglutide. The main obstacles to develop the oral delivery systems of PPs include the harsh environments of gastrointestinal (GI) tract, large molecular size, high hydrophilicity, and poor transmembrane permeability<a href="#bib22" rid="bib22" class=" bibr popnode">22</a>, <a href="#bib23" rid="bib23" class=" bibr popnode">23</a>, <a href="#bib24" rid="bib24" class=" bibr popnode">24</a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC8424290/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232416788064"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 2" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232416788064"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Figure&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>Chronological number of publications about oral delivery of PPs by searching Web of Science to Nov. 9th, 2020 using the phrases of &#x0201c;oral AND (absorption OR delivery) AND (protein&#x02217; OR peptide&#x02217;)&#x0201d;.</p></div></div></div><p id="p0025" class="p p-last">To be honest, there are still numerous excellent reviews about oral delivery of PPs, which however have different viewpoints. For instance, there are lots of reviews focused on oral delivery strategies of peptides<a href="#bib7" rid="bib7" class=" bibr popnode"><sup>7</sup></a><sup>,</sup><a href="#bib17" rid="bib17" class=" bibr popnode"><sup>17</sup></a>, while more reviews focused on how nanoparticles improve the oral delivery of PPs<a href="#bib25" rid="bib25" class=" bibr popnode"><sup>25</sup></a><sup>,</sup><a href="#bib26" rid="bib26" class=" bibr popnode"><sup>26</sup></a>. Some big reviews were written from the biologics which include a large amount of irrelative contents with PPs<a href="#bib4" rid="bib4" class=" bibr popnode"><sup>4</sup></a><sup>,</sup><a href="#bib23" rid="bib23" class=" bibr popnode"><sup>23</sup></a>. This review aims to offer a comprehensive overview of the developing history of oral delivery of PPs, the major delivery challenges and the strategies of improving oral absorption, the current technologies in clinical and preclinical phases, as well as the future prospects.</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">2. The history</h2><p id="p0030" class="p p-first-last">Although it is really tough to develop the oral delivery systems of PPs, various attempts have ever not ceased since the discovery of insulin (<a href="/pmc/articles/PMC8424290/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>). Insulin was discovered by Dr. Frederick Banting and Dr. Charles Best in Canada in 1921 and developed by collaborators in the United States and Europe<a href="#bib18" rid="bib18" class=" bibr popnode"><sup>18</sup></a>. Only after one year, the first attempt of oral delivery of insulin was conducted in 1922<a href="#bib27" rid="bib27" class=" bibr popnode"><sup>27</sup></a>, which opened preclude to develop oral formulations of PPs. Unfortunately, the results of the first attempt were negative, which makes the critical challenges of oral protein delivery become apparent. Therefore, it is necessary to employ novel delivery technologies to facilitate the oral absorption of PPs. The first paper about oral delivery of insulin was published in 1923<a href="#bib28" rid="bib28" class=" bibr popnode"><sup>28</sup></a>, in which alcohol was used to improve the oral absorption of insulin. Edgar A. Ferguson firstly tried to mix anhydroformaldehyde-aniline with insulin as oral absorption enhancer and won the first patent of oral formulation of insulin in 1965<a href="#bib29" rid="bib29" class=" bibr popnode"><sup>29</sup></a>. With the deep research of oral insulin, more and more scientists and companies kept eyes on other PPs drugs. In 1990, Sandimmune&#x000ae; approved by FDA was the first oral formulation of cyclosporin A which is a cyclic peptide with molecular weight of 1202 and also recognized as the first oral dosage form of peptides though it is usually sorted into poorly soluble drugs. After 5 years, the improved formulation of cyclosporin A, Neoral&#x000ae;, was developed by Novartis and approved. Henceforth, self-nanoemulsifying drug delivery systems (SNEDDS) were regarded as an important strategy for improving oral absorption of drug molecules<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a>. However, SNEDDS was not able to increase the oral bioavailability of hydrophilic PPs to large extent. Lots of companies have claimed to develop new delivery technologies to overcome the barriers of oral PPs. Nevertheless, some companies have vanished or been not interested in this field currently, such as AutoImmune, Biosante, Coremed, Coretecs, Eligen, Nobex and Protein Delivery. Five companies are always working on oral insulin for many years and have established some platforms, including Emishphere in USA, Biocon in India, Diabetology in UK, Diasome in USA and Oramed in Israel<a href="#bib27" rid="bib27" class=" bibr popnode"><sup>27</sup></a>. The first oral insulin formulation by Emisphere was allowed to conduct phase I clinical trials by FDA in 2001. In 2006, a 90-day double-blind phase II clinical study in India performed by Emisphere showed no significant differences from placebo. But the pace of development of oral insulin does not stop. In 2014, ORMD-0801 developed by Oramed was approved to perform phase III clinical trials by FDA<a href="#bib30" rid="bib30" class=" bibr popnode"><sup>30</sup></a>. Emisphere developed an enhancer, SNAC (sodium <em>N-</em>[8-(2-hydroxybenzoyl)amino]caprylate)<a href="#bib31" rid="bib31" class=" bibr popnode"><sup>31</sup></a>, for improving oral delivery of insulin, which has been finally used to improve the oral absorption of sermaglutide. In 2019, Rybelsus&#x000ae;, an oral formulation of semaglutide developed by Novo Nordisk, was approved by FDA for treatment of type II diabetes. Subsequently, the sustained release capsule of octreotide (Mycapssa&#x000ae;) developed through transient permeability enhancer (TPE&#x000ae;) technology was also approved by FDA in 2020. These two successful oral products of peptides would bring about revolutionary changes in clinical administration of PPs and accelerate the development of oral delivery systems of PPs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC8424290/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232422009680"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 3" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232422009680"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Figure&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>The historical major events in the development of oral delivery systems of PPs.</p></div></div></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">3. The barriers to the oral absorption of PPs</h2><p id="p0035" class="p p-first">Though the oral delivery of PPs has attracted enormous interests of the pharmaceutical companies and the funding agencies, there are lots of factors impeding the development of oral PPs, such as instability in GI tract, poor permeability across intestinal epithelia and difficulty in development of formulation. The physiological barriers are the major obstacles to hinder the oral absorption of PPs due to the innate nature of GI tract which is not only the major position of food digestion and nutrient uptake but also is the first line defense against toxins and pathogens. Thus, it is necessary to fully understand the physiological and formulation factors for overcoming barriers of oral delivery of PPs.</p><div id="sec3.1" class="sec"><h3 id="sec3.1title">3.1. The physiological barriers</h3><p id="p0040" class="p p-first">After oral administration, drugs suffer from gastric fluids firstly in stomach and then move into small intestine where most of drugs are absorbed. However, it is absolutely different of environments between stomach and intestines, including pH, enzymes, mucus and even epithelial permeability (<a href="/pmc/articles/PMC8424290/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>), all of which influence the stability and absorption of PPs<a href="#bib32" rid="bib32" class=" bibr popnode"><sup>32</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC8424290/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232423758320"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 4" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232423758320"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Figure&#x000a0;4</a></div><!--caption a7--><div class="caption"><p>Schematic representation of physiological barriers in GI tract. PPs are prone to be degraded in harsh environments of gastrointestinal tract including pH gradient and various enzymes in lumen, which is stability challenge for oral delivery of PPs. In addition, most of PPs are hardly to transport across mucus layer and epithelial layer, which is permeability challenge.</p></div></div></div><div id="sec3.1.1" class="sec"><p></p><h4 id="sec3.1.1title" class="inline">3.1.1.  pH gradient </h4><p id="p0045" class="p p-first-last">The GI pH is absolutely different in each region of GI tract and influenced by various factors including presence of food, pathological conditions, even age and gender. Generally, in the healthy adult, the pH of gastric fluids is acidic (pH 1.5&#x02013;3.5), and rises to around pH 5&#x02013;6 in the duodenum due to neutralization of carbonate and bile juices, and then increases to pH 7&#x02013;8 in the distal jejunum and ileum, while the colonic pH could be more than 8 or drop to pH 6 with high interindividual variability<a href="#bib33" rid="bib33" class=" bibr popnode"><sup>33</sup></a><sup>,</sup><a href="#bib34" rid="bib34" class=" bibr popnode"><sup>34</sup></a>. The age growth is almost no effect on GI pH<a href="#bib35" rid="bib35" class=" bibr popnode"><sup>35</sup></a>, which indicates the GI pH condition could maintain relative stable in whole life. However, The gastric pH is high shortly after birth, and rapidly reduces to pH 1 to 3<a href="#bib36" rid="bib36" class=" bibr popnode"><sup>36</sup></a>. The intake of food would influence the GI pH transiently, such as elevation of gastric pH<a href="#bib37" rid="bib37" class=" bibr popnode"><sup>37</sup></a>. In addition, the personal diet custom could be an important reason of individual variability in colonic pH. The GI pH could be changed by diseases significantly, such as inflammatory bowel disease (IBD) and GI cancers. The colonic pH in IBD patients differs from healthy adults and is characterized with big individual variability, but the general trend of pH was becoming more acidic. The average colonic pH was detected to be 5.3 in patients with Crohn's disease (CD)<a href="#bib38" rid="bib38" class=" bibr popnode"><sup>38</sup></a>, while could even drop to 2&#x02013;3 in patients under active ulcerative colitis (UC)<a href="#bib39" rid="bib39" class=" bibr popnode"><sup>39</sup></a>. The GI local cancers could change the pH environment to a large extent. For example, the gastric pH was detected to be around 6&#x02013;7 in 89 gastric cancer patients<a href="#bib40" rid="bib40" class=" bibr popnode"><sup>40</sup></a>, which could be caused by reduction of secretion of gastric acid. The complicated pH environments in GI tract could lead to conformational alteration or enzymatic degradation of PPs, resulting in the loss of therapeutic efficacy. The extreme pHs could result in unfolding due to increase of electrostatic repulsions. Generally, proteins are stable in a narrow pH range which is not far away from their p<em>I</em>, such as pH 6.5&#x02013;7.0 for recombinant factor VIII SQ (FVIII SQ)<a href="#bib41" rid="bib41" class=" bibr popnode"><sup>41</sup></a>. Thus, some proteins could be inactive in gastric fluids due to pH induced unfolding. What's more, the activity of enzymes is dependent on pH, for example, pepsin can exert the strongest ability of degradation in pH 2&#x02013;3, but be inactive completely in pH above 5<a href="#bib32" rid="bib32" class=" bibr popnode"><sup>32</sup></a>. Most PPs are degraded very fast in stomach of healthy adult<a href="#bib42" rid="bib42" class=" bibr popnode"><sup>42</sup></a>.</p></div><div id="sec3.1.2" class="sec"><p></p><h4 id="sec3.1.2title" class="inline">3.1.2.  Enzymes </h4><p id="p0050" class="p p-first-last">PPs are highly susceptible to various proteolytic enzymes including luminal enzymes from gastrointestinal and pancreatic secretions, bacterial enzymes in the colon and mucosal enzymes<a href="#bib43" rid="bib43" class=" bibr popnode"><sup>43</sup></a>. They are primarily degraded by luminal enzymes (<a href="/pmc/articles/PMC8424290/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a><a href="#bib44" rid="bib44" class=" bibr popnode"><sup>44</sup></a><sup>,</sup><a href="#bib45" rid="bib45" class=" bibr popnode"><sup>45</sup></a>) before penetration across mucus. The entry of the protein could stimulate the gastric mucosa to secret pepsins by the cells lining the stomach. Pepsin is able to degrade proteins into smaller fragments of peptides by hydrolyzing the peptide bonds<a href="#bib46" rid="bib46" class=" bibr popnode"><sup>46</sup></a>. A great deal of proteolytic enzymes in the upper part of the small intestine are secreted by pancreas, such as trypsin, chymotrypsin, carboxypeptidase and elastase<a href="#bib47" rid="bib47" class=" bibr popnode"><sup>47</sup></a>. Moreover, the remaining parts of the proteins are finally digested by various peptidases (<em>e.g.</em>, aminopeptidase and dipeptidase) in brush border membrane into tripeptides, dipeptides and respective amino acids that are able to be absorbed into the blood capillaries from epithelium<a href="#bib48" rid="bib48" class=" bibr popnode"><sup>48</sup></a>. However, most degradation data of PPs were obtained by <em>in&#x000a0;vitro</em> simulated gastric or intestinal fluids with specific enzymes which are hard to be same activity as <em>in&#x000a0;vivo</em> condition. For example, the pH 1.2 hydrochloride solution with 0.32% pepsin and the pH 6.8 phosphate buffer with 1% trypsin were often used to evaluate the stability of PPs <em>in&#x000a0;vitro</em><a href="#bib47" rid="bib47" class=" bibr popnode"><sup>47</sup></a>. Most proteins can be degraded very fast in simulated gastric fluids (SGF), such as no insulin detected after 30&#x000a0;min incubation with SGF<a href="#bib49" rid="bib49" class=" bibr popnode"><sup>49</sup></a><sup>,</sup><a href="#bib50" rid="bib50" class=" bibr popnode"><sup>50</sup></a>. Through comparison of human or pig GI fluids and simulated GI fluids, Wang et&#x000a0;al.<a href="#bib51" rid="bib51" class=" bibr popnode"><sup>51</sup></a> found there were good correlation between SGF and both human and pig gastric fluids for the stability of peptides, while the rate of peptide degradation in simulated intestinal fluids (SIF) was more rapid than that in human or pig intestinal fluids. What's more, there is a very interesting result that only 3 of 17 peptides left in human intestinal fluids after 30&#x000a0;min incubation. These 3 peptides are respectively cyclosporin (99%), desmopressin (25%) and octreotide (22%) which are all developed as oral therapeutic products named as Neoral&#x000ae;, Minrin&#x000ae; and Mycapssa&#x000ae;<a href="#bib51" rid="bib51" class=" bibr popnode"><sup>51</sup></a>. Therefore, it is the one of important prerequisites for successful development of oral PPs to protect the stability of PPs in GI tract.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Main digestive enzymes that degrade PPs along with their sites of action<a href="#bib44" rid="bib44" class=" bibr popnode"><sup>44</sup></a><sup>,</sup><a href="#bib45" rid="bib45" class=" bibr popnode"><sup>45</sup></a>.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Secretion site</th><th rowspan="1" colspan="1">Enzyme</th><th rowspan="1" colspan="1">Specificity</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Stomach</td><td rowspan="1" colspan="1">Pepsin</td><td rowspan="1" colspan="1">Asp, hydrophobic amino acids</td></tr><tr><td rowspan="5" colspan="1">Pancreas</td><td rowspan="1" colspan="1">Trypsin</td><td rowspan="1" colspan="1">Arg, Lys</td></tr><tr><td rowspan="1" colspan="1">Chymotrypsin</td><td rowspan="1" colspan="1">Aliphatic amino acids (Phe, Tyr)</td></tr><tr><td rowspan="1" colspan="1">Carboxypeptidase A</td><td rowspan="1" colspan="1">Aromatic amino acids in C-terminal (Tyr, Phe, Ile, Thr, Glu, His, Ala)</td></tr><tr><td rowspan="1" colspan="1">Carboxypeptidase B</td><td rowspan="1" colspan="1">Arg, Lys in C-terminal</td></tr><tr><td rowspan="1" colspan="1">Elastase</td><td rowspan="1" colspan="1">Ala, Gly, Ser</td></tr><tr><td rowspan="13" colspan="1">Small intestine</td><td rowspan="1" colspan="1">Aminopeptidase A</td><td rowspan="1" colspan="1">Asp, Glu in N-terminal</td></tr><tr><td rowspan="1" colspan="1">Aminopeptidase N</td><td rowspan="1" colspan="1">Ala, Leu in N-terminal</td></tr><tr><td rowspan="1" colspan="1">Aminopeptidase P</td><td rowspan="1" colspan="1">Pro in N-terminal</td></tr><tr><td rowspan="1" colspan="1">Aminopeptidase W</td><td rowspan="1" colspan="1">Typ, Tyr, Phe in N-terminal</td></tr><tr><td rowspan="1" colspan="1"><em>&#x003b3;</em>-Glutamyl transpeptidase</td><td rowspan="1" colspan="1"><em>&#x003b3;</em>-Glutamic acid in N-terminal</td></tr><tr><td rowspan="1" colspan="1">Dipeptidyl peptidase IV</td><td rowspan="1" colspan="1">Pro, Ala</td></tr><tr><td rowspan="1" colspan="1">Peptidylpeptidase A</td><td rowspan="1" colspan="1">His&#x02013;Leu</td></tr><tr><td rowspan="1" colspan="1">Carboxypeptidase M</td><td rowspan="1" colspan="1">Lys, Arg in C-terminal</td></tr><tr><td rowspan="1" colspan="1">Carboxypeptidase P</td><td rowspan="1" colspan="1">Pro, Gly, Ala in C-terminal</td></tr><tr><td rowspan="1" colspan="1"><em>&#x003b3;</em>-Glutamyl carboxypeptidase</td><td rowspan="1" colspan="1"><em>&#x003b3;</em>-Glutamic acid</td></tr><tr><td rowspan="1" colspan="1">Endopeptidase-24.11</td><td rowspan="1" colspan="1">Hydrophobic amino acids</td></tr><tr><td rowspan="1" colspan="1">Endopeptidase-24.18</td><td rowspan="1" colspan="1">Aromatic amino acids</td></tr><tr><td rowspan="1" colspan="1">Enteropeptidase</td><td rowspan="1" colspan="1">(Asp)<sub>4</sub>-Lys</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232420132672"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl1/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec3.1.3" class="sec"><p></p><h4 id="sec3.1.3title" class="inline">3.1.3.  Mucus </h4><p id="p0055" class="p p-first">Mucus is a sticky and viscoelastic gel layer covering the entire GI tract. It is secreted by the goblet cells. Mucus can capture the foreign moieties and protect epithelia from the attack of exogenous pathogens<a href="#bib52" rid="bib52" class=" bibr popnode"><sup>52</sup></a>. The mucus in whole GI tract is composed of two layers including loosely and firmly adherent mucus layer from lumen to epithelia (<a href="/pmc/articles/PMC8424290/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>). The thickness of mucus layer varies significantly in different GI regions. Taking rat GI tract as an example, it ranges from 200&#x000a0;&#x003bc;m in upper part to 800&#x000a0;&#x003bc;m in lower part of GI tract<a href="#bib53" rid="bib53" class=" bibr popnode"><sup>53</sup></a>. In humans, the thickest mucus layers are also located on the stomach (180&#x000a0;&#x003bc;m) and the colon (110&#x02013;160&#x000a0;&#x003bc;m)<a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a>. The components of mucus are very complex. The mucin glycoprotein is the major functional constituent and the other components include carbohydrates, proteins, lipids, salts, immunoglobulins, bacteria and cellular remnants<a href="#bib55" rid="bib55" class=" bibr popnode"><sup>55</sup></a>. Mucins, including secreted and cell-bound types, are at least twenty subtypes encoded by the <em>MUC</em> genes. There are three secreted mucin types found in the GI tract, such as <em>MUC2</em>, <em>MUC5AC</em> and <em>MUC6</em><a href="#bib56" rid="bib56" class=" bibr popnode"><sup>56</sup></a>. The interactions between mucins make mucus gel layer viscoelastic, however, the viscoelasticity could be influenced by water, lipid or ion content<a href="#bib57" rid="bib57" class=" bibr popnode"><sup>57</sup></a><sup>,</sup><a href="#bib58" rid="bib58" class=" bibr popnode"><sup>58</sup></a>. What's more, there is a pH gradient across whole mucus layer, especially gastric mucosa. The gastric mucus pH on the luminal surface is about 1&#x02013;2 which is similar as gastric pH, but increases to neutral pH at the epithelial surface<a href="#bib59" rid="bib59" class=" bibr popnode"><sup>59</sup></a>. This pH gradient could be main mechanism to protect gastric epithelial cell against digestion of pepsin.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig5" co-legend-rid="lgnd_fig5"><a href="/pmc/articles/PMC8424290/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232468449392"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 5" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232468449392"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig5"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5">Figure&#x000a0;5</a></div><!--caption a7--><div class="caption"><p>Schematic illustration of the mucus layers covering GI tract. Mucus layer is composed of two layers including outer mucus layer which is loosely adherent and inner mucus layer which is firmly adherent on epithelia. The mucus depth varies with GI sites (A). Outer mucus layer is cleared more rapidly than inner mucus layer (B). Reprinted with the permission from Ref.&#x000a0;<a href="#bib54" rid="bib54" class=" bibr popnode">54</a>. Copyright &#x000a9; 2012 Elsevier.</p></div></div></div><p id="p0060" class="p p-last">The mucus exerts multiple barriers against the transport of drugs into the submucosal tissue. The high viscosity decreases the diffusivity of PPs through mucus, which directly affects the residence time of PPs in the small intestine<a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a>. In the intestine, the average mucus turnover time is around 50&#x02013;270&#x000a0;min resulting in the removal of trapped particles in the mucus layer thereby, limiting the adhesion and holding time of the particles or PPs<a href="#bib60" rid="bib60" class=" bibr popnode"><sup>60</sup></a>. The continuous secretion and replacement of mucus make it quite challenging for the PPs passing through the unstirred mucous layer by infiltration before reaching the surface of the epithelium. Greater interaction through electrostatic force may exist between mucin and drug particles which may be attributed to the fact that mucin is highly negatively charged due to the glycosylation of serine, and the presence of threonine and proline domain<a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a>. Furthermore, mucins may function as a size-exclusion filter lowering the mobility of large compounds like proteins due to their brush-like scaffold structure<a href="#bib61" rid="bib61" class=" bibr popnode"><sup>61</sup></a><sup>,</sup><a href="#bib62" rid="bib62" class=" bibr popnode"><sup>62</sup></a>. What's more, structural modification of proteins or entrapment of particles might occur due to the fact that mucin fibers interact non-covalently with proteins or particles <em>via</em> van der Waals and electrostatic forces, hydrogen bonding, and hydrophobic interactions<a href="#bib64" rid="bib64" class=" bibr popnode">64</a>, <a href="#bib65" rid="bib65" class=" bibr popnode">65</a>, <a href="#bib66" rid="bib66" class=" bibr popnode">66</a>, thus hindering their absorption.</p></div><div id="sec3.1.4" class="sec"><p></p><h4 id="sec3.1.4title" class="inline">3.1.4.  Epithelial barriers </h4><p id="p0065" class="p p-first">The epithelial cells lying beneath the mucus also act as another predominant restrictions towards oral protein drug delivery. The intestinal epithelia include various types of cells with specific functions, such as enterocytes for absorption, goblet cells for secretion of mucus, paneth cells for secretion of enzymes and M cells for transporting foreign particles<a href="#bib63" rid="bib63" class=" bibr popnode"><sup>63</sup></a>. The enterocytes are the major absorptive cells and also comprise around 90% of intestinal epithelium<a href="#bib64" rid="bib64" class=" bibr popnode"><sup>64</sup></a>. A continuous monolayer is formed by these polarized epithelial cells, separating the intestinal lumen from the underlying lamina propria. The tight junctions (TJs), found between two neighboring epithelial cells, make the intestinal epithelium impermeable and a gatekeeper to macromolecules<a href="#bib65" rid="bib65" class=" bibr popnode"><sup>65</sup></a><sup>,</sup><a href="#bib66" rid="bib66" class=" bibr popnode"><sup>66</sup></a>. TJs are elaborate networks formed by multiprotein junctional complexes, which is composed of peripheral membrane proteins like zonula occludens (ZO-1, ZO-2), transmembrane integral proteins like claudins, junctional adhesion molecules and regulatory proteins as well<a href="#bib67" rid="bib67" class=" bibr popnode"><sup>67</sup></a>. Except for normal intestinal epithelium, there are some discontinuous follicle-associated epithelia (FAE) which is featured by few mucus, and the location of M cells, numerous intra-epithelial lymphocytes and macrophages<a href="#bib68" rid="bib68" class=" bibr popnode"><sup>68</sup></a>. M cells are the most important epithelial cell types involved in the uptake and transport of a wide variety of particulates including intestinal antigens and large proteins, and thus recognized as immune cells of intestinal lumen<a href="#bib69" rid="bib69" class=" bibr popnode"><sup>69</sup></a>.</p><p id="p0070" class="p p-last">The intestinal absorption of drugs is primarily dependent on transcellular pathway, while paracellular pathway is the main route of some small hydrophilic molecules<a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a>. According to Lipinksi &#x0201c;Rule of 5&#x0201d;<a href="#bib70" rid="bib70" class=" bibr popnode"><sup>70</sup></a>, PPs are predicted to be extremely low transcellular permeability because Log<em>P</em> of PPs is likely to be below &#x02212;1 that is far lower than 5, and PPs have a great number of hydrogen bond donors or acceptors, and molecular weight is far more than 500&#x000a0;Da. Thus, PPs are hard to be absorbed into portal vein by transcellular pathway. Moreover, the paracellular route refers to the passage of drugs through water-filled pores of TJs, the pore sizes of which usually range between 3 and 10&#x000a0;&#x000c5;<a href="#bib71" rid="bib71" class=" bibr popnode"><sup>71</sup></a>. The molecules larger than 500&#x000a0;Da are generally not recognized to be able to move through these small pores<a href="#bib72" rid="bib72" class=" bibr popnode"><sup>72</sup></a>. TJs can be regulated by some permeation enhancers, which makes pores larger<a href="#bib73" rid="bib73" class=" bibr popnode"><sup>73</sup></a>. However, the width is still less than 20&#x000a0;nm even in fully opened state and the total surface of water filled pores only account for 0.01%&#x02013;0.1% of entire intestinal epithelia<a href="#bib74" rid="bib74" class=" bibr popnode"><sup>74</sup></a>. Therefore, the oral bioavailability of PPs is still extremely low even though the intestinal permeation enhancers have been added in formulation, such as transient permeability enhancer (TPE&#x000ae;) and SNAC<a href="#bib18" rid="bib18" class=" bibr popnode"><sup>18</sup></a><sup>,</sup><a href="#bib75" rid="bib75" class=" bibr popnode"><sup>75</sup></a>. Compared with normal epithelia, lumen antigens, macromolecules and pathogenic particles are transported effectively and rapidly by M cells from the lumen to the underlying gut-associated lymphoid tissue (GALT) <em>via</em> pinocytosis and phagocytosis<a href="#bib76" rid="bib76" class=" bibr popnode"><sup>76</sup></a>, which looks a favorable route for oral delivery of PPs. However, the numbers of M cell are very limited in human intestines, accounting for less than 1%<a href="#bib77" rid="bib77" class=" bibr popnode"><sup>77</sup></a>. In addition, some endogenous PPs transported by M cells may stimulate the immune responses<a href="#bib78" rid="bib78" class=" bibr popnode"><sup>78</sup></a>.</p></div><div id="sec3.1.5" class="sec sec-last"><p></p><h4 id="sec3.1.5title" class="inline">3.1.5.  Inter-individual variability </h4><p id="p0075" class="p p-first-last">The tremendous inter-individual variability is also a barrier to limit the development of oral PPs. Inter-individual variability in the anatomical and physiological properties of humans and animals is a common sense. For oral delivery, the inter-individual variability in the physiology of GI tract has significantly affected the bioavailability of oral PPs, such as the condition of mucus, the secretion of enzymes and gut motility<a href="#bib79" rid="bib79" class=" bibr popnode"><sup>79</sup></a>. Especially in some disease states, the inter-individual variability is more evident. For example, gastric emptying and oesophageal motility have shown large variability in type 2 diabetic patients with different stages<a href="#bib80" rid="bib80" class=" bibr popnode"><sup>80</sup></a>. The variability in gut mobility could be particularly relevant to the difference in absorption rate of PPs, such as insulin for diabetes<a href="#bib80" rid="bib80" class=" bibr popnode"><sup>80</sup></a>. Moreover, the pH and the expression of digestive enzymes in GI tract vary with individuals significantly, which leads to the inter-individual variability of degradation of PPs in GI tract. The relevant transporters potentially contribute to the extent and rate of transmucosal absorption of PPs, but the expression of transporters in the intestinal epithelia is dependent on individual genes<a href="#bib81" rid="bib81" class=" bibr popnode"><sup>81</sup></a>. In addition, most of PPs are endogenous substances for regulating the physiological factors, but some physiological factors can also be influenced by other endogenous PPs. For example, glucose level can be regulated by insulin and glucagon simultaneously. The inter-individual variability of glucagon secretion also cause the differential hypoglycemic effect of oral insulin in different patients or animals<a href="#bib82" rid="bib82" class=" bibr popnode"><sup>82</sup></a>. Therefore, it is necessary to establish some models to evaluate the inter-individual variability of oral PPs for clinical development, such as physiologically based pharmacokinetics (PBPK) modelling<a href="#bib83" rid="bib83" class=" bibr popnode"><sup>83</sup></a>.</p></div></div><div id="sec3.2" class="sec sec-last"><h3 id="sec3.2title">3.2. Formulation factors</h3><p id="p0080" class="p p-first">Except for physiological barriers, formulation is also a great challenge during the development of oral PPs commercial products. The chemical and physical stability of PPs are the most important considerations in formulation development, which aims to enable stability of PPs in manufacturing processes, transportation, storage and administration. There have been some excellent reviews to summarize the formulation factors influencing stability of PPs<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>, <a href="#bib85" rid="bib85" class=" bibr popnode">85</a>, <a href="#bib86" rid="bib86" class=" bibr popnode">86</a>, <a href="#bib87" rid="bib87" class=" bibr popnode">87</a>, especially for parenteral formulations. Unlike small molecular drugs, the major stability of PPs is generally referred to as their conformational integrity which is dominated by hydrophobic interaction, hydrogen bonding and electrostatic interaction<a href="#bib88" rid="bib88" class=" bibr popnode"><sup>88</sup></a><sup>,</sup><a href="#bib89" rid="bib89" class=" bibr popnode"><sup>89</sup></a>. The formulation pH could change the protein's surface charge, density and distribution, which could cause the alteration of conformation of PPs<a href="#bib90" rid="bib90" class=" bibr popnode"><sup>90</sup></a>. Meanwhile, the pH can also influence the colloidal stability of PPs and then changes the rate of protein aggregation and degradation<a href="#bib91" rid="bib91" class=" bibr popnode"><sup>91</sup></a><sup>,</sup><a href="#bib92" rid="bib92" class=" bibr popnode"><sup>92</sup></a>. Ionic strength also affects the physical stability of PPs in solution as pH<a href="#bib93" rid="bib93" class=" bibr popnode"><sup>93</sup></a>. For example, the increase of salts could improve the aggregation of proteins due to enhanced hydrophobic interactions<a href="#bib94" rid="bib94" class=" bibr popnode"><sup>94</sup></a>. Hence, buffer solutions are usually employed to stabilize PPs in solution formulation. In addition, some excipients are very necessary to be added in formulation to improve solubility or suppress aggregation of proteins, such as arginine, histidine, glycine and so on<a href="#bib95" rid="bib95" class=" bibr popnode"><sup>95</sup></a>. Arginine can reduce aggregation of proteins to stabilize the proteins' structure<a href="#bib96" rid="bib96" class=" bibr popnode"><sup>96</sup></a>. The surfactant is also generally used to stabilize proteins through reducing molecular interactions in different interfaces, such as polysorbate<a href="#bib97" rid="bib97" class=" bibr popnode"><sup>97</sup></a>. Chemical instability of PPs involves in product development, manufacturing and even post-administration. Oxidation is the most common factor inducing instability of PPs with residues of methionine, tryptophan, histidine, cysteine, phenylalanine or tyrosine<a href="#bib98" rid="bib98" class=" bibr popnode"><sup>98</sup></a>, which could be hindered by anti-oxidants including methionine and ascorbic acid. However, enzymatic degradation is the biggest challenge in protecting PPs in GI environments after oral administration as described in Section <a href="#sec3.1.2" rid="sec3.1.2" class=" sec">3.1.2</a>. Most oral formulations are primarily to protect stability of PPs in GI tract against various digestive enzymes, such as enteric coating, encapsulation and enzymatic inhibitors, which will be described in detail in Section <a href="#sec4.1" rid="sec4.1" class=" sec">4.1</a>. In order to enhance epithelial permeability, some permeation enhancers are added in oral formulations, such as SNAC, bile salts and non-ionic surfactants (Section <a href="#sec4.3.2" rid="sec4.3.2" class=" sec">4.3.2</a>).</p><p id="p0085" class="p p-last">Excipients can reduce the molecular interactions between PPs to avoid aggregations, but the interactions between PPs and excipients can also not be ignored. Understanding the protein&#x02013;excipient interactions is indispensable to better design stable formulations of PPs. There is an excellent review to fully sum up the protein&#x02012;excipient interactions in liquid formulations including mechanism and characterization<a href="#bib99" rid="bib99" class=" bibr popnode"><sup>99</sup></a>. Owing to the complexity of PPs molecules, multiple interactions involved between PPs and excipients, such as electrostatic interactions, hydrogen bonding, preferential hydration and dispersive forces, which can be characterized by various technologies including Raman spectroscopy, circular dichroism, fluorescence, nuclear magnetic resonance, scanning probe microscopy and electron paramagnetic resonance (EPR) spectroscopy, and some advance numerical analysis methods including principal component analysis (PCA) and empirical phase diagrams (EPD). For example, most of amino acids are able to stabilize proteins in liquid formulation through preferential hydration or direct binding<a href="#bib100" rid="bib100" class=" bibr popnode"><sup>100</sup></a>, while sugars and carbohydrates can stabilize protein in solid state with the combining effect of specific interactions and formation of highly viscous glassy matrices<a href="#bib101" rid="bib101" class=" bibr popnode"><sup>101</sup></a>. In PPs formulations, some polymers and non-ionic surfactants are usually used to increase the stability. The non-ionic surfactants can compete the hydrophobic surface with protein molecules to avoid adsorbing-induced denaturation<a href="#bib102" rid="bib102" class=" bibr popnode"><sup>102</sup></a>. Some polymers are employed to encapsulate PPs for improving the stability or controlling the release. But the hydrophobic domain and charges of polymers can influence the stability of PPs, such as aggregation or adsorption<a href="#bib103" rid="bib103" class=" bibr popnode"><sup>103</sup></a><sup>,</sup><a href="#bib104" rid="bib104" class=" bibr popnode"><sup>104</sup></a>.</p></div></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">4. Current strategies towards enhancement of the oral absorption of PPs</h2><p id="p0090" class="p p-first">Despite multiple strategies to increase the oral absorption of PPs, the primary principles are based on three aspects including stabilization, mucus penetration or adhesion, and permeation enhancer (<a href="/pmc/articles/PMC8424290/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>). These approaches are commonly integrated into one delivery system together.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig6" co-legend-rid="lgnd_fig6"><a href="/pmc/articles/PMC8424290/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232422178272"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr6.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 6" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr6.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232422178272"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig6"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6">Figure&#x000a0;6</a></div><!--caption a7--><div class="caption"><p>Flow chart of the general considerations in enhancement of oral bioavailability of PPs. There are various technologies based on three rationales including stabilization, absorption enhancement and mucus-related technologies.</p></div></div></div><div id="sec4.1" class="sec"><h3 id="sec4.1title">4.1. Stabilization</h3><p id="p0095" class="p p-first">Based on physiological and formulation factors, the stability of PPs after oral administration is primarily affected by pH and enzymes in GI tract. In addition, the structure of peptides influences their stability significantly. This section explores the stabilization strategies for oral PPs which have been widely used in formulation development.</p><div id="sec4.1.1" class="sec"><p></p><h4 id="sec4.1.1title" class="inline">4.1.1.  pH modulation </h4><p id="p0100" class="p p-first-last">The GI enzymes are the main sources to degrade oral PPs, but they need optimal pH to exert their effect. For example, pepsin can cleaves multiple proteins or peptides readily in the acidic environment, however, pepsin starts to lose their effect when the pH is over 3<a href="#bib105" rid="bib105" class=" bibr popnode"><sup>105</sup></a>. Therefore, if we can modify the pH of microenvironment to 5, PPs can be protected against degradation in stomach. Nevertheless, enteric coating is generally used to overcome the degradation of PPs in stomach rather than pH modulation due to simpler formulation<a href="#bib106" rid="bib106" class=" bibr popnode"><sup>106</sup></a>. Unfortunately, the proteolytic enzymes in the small intestine are also proficient at degradation of PPs. Similarly, these enzymes are also dependent on pH environment. Luminal proteases, such as trypsin and chymotrypsin, exhibit maximum activity at pH&#x000a0;&#x02265;&#x000a0;6.5<a href="#bib107" rid="bib107" class=" bibr popnode"><sup>107</sup></a>. Therefore, adjusting the pH of the intestinal contents has become an efficient approach to protect PPs in intestine. Some organic acids, such as citric acid, have been generally used as pH-lowering agents to inhibit the activity of intestinal enzymes<a href="#bib108" rid="bib108" class=" bibr popnode"><sup>108</sup></a>. It has been proven that co-administration of citric acid and salmon calcitonin (sCT) is able to enhance the oral absorption of sCT in beagle dogs by reducing the activity of pancreatic serine protease trypsin<a href="#bib109" rid="bib109" class=" bibr popnode"><sup>109</sup></a>. In addition, Tarsa Therapeutics (Philadelphia, USA) has successfully completed a phase III trial for oral delivery of sCT (ORACAL&#x000ae;) which comprises of an enteric coated capsule to bypass the stomach and citric acid to modulate the pH microenvironment in intestine<a href="#bib110" rid="bib110" class=" bibr popnode"><sup>110</sup></a>.</p></div><div id="sec4.1.2" class="sec"><p></p><h4 id="sec4.1.2title" class="inline">4.1.2.  Enzymatic inhibitors </h4><p id="p0105" class="p p-first">Except for pH modulation, the most important approach for inhibiting enzymes is using enzyme inhibitors. Enzyme inhibitors inactivate the target enzymes by binding to the specific site of the enzyme reversibly or irreversibly<a href="#bib111" rid="bib111" class=" bibr popnode"><sup>111</sup></a>. There are multiple categories of enzyme inhibitors including non-amino acids, amino acids and modified amino acids, peptides and modified peptides. Many chemical molecules can inhibit the activity of enzymes, such as cholic acids and their derivatives, diisopropyl fluorophosphates<a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a><sup>,</sup><a href="#bib112" rid="bib112" class=" bibr popnode"><sup>112</sup></a>. However, these chemical molecules are rarely used due to their high toxicity. Besides, they could be absorbed faster than PPs itself due to low mass, leading to systemic side effects and loss of inhibition capacity. Amino acids and modified amino acids have the same problems as chemical inhibitors<a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a>. Hence, peptides and modified peptides derived enzymatic inhibitors have been extensively studied, such as aprotinin inhibiting trypsin and chymotrypsin and soybean trypsin inhibiting pancreatic endopeptidases. However, it is noteworthy that long duration administration of such enzymatic inhibitors could result in the deficiency of these enzymes in humans. The chicken and duck ovomucoids are recently developed and recognized as safer. They can efficiently inhibit the activity of <em>&#x003b1;</em>-chymotrypsin and trypsin and offer 100% protection for insulin<a href="#bib113" rid="bib113" class=" bibr popnode"><sup>113</sup></a>.</p><p id="p0110" class="p p-last">The enzymatic inhibitors have been extensively used in clinically developing products. For instance, soybean trypsin inhibitor and chelating agent which is a cofactor for many proteases have been used in ORMD-0801 (developed by Oramed) as a formulation component for oral delivery of insulin<a href="#bib114" rid="bib114" class=" bibr popnode"><sup>114</sup></a>. The Chronotropic&#x02122; platform technologies developed by Dexcel Pharma Technologies, Ltd. (Jerusalem, Israel) combine the protease inhibitor (camostat mesilate) and absorption enhancer (sodium glycocholate) to improve the oral bioavailability of insulin<a href="#bib115" rid="bib115" class=" bibr popnode"><sup>115</sup></a>. However, we have to consider their toxicities which are caused by high concentration and long duration.</p></div><div id="sec4.1.3" class="sec"><p></p><h4 id="sec4.1.3title" class="inline">4.1.3.  Enteric coating and colon-specific delivery </h4><p id="p0115" class="p p-first">The enteric coating can prevent the drug release in stomach but permit the drug release in the small intestine due to the dissolution of coating materials in higher pH<a href="#bib116" rid="bib116" class=" bibr popnode"><sup>116</sup></a>. Thus, the enteric coating is able to protect PPs against degradation by low pH and pepsin in stomach completely. Some pH-responsive polymers are usually used to coat the tablet, capsule or even micro-/nano-particles. Polyacrylic polymers have been widely used for enteric coating and shown to release insulin at different rates and different pH, such as Eudragit S100 or L100<a href="#bib117" rid="bib117" class=" bibr popnode"><sup>117</sup></a>. Most of oral PPs products have adopted enteric coating technology to bypass the stomach, such as enteric coating capsule for oral insulin by Oramed (ORMD 0801) and Diabetology (Capsulin&#x02122; OAD)<a href="#bib118" rid="bib118" class=" bibr popnode"><sup>118</sup></a>. However, the oral bioavailability of PPs can't be improved significantly if only enteric coating is used because there are still a great amount of digestive enzymes in intestine. Therefore, enteric coating is usually employed to improve the oral absorption of PPs by combination with protease inhibitors or permeation technologies<a href="#bib119" rid="bib119" class=" bibr popnode"><sup>119</sup></a>. Nanoparticles coated by enteric materials have shown significant enhanced effect for oral absorption of PPs. The relative bioavailability of insulin was found to be approximately 20% after oral administration of enteric coated capsules filled with chitosan/poly(<em>&#x003b3;</em>-glutamic acid) nanoparticles<a href="#bib120" rid="bib120" class=" bibr popnode"><sup>120</sup></a>. In addition, pH-responsive polymers can fabricate nanoparticles directly with other polymers which can enhance the permeability for oral delivery of PPs. Nanoparticles composed of hydroxypropyl methylcellulose phthalate (HPMCP) and chitosan increased the hypoglycemic effect of insulin by more than 9.8 and 2.8-fold as compared to oral insulin solution and chitosan nanoparticles without enteric materials<a href="#bib121" rid="bib121" class=" bibr popnode"><sup>121</sup></a>.</p><p id="p0120" class="p p-last">The colon acts as a more suitable absorption site for PPs compared to stomach and small intestine due to its decrease of enzyme activity and neutral pH value. Moreover, longer residence time and higher responsiveness to absorption enhancers make colon as ideal administration site of oral PPs<a href="#bib122" rid="bib122" class=" bibr popnode"><sup>122</sup></a>. There are a number of examples to develop colon targeted delivery systems for PPs, such as vasopressin, insulin, calcitonin, glucagon and so on<a href="#bib123" rid="bib123" class=" bibr popnode"><sup>123</sup></a>. However, proper care must be taken to enable the release of the PPs at the target site. Among the various pH responsive polymers, Eudragit&#x000ae; enteric release polymers have been extensively exploited for oral delivery of PPs. It was reported that the oral bioavailability of insulin was enhanced by 1.73-fold <em>via</em> Eudragit S100&#x000ae;-coated chitosan nanoparticles loaded with insulin and <em>trans-</em>activating transcriptional peptide (TAT), compared to nanoparticles without enteric coating<a href="#bib124" rid="bib124" class=" bibr popnode"><sup>124</sup></a>. Other carbohydrate polymers that are used to specifically deliver oral PPs to the colon include anionic carboxymethyl starch, cationic quaternary ammonium starch, gellan gum, retrograded starch and pectin etc<a href="#bib125" rid="bib125" class=" bibr popnode"><sup>125</sup></a><sup>,</sup><a href="#bib126" rid="bib126" class=" bibr popnode"><sup>126</sup></a>. However, there are some challenges hindering the colon-specific delivery systems of PPs including lower surface area and tight junctions in colonic absorption site. What's more, alteration of enzymatic activity induced by some certain colonic diseases could affect drug release or stability<a href="#bib127" rid="bib127" class=" bibr popnode"><sup>127</sup></a>.</p></div><div id="sec4.1.4" class="sec"><p></p><h4 id="sec4.1.4title" class="inline">4.1.4.  Micro/nano-encapsulation </h4><p id="p0125" class="p p-first-last">Therapeutic drugs or PPs can be protected from hydrolytic and enzymatic degradation in the harsh gastric milieu of the GI tract <em>via</em> encapsulation, by which a drug or protein of interest is encaged inside polymeric carriers, so as to improving their intestinal absorption<a href="#bib128" rid="bib128" class=" bibr popnode"><sup>128</sup></a>. Particles can also enhance transport across epithelia except for protecting PPs against degradation<a href="#bib25" rid="bib25" class=" bibr popnode"><sup>25</sup></a>. Therefore, the therapeutic PPs could be encapsulated in nanoparticles to improve the blood concentration after oral administration, while vaccines encapsulated in microparticles can be taken up by Peyer's patches for enhancing mucosal immunity<a href="#bib129" rid="bib129" class=" bibr popnode"><sup>129</sup></a>. The particle transport is also affected by the stability in GI tract, surface properties, morphology and specific ligands<a href="#bib130" rid="bib130" class=" bibr popnode"><sup>130</sup></a><sup>,</sup><a href="#bib131" rid="bib131" class=" bibr popnode"><sup>131</sup></a>. Both natural and synthetic materials can be used to encapsulate PPs, such as natural materials including chitosan, dextran, alginate, hyaluronic acid, and lipidic materials, and synthetic polymers including poly(latic acid) (PLA), poly(lactic<em>-co-</em>glycolic acid) (PLGA), polycarprolacton (PCL), and so on<a href="#bib128" rid="bib128" class=" bibr popnode"><sup>128</sup></a>. The generally recognized as safe (GRAS) ingredients are highly recommended to prepare edible micro/nano-particles. So far, nanoparticles have been extensively developed for oral macromolecular drug delivery, such as polymeric nanoparticles, lipid nanoparticles, liposomes, nanoemulsions and inorganic nanoparticles, which were described in detail in Section <a href="#sec4.3.8" rid="sec4.3.8" class=" sec">4.3.8</a>.</p></div><div id="sec4.1.5" class="sec sec-last"><p></p><h4 id="sec4.1.5title" class="inline">4.1.5.  PEGylation and peptide cyclization </h4><p id="p0130" class="p p-first">The stability of PPs can be also improved by chemical approaches, such as PEGylation and peptide cyclization. PEGylation is generally used to reduce plasma clearance rate by increase the stability of PPs in the systemic circulation<a href="#bib132" rid="bib132" class=" bibr popnode"><sup>132</sup></a>. Several injectable PEGylated proteins have been launched to the market, such as growth hormone antagonist (Somavert&#x000ae;, Pfizer, USA), erythropoietin (Mircera&#x000ae;, Roche, Switzerland), and anti-TNF-<em>&#x003b1;</em> Fab (Cimzia&#x000ae;, UCB, Belgium)<a href="#bib133" rid="bib133" class=" bibr popnode"><sup>133</sup></a>. Similarly, PEGylation can increase pH and thermal stability of PPs, and also resistance to intestinal proteolytic digestion<a href="#bib134" rid="bib134" class=" bibr popnode"><sup>134</sup></a>. In addition, the branched chain PEGs demonstrate better than the linear PEGs<a href="#bib135" rid="bib135" class=" bibr popnode"><sup>135</sup></a>. However, it is important to realize that PEGylation could lead to risk of different efficacy and side effect profiles with parent protein.</p><p id="p0135" class="p p-last">Cyclization makes peptide non-susceptible to enzymes by removing exposed N and C terminal from peptide molecules<a href="#bib136" rid="bib136" class=" bibr popnode"><sup>136</sup></a><sup>,</sup><a href="#bib137" rid="bib137" class=" bibr popnode"><sup>137</sup></a>. It is inspired by many natural small cyclic proteins, such as cyclosporine and desmopressin<a href="#bib138" rid="bib138" class=" bibr popnode"><sup>138</sup></a>. Desmopressin which is a cyclic analogue of vasopressin displays greater resistance to enzymatic degradation than vasopressin<a href="#bib139" rid="bib139" class=" bibr popnode"><sup>139</sup></a>. Ring closure of a peptide can be attained by four different ways: head-to-tail (C-terminus to N<em>-</em>terminus), head-to-side chain, side chain-to-tail or side chain-to-side chain, depending on its functional groups<a href="#bib140" rid="bib140" class=" bibr popnode"><sup>140</sup></a>. The typical example is Arg-Gly-Asp (RGD) which is highly susceptible to chemical degradation due to presence an aspartic acid residue in its structure, while the rigidity can prevent the Asp side chain carboxylic acid from positioning itself in the right position for attack on the peptide backbone after cyclization<a href="#bib141" rid="bib141" class=" bibr popnode"><sup>141</sup></a>. Furthermore, cyclization can also decrease the exposure of polar atoms to surroundings by folding peptides into bioactive conformations, leading to the increase of oral bioavailability<a href="#bib142" rid="bib142" class=" bibr popnode"><sup>142</sup></a>.</p></div></div><div id="sec4.2" class="sec"><h3 id="sec4.2title">4.2. Mucus penetrating and mucoadhesive systems</h3><p id="p0140" class="p p-first">As mentioned before, mucus lining along the intestinal membrane of the GIT serves major hurdle for protein absorption by presenting multiple barriers. However, mucus is a double-edge sword in design of drug delivery systems. There are two opposing approaches to improve the delivery efficiency, including mucus-penetrating and muco-adhesive systems. Mucus penetrating systems are able to pass through the unstirred layer rapidly to reach intestinal epithelium for absorption. In contrast, muco-adhesive systems can prolong drug residence time for absorption at the intestinal tract by avoiding mucociliary clearance. There have been lots of excellent reviews to clarify the mucus-penetrating and mucoadhesive systems<a href="#bib143" rid="bib143" class=" bibr popnode">143</a>, <a href="#bib144" rid="bib144" class=" bibr popnode">144</a>, <a href="#bib145" rid="bib145" class=" bibr popnode">145</a>.</p><div id="sec4.2.1" class="sec"><p></p><h4 id="sec4.2.1title" class="inline">4.2.1.  Mucus penetrating systems </h4><p id="p0145" class="p p-first">For mucus-penetrating systems, the mucolytics have been firstly used to disrupt mucus barrier. The mucolytics are generally used to remove abnormal mucus in pulmonary disease, such as chronic obstructive pulmonary disease (COPD), while able to diminish the mucus barrier transiently for healthy mucosa<a href="#bib146" rid="bib146" class=" bibr popnode"><sup>146</sup></a>. For example, <em>N-</em>acetyl-<span class="small-caps">l</span>-cysteine (NAC) is a commonly used mucolytic and can cause a 6-fold increase in the absorption of 3.2&#x000a0;&#x003bc;m polystyrene particles in Peyer's patches<a href="#bib147" rid="bib147" class=" bibr popnode"><sup>147</sup></a>. Although mucolytics can facilitate the attachment of particles to intestinal absorptive cells by removing mucus covering surface of epithelium and further enhance the oral absorption, the depletion of mucus barrier could lead to the injury of intestinal epithelium due to direct contact with proteolytic enzymes and acid. Therefore, it is necessary to employ the particles with specific properties to penetrate through mucus for drug delivery.</p><p id="p0150">Inspiring from viruses, scientists deduced some possible characteristics of mucus-penetrating particles, including small size, highly hydrophilic and net-neural surfaces<a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a><sup>,</sup><a href="#bib148" rid="bib148" class=" bibr popnode"><sup>148</sup></a>. A study has demonstrated that polymeric particle less than 230&#x000a0;nm could pass through mouse colorectal mucus rapidly<a href="#bib149" rid="bib149" class=" bibr popnode"><sup>149</sup></a>, which is similar as the size of some viruses. In order to increase the hydrophilicity of particle surface, the particles are commonly modified by PEG to enhance mucus penetration<a href="#bib150" rid="bib150" class=" bibr popnode"><sup>150</sup></a>. In addition to PEG, poly vinyl alcohol (PVA)<a href="#bib151" rid="bib151" class=" bibr popnode"><sup>151</sup></a> and <em>N-</em>(2-hydroxypropyl)methacrylamide copolymer (pHPMA)<a href="#bib152" rid="bib152" class=" bibr popnode"><sup>152</sup></a> can also engineer the mucus-inert particles to improve the oral absorption. The nanocomplex of insulin and cell penetrating peptide (CPP) demonstrated no evident hypoglycemic effect after oral administration to diabetic rats, while the blood glucose level can decline to around 50% by nanocomplex coated by pHPMA. Meanwhile, nanocomplex coated by pHPMA exhibited 20-fold higher transport than free insulin on mucus-secreting epithelium cells<a href="#bib152" rid="bib152" class=" bibr popnode"><sup>152</sup></a>. Recently, protein corona liposomes are also able to facilitate the penetration of mucus and transepithelial transport<a href="#bib153" rid="bib153" class=" bibr popnode"><sup>153</sup></a>.</p><p id="p0155" class="p p-last">Another important factor influencing the mucus-penetrating is surface charge of nanoparticles. Both positive and negative charge are not good for mucus-penetrating, but nanoparticles with densely charges coated net-neutral surfaces which is like virus surface exhibited higher diffusion through mucus layer. A biomimetic virus-like or charge reversible nanoparticles are able to improve the oral insulin delivery by overcoming mucus barriers<a href="#bib154" rid="bib154" class=" bibr popnode"><sup>154</sup></a>. In addition, particle geometry can affect the mucus-penetrating ability significantly by micromovement<a href="#bib155" rid="bib155" class=" bibr popnode"><sup>155</sup></a>. It has been revealed that the nanorods diffused across mucus layer rapidly by rotation<a href="#bib156" rid="bib156" class=" bibr popnode"><sup>156</sup></a>. Owing to the strong mucus-penetrating capacity, the rod shaped nanoparticles can penetrate into deep mucus and reside there to prolong the residence time in GI tract<a href="#bib130" rid="bib130" class=" bibr popnode"><sup>130</sup></a>. What's more, SNEDDS produces droplets (&#x02264;50&#x000a0;nm) with hydrophilic surfaces and their shape deformability facilitates them suitable for diffusion through mucus<a href="#bib157" rid="bib157" class=" bibr popnode"><sup>157</sup></a>. Better mucus diffusion was achieved by medium chain lipids (MC)-SNEDDS compared to lipids with short or long chains. For example, MC-SNEDDS produced 2-fold increase of oral bioavailability of enoxaparin<a href="#bib158" rid="bib158" class=" bibr popnode"><sup>158</sup></a>.</p></div><div id="sec4.2.2" class="sec sec-last"><p></p><h4 id="sec4.2.2title" class="inline">4.2.2.  Mucoadhesive systems </h4><p id="p0160" class="p p-first">Mucoadhesion is a common phenomenon for particles, which was found by Florey in 1962 from India ink particles adhering intestinal mucus<a href="#bib159" rid="bib159" class=" bibr popnode"><sup>159</sup></a>. Most of microparticles or nanoparticles exerted non-specific mucoadhesion with intestinal mucus. However, mucoadhesive polymers have to be used for improving residence time significantly. For example, mucoadhesive microspheres with a diameter of 680&#x02013;850&#x000a0;&#x003bc;m fabricated by copolymers of fumaric acid and sebacic acid were able to significantly prolong retention time in the rat GI tract compared to that of non-adhesive polymers<a href="#bib160" rid="bib160" class=" bibr popnode"><sup>160</sup></a>. The hydrophobicity, surface charge and chemistry influence the mucoadhesive properties of polymers significantly. The hydrophobic particles were absorbed 100-fold more than particles composed of hydrophilic cellulose<a href="#bib161" rid="bib161" class=" bibr popnode"><sup>161</sup></a>, which indicated that hydrophobic interactions was also an important aspect for mucoadhesion. Due to the negative charge of mucus layer, the positively charged particles are strongly mucoadhesive. Chitosan, especially <em>N-</em>trimethyl chitosan (TMC), was commonly used to engineer or coat nanoparticles for improving the drug absorption through electrostatic mucoadhesive with mucins. TMC nanoparticles produced much higher antibody titers of IgG and secretory IgA after oral delivery of urease than the solution by increasing mucoadhesion and epithelial permeability<a href="#bib162" rid="bib162" class=" bibr popnode"><sup>162</sup></a>. Thiolation on the surface of polymer is a common strategy to increase the mucoadhesive ability owing to formation of disulfide between thiol group of polymer or cysteine-rich subdomains of mucus glycoproteins<a href="#bib163" rid="bib163" class=" bibr popnode"><sup>163</sup></a>. The mucoadhesive properties of polymers could be enhanced by up to 100-fold after thiolation<a href="#bib164" rid="bib164" class=" bibr popnode"><sup>164</sup></a>. TMC nanoparticles modified by cysteine increased insulin transport by 1.7&#x02013;2.6-fold compared to TMC nanoparticles<a href="#bib165" rid="bib165" class=" bibr popnode"><sup>165</sup></a>. Compared with the mucoadhesive polymers, the another category of molecules exert the bioadhesion on epithelial cells rather than mucus gel layer, such as lectins. They are able to specifically recognize receptor-like structures of the cell membrane and therefore bind directly to epithelium and hence called as the second generation of bioadhesives<a href="#bib166" rid="bib166" class=" bibr popnode"><sup>166</sup></a>. The lectin modified nanoparticles are able to not only bind to intestinal epithelium for prolonging the residence time but also probably triggering the active transport by receptor mediated uptake. Many studies employed lectin modified nanoparticles to target M cell for enhancing transport of large molecules<a href="#bib167" rid="bib167" class=" bibr popnode"><sup>167</sup></a><sup>,</sup><a href="#bib168" rid="bib168" class=" bibr popnode"><sup>168</sup></a>. The absorption enhancement of lectin was described in Section <a href="#sec4.3.3" rid="sec4.3.3" class=" sec">4.3.3</a>. in detail.</p><p id="p0165">In addition to mucoadhesive micro-/nano-particles, intestinal patches have also been attempted to improve the oral delivery of PPs<a href="#bib169" rid="bib169" class=" bibr popnode"><sup>169</sup></a><sup>,</sup><a href="#bib170" rid="bib170" class=" bibr popnode"><sup>170</sup></a>. Intestinal patches are like transdermal patches and millimeter sized patches composed of a pH sensitive layer, mucoadhesive drug reservoir layer and a backing layer<a href="#bib171" rid="bib171" class=" bibr popnode"><sup>171</sup></a>, which are suitable to deliver PPs orally because they can release PPs locally near the mucosa and protect it from proteolytic degradation<a href="#bib172" rid="bib172" class=" bibr popnode"><sup>172</sup></a><sup>,</sup><a href="#bib173" rid="bib173" class=" bibr popnode"><sup>173</sup></a>. Insulin-loaded intestinal patches can significantly reduce the blood glucose level at the dose of 10 IU/kg after jejunal administration. The author attributed it that the intestinal micropatches can be put into enteric capsules and strongly adhesive to the intestinal mucosa after entering small intestine (<a href="/pmc/articles/PMC8424290/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>), which also facilitate oral absorption of insulin significantly<a href="#bib174" rid="bib174" class=" bibr popnode"><sup>174</sup></a>. Similar as transdermal patches, intestinal patches can load various formulations to modify the drug loading, release or absorption, such as solid-in-oil formulation as a drug reservoir in intestinal patch for oral delivery of insulin<a href="#bib175" rid="bib175" class=" bibr popnode"><sup>175</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig7" co-legend-rid="lgnd_fig7"><a href="/pmc/articles/PMC8424290/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232424396256"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr7.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 7" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr7.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232424396256"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig7"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7">Figure&#x000a0;7</a></div><!--caption a7--><div class="caption"><p>Schematic illustration of structure of intestinal patch and administration device, and <em>in&#x000a0;vivo</em> mechanism of adhesion, drug release and absorption across intestinal epithelium. Reprinted with the permission from Ref.&#x000a0;<a href="#bib176" rid="bib176" class=" bibr popnode">176</a>. Copyright &#x000a9; 2016 Springer.</p></div></div></div><p id="p0170" class="p p-last">Hydrogels have also been extensively explored for enhancing oral absorption of PPs<a href="#bib177" rid="bib177" class=" bibr popnode"><sup>177</sup></a>. Hydrogels can enable PPs reside within specific gut regions for a prolonged residence time due to their mucoadhesive properties and resist enzymatic degradation simultaneously. Complexation hydrogels are the optimal choice for oral delivery of PPs due to their environment responsiveness. For example, complexation hydrogels composed of poly(methacrylic acid) grafted with poly(ethylene glycol) do not swell in acidic environment due to strong hydrogen bonds and hence prevent insulin release in stomach, while dissociate in small intestine, resulting in rapid swelling and release<a href="#bib178" rid="bib178" class=" bibr popnode"><sup>178</sup></a>. The complexation hydrogels led to a drastic reduction of plasma calcium concentration by improving intestinal absorption of sCT. Moreover, the oral bioavailability of insulin-loaded complexation hydrogels reached up to 7.2%<a href="#bib179" rid="bib179" class=" bibr popnode"><sup>179</sup></a>. In addition, superporous hydrogels have also been used for enhancing intestinal absorption of PPs<a href="#bib180" rid="bib180" class=" bibr popnode"><sup>180</sup></a>. They can swell to several hundred times within a few minutes and exhibit enhanced mucoadhesive force<a href="#bib181" rid="bib181" class=" bibr popnode"><sup>181</sup></a>. Oral administration of insulin-loaded superporous hydrogels leads to notable insulin absorption and hypoglycemic effect, which could attribute the prolonged residence time in high concentration of insulin within specific intestinal region and reversible opening of tight junctions<a href="#bib182" rid="bib182" class=" bibr popnode"><sup>182</sup></a>.</p></div></div><div id="sec4.3" class="sec sec-last"><h3 id="sec4.3title">4.3. Absorption enhancement</h3><p id="p0175" class="p p-first">In addition to instability in GI tract, another important factor limiting oral bioavailability of PPs is their extremely poor permeability across epithelial membrane due to large molecular weight and high hydrophilicity. It is indispensable to enhance the intestinal permeability of PPs by chemical or pharmaceutical approaches for development of oral products. So far, there are various strategies to enhance oral absorption of PPs, among which absorption enhancers could be the most commonly used in clinical or preclinical products.</p><div id="sec4.3.1" class="sec"><p></p><h4 id="sec4.3.1title" class="inline">4.3.1.  Prodrugs </h4><p id="p0180" class="p p-first-last">The prodrugs strategy is the most common approach to modulate physicochemical properties of drugs <em>via</em> chemical derivatization, such as improving stability, solubility or permeability. The prodrugs molecules are able to overcome barriers and then converted to be active form by <em>in&#x000a0;vivo</em> degradation reactions<a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a>. The bioreversible cyclization of peptide backbone has been recognized as a promising prodrug methodology for PPs, which increases the intramolecular hydrogen bonding interactions, but decreases the intermolecular hydrogen bonding interactions with aqueous solvent<a href="#bib183" rid="bib183" class=" bibr popnode"><sup>183</sup></a>. Borchardt et&#x000a0;al.<a href="#bib184" rid="bib184" class=" bibr popnode"><sup>184</sup></a> used this method to develop the pheylpropionic acid based cyclic prodrugs of (Leu<sup>5</sup>)-enkephaline which have shown around 1680 folds higher permeability across Caco-2&#x000a0;cell monolayer than parent peptide. In the same study, coumarinic acid-based prodrugs of (Leu<sup>5</sup>)-enkephaline exhibited both high permeability and good stability. Lipidization is another promising approach to create prodrugs of PPs. Lipidization can increase hydrophobicity of peptides, leading to improved permeability. For example, two palmitoylated insulins lipidized by B1-monopalmitoyl and B29-dipalmityl showed higher lipophilicity and greater stability, which leads to increased intestinal absorption<a href="#bib185" rid="bib185" class=" bibr popnode"><sup>185</sup></a>. However, lipidization could reduce the biological activity of a peptide, which have been overcome by a reversible lipidization technique<a href="#bib186" rid="bib186" class=" bibr popnode"><sup>186</sup></a>. This method can be carried out in an aqueous solution for conjugation of fatty acid and polypeptide, and can regenerate the original active polypeptides after oral absorption<a href="#bib187" rid="bib187" class=" bibr popnode"><sup>187</sup></a>. The oral absorption of reversible lipidic prodrugs of salmon calcitonin was improved by at least 19 times compared to parent peptide<a href="#bib188" rid="bib188" class=" bibr popnode"><sup>188</sup></a>. In addition, the prodrug design combining with lipid raft can generate site specific delivery by conjugation with targeting moiety. The combination of lipid and receptor targeting exhibited synergistic effect, leading to rapid transport through the cell membrane, which could be an alternative technology for enhancing absorption of hydrophilic biomacromolecules including PPs<a href="#bib189" rid="bib189" class=" bibr popnode"><sup>189</sup></a>. However, the prodrug strategy is currently limited in modification of peptides. Proteins are hard to optimize their characteristics by chemical modification due to huge molecule, and conformational instability during chemical reaction.</p></div><div id="sec4.3.2" class="sec"><p></p><h4 id="sec4.3.2title" class="inline">4.3.2.  Absorption enhancers </h4><p id="p0185" class="p p-first">The largest obstruct for oral delivery of PPs is poor permeability across intestinal epithelium. The absorption enhancers are recognized to improve the intestinal permeability by altering the epithelial structure transiently, therefore extensively used in oral formulations of PPs. The possible mechanisms involved in current absorption enhancers are shown as <a href="/pmc/articles/PMC8424290/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>. There are over 250 substances that have been used in preclinical studies as absorption enhancers for oral delivery of PPs according to an excellent review about intestinal permeation enhancers<a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a>, some of typical which have been listed in <a href="/pmc/articles/PMC8424290/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>. Absorption enhancers have attracted more attention from pharmaceutical and biomaterial scientists since 1961 when a study found that sodium ethylene diamine tetraacetic acid (EDTA) was able to improve the oral absorption of heparin at dose of 50&#x000a0;mg/kg in dogs<a href="#bib190" rid="bib190" class=" bibr popnode"><sup>190</sup></a>. Some semi-synthetic and synthetic substances have been developed as absorption enhancers including chelating agents, surfactants, polymers and bacterial toxins. These absorption enhancers can facilitate oral absorption of PPs either paracellularly <em>via</em> the opening of tight junctions or transcellularly through increasing membrane permeability, or a combination of both.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig8" co-legend-rid="lgnd_fig8"><a href="/pmc/articles/PMC8424290/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232428161584"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr8.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 8" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr8.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232428161584"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig8"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8">Figure&#x000a0;8</a></div><!--caption a7--><div class="caption"><p>The schematic illustration of mechanisms of absorption enhancers including transcellular and paracellular pathways. Reprinted with the permission from Ref.&#x000a0;21. Copyright &#x000a9; 2016 Elsevier.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>List of some typical permeation enhancers for oral absorption of PPs.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Enhancer</th><th rowspan="1" colspan="1">Mechanism</th><th rowspan="1" colspan="1">Application</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">EDTA</td><td rowspan="1" colspan="1">Chelating agents; paracellular</td><td rowspan="1" colspan="1">ORMD-0801; ORMD-0901 (Oramed Pharma, USA)</td></tr><tr><td rowspan="1" colspan="1">Citric acid</td><td rowspan="1" colspan="1">Chelating agents; paracellular</td><td rowspan="1" colspan="1">Peptelligence&#x02122; (Tarsa, USA)</td></tr><tr><td rowspan="1" colspan="1">Bile salts</td><td rowspan="1" colspan="1">Multimodal</td><td rowspan="1" colspan="1">IN-105 (Biocon, India)</td></tr><tr><td rowspan="1" colspan="1">Sodium caprate (C<sub>10</sub>)</td><td rowspan="1" colspan="1">Multimodal</td><td rowspan="1" colspan="1">GIPET&#x000ae; (Merrion Pharma, Ireland)</td></tr><tr><td rowspan="1" colspan="1">Sodium carprylate (C<sub>8</sub>)</td><td rowspan="1" colspan="1">Multimodal</td><td rowspan="1" colspan="1">TPE&#x000ae; (Chiasma, Israel)</td></tr><tr><td rowspan="1" colspan="1">SNAC/5-CNAC</td><td rowspan="1" colspan="1">Transcellular</td><td rowspan="1" colspan="1">Eligen&#x000ae; (Emisphere, USA)</td></tr><tr><td rowspan="1" colspan="1">Chitosan</td><td rowspan="1" colspan="1">Multimodal</td><td rowspan="1" colspan="1">Oral insulin (NanoMega, USA)</td></tr><tr><td rowspan="1" colspan="1">Penetratin/PenetraMax</td><td rowspan="1" colspan="1">Transcellular</td><td rowspan="1" colspan="1">Reported for various peptides</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232464880304"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl2/?report=objectonly">Open in a separate window</a></div></div><p id="p0190">Chelating agents, like EDTA and citric acid, can generally enhance paracellular absorption by opening tight junctions which is caused by reduction of intracellular calcium due to chelating properties<a href="#bib108" rid="bib108" class=" bibr popnode"><sup>108</sup></a>. Diethylene triamine pentaacetic acid (DTPA), a novel chelator, has been approved to improve the oral insulin absorption with relative bioavailability of 20% by integrating into chitosan nanoparticles<a href="#bib191" rid="bib191" class=" bibr popnode"><sup>191</sup></a>.</p><p id="p0195">Surfactants are main absorption enhancers in clinical studies, such as sodium caprylate/caprate and their derivatives, and endogenous bile salts. Endogenous bile salts and their derivatives have been investigated to increase oral relative bioavailability of insulin by protecting stability of PPs and enhancing intestinal permeability<a href="#bib47" rid="bib47" class=" bibr popnode"><sup>47</sup></a><sup>,</sup><a href="#bib192" rid="bib192" class=" bibr popnode"><sup>192</sup></a><sup>,</sup><a href="#bib193" rid="bib193" class=" bibr popnode"><sup>193</sup></a>. The advantages of endogenous bile salts and their derivatives include good biocompatibility and high drug loading for PPs when they are used in fabrication of liposomes<a href="#bib194" rid="bib194" class=" bibr popnode"><sup>194</sup></a>. Sodium caprylate/caprate and their derivatives are the most promising absorption enhancers and have been marketed for oral delivery of PPs, such as sodium caprylate in oral octreotide (Mycappssa&#x000ae;, Chiasma Pharma, USA/Israel) and SNAC in oral semaglutide (Rybelsus&#x000ae;, Novo Nordisk, Denmark). The SNAC was firstly approved using in Eligen&#x000ae; carrier for improving oral delivery of vitamin B<sub>12</sub> developed by Emisphere (USA). It is a derivative of sodium caprylate whose structure and mechanism of action are presented in <a href="/pmc/articles/PMC8424290/figure/fig9/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig9" rid-ob="ob-fig9" co-legend-rid="lgnd_fig9"><span>Fig.&#x000a0;9</span></a>. It was reported that SNAC were capable of enhancing permeation of heparin, sCT and insulin significantly<a href="#bib195" rid="bib195" class=" bibr popnode">195</a>, <a href="#bib196" rid="bib196" class=" bibr popnode">196</a>, <a href="#bib197" rid="bib197" class=" bibr popnode">197</a>. Most of studies regarded hydrophobic SNAC non-covalently associated with peptides improves their absorption across the intestinal epithelium. After transported, the peptide disassociated from the SNAC carrier and passed into the circulation freely<a href="#bib198" rid="bib198" class=" bibr popnode"><sup>198</sup></a>. The success of Rybelsus&#x000ae; is related to its strong association with semaglutide<a href="#bib199" rid="bib199" class=" bibr popnode"><sup>199</sup></a>. However, some studies also thought the SNAC enhanced transport of peptides through opening tight junctions because they caused significant decline of TEER and a 36-fold increase in mannitol permeability across Caco-2 monolayers<a href="#bib200" rid="bib200" class=" bibr popnode"><sup>200</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig9" co-legend-rid="lgnd_fig9"><a href="/pmc/articles/PMC8424290/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232427623616"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr9.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 9" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr9.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232427623616"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig9/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig9"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9">Figure&#x000a0;9</a></div><!--caption a7--><div class="caption"><p>The chemical structure of semaglutide (A) and SNAC (B), and the rationale of permeation enhancing effect of SNAC on semaglutide (C). Reprinted with the permission from Ref.&#x000a0;<a href="#bib201" rid="bib201" class=" bibr popnode">201</a>. Copyright &#x000a9; 2016 Springer.</p></div></div></div><p id="p0200">Chitosan and its derivatives are the most common polymers for enhancing oral delivery of PPs depending on the positive charge density and bioadhesive ability. They are generally fabricated as nano/micro particles to encapsulate PPs for improving oral absorption, which described in Section 4.4 in detail.</p><p id="p0205">Some absorption enhancers emerging from toxins have gradually been used in improving oral delivery of PPs by altering paracellular or transcellular permeability<a href="#bib202" rid="bib202" class=" bibr popnode"><sup>202</sup></a>. Due to safety consideration of native toxin, the common approach is that the short peptide sequence is developed by structure activity relationships (SAR) studies. For example, native ZoT (45&#x000a0;kDa) can enhance small intestine permeability <em>via</em> PKC-dependent cytoskeletal contraction which is exerted by its first six amino acids<a href="#bib203" rid="bib203" class=" bibr popnode"><sup>203</sup></a><sup>,</sup><a href="#bib204" rid="bib204" class=" bibr popnode"><sup>204</sup></a>. Alba Therapeutics (USA) developed a short peptide sequence AT1002 (H-FCIGRL-OH) which can lead to 40-fold increment of lucifer yellow in Caco-2 monolayer<a href="#bib205" rid="bib205" class=" bibr popnode"><sup>205</sup></a>. The larazotide acetate, an 8-mer peptide that promotes tight junctions assembly, has been used in clinical development by Alba therapeutics (USA)<a href="#bib206" rid="bib206" class=" bibr popnode"><sup>206</sup></a>. In addition, some short peptides emerging from toxins could target tight junctions related proteins, such as claudins or occludins, to increase paracellular permeability<a href="#bib207" rid="bib207" class=" bibr popnode"><sup>207</sup></a><sup>,</sup><a href="#bib208" rid="bib208" class=" bibr popnode"><sup>208</sup></a>. CPP are a sort of peptides derived from the transactivator of transcription (HIV-1 TAT) protein of the human immunodeficiency virus and can increase the membrane permeability of PPs<a href="#bib209" rid="bib209" class=" bibr popnode"><sup>209</sup></a>. The first CPP, Penetratin&#x000ae; (RQIKIWFQNRRMKWKK) consisting of 16 amino acids, was discovered in 1994<a href="#bib210" rid="bib210" class=" bibr popnode"><sup>210</sup></a>. The therapeutic PPs are linked with the CPPs by chemical conjugation or complexed with the CPPs by non-covalent bonds<a href="#bib211" rid="bib211" class=" bibr popnode"><sup>211</sup></a>. The possible mechanism of CPPs on enhancing cellular uptake is that they can increase paracellular and transcellular transport through endocytic pathway<a href="#bib212" rid="bib212" class=" bibr popnode"><sup>212</sup></a>. The low molecular weight protamine (LMWP) with a sequence of VSRRRRRRGGRRRRC is the one of CPPs, which can increase the intestinal cell membrane permeability and oral relative bioavailability of exenatide-Zn<sup>2+</sup> by 29-fold<a href="#bib213" rid="bib213" class=" bibr popnode"><sup>213</sup></a>. Both Penetratin&#x000ae; and its analog PenetraMax&#x000ae; exerted absorption enhanced ability for oral insulin in D-form by non-covalent approach; but there is no synergistic effect observed when using the combination of these two CPPs<a href="#bib214" rid="bib214" class=" bibr popnode"><sup>214</sup></a>. Although CPPs have exerted excellent capacity in improving membrane permeability, they have not yet been validated in the clinic studies of oral delivery of peptides due to complex GI environment.</p><p id="p0210" class="p p-last">Absorption enhancers have been evidenced in improving oral absorption of PPs, even some enhancers have been used in marketed products, such as SNAC and EDTA. However, safety and regulation are the main concerns in the application of absorption enhancers in oral delivery. Toxicity has been considered as a potential drawback impeding the application of enhancers<a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a>. Fortunately, there have no significant adverse events reported for any absorption enhancers tested in clinical trials to date.</p></div><div id="sec4.3.3" class="sec"><p></p><h4 id="sec4.3.3title" class="inline">4.3.3.  Active targeting </h4><p id="p0215" class="p p-first">Increasing active transport has also become a promising approach to facilitate the oral absorption of PPs by targeting receptors, transporters and specialized cells in intestinal epithelia<a href="#bib215" rid="bib215" class=" bibr popnode"><sup>215</sup></a>. The colloidal carriers decorated with a specific ligand (<a href="/pmc/articles/PMC8424290/table/tbl3/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a><a href="#bib168" rid="bib168" class=" bibr popnode"><sup>168</sup></a><sup>,</sup><a href="#bib216" rid="bib216" class=" bibr popnode">216</a>, <a href="#bib217" rid="bib217" class=" bibr popnode">217</a>, <a href="#bib218" rid="bib218" class=" bibr popnode">218</a>, <a href="#bib219" rid="bib219" class=" bibr popnode">219</a>, <a href="#bib220" rid="bib220" class=" bibr popnode">220</a>, <a href="#bib221" rid="bib221" class=" bibr popnode">221</a>, <a href="#bib222" rid="bib222" class=" bibr popnode">222</a>, <a href="#bib223" rid="bib223" class=" bibr popnode">223</a>, <a href="#bib224" rid="bib224" class=" bibr popnode">224</a>, <a href="#bib225" rid="bib225" class=" bibr popnode">225</a>, <a href="#bib226" rid="bib226" class=" bibr popnode">226</a>, <a href="#bib227" rid="bib227" class=" bibr popnode">227</a>, <a href="#bib228" rid="bib228" class=" bibr popnode">228</a>) have emerged as a promising technology to increase interaction with the epithelium by active targeting followed by higher transport.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p>List of ligands for actively targeting the enteric epithelia.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Ligand</th><th rowspan="1" colspan="1">Target</th><th rowspan="1" colspan="1">Cell</th><th rowspan="1" colspan="1">Carrier</th><th rowspan="1" colspan="1">Biologic</th><th rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Folate</td><td rowspan="1" colspan="1">Folate receptor</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">PLGA nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib216" rid="bib216" class=" bibr popnode">216</a></td></tr><tr><td rowspan="1" colspan="1">Biotin</td><td rowspan="1" colspan="1">Avidin</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">Liposomes</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib217" rid="bib217" class=" bibr popnode">217</a></td></tr><tr><td rowspan="1" colspan="1">Vitamin B<sub>12</sub></td><td rowspan="1" colspan="1">IF-CbI receptor&#x02217;</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">Dextran nanoparticles; calcium phosphate nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib218" rid="bib218" class=" bibr popnode">218</a>,<a href="#bib219" rid="bib219" class=" bibr popnode">219</a></td></tr><tr><td rowspan="1" colspan="1">Galactose</td><td rowspan="1" colspan="1">Galactose receptor</td><td rowspan="1" colspan="1">Macrophage</td><td rowspan="1" colspan="1">PLGA nanoparticles</td><td rowspan="1" colspan="1">siRNA</td><td rowspan="1" colspan="1"><a href="#bib220" rid="bib220" class=" bibr popnode">220</a></td></tr><tr><td rowspan="1" colspan="1">Mannose</td><td rowspan="1" colspan="1">Mannose receptor (DEC-205)</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">Proliposome</td><td rowspan="1" colspan="1">Glutathione</td><td rowspan="1" colspan="1"><a href="#bib221" rid="bib221" class=" bibr popnode">221</a>,<a href="#bib222" rid="bib222" class=" bibr popnode">222</a></td></tr><tr><td rowspan="1" colspan="1">Hyaluronate</td><td rowspan="1" colspan="1">CD44 receptor</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">CaCO<sub>3</sub> nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib223" rid="bib223" class=" bibr popnode">223</a></td></tr><tr><td rowspan="1" colspan="1">Transferrin</td><td rowspan="1" colspan="1">Transferrin receptor</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">Fuse protein</td><td rowspan="1" colspan="1">Human growth hormone</td><td rowspan="1" colspan="1"><a href="#bib224" rid="bib224" class=" bibr popnode">224</a></td></tr><tr><td rowspan="1" colspan="1">Fc fragments</td><td rowspan="1" colspan="1">Neonatal Fc receptor</td><td rowspan="1" colspan="1">Enterocyte</td><td rowspan="1" colspan="1">PLA-PEG nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib225" rid="bib225" class=" bibr popnode">225</a></td></tr><tr><td rowspan="1" colspan="1">lectin</td><td rowspan="1" colspan="1">Integrin receptor</td><td rowspan="1" colspan="1">M-cell</td><td rowspan="1" colspan="1">Liposome; solid lipid nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib168" rid="bib168" class=" bibr popnode">168</a>,<a href="#bib226" rid="bib226" class=" bibr popnode">226</a></td></tr><tr><td rowspan="1" colspan="1">RGD</td><td rowspan="1" colspan="1">Integrin <em>&#x003b1;</em>v<em>&#x003b2;</em>3 receptor</td><td rowspan="1" colspan="1">Enterocyte; M-cell</td><td rowspan="1" colspan="1">PLGA-mPEG nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib227" rid="bib227" class=" bibr popnode">227</a></td></tr><tr><td rowspan="1" colspan="1">CSKSSDYQC (CSK)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Goblet cell</td><td rowspan="1" colspan="1">Chitosan nanoparticles</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1"><a href="#bib228" rid="bib228" class=" bibr popnode">228</a></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232413345184"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.ae.d.f.f.c.r.e.a"><p class="p p-first-last">IF-CBI: combination of gastric intrinsic factor (IF) and cobalamin (CbI, vitamin B12).</p></div></div></div><p id="p0220">Receptor-mediated endocytosis can take up extracellular substances efficiently by internalization triggered by binding ligand molecules with receptors, which is a critical pathway to acquire sufficient essential nutrients for human body, such as vitamins, transferrin and hormones<a href="#bib229" rid="bib229" class=" bibr popnode"><sup>229</sup></a>. Therefore, some nutritional components including vitamins, saccharides and fatty acids have been extensively explored to decorate drug carriers for enhancing active transport. Some nutritional vitamins have to be transported by receptor mediated mechanisms from diet and other exogenous sources, such as vitamin B<sub>12</sub> (VB<sub>12</sub>) and folate. VB<sub>12</sub> was used as a ligand to modify dextran<em>-g-</em>poly-ethyleneoxide cetyl ether micelles for oral delivery of cyclosporine A, which demonstrated increased permeability of cyclosporine A on Caco-2 monolayer. Moreover, VB<sub>12</sub> modified nanoparticles loading insulin produced 70%&#x02013;75% blood glucose reductions<a href="#bib218" rid="bib218" class=" bibr popnode"><sup>218</sup></a>. However, the limited absorption site of VB<sub>12</sub> in the distal ileum leads to slow uptake<a href="#bib230" rid="bib230" class=" bibr popnode"><sup>230</sup></a>, compromising its potential application. Folate and biotin are also the aqueous vitamin B family members and there are a large number of receptors in whole intestinal tract. A folic acid (FA)-pluronic 85-poly(lactide<em>-co-</em>glycolide) polymersome exhibited higher cellular uptake than unmodified polymersome and showed better enhanced absorption effect of insulin. The folate receptor mediated endocytosis pathway was also validated by cellular uptake mechanisms study<a href="#bib231" rid="bib231" class=" bibr popnode"><sup>231</sup></a>. Insulin loaded liposomes modified by biotin showed significantly higher hypoglycemic effect with almost 2-fold relative bioavailability compared to the conventional liposomes<a href="#bib217" rid="bib217" class=" bibr popnode"><sup>217</sup></a>. Like vitamins, there are a variety of saccharide receptors located on the intestinal epithelia for active transport, such as mannose, galactose and hyaluronic acid receptors<a href="#bib232" rid="bib232" class=" bibr popnode"><sup>232</sup></a>. For example, the galactose-modified nanoparticles exhibited higher cellular uptake and <em>ex&#x000a0;vivo</em> intestinal epithelial permeability compared with galactose free nanoparticles<a href="#bib233" rid="bib233" class=" bibr popnode"><sup>233</sup></a>. However, most saccharide receptors locate in M cells, by which oral delivery of vaccines can be enhanced<a href="#bib234" rid="bib234" class=" bibr popnode"><sup>234</sup></a>. Transferrin receptors (TfR) has recently become a promising target for oral delivery of PPs because they are distributed throughout the small intestinal epithelium<a href="#bib235" rid="bib235" class=" bibr popnode"><sup>235</sup></a>. In a recent study, Yong et&#x000a0;al.<a href="#bib236" rid="bib236" class=" bibr popnode"><sup>236</sup></a> found that nanoparticles modified by transferrin (Tf) were taken up by Caco-2&#x000a0;cells <em>via</em> TfR-mediated transcytosis more than the unmodified counterparts significantly. However, the increased number of endogenous Tf reduces the specificity of Tf-functionalized nanocarriers<a href="#bib237" rid="bib237" class=" bibr popnode"><sup>237</sup></a>. To address this issue, Liu et&#x000a0;al. developed a nanosystem modified by cycle peptide CRTIGPSVC (CRT) to target the Tf&#x02013;TfR complex for circumventing the competitive inhibition, which significantly increased the Caco-2 cellular uptake <em>via</em> a non-canonical allosteric directed mechanism<a href="#bib238" rid="bib238" class=" bibr popnode"><sup>238</sup></a>. The Fc receptor (FcRn) is the most promising ligand candidate to actively transport biomacromolecules into circulation from small intestines due to its high efficiency in transporting immunoglobulin G antibodies across epithelial barriers<a href="#bib239" rid="bib239" class=" bibr popnode"><sup>239</sup></a>. FcRn targeted nanoparticles were able to increase a mean absorption efficiency up to approximately 13-fold and oral insulin-loaded FcRn targeted nanoparticles could leads to similar hypoglycemic effect as s.c. insulin at the same dose<a href="#bib225" rid="bib225" class=" bibr popnode"><sup>225</sup></a>. More recently, Martins et&#x000a0;al.<a href="#bib240" rid="bib240" class=" bibr popnode"><sup>240</sup></a> developed porous silica nanoparticles conjugated with Fc fragment of immunoglobulin G by microfluidics technology which exerted higher cytocompatibility and greater interaction with the intestinal cells, as well as ensued better absorption of glucagon-like peptide 1 (GLP-1).</p><p id="p0225">Transporters located on the epithelia surface can selectively transport some specific molecules into the cytoplasm but rarely cause cell membrane active deformation to engulf the particles unlike receptor mediated endocytosis<a href="#bib241" rid="bib241" class=" bibr popnode"><sup>241</sup></a>. Therefore, most transporters are used for improving oral bioavailability of small molecular drugs through development of prodrugs, but rarely for biomacromolecules. For example, the prodrug of zanamivir with amino acid groups increased intestinal jejunal permeation by transportation of amino acid transporter<a href="#bib242" rid="bib242" class=" bibr popnode"><sup>242</sup></a>. However, some studies also demonstrated ligand modified nanoparticles were also transported by transporters. For example, the nanoparticles functionalized with deoxycholic acid are able to overcome multiple obstacles and enhance oral absorption of insulin by targeting the apical sodium-dependent bile acid transporter (ASBT)<a href="#bib243" rid="bib243" class=" bibr popnode"><sup>243</sup></a>. Moreover, the insulin-loaded butyrate-PEG nanoparticles produced approximately 3.0-fold improvement of relative pharmacological bioavailability of oral insulin by targeting monocarboxylate transporter 1 (MCT-1) compared to the unmodified nanoparticles<a href="#bib244" rid="bib244" class=" bibr popnode"><sup>244</sup></a>.</p><p id="p0230">Recently, targeting specialized cells in intestinal epithelia attracted lots of interests as an approach of improving oral delivery, such as M cells in peyer's patches, goblet cells and some immune cells. M cells are the most common target cell for oral drug delivery of antigens or proteins due to their special physiological functions<a href="#bib245" rid="bib245" class=" bibr popnode"><sup>245</sup></a>. Particles in intestinal gut can be transported by M cells very fast from apical side to basolateral side and then captured by immune cells in &#x0201c;dome trap&#x0201d; or further enter into lymphatic vessels<a href="#bib63" rid="bib63" class=" bibr popnode"><sup>63</sup></a>. There are a variety of receptors expressed on the surface of M cells for targeting, such as intercellular adhesion molecule (ICAM)-1, <span class="small-caps">l</span>-fucose, <em>&#x003b2;</em>1 integrin and glycoprotein 2 (GP2)<a href="#bib246" rid="bib246" class=" bibr popnode"><sup>246</sup></a>. Lectins are the most common used ligand binding reversibly to receptors of M cells, such as wheat germ agglutinin (WGA) and ulex europaeus agglutinin 1 (UEA1)<a href="#bib226" rid="bib226" class=" bibr popnode"><sup>226</sup></a><sup>,</sup><a href="#bib247" rid="bib247" class=" bibr popnode"><sup>247</sup></a>. Lectin conjugated microparticles and lipid nanoparticles loading insulin resulted in larger glucose level reduction and increment of residence time at intestinal membrane<a href="#bib168" rid="bib168" class=" bibr popnode"><sup>168</sup></a><sup>,</sup><a href="#bib248" rid="bib248" class=" bibr popnode"><sup>248</sup></a>. The tripeptide RGD are extensively used for enhancing the transport of nanoparticles across M cells through targeting <em>&#x003b2;</em>1 integrin<a href="#bib234" rid="bib234" class=" bibr popnode"><sup>234</sup></a>. Besides, some new ligands for targeting M cells were obtained by the phage display technique, such as CKS9<a href="#bib249" rid="bib249" class=" bibr popnode"><sup>249</sup></a>. Goblet cells, a mucus secretion cells, are rarely used to be as target sites for oral delivery. However, recent studies started to pay attention to drug delivery system based on targeting goblet cells. Nanoparticles modified with a peptide of CSKSSDYQC (CSK) which can target to goblet cells can facilitate the uptake in villi and higher internalization <em>via</em> calthrin and caveolae mediated endocytosis on HT29-MTX cells (goblet cell like model)<a href="#bib250" rid="bib250" class=" bibr popnode"><sup>250</sup></a>. Moreover, this nanoparticles loading insulin showed 1.5-fold improvement of relative bioavailability compared to the unmodified ones<a href="#bib228" rid="bib228" class=" bibr popnode"><sup>228</sup></a>. Besides, targeting dendritic cells (DCs) located on apical side of intestinal epithelia has been attempted to improve delivery of vaccines. Several DCs targeting peptides have been validated to increase oral delivery efficiency of antigen and enhance immunization, such as DC-pep that was screened out by phage display<a href="#bib251" rid="bib251" class=" bibr popnode"><sup>251</sup></a><sup>,</sup><a href="#bib252" rid="bib252" class=" bibr popnode"><sup>252</sup></a>.</p><p id="p0235" class="p p-last">Although active targeting is able to increase the uptake in specific intestinal cell group, the insufficient absorption area limits the absorption extent of PPs, which is difficult to increase the oral bioavailability to a large extent. More targets which distribute more extensively in intestinal epithelia need to be explored for oral delivery.</p></div><div id="sec4.3.4" class="sec"><p></p><h4 id="sec4.3.4title" class="inline">4.3.4.  Lymphatic transport </h4><p id="p0240" class="p p-first">Lymphatic route is also an important way for oral absorption. There are various accesses to lymph depending on characteristic of drugs (<a href="/pmc/articles/PMC8424290/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>). After transported across intestinal epithelia, small hydrophilic drug molecules or macromolecules that are smaller than 10&#x000a0;nm (or 16&#x02013;20&#x000a0;kDa for proteins) are transported primarily into the blood capillaries<a href="#bib253" rid="bib253" class=" bibr popnode"><sup>253</sup></a><sup>,</sup><a href="#bib254" rid="bib254" class=" bibr popnode"><sup>254</sup></a>. Nevertheless, the highly lipophilic drugs could be assembled into chylomicron with lipoproteins and subsequently transported into lymph. Particles or macromolecules (antigens or proteins) that are larger than 10&#x000a0;nm are hard to enter into blood capillaries due to small interstitial space of blood capillaries, but able to drain into lymph vessels. However, particles larger than 100&#x000a0;nm are poorly transported into lymph due to reduced diffusion and convection through the interstitium<a href="#bib255" rid="bib255" class=" bibr popnode"><sup>255</sup></a><sup>,</sup><a href="#bib256" rid="bib256" class=" bibr popnode"><sup>256</sup></a>. Both lymphoid (Peyer's patches) and non-lymphoid tissue (villous) in intestinal lumen contribute to the lymphatic transport. Transferring into lymph vessels <em>via</em> non-lymphoid tissue depends upon the lipid pathway, vehicle effects, sieving mechanisms of the blood vessels and the application site. The proximal small intestine is the best lymphatic transport site, while the presence of lymphatic transport has also been proven in rectal administration. M cell in Peyer's patches can take up intestinal particles by phagocytosis and complete transcytosis very fast, which is the main route for highly potent compounds such as lymphokines and antigens. Some excellent reviews have showed various approaches for improving oral lymphatic delivery<a href="#bib257" rid="bib257" class=" bibr popnode"><sup>257</sup></a><sup>,</sup><a href="#bib258" rid="bib258" class=" bibr popnode"><sup>258</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig10" co-legend-rid="lgnd_fig10"><a href="/pmc/articles/PMC8424290/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232411478480"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr10.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 10" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr10.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232411478480"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig10/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig10"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10">Figure&#x000a0;10</a></div><!--caption a7--><div class="caption"><p>The schematic illustration of the intestinal lymphatic transport of chemical drugs or antigens (proteins) after oral administration. (A) Dietary lipids and some highly lipophilic drugs are taken up by enterocytes and then assembled as chylomicron with lipoproteins to be drained into mesenteric lymph. (B) Soluble antigens (proteins) access the mesenteric lymphatics directly or <em>via</em> phagocytosis by dendritic cells after transport by various routes including paracellular diffusion (&#x02460;), uptake into endosome and then exocytosis by exosomes (&#x02461;), transcytosis by enterocytes (&#x02462;), transport by M cells (&#x02463;) or dendritic cells (&#x02464;). (C) Particulate antigens (proteins) are primarily transported by M cells and then processed by a large amount of immune cells under subepithelial dome. Reprinted with the permission from Ref.&#x000a0;<a href="#bib259" rid="bib259" class=" bibr popnode">259</a>. Copyright &#x000a9; 2016 Nature.</p></div></div></div><p id="p0245" class="p p-last">In order to increase absorption of lipid pathway, some lipid formulations were used to mimic the absorption process of dietary fats for improving oral lymphatic transport of PPs. For example, insulin-loaded solid lipid nanoparticles (SLNs) demonstrated significant drug accumulation within intestinal lymphatic system<a href="#bib260" rid="bib260" class=" bibr popnode"><sup>260</sup></a>. In addition, lipidization of peptides <em>via</em> chemical modification with fatty acids is an important approach to increase the lymphatic transport by improving association with chylomicrons, which have been applied in oral delivery of several peptides, such as sCT, encephalin, tetragastrin and insulin<a href="#bib261" rid="bib261" class=" bibr popnode"><sup>261</sup></a>. However, the flow rate of lymph through the intestinal lymphatic system is approximately 500-fold slower than that of blood through intestinal blood capillaries and portal vein, which leads to not sufficient quantity absorbed in systemic circulation for therapeutics<a href="#bib262" rid="bib262" class=" bibr popnode"><sup>262</sup></a>. Therefore, it is very limited to elevate oral bioavailability of therapeutic PPs by targeting lymphatic systems. So far, there are no clinical and commercial products developed by lymphatic targeting technology. However, M cells route has been regarded as an effective pathway to oral deliver vaccine and protein therapeutics. The glucan microparticles incorporating with thermosensitive poloxamer 407 gel improved the oral absorption of insulin, hence producing mild reduction in blood glucose level for over 20&#x000a0;h in diabetic rats<a href="#bib263" rid="bib263" class=" bibr popnode"><sup>263</sup></a>. Meanwhile, the lymphatic transportation is highly correlated with pharmacological bioavailability, which indicates the lymphatic route plays critical role in oral absorption of insulin<a href="#bib264" rid="bib264" class=" bibr popnode"><sup>264</sup></a>. The M cell transport is likely related to the physicochemical characteristics of the particles, such as physical and chemical stability, size, surface charge, shape and elasticity. For example, the polystyrene particles with a range of 50&#x000a0;nm and 3&#x000a0;&#x003bc;m have 6%&#x02013;34% absorption ratios after oral administration<a href="#bib265" rid="bib265" class=" bibr popnode"><sup>265</sup></a>. But particles larger than 10&#x000a0;&#x003bc;m are rarely able to be transported by M cell<a href="#bib266" rid="bib266" class=" bibr popnode"><sup>266</sup></a>. Meanwhile, the targeting ligands may influence the adhesive to M cell or uptake of M cell significantly, such as lectins and RGD peptides, which has been described in section <a href="#sec4.3.3" rid="sec4.3.3" class=" sec">4.3.3</a> in detail. However, the GALT comprises less than 10% of whole intestinal epithelial surface, which limits the absorption extent of therapeutic PPs. In addition, the particles could be captured in dome trap after transcytosis by M cells to inhibit the entry of therapeutic PPs into systemic circulation <em>via</em> lymph vessels<a href="#bib63" rid="bib63" class=" bibr popnode"><sup>63</sup></a>. Due to high potency of vaccines, M cell uptake of particulate oral vaccines demonstrated promising potential in clinical trials. The PLGA microspheres containing the <em>Escherichia coli</em> colonization factor antigen II as potential vaccine for enterotoxigenic <em>E. coli</em> can generate antibody responses in 5 out of 10 human subjects<a href="#bib267" rid="bib267" class=" bibr popnode"><sup>267</sup></a>. The PLGA microspheres encapsulating CS6 antigen also demonstrated effective vaccination in phase I clinical trials<a href="#bib268" rid="bib268" class=" bibr popnode"><sup>268</sup></a>. Nevertheless, these clinical trials have not been continued because of variability in immune response generation. Except for the immunology issues, the formulation design may be important hurdles for antigen-loaded particles, including stability of antigen, and release in intestinal lumen or Peyer's patches.</p></div><div id="sec4.3.5" class="sec"><p></p><h4 id="sec4.3.5title" class="inline">4.3.5.  Ionic liquids </h4><p id="p0250" class="p p-first-last">Ionic liquids (ILs) are a category of ionic compounds with melting point below 100&#x000a0;&#x000b0;C, while are called as room temperature ILs (RTILs) if the melting point declines to room temperature<a href="#bib269" rid="bib269" class=" bibr popnode"><sup>269</sup></a>. ILs have been extensively used in chemical engineering as solvents, catalysts, reagents and so on. ILs have good capacity for solubilizing poorly soluble drugs<a href="#bib270" rid="bib270" class=" bibr popnode"><sup>270</sup></a> and strong permeation enhanced ability for biomacromolecules<a href="#bib271" rid="bib271" class=" bibr popnode"><sup>271</sup></a><sup>,</sup><a href="#bib272" rid="bib272" class=" bibr popnode"><sup>272</sup></a>. However, most of ILs in chemistry are not biocompatible for drug delivery or other biological use<a href="#bib273" rid="bib273" class=" bibr popnode"><sup>273</sup></a>. Recently, a class of RTILs based on natural components were developed for improving drug delivery, such as choline and organic acids<a href="#bib274" rid="bib274" class=" bibr popnode"><sup>274</sup></a>. They demonstrated good biocompatibility and permeation enhanced capacity. They are firstly employed to improve transdermal delivery of PPs, such as insulin and bovine serum albumin (BSA)<a href="#bib275" rid="bib275" class=" bibr popnode"><sup>275</sup></a>. Recent study indicated that choline and geranate (CAGE) ILs were able to enhance oral absorption of insulin and insulin-loaded CAGE ILs (3&#x02013;10 IU/kg) produced a significant hypoglycemic effect after intrajejunal administration or oral intake of enteric capsules<a href="#bib276" rid="bib276" class=" bibr popnode"><sup>276</sup></a>. Meanwhile, insulin can maintain conformational and chemical stability in CAGE ILs. ILs could form a self-assembled nanostructure with gastrointestinal fluids spontaneously, which probably contribute to oral absorption or biodistribution <em>in&#x000a0;vivo</em><a href="#bib277" rid="bib277" class=" bibr popnode"><sup>277</sup></a>. Angsantikul et&#x000a0;al.<a href="#bib278" rid="bib278" class=" bibr popnode"><sup>278</sup></a> found that choline and glycolate ILs were also able to reduce the viscosity of the intestinal mucus and enhance the paracellular transport. Therefore, they can effectively deliver TNF<em>&#x003b1;</em> antibodies into the intestinal mucosa as well as systemic circulation. ILs also act as permeation enhancer for biomacromolecules in other mucosal barrier, such as nasal delivery<a href="#bib279" rid="bib279" class=" bibr popnode"><sup>279</sup></a>. ILs can also combine with other formulations as a permeation enhancer. For example, Peng et&#x000a0;al.<a href="#bib280" rid="bib280" class=" bibr popnode"><sup>280</sup></a> fabricated a mucoadhesive ionic liquid gel patches that can improve the oral transport of insulin. However, the interaction between ILs and water has to be highly valued because water is the most common substances in biological body. It is not clear whether water can attenuate the effect of ILs or not<a href="#bib281" rid="bib281" class=" bibr popnode"><sup>281</sup></a>.</p></div><div id="sec4.3.6" class="sec"><p></p><h4 id="sec4.3.6title" class="inline">4.3.6.  Intestinal microneedles </h4><p id="p0255" class="p p-first">Microneedle-based technology has been broadly used in transdermal delivery in pharmaceutical and cosmetics products. Microneedles are able to overcome the main barriers hindering drug absorption, such as stratum corneum in transdermal delivery<a href="#bib282" rid="bib282" class=" bibr popnode"><sup>282</sup></a>. In addition, microneedles can penetrate the physical barrier to improve drug penetration but bring about no damage to the tissue or nerves by tuning the needle length to appropriate size. Therefore, microneedle is a pain-free administration technology<a href="#bib283" rid="bib283" class=" bibr popnode"><sup>283</sup></a>. Recently, microneedles have gradually used in other mucosal delivery routes, such as ocular, oral and vaginal<a href="#bib284" rid="bib284" class=" bibr popnode"><sup>284</sup></a>.</p><p id="p0260" class="p p-last">Mucosal and epithelial barriers are the main factors influencing the oral absorption of PPs. Traverso et&#x000a0;al.<a href="#bib285" rid="bib285" class=" bibr popnode"><sup>285</sup></a> firstly demonstrated proof-of-concept experiments in swine that microneedles were capable to completely overcome the gastrointestinal mucosa and epithelia, and promote oral bioavailability of a biologically active molecule (<a href="/pmc/articles/PMC8424290/figure/fig11/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig11" rid-ob="ob-fig11" co-legend-rid="lgnd_fig11"><span>Fig.&#x000a0;11A&#x02012;</span></a>C). This device was 2&#x000a0;cm in length and 1&#x000a0;cm in diameter, and the microneedles were made of metals. The drug can be loaded in hollow or solid microneedles for release (<a href="/pmc/articles/PMC8424290/figure/fig11/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig11" rid-ob="ob-fig11" co-legend-rid="lgnd_fig11"><span>Fig.&#x000a0;11</span></a>D). In spite of good safety and tolerability of this device indicating in experimental period, the biocompatibility is still a significant concern if it would be developed to be a clinical product. In order to avoid the toxicity caused by metals, biodegradable or dissolvable microneedles are fabricated for biomedical use. Abramson et&#x000a0;al.<a href="#bib286" rid="bib286" class=" bibr popnode"><sup>286</sup></a> employed polymers to fabricate a unfolding microneedle injector (LUMI) (<a href="/pmc/articles/PMC8424290/figure/fig11/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig11" rid-ob="ob-fig11" co-legend-rid="lgnd_fig11"><span>Fig.&#x000a0;11</span></a>E). This injector is composed of three flexible arms, each of which has a 0.5&#x000a0;cm<sup>2</sup> microneedle patch on the far end. The arms are initially bundled together and then the injector is filled in a capsule. The LUMI arms unfold outward after the injector is pushed out of capsule when the capsule reaches the intestine <em>via</em> intragastric administration. Then the arms press the microneedle patches against the intestinal wall to penetrate the epithelia barriers. A company (Rani Therapeutics, San Jose, CA, USA) is developing a related technology to deliver oral biologics, which has been studied in clinical trials<a href="#bib287" rid="bib287" class=" bibr popnode"><sup>287</sup></a>. However, future studies have to be determined whether the microneedle cause distension of small intestine. In addition, the small damage of intestine caused by microneedle could bring about large risk of systemic infection due to presence of a large amount of microorganisms in intestines.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig11" co-legend-rid="lgnd_fig11"><a href="/pmc/articles/PMC8424290/figure/fig11/" target="figure" rid-figpopup="fig11" rid-ob="ob-fig11"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232415514032"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr11.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 11" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr11.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232415514032"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig11/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig11"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig11/" target="figure" rid-figpopup="fig11" rid-ob="ob-fig11">Figure&#x000a0;11</a></div><!--caption a7--><div class="caption"><p>Schematic illustration of the rationale of orally administered microneedles. (A) Computer-aided design of the radial prototype; (B) The produced microdevice with metal endcap and pin; (C) Radiography of the microneedle; (D) Therapeutic use concept of both hollow and solid microneedles; (E) The concept of oral delivery of PPs <em>via</em> microneedle patch. Reprinted with the permission from Refs. 286 and 288. Copyright &#x000a9; 2015 Elsevier and 2019 Nature.</p></div></div></div></div><div id="sec4.3.7" class="sec"><p></p><h4 id="sec4.3.7title" class="inline">4.3.7.  Self-orienting millimeter-scale applicator (SOMA) </h4><p id="p0265" class="p p-first-last">In order to efficiently deliver the biomacromolecules by oral routes, various administration devices were attempted. A self-orienting millimeter scale applicator (SOMA) was inspired by the leopard tortoise's ability to passively reorient (<a href="/pmc/articles/PMC8424290/figure/fig12/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig12" rid-ob="ob-fig12" co-legend-rid="lgnd_fig12"><span>Fig.&#x000a0;12</span></a>) and could deliver biologic drugs by penetrating gastric mucosa rather than intestinal gut<a href="#bib288" rid="bib288" class=" bibr popnode"><sup>288</sup></a>. The thickness of stomach's wall is approximately 4- to 6-mm which provides more space to design the length of needles for safety and efficacy. The hypoglycemic effect of insulin delivered by SOMA is similar as that of sc insulin. However, this oral device is intrinsically an injectable administration and the difference from the common injection is only injection site. Moreover, the injection in GI tract could cause larger risk than sc or intramuscular injection. Recently, a microjet vaccination system was developed to avoid the use of needles. It is a three-dimensional microelectromechanical systems-based drug delivery technology and can produce a high-pressure liquid jet of vaccine to penetrate the buccal mucosal layer<a href="#bib289" rid="bib289" class=" bibr popnode"><sup>289</sup></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig12" co-legend-rid="lgnd_fig12"><a href="/pmc/articles/PMC8424290/figure/fig12/" target="figure" rid-figpopup="fig12" rid-ob="ob-fig12"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140232418230160"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8424290_gr12.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Figure 12" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8424290/bin/gr12.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140232418230160"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/figure/fig12/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig12"><div><a class="figpopup" href="/pmc/articles/PMC8424290/figure/fig12/" target="figure" rid-figpopup="fig12" rid-ob="ob-fig12">Figure&#x000a0;12</a></div><!--caption a7--><div class="caption"><p>The schematic diagram of SOMA. (A) The mechanism of localization, orientation and injection of SOMA in stomach; (B) The fabricated product of SOMA; (C) The shape comparison between SOMA and the leopard tortoise <em>(S. pardalis</em>); (D) The injection device in SOMA. Reprinted with the permission from Ref.&#x000a0;289. Copyright &#x000a9; 2019 Science.</p></div></div></div></div><div id="sec4.3.8" class="sec sec-last"><p></p><h4 id="sec4.3.8title" class="inline">4.3.8.  Nanocarrier-facilitated oral delivery of PPs </h4><p id="p0270" class="p p-first">The largest barriers in oral delivery of PPs are mainly enzymatic degradation and poor permeability across intestinal epithelium. Almost most of strategies are based on overcoming these two barriers to improve oral bioavailability of PPs. Nanocarriers can entrap the active biomacromolecules into the matrix or the core to protect against enzyme degradation through GI lumen. In addition, nanocarriers can be taken up by epithelial cells or M cells in Peyer's patches. Nanocarriers are also able to entrap penetration enhancers together with PPs or be decorated by ligands to further enhance the oral absorption. Hence, various nanocarrier systems have been extensively investigated in oral delivery of biologics including PPs, vaccines and nucleic acids. According to materials of nanocarriers, there are primarily three categories of nanoparticles, such as polymeric, lipid-based and inorganic nanoparticles, some of which have demonstrated good delivery effect for PPs by oral routes (<a href="/pmc/articles/PMC8424290/table/tbl4/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl4" rid-ob="ob-tbl4" co-legend-rid=""><span>Table 4</span></a><a href="#bib106" rid="bib106" class=" bibr popnode"><sup>106</sup></a><sup>,</sup><a href="#bib120" rid="bib120" class=" bibr popnode"><sup>120</sup></a><sup>,</sup><a href="#bib217" rid="bib217" class=" bibr popnode"><sup>217</sup></a><sup>,</sup><a href="#bib219" rid="bib219" class=" bibr popnode"><sup>219</sup></a><sup>,</sup><a href="#bib225" rid="bib225" class=" bibr popnode"><sup>225</sup></a><sup>,</sup><a href="#bib290" rid="bib290" class=" bibr popnode">290</a>, <a href="#bib291" rid="bib291" class=" bibr popnode">291</a>, <a href="#bib292" rid="bib292" class=" bibr popnode">292</a>, <a href="#bib293" rid="bib293" class=" bibr popnode">293</a>, <a href="#bib294" rid="bib294" class=" bibr popnode">294</a>, <a href="#bib295" rid="bib295" class=" bibr popnode">295</a>, <a href="#bib296" rid="bib296" class=" bibr popnode">296</a>, <a href="#bib297" rid="bib297" class=" bibr popnode">297</a>, <a href="#bib298" rid="bib298" class=" bibr popnode">298</a>, <a href="#bib299" rid="bib299" class=" bibr popnode">299</a>, <a href="#bib300" rid="bib300" class=" bibr popnode">300</a>, <a href="#bib301" rid="bib301" class=" bibr popnode">301</a>, <a href="#bib302" rid="bib302" class=" bibr popnode">302</a>, <a href="#bib303" rid="bib303" class=" bibr popnode">303</a>, <a href="#bib304" rid="bib304" class=" bibr popnode">304</a>, <a href="#bib305" rid="bib305" class=" bibr popnode">305</a>, <a href="#bib306" rid="bib306" class=" bibr popnode">306</a>, <a href="#bib307" rid="bib307" class=" bibr popnode">307</a>, <a href="#bib308" rid="bib308" class=" bibr popnode">308</a>, <a href="#bib309" rid="bib309" class=" bibr popnode">309</a>, <a href="#bib310" rid="bib310" class=" bibr popnode">310</a>, <a href="#bib311" rid="bib311" class=" bibr popnode">311</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p>Representative examples of nanotechnology-based strategies used for enhancing oral absorption of PPs.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Nanotechnology</th><th rowspan="1" colspan="1">Material</th><th rowspan="1" colspan="1">Modification</th><th rowspan="1" colspan="1">Size (nm)</th><th rowspan="1" colspan="1">PPs</th><th rowspan="1" colspan="1">Absorption</th><th rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="10" colspan="1">Polymeric nanoparticles</td><td rowspan="4" colspan="1">PLGA</td><td rowspan="1" colspan="1">TMC</td><td rowspan="1" colspan="1">247.6</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">2-Fold higher relative bioavailability for insulin</td><td rowspan="1" colspan="1"><a href="#bib290" rid="bib290" class=" bibr popnode">290</a></td></tr><tr><td rowspan="1" colspan="1">WGA</td><td rowspan="1" colspan="1">231.9</td><td rowspan="1" colspan="1">Thymopentin</td><td rowspan="1" colspan="1">Enhancing the interaction with M cells by 1.8&#x02013;4.2-fold and increasing the values of CD4<sup>+</sup>/CD8<sup>+</sup> ratios</td><td rowspan="1" colspan="1"><a href="#bib291" rid="bib291" class=" bibr popnode">291</a></td></tr><tr><td rowspan="1" colspan="1">RGD-PEG</td><td rowspan="1" colspan="1">200</td><td rowspan="1" colspan="1">Ovalbumin</td><td rowspan="1" colspan="1">Concentrating in M cells particularly</td><td rowspan="1" colspan="1"><a href="#bib292" rid="bib292" class=" bibr popnode">292</a></td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">302&#x02013;328</td><td rowspan="1" colspan="1"><em>&#x003b2;</em>-LGDP</td><td rowspan="1" colspan="1">Increasing mucosal immunity and milk allergy prevention</td><td rowspan="1" colspan="1"><a href="#bib293" rid="bib293" class=" bibr popnode">293</a></td></tr><tr><td rowspan="1" colspan="1">PLA-PEG</td><td rowspan="1" colspan="1">Fc fragments</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Producing a prolonged hypoglycemic effect in wild-type mice at a clinically relevant insulin dose of 1.1 U/kg</td><td rowspan="1" colspan="1"><a href="#bib225" rid="bib225" class=" bibr popnode">225</a></td></tr><tr><td rowspan="4" colspan="1">Chitosan</td><td rowspan="1" colspan="1">PGA</td><td rowspan="1" colspan="1">232.9</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Approximately 20% of relative oral bioavailability</td><td rowspan="1" colspan="1"><a href="#bib120" rid="bib120" class=" bibr popnode">120</a></td></tr><tr><td rowspan="1" colspan="1">PEG</td><td rowspan="1" colspan="1">200&#x02013;250</td><td rowspan="1" colspan="1">PTH1-34</td><td rowspan="1" colspan="1">Improving oral bioavailability of PTH remarkably</td><td rowspan="1" colspan="1"><a href="#bib294" rid="bib294" class=" bibr popnode">294</a></td></tr><tr><td rowspan="1" colspan="1">Dextran/TMC</td><td rowspan="1" colspan="1">200&#x02013;300</td><td rowspan="1" colspan="1">Lipoprotein</td><td rowspan="1" colspan="1">Increasing the humoral immunity and the level of antibody</td><td rowspan="1" colspan="1"><a href="#bib295" rid="bib295" class=" bibr popnode">295</a></td></tr><tr><td rowspan="1" colspan="1">Eudragit L100/mannosylated</td><td rowspan="1" colspan="1">558.2</td><td rowspan="1" colspan="1">BSA</td><td rowspan="1" colspan="1">Eliciting strong systemic IgG antibody and mucosal IgA responses</td><td rowspan="1" colspan="1"><a href="#bib106" rid="bib106" class=" bibr popnode">106</a></td></tr><tr><td rowspan="1" colspan="1">Dendrimer</td><td rowspan="1" colspan="1">PEG</td><td rowspan="1" colspan="1">1100</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Controlling the blood glucose levels</td><td rowspan="1" colspan="1"><a href="#bib296" rid="bib296" class=" bibr popnode">296</a></td></tr><tr><td rowspan="10" colspan="1">Lipid-based nanoparticles</td><td rowspan="6" colspan="1">Liposomes</td><td rowspan="1" colspan="1">WGA-carbopol</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">sCT</td><td rowspan="1" colspan="1">Enhancing oral absorption of sCT by more than 20-fold</td><td rowspan="1" colspan="1"><a href="#bib297" rid="bib297" class=" bibr popnode">297</a></td></tr><tr><td rowspan="1" colspan="1">Biotinylated</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">The relative oral bioavailability achieved to 12.09%</td><td rowspan="1" colspan="1"><a href="#bib217" rid="bib217" class=" bibr popnode">217</a></td></tr><tr><td rowspan="1" colspan="1">Sodium caprate</td><td rowspan="1" colspan="1">200&#x02013;250</td><td rowspan="1" colspan="1">hGH</td><td rowspan="1" colspan="1">Leading to a relative bioavailability of hGH of 3.4%</td><td rowspan="1" colspan="1"><a href="#bib298" rid="bib298" class=" bibr popnode">298</a></td></tr><tr><td rowspan="1" colspan="1">PLFE</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">OVA</td><td rowspan="1" colspan="1">Improving the immune response of OVA</td><td rowspan="1" colspan="1"><a href="#bib299" rid="bib299" class=" bibr popnode">299</a></td></tr><tr><td rowspan="1" colspan="1">MPC</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">BSA</td><td rowspan="1" colspan="1">Higher levels of IgG in the sera and IgA in the mucosa</td><td rowspan="1" colspan="1"><a href="#bib300" rid="bib300" class=" bibr popnode">300</a></td></tr><tr><td rowspan="1" colspan="1">UEA-1</td><td rowspan="1" colspan="1">400&#x02013;500</td><td rowspan="1" colspan="1">BSM</td><td rowspan="1" colspan="1">Higher sIgA level and cytokines level</td><td rowspan="1" colspan="1"><a href="#bib301" rid="bib301" class=" bibr popnode">301</a></td></tr><tr><td rowspan="2" colspan="1">SLN</td><td rowspan="1" colspan="1">Cationic lipids</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Protecting insulin from the enzymatic degradation</td><td rowspan="1" colspan="1"><a href="#bib302" rid="bib302" class=" bibr popnode">302</a></td></tr><tr><td rowspan="1" colspan="1">CSK/IRQ</td><td rowspan="1" colspan="1">244/410</td><td rowspan="1" colspan="1">sCT</td><td rowspan="1" colspan="1">Leading to the absolute bioavailability of 12.41% and 10.05%, respectively</td><td rowspan="1" colspan="1"><a href="#bib303" rid="bib303" class=" bibr popnode">303</a></td></tr><tr><td rowspan="2" colspan="1">Nanoemulsions</td><td rowspan="1" colspan="1">Alginate/chitosan</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">The oral relative bioavailability was 8.42%</td><td rowspan="1" colspan="1"><a href="#bib304" rid="bib304" class=" bibr popnode">304</a></td></tr><tr><td rowspan="1" colspan="1">Oil-structured nanoemulsion</td><td rowspan="1" colspan="1">250.8</td><td rowspan="1" colspan="1">Exenatide</td><td rowspan="1" colspan="1">Improving the bioavailability of exenatide <em>via</em> intestinal lymphatic transport</td><td rowspan="1" colspan="1"><a href="#bib305" rid="bib305" class=" bibr popnode">305</a></td></tr><tr><td rowspan="7" colspan="1">Inorganic nanoparticles</td><td rowspan="4" colspan="1">Silica</td><td rowspan="1" colspan="1">Chitosan</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">Exenatide</td><td rowspan="1" colspan="1">Enhancing transport across Caco-2 monolayer by 1.7-fold</td><td rowspan="1" colspan="1"><a href="#bib306" rid="bib306" class=" bibr popnode">306</a></td></tr><tr><td rowspan="1" colspan="1">CPP-PEG</td><td rowspan="1" colspan="1">173.2</td><td rowspan="1" colspan="1">hGH</td><td rowspan="1" colspan="1">Leading to 4.91-fold increase in pharmacodynamics</td><td rowspan="1" colspan="1"><a href="#bib307" rid="bib307" class=" bibr popnode">307</a></td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">200</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Showing sustaining hypoglycemic effect.</td><td rowspan="1" colspan="1"><a href="#bib308" rid="bib308" class=" bibr popnode">308</a></td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">175&#x02013;321</td><td rowspan="1" colspan="1">OVA</td><td rowspan="1" colspan="1">Enhancing the phagocytosis by dendritic cells and the production of specific antibodies</td><td rowspan="1" colspan="1"><a href="#bib309" rid="bib309" class=" bibr popnode">309</a></td></tr><tr><td rowspan="2" colspan="1">Calcium phosphate</td><td rowspan="1" colspan="1">VB<sub>12</sub></td><td rowspan="1" colspan="1">&#x0003c;250</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Enhancing oral bioavailability by 4-fold and showing sustained hypoglycemic effects up to 12&#x000a0;h</td><td rowspan="1" colspan="1"><a href="#bib219" rid="bib219" class=" bibr popnode">219</a></td></tr><tr><td rowspan="1" colspan="1">Polysaccharide</td><td rowspan="1" colspan="1">14&#x02013;35</td><td rowspan="1" colspan="1">OVA</td><td rowspan="1" colspan="1">Enhancing the mucosal IgA and serum IgG responses</td><td rowspan="1" colspan="1"><a href="#bib310" rid="bib310" class=" bibr popnode">310</a></td></tr><tr><td rowspan="1" colspan="1">Gold</td><td rowspan="1" colspan="1">Chondroitin sulfate</td><td rowspan="1" colspan="1">123</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">The oral absorption was enhanced with 6.61-fold</td><td rowspan="1" colspan="1"><a href="#bib311" rid="bib311" class=" bibr popnode">311</a></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232427692224"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.ae.d.f.k.c.ah.e.a"><p class="p p-first-last">Abbreviations: PLGA, poly(<span class="small-caps">d</span>,<span class="small-caps">l</span>-lactide-<em>co</em>-glycolide); TMC, <em>N</em>-trimethyl chitosan chloride; WGA, wheat germ agglutinin; RGD, arginylglycylaspartic acid; PLA-PEG, poly(lactic acid)-poly(ethylene oxide); PGA, poly(<em>&#x003b3;</em>-glutamic acid); PTH1&#x02013;34, parathyroid hormone 1&#x02013;34; <em>&#x003b2;</em>-LGDP, beta-lactoglobulin-derived peptides; BSA, bovine serum albumin; sCT, salmon calcitonin; hGH, human growth hormone; PLFE, polar lipid fraction E; UEA-1, ulex europaeus agglutinin 1; BSM, bovine submaxillary mucin; MPC, mannose-PEG-cholesterol conjugate; CPP, cell-penetrating peptide; OVA, ovalbumin; VB<sub>12</sub>, vitamin B<sub>12</sub>.</p></div></div></div><div id="sec4.3.8.1" class="sec"><p></p><h5 id="sec4.3.8.1title" class="inline">4.3.8.1.  Polymeric nanoparticles </h5><p id="p0275" class="p p-first-last">Polymeric nanoparticles have been widely explored to circumvent multiple barriers hindering oral delivery of PPs. Except for protecting PPs from degradation in harsh GI environments, polymeric nanoparticles can increase the epithelial transport by improving cellular uptake and inhibiting efflux of P-gp<a href="#bib312" rid="bib312" class=" bibr popnode"><sup>312</sup></a>. In addition, some polymers can reversibly open tight junctions, allowing transport of PPs through paracellular pathway, such as chitosan and its derivatives<a href="#bib313" rid="bib313" class=" bibr popnode"><sup>313</sup></a>. The active transport through enterocytes, goblet and M cells can be enhanced by decorating ligands on the surface of nanoparticles<a href="#bib215" rid="bib215" class=" bibr popnode"><sup>215</sup></a>. Polymeric nanoparticles are generally composed of synthetic, semi-synthetic or natural polymers with diameter ranging from 10 to 1000&#x000a0;nm. Natural polymers are abundantly present in nature and have good compatibility, hence, have gained extensive interests in oral delivery of PPs, such as chitosan, gelatin, alginate and hyaluronic acid<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a>. Chitosan is the most common materials as nanoparticulate delivery system for PPs due to its mucoadhesive and permeation enhancement characteristics. In addition, chitosan is also easily modified to achieve various aims, such as pH-responsive release, increasing hydrophilicity and positive charges or improving mucoadhesive ability<a href="#bib314" rid="bib314" class=" bibr popnode">314</a>, <a href="#bib315" rid="bib315" class=" bibr popnode">315</a>, <a href="#bib316" rid="bib316" class=" bibr popnode">316</a>. A pH-responsive nanoparticles developed by conjugating chitosan and poly<em>-&#x003b3;-</em>glutamic acid (PGA) can enhance the paracellular transport of insulin by opening the tight junctions between adjacent cells<a href="#bib317" rid="bib317" class=" bibr popnode"><sup>317</sup></a>. Chitosan/alginate nanoparticles can increase pharmacological availability of insulin to 6.8% and 3.4% for the 50 and 100 IU/kg dose respectively<a href="#bib318" rid="bib318" class=" bibr popnode"><sup>318</sup></a>. The <em>N-</em>trimethyl chitosan (TMC) can significantly enhance the permeability of peptides or proteins in comparison of normal chitosan<a href="#bib319" rid="bib319" class=" bibr popnode"><sup>319</sup></a>, hence, has been used as permeation enhancer to coat other nanocarriers<a href="#bib320" rid="bib320" class=" bibr popnode"><sup>320</sup></a> or engineer nanocarriers together with other materials<a href="#bib321" rid="bib321" class=" bibr popnode"><sup>321</sup></a>. Recently, chitosan oligomers were found to reduce the coulombic repulsion between anionic calcitonin and negatively charged intestinal epithelial cells, which facilitates the oral absorption of calcitonin<a href="#bib322" rid="bib322" class=" bibr popnode"><sup>322</sup></a>. In terms of synthetic polymers, the PLGA, PCL, PLA and polyacrylic acid (PAA) are frequently studied for PPs delivery due to good biocompatibility. These polymeric nanoparticles exhibited better capacity to protect against GI digestion, but it is necessary to combine with other permeation enhancers for improving intestinal epithelial permeability of PPs<a href="#bib323" rid="bib323" class=" bibr popnode"><sup>323</sup></a>. However, lack of self-regulating release of insulin is still a big issue for oral delivery. Recently, Paul et&#x000a0;al.<a href="#bib324" rid="bib324" class=" bibr popnode"><sup>324</sup></a><sup>,</sup><a href="#bib325" rid="bib325" class=" bibr popnode"><sup>325</sup></a> developed a biomimetic imprinted nanoparticles to increase self-regulating adhesion and release of insulin by molecular imprinting technique. The imprinted nanoparticles significantly prolonged hypoglycemic effect for up to 24&#x000a0;h and increased insulin transport <em>via</em> transcellular pathway. Yet, the oral bioavailability of PPs delivered by polymeric nanoparticles is still very limited and not sufficient for clinical therapy. Meanwhile, long-term exposure of these nanoparticles in GI tract is still a concern.</p></div><div id="sec4.3.8.2" class="sec"><p></p><h5 id="sec4.3.8.2title" class="inline">4.3.8.2.  Lipid-based nanocarriers </h5><p id="p0280" class="p p-first">Lipid-based nanocarriers (LBNs) are composed of natural lipids or phospholipids to form emulsion, solid particles or vesicles<a href="#bib326" rid="bib326" class=" bibr popnode"><sup>326</sup></a>. Due to high biocompatibility, LBNs have received much attention as oral delivery systems. However, LBNs are difficult to entrap hydrophilic macromolecules with high efficiency, which is a primary hurdle to be developed for oral delivery of PPs<a href="#bib327" rid="bib327" class=" bibr popnode"><sup>327</sup></a>. In addition, LBNs can be degraded by lipolysis in GI tract, leading to poor protecting ability for entrapped PPs<a href="#bib328" rid="bib328" class=" bibr popnode"><sup>328</sup></a>. Therefore, SLNs appear to be better than emulsions or liposomes. Nevertheless, nanoemulsions and liposomes have also exerted certain superiority for oral delivery of some PPs by regulating formulation.</p><p id="p0285">The nanoemulsions are generally used to incorporate lipophilic drugs into the oil droplets for improving oral absorption. Although the incorporation of hydrophilic PPs in the internal phase of o/w nanoemulsions is difficult to achieve, some poorly water soluble peptides have been successfully developed to be oral products by SNEDDS, such as Sandimmum Neoral&#x000ae; for cyclosporine A<a href="#bib329" rid="bib329" class=" bibr popnode"><sup>329</sup></a>. In order to effectively entrap hydrophilic PPs in nanoemulsions, the w/o nanoemulsion was employed for oral delivery of PPs. The PPs can be completely encapsulated in the core of w/o nanoemulsions to protect against degradation in the harsh GI environments<a href="#bib330" rid="bib330" class=" bibr popnode"><sup>330</sup></a>. A insulin-loaded w/o nanoemulsions with the diameter of 161.7&#x000a0;&#x000b1;&#x000a0;24.7&#x000a0;nm enhanced oral bioavailability of insulin by 10-fold compared with plain insulin solution<a href="#bib331" rid="bib331" class=" bibr popnode"><sup>331</sup></a>. Moreover, the w/o microemulsion exhibited more significant effect in oral delivery of other proteins, such as earthworm fibrinolytic enzyme which are increased to 208-fold higher bioavailability than that of control solution by intraduodenal administration<a href="#bib332" rid="bib332" class=" bibr popnode"><sup>332</sup></a>. However, the w/o nanoemulsions definitely occur phase conversion due to a large amount of water in GI tract, which could cause the leakage of encapsulated PPs. Therefore, Li et&#x000a0;al.<a href="#bib304" rid="bib304" class=" bibr popnode"><sup>304</sup></a> employed chitosan and alginate to coat the nanoemulsion to avoid fast leakage of insulin from the core of nanoemulsion.</p><p id="p0290">Liposomes are simulated natural cell membrane structure and have been successfully used in delivery of anticancer drugs to decrease the toxicity, such as Doxil&#x000ae; for doxorubicin. Likewise, multiple remarkable advantages of liposomes received much interests in oral drug delivery, such as good biocompatibility, flexible encapsulation and tunable characteristics<a href="#bib333" rid="bib333" class=" bibr popnode"><sup>333</sup></a>. Liposomes have been attempted to be investigated in oral drug delivery of insulin as early as the late 1970s<a href="#bib334" rid="bib334" class=" bibr popnode"><sup>334</sup></a><sup>,</sup><a href="#bib335" rid="bib335" class=" bibr popnode"><sup>335</sup></a>. Unfortunately, the results are always indistinct. For example, a study indicated that oral insulin-loaded liposomes were able to exhibit hypoglycemic effect in only 54% of the normal rats and 67% of the diabetic rabbits<a href="#bib336" rid="bib336" class=" bibr popnode"><sup>336</sup></a>, which could be ascribed to poor stability of conventional liposomes in GI tract<a href="#bib112" rid="bib112" class=" bibr popnode"><sup>112</sup></a><sup>,</sup><a href="#bib337" rid="bib337" class=" bibr popnode"><sup>337</sup></a>. Recent modification technologies facilitate the development of liposomes in oral delivery by addition of polymer coating and modulating liposomal compositions. Liposomes containing bile salts have revealed better stability in GI tract than conventional liposomes<a href="#bib192" rid="bib192" class=" bibr popnode"><sup>192</sup></a><sup>,</sup><a href="#bib193" rid="bib193" class=" bibr popnode"><sup>193</sup></a> by avoiding the destructive effect of physiological bile salts. In addition, bile salts, such as sodium glycocholate (SGC), sodium taurocholate (STC) and sodium deoxycholate (SDC), are capable of inhibiting the activity of GI enzymes including pepsin, trypsin and <em>&#x003b1;</em>-chymotrypsin<a href="#bib112" rid="bib112" class=" bibr popnode"><sup>112</sup></a>. Moreover, liposomes containing bile salts can improve the <em>trans-</em>enterocytic internalization compared with conventional liposomes, which could be an important mechanism for enhanced oral absorption of PPs<a href="#bib192" rid="bib192" class=" bibr popnode"><sup>192</sup></a>. Besides, cholesterols in conventional liposomes replaced by other sterols (<em>i.e.</em>, ergosterol) is also a promising strategy for improving stability and transmembrane ability of liposomes in GI tract<a href="#bib47" rid="bib47" class=" bibr popnode"><sup>47</sup></a>. Liposomes containing bile salts, also named as bilosomes, have been widely used in the fields of vaccine delivery<a href="#bib338" rid="bib338" class=" bibr popnode"><sup>338</sup></a>. The general sense of bilosomes refers to bilayer vesicles fabricated by surfactants with the incorporation of bile salts which is to stabilize the vesicles in GI tract by preventing membrane destabilization. For example, bilosomes constructed from monopalmitoylglycerol, cholesterol, dicetyl phosphate and SDC showed promoted effect in reduction of viral cell load in an influenza challenge study by increasing uptake within the Peyer's patches<a href="#bib339" rid="bib339" class=" bibr popnode"><sup>339</sup></a>.</p><p id="p0295" class="p p-last">Lipid nanoparticles are composed of solid lipids or mixtures of solid and liquid lipids with a diameter size smaller than 1000&#x000a0;nm, including SLNs and nanostructured lipid carriers (NLCs)<a href="#bib340" rid="bib340" class=" bibr popnode"><sup>340</sup></a>. Due to highly hydrophilic nature of PPs, they are poorly encapsulated in the matrix of SLNs and could distributed in the water phase or interface between oil and water owing to the presence of surfactants<a href="#bib341" rid="bib341" class=" bibr popnode"><sup>341</sup></a>. In addition, the drug expulsion usually occurs in SLNs after polymorphic transition during storage. NLCs can improve the loading capacity and avoid drug expulsion due to the involvement of liquid lipids compared with SLNs<a href="#bib342" rid="bib342" class=" bibr popnode"><sup>342</sup></a>. Since the mid 1990's, many groups have explored the encapsulation of various PPs in lipid nanoparticles through optimization of formulation and preparation, such as BSA, insulin, sCT, LHRH and protein antigens<a href="#bib341" rid="bib341" class=" bibr popnode"><sup>341</sup></a>. Although entrapment efficiency can be improved significantly, the loading capacity for most of PPs is still not more than 10%. Sarmento et&#x000a0;al.<a href="#bib343" rid="bib343" class=" bibr popnode"><sup>343</sup></a> engineered an insulin-loaded SLNs with entrapment efficiency of over 43% demonstrated a considerable hypoglycemic effect during 24&#x000a0;h after oral administration to diabetic rats. Various surface modification technologies were employed to further increase the delivery efficiency of SLNs, such as chitosan coating<a href="#bib344" rid="bib344" class=" bibr popnode"><sup>344</sup></a>, lectin<a href="#bib168" rid="bib168" class=" bibr popnode"><sup>168</sup></a> and octaarginine modification<a href="#bib345" rid="bib345" class=" bibr popnode"><sup>345</sup></a>. In addition, surface charge of lipid nanoparticles is a crucial factor determining the <em>in&#x000a0;vivo</em> behaviors after oral administration. Anionic charges can slow down the lipolysis of SLNs, while cationic charge can accelerate this process. The absorption of intact SLNs into blood circulation with the fastest and largest absorption was observed for net neutral SLNs<a href="#bib346" rid="bib346" class=" bibr popnode"><sup>346</sup></a>. The absorption amount of intact SLNs is highly significant for therapeutic PPs.</p></div><div id="sec4.3.8.3" class="sec sec-last"><p></p><h5 id="sec4.3.8.3title" class="inline">4.3.8.3.  Inorganic nanoparticles </h5><p id="p0300" class="p p-first">Inorganic nanoparticles have attracted increasing attention in drug delivery systems and also been used in improving oral delivery of PPs, such as silica nanoparticles<a href="#bib26" rid="bib26" class=" bibr popnode"><sup>26</sup></a>, gold nanoparticles<a href="#bib311" rid="bib311" class=" bibr popnode"><sup>311</sup></a>, calcium carbonate or phosphate nanoparticles<a href="#bib347" rid="bib347" class=" bibr popnode"><sup>347</sup></a>.</p><p id="p0305">Silica nanoparticles are the most commonly used drug carrier in inorganic nanoparticles due to good biocompatibility and tunability in size or morphology. Mesoporous silica nanoparticles (MSNs) have been widely used in improving oral bioavailability of poorly water soluble drugs<a href="#bib348" rid="bib348" class=" bibr popnode"><sup>348</sup></a>. PPs can be loaded in MSNs by physical absorption and covalent conjugation. Physical absorption is difficult to achieve higher loading capacity which is generally lower than 15%. Whereas, covalent conjugation can bring about environmental sensitive release for PPs<a href="#bib26" rid="bib26" class=" bibr popnode"><sup>26</sup></a>. MSNs can protect PPs against degradation by harsh GI environments. In addition, the surface of MSNs can also be coated or modified for improving stability or intestinal transport. PEGylated MSNs are able to protect the conformation of insulin under simulated gastric and intestinal condition<a href="#bib349" rid="bib349" class=" bibr popnode"><sup>349</sup></a> and polymethacrylates coating enables pH responsive release of insulin from MSNs<a href="#bib350" rid="bib350" class=" bibr popnode"><sup>350</sup></a>. The SBA-15, a kind of MSNs, were used to deliver hepatitis B orally, indicating that they were able to protect and release the hepatitis B surface antigen (HBsAg) and offer better antibody response than intravenous delivery<a href="#bib351" rid="bib351" class=" bibr popnode"><sup>351</sup></a>. Calcium based nanoparticles have attracted more interests in nanocarrier for PPs, such as calcium phosphate (CaP) and calcium carbonate (CaCO<sub>3</sub>)<a href="#bib352" rid="bib352" class=" bibr popnode"><sup>352</sup></a>. Similarly as MSNs, calcium based nanoparticles were generally coated using some polymers to improve the oral absorption and biocompatibility, for instance, hyaluronic acid coated CaCO<sub>3</sub> nanoparticles exerted satisfied hypoglycemic effect for oral insulin delivery<a href="#bib223" rid="bib223" class=" bibr popnode"><sup>223</sup></a> and PEGylated CaP nanoparticles were found to be able to protect the insulin and sustain the release at the physiological pH<a href="#bib353" rid="bib353" class=" bibr popnode"><sup>353</sup></a>. Further, vitamin B<sub>12</sub> was grafted to chitosan as a ligand to coat CaP nanoparticles for improving oral insulin absorption by 4.3-fold compared with naked nanoparticles<a href="#bib219" rid="bib219" class=" bibr popnode"><sup>219</sup></a>. Gold nanoparticles capped with chondroitin sulfate or apple polysaccharide are able to increase plasma insulin concentration and anti-diabetic capability<a href="#bib311" rid="bib311" class=" bibr popnode"><sup>311</sup></a><sup>,</sup><a href="#bib354" rid="bib354" class=" bibr popnode"><sup>354</sup></a>. The composites of insulin/zirconium phosphate (ZrP) coated with titanium dioxide (TiO<sub>2</sub>) were found to be non-toxic to biological environment and used for oral insulin delivery, which indicates promising <em>in&#x000a0;vitro</em> drug release for a long time<a href="#bib355" rid="bib355" class=" bibr popnode"><sup>355</sup></a>.</p><p id="p0310" class="p p-last">However, biosafety is a big concern for inorganic nanoparticles in drug delivery since they are non-degradable in biological environments<a href="#bib356" rid="bib356" class=" bibr popnode"><sup>356</sup></a>. Most of PPs are needed to be administered for a long time due to short half-life, which could lead to accumulation of inorganic nanoparticles in human body<a href="#bib357" rid="bib357" class=" bibr popnode"><sup>357</sup></a>. Thus, inorganic nanoparticles could be not ideal carriers for oral delivery of PPs.</p></div></div></div></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">5. Oral delivery systems of PPs commercially available and under clinical and preclinical studies</h2><div id="sec5.1" class="sec sec-first"><h3 id="sec5.1title">5.1. Current oral PPs on the market</h3><p id="p0315" class="p p-first">Since the approval of first recombinant insulin in 1981, a great number of PPs have been developed in the recent years as new therapeutics. However, few PPs are administered <em>via</em> oral route due to great challenges in oral delivery<a href="#bib358" rid="bib358" class=" bibr popnode"><sup>358</sup></a>. Moreover, current oral PPs on the market include both systemic delivery and local retention in the GI tract. For instance, cyclosporine A is one of the marketed oral peptides and formulated as SNEDDS<a href="#bib359" rid="bib359" class=" bibr popnode"><sup>359</sup></a>. While, numerous oral enzyme products are delivered to local GI tract to treat metabolic disorders. Some oral PPs commercially available are listed in <a href="/pmc/articles/PMC8424290/table/tbl5/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl5" rid-ob="ob-tbl5" co-legend-rid=""><span>Table 5</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p>Oral products of PPs on markets.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">PPs</th><th rowspan="1" colspan="1">Trade name</th><th rowspan="1" colspan="1">Technology</th><th rowspan="1" colspan="1">Indication</th><th rowspan="1" colspan="1">Company</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cyclosporin A</td><td rowspan="1" colspan="1">Neoral&#x000ae;/Sandimmune&#x000ae;</td><td rowspan="1" colspan="1">SNEDDS</td><td rowspan="1" colspan="1">Immunosuppression; systemic delivery</td><td rowspan="1" colspan="1">Novatis AG (Switzerland)</td></tr><tr><td rowspan="1" colspan="1">Desmopressin acetate</td><td rowspan="1" colspan="1">DDAVP&#x000ae;</td><td rowspan="1" colspan="1">Chemical modification</td><td rowspan="1" colspan="1">Central diabetes insipidus; systemic delivery</td><td rowspan="1" colspan="1">Ferring Pharmaceuticals (Switzerland)</td></tr><tr><td rowspan="1" colspan="1">Octreotide</td><td rowspan="1" colspan="1">Mycapssa&#x000ae;</td><td rowspan="1" colspan="1">Enteric coating; permeation enhancer</td><td rowspan="1" colspan="1">Long-term maintenance treatment in acromegaly patients; systemic delivery</td><td rowspan="1" colspan="1">Chiasma (USA)</td></tr><tr><td rowspan="1" colspan="1">Semaglutide</td><td rowspan="1" colspan="1">Rybelsus&#x000ae;</td><td rowspan="1" colspan="1">Permeation enhancer</td><td rowspan="1" colspan="1">Type 2 diabetes mellitus; systemic delivery</td><td rowspan="1" colspan="1">Novo Nordisk (Denmark)</td></tr><tr><td rowspan="1" colspan="1">Taltirelin hydrate</td><td rowspan="1" colspan="1">Ceredist&#x000ae;/Ceredist OD&#x000ae;</td><td rowspan="1" colspan="1">Chemical modification</td><td rowspan="1" colspan="1">Spinocerebellar degeneration; systemic delivery</td><td rowspan="1" colspan="1">Mitsubishi Tanabe Pharma Co. (Japan)</td></tr><tr><td rowspan="1" colspan="1">Linaclotide</td><td rowspan="1" colspan="1">Linzess&#x000ae;</td><td rowspan="1" colspan="1">Acts locally</td><td rowspan="1" colspan="1">Irritable bowel syndrome, chronic idiopathic constipation; local delivery</td><td rowspan="1" colspan="1">Actavis, Inc. (USA)</td></tr><tr><td rowspan="1" colspan="1">Vancomycin</td><td rowspan="1" colspan="1">Vancocin&#x000ae;</td><td rowspan="1" colspan="1">Acts locally</td><td rowspan="1" colspan="1">Infection</td><td rowspan="1" colspan="1">ANI Pharmaceuticals, Inc (USA)</td></tr><tr><td rowspan="1" colspan="1">Colistin sulfate</td><td rowspan="1" colspan="1">Koolistin&#x000ae;</td><td rowspan="1" colspan="1">Acts locally</td><td rowspan="1" colspan="1">Infection</td><td rowspan="1" colspan="1">Biocon Ltd. (India)</td></tr><tr><td rowspan="1" colspan="1">Tyrothricin</td><td rowspan="1" colspan="1">Lozenges&#x000ae;</td><td rowspan="1" colspan="1">Acts locally on the throat</td><td rowspan="1" colspan="1">Pharyngitis</td><td rowspan="1" colspan="1">The Boots Company PLC (UK)</td></tr><tr><td rowspan="1" colspan="1">Pancrelipase</td><td rowspan="1" colspan="1">Creon&#x000ae;</td><td rowspan="1" colspan="1">Delayed release; acts locally</td><td rowspan="1" colspan="1">Exocrine pancreatic insufficiency</td><td rowspan="1" colspan="1">AbbVie Inc. (USA)</td></tr><tr><td rowspan="1" colspan="1">Tilactase</td><td rowspan="1" colspan="1">Lacteeze&#x000ae;</td><td rowspan="1" colspan="1">Chewable tablets; acts locally</td><td rowspan="1" colspan="1">Lactose intolerance</td><td rowspan="1" colspan="1">Lacteeze (USA)</td></tr><tr><td rowspan="1" colspan="1">Sacrosidase</td><td rowspan="1" colspan="1">Sucraid&#x000ae;</td><td rowspan="1" colspan="1">Oral solutions; acts locally</td><td rowspan="1" colspan="1">Congenital sucrase-isomaltase deficiency</td><td rowspan="1" colspan="1">QOL Medical, LLC (USA)</td></tr><tr><td rowspan="1" colspan="1">Diamine oxidase</td><td rowspan="1" colspan="1">DAOSiN&#x000ae;</td><td rowspan="1" colspan="1">Acts locally</td><td rowspan="1" colspan="1">Histamine intolerance</td><td rowspan="1" colspan="1">SCiOTEC (Austria)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232414132304"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl5/?report=objectonly">Open in a separate window</a></div></div><p id="p0320">Cyclosporine A is the one of the most successful oral peptide products in market. The combination of the cyclic lipophilic undecapeptide with SNEDDS technologies enables the oral bioavailability achieve 19%&#x02013;40%<a href="#bib360" rid="bib360" class=" bibr popnode"><sup>360</sup></a>. Meanwhile, SNEDDS formulation (Neoral&#x000ae;) overcome the high intra- and inter-patients pharmacokinetics variability in a high percentage of patients by better control of droplet size, increasing intestinal permeability and inhibiting P-glycoprotein efflux and P450 metabolism<a href="#bib360" rid="bib360" class=" bibr popnode"><sup>360</sup></a>. Desmopressin acetate (DDVAP) is also a cyclic peptide and an analog of arginine vasopressin. Its stability is improved by chemical modifications including deamination of the first amino acid and substitution of the eighth amino acid <span class="small-caps">l</span>-arginine by <span class="small-caps">d</span>-arginine<a href="#bib361" rid="bib361" class=" bibr popnode"><sup>361</sup></a>. It was developed as an oral tablet by Ferring Pharmaceuticals (Denmark) as early as 1995 and subsequently a variety of generic products were also approved by FDA. However, the oral bioavailability of DDVAP is only around 0.1% because there is no any permeation enhanced technology used in these oral tablet<a href="#bib362" rid="bib362" class=" bibr popnode"><sup>362</sup></a>. Octreotide is another cyclic peptide which has been commercially available oral products on the market. It is a synthetic analog of the endogenous hormone somatostatin and exerts higher stability than somatostatin in SGF with pepsin due to cyclic structure<a href="#bib49" rid="bib49" class=" bibr popnode"><sup>49</sup></a><sup>,</sup><a href="#bib363" rid="bib363" class=" bibr popnode"><sup>363</sup></a>. The oral enteric capsule of octreotide developed by an oily suspension containing the permeation enhancer sodium caprylate was approved in June 2020 by FDA. However, the phase I and II clinical pharmacokinetics showed the oral bioavailability was only 0.5%<a href="#bib364" rid="bib364" class=" bibr popnode"><sup>364</sup></a>. As a peptide drug treating diabetes, semaglutide was successfully developed as oral formulation by Novo Nordisk. Semaglutide is a GLP-1 analog consisting of 31 amino acid residues and far larger than DDVAP and octreotide. The oral semaglutide (Rybelsus&#x000ae;) was formulated as a tablet combining with permeation enhancer SNAC developed by Emisphere technologies<a href="#bib75" rid="bib75" class=" bibr popnode"><sup>75</sup></a>. The clinical trials demonstrated that 40&#x000a0;mg oral dose was comparable with the 1&#x000a0;mg sc dose<a href="#bib365" rid="bib365" class=" bibr popnode"><sup>365</sup></a>. In addition, taltirelin and reduced <span class="small-caps">l</span>-glutathione can also be administered orally to exert therapeutic efficacy.</p><p id="p0325" class="p p-last">Some proteins are not needed to be delivered systemically, but needed to retain in GI tract to treat some local diseases, such as linaclotide for irritable bowel syndrome and oral enzyme products for GI metabolic disorders. Linaclotide acts as a guanylyl cyclase C agonist locally in the small intestine and was developed as an oral hard capsules to treat chronic idiopathic constipation and irritable bowel syndrome with constipation<a href="#bib366" rid="bib366" class=" bibr popnode"><sup>366</sup></a>. The oral linaclotide is almost not absorbed into systemic circulation. Vancomycin is a glycosylated tricyclic heptapeptide antibiotics and poorly absorbed due to high hydrophilicity and large cyclic structure<a href="#bib367" rid="bib367" class=" bibr popnode"><sup>367</sup></a>. Thus, oral vancomycin capsule was approved for treatment of pseudomembranous colitis by FDA. Some enzymes related with GI function prefer to be administered by oral route. There are a variety of oral enzyme products on the market for GI metabolic disorders such as Creon&#x000ae;, Lacteeze&#x000ae;, Sucraid&#x000ae; and DAOSiN&#x000ae;<a href="#bib368" rid="bib368" class=" bibr popnode"><sup>368</sup></a>. However, most of them are approved as dietary supplements and only pancreatin was approved as drug by FDA.</p></div><div id="sec5.2" class="sec"><h3 id="sec5.2title">5.2. Overview of the current clinical studies</h3><p id="p0330" class="p p-first">In the past decades, the non-invasive routes have attracted more attention for delivery of PPs. A number of oral PPs developed by various new technologies are being clinically evaluated (<a href="/pmc/articles/PMC8424290/table/tbl6/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl6" rid-ob="ob-tbl6" co-legend-rid=""><span>Table 6</span></a>) for both systemic and local delivery. The majority of the technologies for systemic delivery of PPs under clinical trials are for oral insulin<a href="#bib133" rid="bib133" class=" bibr popnode"><sup>133</sup></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl6"><h3>Table 6</h3><!--caption a7--><div class="caption"><p>Oral PP products under clinical trials (clinical <a href="http://trials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">trials.gov</a>).</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">PPs</th><th rowspan="1" colspan="1">Phase</th><th rowspan="1" colspan="1">Technology</th><th rowspan="1" colspan="1">Company</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">Enteric coating; bioadhesive calcium phosphate nanoparticles (Nodlin&#x02122;)</td><td rowspan="1" colspan="1">NOD Pharmaceuticals, Inc. (China)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">Gastrointestinal permeation enhancement technology (GIPET&#x02122;)</td><td rowspan="1" colspan="1">Merrion Pharmaceuticals Ltd. (Ireland) with Novo Nordisk (Denmark)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">Permeation enhancer (Eligen&#x000ae;)</td><td rowspan="1" colspan="1">Emishphere (USA) with Novo Nordisk (Denmark)</td></tr><tr><td rowspan="1" colspan="1">GLP-1 analog</td><td rowspan="1" colspan="1">I</td><td rowspan="1" colspan="1">Permeation enhancer (sodium caparate)</td><td rowspan="1" colspan="1">Merrion Pharmaceuticals Ltd. (Ireland) with Novo Nordisk (Denmark)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Silica-based nanoparticles</td><td rowspan="1" colspan="1">Oshadi (Israel)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Enteric coating; enzyme inhibitor; permeation enhancer</td><td rowspan="1" colspan="1">Oramed (Israel)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Permeation enhancers (Axess&#x02122;, Capsulin&#x02122;)</td><td rowspan="1" colspan="1">Proxima Concepts Ltd/Diabetology (UK)</td></tr><tr><td rowspan="1" colspan="1">PTH</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Permeation enhancers (Axess&#x02122;, CaPTHymone&#x02122;)</td><td rowspan="1" colspan="1">Proxima Concepts Ltd./Diabetology (UK)</td></tr><tr><td rowspan="1" colspan="1">rhPTH(1&#x02013;31)</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Permeation enhancers; enzyme inhibitor (Peptelligence <sup>TM</sup>)</td><td rowspan="1" colspan="1">Enteris Biopharma, Inc. (USA)</td></tr><tr><td rowspan="1" colspan="1">CsA</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Oil in water emulsion</td><td rowspan="1" colspan="1">Sigmoid Pharma (Ireland)</td></tr><tr><td rowspan="1" colspan="1">Dolcanatide</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Chemical modification</td><td rowspan="1" colspan="1">Synergy Pharmaceuticals Inc. (USA)</td></tr><tr><td rowspan="1" colspan="1">Acyline</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Gastrointestinal permeation enhancement technology (GIPET&#x02122;)</td><td rowspan="1" colspan="1">Merrion Pharmaceuticals Ltd. (Ireland)</td></tr><tr><td rowspan="1" colspan="1">Leuprolide</td><td rowspan="1" colspan="1">II</td><td rowspan="1" colspan="1">Permeation enhancer; pH modulator; enzyme inhibitor</td><td rowspan="1" colspan="1">Enteris Biopharm (USA)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">Liver-targeted liposomes</td><td rowspan="1" colspan="1">Diasome Pharma (USA)</td></tr><tr><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">Chemical modification (PEGylated insulin)</td><td rowspan="1" colspan="1">Biocon (India)</td></tr><tr><td rowspan="1" colspan="1">sCT</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">Permeation enhancers (Axess&#x02122;, Capsitonin&#x02122;)</td><td rowspan="1" colspan="1">Proxima Concepts Ltd./Diabetology (UK)</td></tr><tr><td rowspan="1" colspan="1">sCT</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">pH modulator (Peptelligence <sup>TM</sup>)</td><td rowspan="1" colspan="1">Tarsa therapeutics, Inc. (USA)</td></tr><tr><td rowspan="1" colspan="1">sCT</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">Permeation enhancer (5-CNC)</td><td rowspan="1" colspan="1">Emisphere (USA)</td></tr><tr><td rowspan="1" colspan="1">Plenacatide</td><td rowspan="1" colspan="1">III</td><td rowspan="1" colspan="1">Chemical modification; local delivery</td><td rowspan="1" colspan="1">Chiasma (Israel)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232422697792"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl6/?report=objectonly">Open in a separate window</a></div></div><p id="p0335">There are two typical oral insulin products under phase I clinical trials which are developed by Novo Nordisk (Denmark) and NOD Pharmaceuticals Inc. (China). Novo Nordisk employed gastrointestinal permeation enhancement technology (GIPET) to formulate an oral insulin tablet with Merrion Pharmaceuticals (Ireland)<a href="#bib369" rid="bib369" class=" bibr popnode"><sup>369</sup></a>. The formulation is comprised of micelles with absorption enhancers (sodium caprate). Moreover, NOD encapsulated insulin into enteric coated bioadhesive calcium phosphate nanoparticles which were filled into a capsule (Nodlin&#x02122;). Nodlin&#x02122; has completed phase I clinical trials (ChiCTR-TRC-12001872) on healthy volunteers, which exhibited similar hypoglycemic effect compared with sc insulin<a href="#bib370" rid="bib370" class=" bibr popnode"><sup>370</sup></a>.</p><p id="p0340">An oral insulin enteric capsule containing protease inhibitors and permeation enhancers developed by Oramed Pharmaceuticals Inc. (Israel) has completed phase II clinical evaluation for the treatment of T1DM and T2DM. In phase II trial (<a id="__tag_985713723" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00867594" ref="reftype=extlink-clinical-trial&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00867594","term_id":"NCT00867594"}}</span>NCT00867594</a>), the ORME-0801 capsule is able to reduce blood glucose level on eight T1DM patients significantly<a href="#bib371" rid="bib371" class=" bibr popnode"><sup>371</sup></a>. The capsules showed good tolerance and no hypoglycemic phenomenon on all patients ever though a high dose of insulin was administered. Inorganic silica nanoparticles were firstly used for oral insulin delivery by the Oshadi Drug Administration Ltd. (Israel), which is under phase II clinical trial. The formulation is developed by inert silica nanoparticles (1&#x02013;100&#x000a0;nm) loading oily suspended insulin together with the branched polysaccharides<a href="#bib372" rid="bib372" class=" bibr popnode"><sup>372</sup></a>. Biocon limited (India) developed an oral insulin named Tregopil based on chemical modification. Tregopil employed chemical modification to conjugate the <em>&#x003b2;</em>29-Lys-amino group of human insulin with a single methoxy triethylene glycol propionyl unit through amide linkage<a href="#bib373" rid="bib373" class=" bibr popnode"><sup>373</sup></a>. Recently, Tregopil has completed phase II clinical trials for two doses (45&#x000a0;mg and 30&#x000a0;mg). Tregopil demonstrated well toleration with the patients, and rapid and prolonged hypoglycemic effect at different dosing interval. Besides, the composition of the observed meal has no influences on pharmacodynamic effect of the insulin<a href="#bib374" rid="bib374" class=" bibr popnode"><sup>374</sup></a>. In addition, there are some other oral peptides under phase II clinical trials, such as PTH for osteoporosis and leuprolide for endometriosis.</p><p id="p0345">It is very interesting that a hepatocyte targeting liposomes of oral insulin developed by Diasome Pharmaceuticals (USA) has completed phase II clinical trials and is preparing for phase III clinical trials. This product is formulated by nanoparticle technology and comprised of liposomes smaller than 150&#x000a0;nm containing insulin conjugated with hepatocyte-targeting moieties (biotin-phosphatidyl-ethanolamine)<a href="#bib375" rid="bib375" class=" bibr popnode"><sup>375</sup></a>. These liposomes are transported by intestinal epithelia into portal vein and then captured by hepatocytes to mimic the physiological insulin delivery. Although recent results of clinical trials have not yet been disclosed, the preliminary results revealed that it showed well toleration with the patients and better control of blood glucose level even after oral administration of a low dose of insulin (5 IU)<a href="#bib376" rid="bib376" class=" bibr popnode"><sup>376</sup></a>. sCT is also one of the most developed peptides for oral delivery except for insulin. Emisphere technologies Inc (NJ, USA) employed their Eligen&#x000ae; technology to develop oral sCT (SMC021) which is under phase III clinical trials. This formulation used permeation enhancer 8-(<em>N-</em>2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid) (5-CNAC) to improve the oral absorption of sCT, which is similar rationale with oral semaglutide<a href="#bib377" rid="bib377" class=" bibr popnode"><sup>377</sup></a>.</p><p id="p0350" class="p p-last">For local delivery, most of products primarily employed new technologies to make them resistant against enzymatic degradation in GI tract. For instance, the Vectrix&#x02122; platform developed by Protagonist Therapeutics Inc. designed highly constrained and stable peptides by molecular design tools and libraries of scaffolds. Currently, there have been two products in clinical trials based on Vectrix&#x02122; platform, including P<em>N-</em>10-943 for UC and PTG-200 for the treatment of CD<a href="#bib378" rid="bib378" class=" bibr popnode"><sup>378</sup></a>. Following a similar rationale, Avaxia Biologics, Inc developed a milk-derived antibody (AVX-470) to treat UC, which is now in phase I<a href="#bib379" rid="bib379" class=" bibr popnode"><sup>379</sup></a>. In addition, biomimetic drug delivery systems are broadly used in local delivery of PPs. The cellulose wall of plant cell is able to protect the recombinant proteins from degradation along the GI tract. The company Protalix Biotherapeutics have developed several candidates in clinical trials based on the ProCellEx delivery platform, such as a recombinant human tumor necrosis factor receptor II fused to an IgG1 Fc domain (TNFRII-Fc)) for UC in phase II and the glycosylated glucocerebrosidase enzyme (prGCD) for the treatment of Gaucher disease also in phase II<a href="#bib380" rid="bib380" class=" bibr popnode"><sup>380</sup></a>. Furthermore, more and more new technologies are emerging for oral delivery of PPs to treat local diseases in GI tract, such as Vorabodies&#x02122; or ActoBio Therapeutics&#x02122;<a href="#bib23" rid="bib23" class=" bibr popnode"><sup>23</sup></a>.</p></div><div id="sec5.3" class="sec sec-last"><h3 id="sec5.3title">5.3. Recent status of preclinical strategies</h3><p id="p0355" class="p p-first">As mentioned above, there have been a variety of strategies to improve oral delivery of PPs, some of which have been widely used in marketed products and clinical trials, such as enteric coating, enzyme inhibitors, permeation enhancers, nanotechnology, colonic targeting, as well as chemical modification. There are hundreds of papers published about new oral delivery systems for PPs every year. <a href="/pmc/articles/PMC8424290/table/tbl7/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl7" rid-ob="ob-tbl7" co-legend-rid=""><span>Table 7</span></a> lists partial projects of oral delivery systems for PPs in preclinical phase.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl7"><h3>Table 7</h3><!--caption a7--><div class="caption"><p>Examples of preclinical projects of oral delivery systems for PPs.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Company</th><th rowspan="1" colspan="1">PPs</th><th rowspan="1" colspan="1">Technology</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Emisphere (USA)</td><td rowspan="1" colspan="1">hGH<br />PTH(1&#x02013;34)<br />PYY</td><td rowspan="1" colspan="1">Permeation enhancer (Eligen&#x000ae;)</td></tr><tr><td rowspan="1" colspan="1">NanoMega Medical Corp. (USA)</td><td rowspan="1" colspan="1">Insulin<br />Exendin-4</td><td rowspan="1" colspan="1">Chitosan nanoparticles</td></tr><tr><td rowspan="1" colspan="1">Transgene Biotek Ltd. (India)</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Solid lipid nanoparticles</td></tr><tr><td rowspan="1" colspan="1">Aegis Therapeutics, LLC. (USA)</td><td rowspan="1" colspan="1">Octreotide<br />D-Leu-OB-3 (leptin)<br />PTH<br />GLP-1 analogs</td><td rowspan="1" colspan="1">Permeation enhancer (Intravail&#x000ae;)</td></tr><tr><td rowspan="1" colspan="1">Rani Therepeutics, LLC (USA)</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Microneedles; pH modulator; Robotic pill</td></tr><tr><td rowspan="1" colspan="1">Oramed</td><td rowspan="1" colspan="1">Exenatide (ORMD-0901)</td><td rowspan="1" colspan="1">Enteric coating; permeation enhancer; enzyme inhibitor</td></tr><tr><td rowspan="1" colspan="1">I2O therapeutics (USA)</td><td rowspan="1" colspan="1">Insulin</td><td rowspan="1" colspan="1">Ionic liquids</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140232416365824"><a target="object" rel="noopener" href="/pmc/articles/PMC8424290/table/tbl7/?report=objectonly">Open in a separate window</a></div></div><p id="p0360">Currently, nanotechnology have become as the main research hotspot to improve the oral bioavailability of PPs. The nanoparticle system of NanoMega (CA, USA) is capable of decreasing the blood glucose over 8&#x000a0;h in diabetic rats. What's more, an oral suspension of nanoparticles demonstrates a relative bioavailability of 15%, while an enteric capsule containing freeze-dried nanoparticles shows a relative bioavailability of 20%. This nanoparticles is composed of chitosan and PGA<a href="#bib120" rid="bib120" class=" bibr popnode"><sup>120</sup></a>. Chitosan could act as a permeation enhancer by transient opening of tight junctions. Meanwhile, this technology has also been used for oral delivery of exendin-4<a href="#bib381" rid="bib381" class=" bibr popnode"><sup>381</sup></a>. Nanoparticles are further conjugated with ligands on surface to facilitate intestinal absorption by targeting intestinal receptors or transporters. Transgene Biotek Ltd. (India) conjugated VB<sub>12</sub> or Tf on SLNs to establish a TrabiOral&#x02122; platform for oral delivery of PPs. A oral insulin project (TBL-1002OI) led by Transgene has revealed prolonged hypoglycemia in rats for 10&#x000a0;h after oral administration<a href="#bib382" rid="bib382" class=" bibr popnode"><sup>382</sup></a>).</p><p id="p0365">Additionally, the intestinal microdevices attract more and more attention in oral delivery of PPs, such as microneedles. A robotic pill was developed by Rani Therapeutics (USA) for oral protein delivery. It is actually a balloon-like structure of sugar microneedles encapsulated by PLGA which is a degradable polymer. Insulin loaded the microneedles exhibited encouraging hypoglycemic effect with oral bioavailability of 50% in preclinical trials<a href="#bib383" rid="bib383" class=" bibr popnode"><sup>383</sup></a>. Likewise, intestinal patches have also been attempted to orally delivery sCT, exenatide, insulin and interferon-<em>&#x003b1;</em>. The patches can be prepared as the size of millimeters or micrometers coated with pH-responsive polymer and contain drug reservoir. This device could also integrate absorption enhancers or enzyme inhibitors to further improve oral absorption of PPs<a href="#bib170" rid="bib170" class=" bibr popnode"><sup>170</sup></a>.</p><p id="p0370" class="p p-last">Permeation enhancers are the main components in products of oral PPs in market or clinical trials. Until now, a number of companies are still developing various permeation enhancers. For instance, Emisphere developed a series of derivatives of caprylic acid as permeation enhancers, such as SNAC and 5-CNAC<a href="#bib384" rid="bib384" class=" bibr popnode"><sup>384</sup></a>. Aegis Therapeutics (CA, USA) developed a category of permeation enhanced excipients named Intravail&#x000ae; which are a group of alkylsaccharides composed of disaccharides and alkyl chain substituents with lengths between 10 and 16 carbons. They have been used in oral delivery of various peptides including octreotide and D-Leu-OB3. The results showed high systemic bioavailability after combination of peptides and Intravail&#x000ae; in rodents compared to sc administration<a href="#bib385" rid="bib385" class=" bibr popnode"><sup>385</sup></a>.</p></div></div><div id="sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="sec6title">6. Conclusions and future perspectives</h2><p id="p0375" class="p p-first">Oral delivery of PPs has become more attractive in drug research and development since the increasing market share in the last decade. Therefore, various new technologies are emerging for improving oral bioavailability of PPs by overcoming obstacles of PPs in terms of stability and permeability. Some technologies have been successfully used in oral marketed products of PPs, such as enteric coating, enzyme inhibitors, permeation enhancers, as well as chemical modification. Currently, nanotechnology-based approaches have shown potential for developing oral PPs formulation. Moreover, intestinal microdevices were also developed for delivering PPs by oral route, such as intestinal microneedles. However, the safety, efficacy and reproducibility in preparation technique of these new technologies are needed to be improved and evaluated thoroughly. Furthermore, the oral bioavailability of PPs for systemic delivery is still very low, even lower than 1% for some products despite using new technology to improve the stability and permeability.</p><p id="p0380" class="p p-last">Nanoparticles are able to facilitate the intestinal transport of PPs, which has been reported by numerous papers. However, it is more important to shed light on well-understanding the detailed mechanism of interaction between these nanocarriers and PPs or the intestinal milieu. Moreover, elucidation of PPs transport in the intestinal epithelium and the influence of physiological factors on absorption of PPs are also indispensable. Therefore, elucidating the <em>in&#x000a0;vivo</em> fate of nanoparticles and PPs after oral administration is the necessary prerequisite to development of highly efficient oral systems of PPs.</p></div><div id="sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="sec7title">Author contributions</h2><p id="p0385" class="p p-first-last">Quangang Zhu, Zhongjian Chen and Pijush Kumar Paul collected references and drafted the manuscript. Yi Lu collected references. Jianping Qi and Wei Wu proposed the concept and revised the manuscript. All of the authors have read and approved the final manuscript.</p></div><div id="sec-a.ae.h" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.ae.htitle">Conflicts of interest</h2><p id="p0390" class="p p-first-last">The authors have no conflicts of interest to declare.</p></div><div id="ack0010" class="tsec sec"><h2 class="head no_bottom_margin" id="ack0010title">Acknowledgments</h2><div class="sec"><p id="p0395">This work is financially supported by National Natural Science Foundation of China (No.s 81872815, 81872826 and 82073801), Science and Technology Commission of Shanghai Municipality (No. 18ZR1404100, China), Shanghai Pujiang Program (No. 18PJD001, China), and Key Subject of Shanghai Skin Disease Hospital (No. 2019ZDXK03, China).</p></div></div><div id="fn-group-a.af.c" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.af.ctitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="d35e1464"><p id="ntpara0010" class="p p-first-last">Peer review under responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.</p></p></div></div><div id="cebib0010" class="tsec sec"><h2 class="head no_bottom_margin" id="cebib0010title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation" id="sref1">Patel A., Patel M., Yang X., Mitra A.K. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. <span><span class="ref-journal">Protein Pept Lett. </span>2014;<span class="ref-vol">21</span>:1102–1120.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4407643/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25106908" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Pept+Lett&amp;title=Recent+advances+in+protein+and+peptide+drug+delivery:+a+special+emphasis+on+polymeric+nanoparticles&amp;author=A.+Patel&amp;author=M.+Patel&amp;author=X.+Yang&amp;author=A.K.+Mitra&amp;volume=21&amp;publication_year=2014&amp;pages=1102-1120&amp;pmid=25106908&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation" id="sref2">Rengasamy K.R.R., Khan H., Ahmad I., Lobine D., Mahomoodally F., Suroowan S. Bioactive peptides and proteins as alternative antiplatelet drugs. <span><span class="ref-journal">Med Res Rev. </span>2019;<span class="ref-vol">39</span>:2153–2171.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31006878" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Res+Rev&amp;title=Bioactive+peptides+and+proteins+as+alternative+antiplatelet+drugs&amp;author=K.R.R.+Rengasamy&amp;author=H.+Khan&amp;author=I.+Ahmad&amp;author=D.+Lobine&amp;author=F.+Mahomoodally&amp;volume=39&amp;publication_year=2019&amp;pages=2153-2171&amp;pmid=31006878&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation" id="sref3">Choi Y.A., Yoon Y.H., Choi K., Kwon M., Goo S.H., Cha J.S. Enhanced oral bioavailability of morin administered in mixed micelle formulation with pluronic F127 and tween 80 in rats. <span><span class="ref-journal">Biol Pharm Bull. </span>2015;<span class="ref-vol">38</span>:208–217.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25747979" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biol+Pharm+Bull&amp;title=Enhanced+oral+bioavailability+of+morin+administered+in+mixed+micelle+formulation+with+pluronic+F127+and+tween+80+in+rats&amp;author=Y.A.+Choi&amp;author=Y.H.+Yoon&amp;author=K.+Choi&amp;author=M.+Kwon&amp;author=S.H.+Goo&amp;volume=38&amp;publication_year=2015&amp;pages=208-217&amp;pmid=25747979&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation" id="sref4">Anselmo A.C., Gokarn Y., Mitragotri S. Non-invasive delivery strategies for biologics. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2019;<span class="ref-vol">18</span>:19–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30498202" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Non-invasive+delivery+strategies+for+biologics&amp;author=A.C.+Anselmo&amp;author=Y.+Gokarn&amp;author=S.+Mitragotri&amp;volume=18&amp;publication_year=2019&amp;pages=19-40&amp;pmid=30498202&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation" id="sref5">Van Der Walle C.  1st ed. Academic Press; London: 2011. Peptide and protein delivery. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Van+Der+Walle+C.+Peptide+and+protein+delivery+1st+ed.+2011+Academic+Press+London+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation" id="sref6">Ismail R., Csoka I. Novel strategies in the oral delivery of antidiabetic peptide drugs&#x02014;insulin, GLP 1 and its analogs. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2017;<span class="ref-vol">115</span>:257–267.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28336368" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Novel+strategies+in+the+oral+delivery+of+antidiabetic+peptide+drugs&#x02014;insulin,+GLP+1+and+its+analogs&amp;author=R.+Ismail&amp;author=I.+Csoka&amp;volume=115&amp;publication_year=2017&amp;pages=257-267&amp;pmid=28336368&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation" id="sref7">Rader A.F.B., Weinmuller M., Reichart F., Schumacher-Klinger A., Merzbach S., Gilon C. Orally active peptides: is there a magic bullet? <span><span class="ref-journal">Angew Chem Int Ed. </span>2018;<span class="ref-vol">57</span>:14414–14438.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30144240" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Angew+Chem+Int+Ed&amp;title=Orally+active+peptides:+is+there+a+magic+bullet?&amp;author=A.F.B.+Rader&amp;author=M.+Weinmuller&amp;author=F.+Reichart&amp;author=A.+Schumacher-Klinger&amp;author=S.+Merzbach&amp;volume=57&amp;publication_year=2018&amp;pages=14414-14438&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation" id="sref8">Drucker D.J. Advances in oral peptide therapeutics. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2020;<span class="ref-vol">19</span>:277–289.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31848464" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Advances+in+oral+peptide+therapeutics&amp;author=D.J.+Drucker&amp;volume=19&amp;publication_year=2020&amp;pages=277-289&amp;pmid=31848464&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation" id="sref9">Di L. Strategic approaches to optimizing peptide adme properties. <span><span class="ref-journal">AAPS J. </span>2015;<span class="ref-vol">17</span>:134–143.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4287298/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25366889" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AAPS+J&amp;title=Strategic+approaches+to+optimizing+peptide+adme+properties&amp;author=L.+Di&amp;volume=17&amp;publication_year=2015&amp;pages=134-143&amp;pmid=25366889&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation" id="sref10">Bohley M., Haunberger A., Goepferich A.M. Intracellular availability of poorly soluble drugs from lipid nanocapsules. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2019;<span class="ref-vol">139</span>:23–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30851353" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Intracellular+availability+of+poorly+soluble+drugs+from+lipid+nanocapsules&amp;author=M.+Bohley&amp;author=A.+Haunberger&amp;author=A.M.+Goepferich&amp;volume=139&amp;publication_year=2019&amp;pages=23-32&amp;pmid=30851353&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation" id="sref11">Renukuntla J., Vadlapudi A.D., Patel A., Boddu S.H., Mitra A.K. Approaches for enhancing oral bioavailability of peptides and proteins. <span><span class="ref-journal">Int J Pharm. </span>2013;<span class="ref-vol">447</span>:75–93.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3680128/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23428883" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Approaches+for+enhancing+oral+bioavailability+of+peptides+and+proteins&amp;author=J.+Renukuntla&amp;author=A.D.+Vadlapudi&amp;author=A.+Patel&amp;author=S.H.+Boddu&amp;author=A.K.+Mitra&amp;volume=447&amp;publication_year=2013&amp;pages=75-93&amp;pmid=23428883&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation" id="sref12">Goldberg M., Gomez-Orellana I. Challenges for the oral delivery of macromolecules. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2003;<span class="ref-vol">2</span>:289–295.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12669028" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Challenges+for+the+oral+delivery+of+macromolecules&amp;author=M.+Goldberg&amp;author=I.+Gomez-Orellana&amp;volume=2&amp;publication_year=2003&amp;pages=289-295&amp;pmid=12669028&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation" id="sref13">Morishita M., Peppas N.A. Is the oral route possible for peptide and protein drug delivery?. <span><span class="ref-journal">Drug Discov Today. </span>2006;<span class="ref-vol">11</span>:905–910.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16997140" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Is+the+oral+route+possible+for+peptide+and+protein+drug+delivery?.&amp;author=M.+Morishita&amp;author=N.A.+Peppas&amp;volume=11&amp;publication_year=2006&amp;pages=905-910&amp;pmid=16997140&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation" id="sref14">Jain D., Mahammad S.S., Singh P.P., Kodipyaka R. A review on parenteral delivery of peptides and proteins. <span><span class="ref-journal">Drug Dev Ind Pharm. </span>2019;<span class="ref-vol">45</span>:1403–1420.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31215293" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Dev+Ind+Pharm&amp;title=A+review+on+parenteral+delivery+of+peptides+and+proteins&amp;author=D.+Jain&amp;author=S.S.+Mahammad&amp;author=P.P.+Singh&amp;author=R.+Kodipyaka&amp;volume=45&amp;publication_year=2019&amp;pages=1403-1420&amp;pmid=31215293&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation" id="sref15">Chung S.W., Hil-lal T.A., Byun Y. Strategies for non-invasive delivery of biologics. <span><span class="ref-journal">J Drug Target. </span>2012;<span class="ref-vol">20</span>:481–501.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22632037" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Target&amp;title=Strategies+for+non-invasive+delivery+of+biologics&amp;author=S.W.+Chung&amp;author=T.A.+Hil-lal&amp;author=Y.+Byun&amp;volume=20&amp;publication_year=2012&amp;pages=481-501&amp;pmid=22632037&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation" id="sref16">Hwang S.R., Byun Y. Advances in oral macromolecular drug delivery. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2014;<span class="ref-vol">11</span>:1955–1967.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25078141" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Advances+in+oral+macromolecular+drug+delivery&amp;author=S.R.+Hwang&amp;author=Y.+Byun&amp;volume=11&amp;publication_year=2014&amp;pages=1955-1967&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation" id="sref17">Brayden D.J., Alonso M.J. Oral delivery of peptides: opportunities and issues for translation. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">106</span>:193–195.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27865345" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+delivery+of+peptides:+opportunities+and+issues+for+translation&amp;author=D.J.+Brayden&amp;author=M.J.+Alonso&amp;volume=106&amp;publication_year=2016&amp;pages=193-195&amp;pmid=27865345&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation" id="sref18">Moroz E., Matoori S., Leroux J.C. Oral delivery of macromolecular drugs: where we are after almost 100 years of attempts. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">101</span>:108–121.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26826437" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+delivery+of+macromolecular+drugs:+where+we+are+after+almost+100+years+of+attempts&amp;author=E.+Moroz&amp;author=S.+Matoori&amp;author=J.C.+Leroux&amp;volume=101&amp;publication_year=2016&amp;pages=108-121&amp;pmid=26826437&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation" id="sref19">Shaikh S., Jaiswal P.  2018. Oral proteins and peptides market overview.<a href="https://www.alliedmarketresearch.com/oral-proteins-peptides-market" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.alliedmarketresearch.com/oral-proteins-peptides-market</a> Available from: <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Shaikh+S.+Jaiswal+P.+Oral+proteins+and+peptides+market+overview+2018+Available+from:+https://www.alliedmarketresearch.com/oral-proteins-peptides-market+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation" id="sref20">Mahmood A., Bernkop-Schnurch A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2019;<span class="ref-vol">142</span>:91–101.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29981355" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=SEDDS:+a+game+changing+approach+for+the+oral+administration+of+hydrophilic+macromolecular+drugs&amp;author=A.+Mahmood&amp;author=A.+Bernkop-Schnurch&amp;volume=142&amp;publication_year=2019&amp;pages=91-101&amp;pmid=29981355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation" id="sref21">Maher S., Mrsny R.J., Brayden D.J. Intestinal permeation enhancers for oral peptide delivery. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">106</span>:277–319.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27320643" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Intestinal+permeation+enhancers+for+oral+peptide+delivery&amp;author=S.+Maher&amp;author=R.J.+Mrsny&amp;author=D.J.+Brayden&amp;volume=106&amp;publication_year=2016&amp;pages=277-319&amp;pmid=27320643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation" id="sref22">Liu C., Kou Y., Zhang X., Cheng H., Chen X., Mao S. Strategies and industrial perspectives to improve oral absorption of biological macromolecules. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2018;<span class="ref-vol">15</span>:223–233.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29111841" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Strategies+and+industrial+perspectives+to+improve+oral+absorption+of+biological+macromolecules&amp;author=C.+Liu&amp;author=Y.+Kou&amp;author=X.+Zhang&amp;author=H.+Cheng&amp;author=X.+Chen&amp;volume=15&amp;publication_year=2018&amp;pages=223-233&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation" id="sref23">Duran-Lobato M., Niu Z., Alonso M.J. Oral delivery of biologics for precision medicine. <span><span class="ref-journal">Adv Mater. </span>2020;<span class="ref-vol">32</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31222910" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Mater&amp;title=Oral+delivery+of+biologics+for+precision+medicine&amp;author=M.+Duran-Lobato&amp;author=Z.+Niu&amp;author=M.J.+Alonso&amp;volume=32&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation" id="sref24">Smart A.L., Gaisford S., Basit A.W. Oral peptide and protein delivery: intestinal obstacles and commercial prospects. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2014;<span class="ref-vol">11</span>:1323–1335.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24816134" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Oral+peptide+and+protein+delivery:+intestinal+obstacles+and+commercial+prospects&amp;author=A.L.+Smart&amp;author=S.+Gaisford&amp;author=A.W.+Basit&amp;volume=11&amp;publication_year=2014&amp;pages=1323-1335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation" id="sref25">Cao S.J., Xu S., Wang H.M., Ling Y., Dong J., Xia R.D. Nanoparticles: oral delivery for protein and peptide drugs. <span><span class="ref-journal">AAPS PharmSciTech. </span>2019;<span class="ref-vol">20</span>:190.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6527526/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31111296" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AAPS+PharmSciTech&amp;title=Nanoparticles:+oral+delivery+for+protein+and+peptide+drugs&amp;author=S.J.+Cao&amp;author=S.+Xu&amp;author=H.M.+Wang&amp;author=Y.+Ling&amp;author=J.+Dong&amp;volume=20&amp;publication_year=2019&amp;pages=190&amp;pmid=31111296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation" id="sref26">Tan X., Liu X., Zhang Y., Zhang H., Lin X., Pu C. Silica nanoparticles on the oral delivery of insulin. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2018;<span class="ref-vol">15</span>:805–820.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30025216" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Silica+nanoparticles+on+the+oral+delivery+of+insulin&amp;author=X.+Tan&amp;author=X.+Liu&amp;author=Y.+Zhang&amp;author=H.+Zhang&amp;author=X.+Lin&amp;volume=15&amp;publication_year=2018&amp;pages=805-820&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation" id="sref27">Heinemann L., Jacques Y. Oral insulin and buccal insulin: a critical reappraisal. <span><span class="ref-journal">J Diabetes Sci Technol. </span>2009;<span class="ref-vol">3</span>:568–584.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2769877/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20144297" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Sci+Technol&amp;title=Oral+insulin+and+buccal+insulin:+a+critical+reappraisal&amp;author=L.+Heinemann&amp;author=Y.+Jacques&amp;volume=3&amp;publication_year=2009&amp;pages=568-584&amp;pmid=20144297&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation" id="sref28">Harrison G.A. Insulin in alcoholic solution by the mouth. <span><span class="ref-journal">Br Med J. </span>1923;<span class="ref-vol">2</span>:1204–1205.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2317756/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20771392" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+Med+J&amp;title=Insulin+in+alcoholic+solution+by+the+mouth&amp;author=G.A.+Harrison&amp;volume=2&amp;publication_year=1923&amp;pages=1204-1205&amp;pmid=20771392&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation" id="sref29">Ferguson J.E.A.  1965. Oral blood sugar lowering compositions. US3172814 A. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Ferguson+J.E.A.+Oral+blood+sugar+lowering+compositions+1965+US3172814+A+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation" id="sref30">Wong C.Y., Martinez J., Dass C.R. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. <span><span class="ref-journal">J Pharm Pharmacol. </span>2016;<span class="ref-vol">68</span>:1093–1108.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27364922" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;title=Oral+delivery+of+insulin+for+treatment+of+diabetes:+status+quo,+challenges+and+opportunities&amp;author=C.Y.+Wong&amp;author=J.+Martinez&amp;author=C.R.+Dass&amp;volume=68&amp;publication_year=2016&amp;pages=1093-1108&amp;pmid=27364922&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation" id="sref31">Muheem A., Shakeel F., Jahangir M.A., Anwar M., Mallick N., Jain G.K. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. <span><span class="ref-journal">Saudi Pharmaceut J. </span>2016;<span class="ref-vol">24</span>:413–428.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4908063/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27330372" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Saudi+Pharmaceut+J&amp;title=A+review+on+the+strategies+for+oral+delivery+of+proteins+and+peptides+and+their+clinical+perspectives&amp;author=A.+Muheem&amp;author=F.+Shakeel&amp;author=M.A.+Jahangir&amp;author=M.+Anwar&amp;author=N.+Mallick&amp;volume=24&amp;publication_year=2016&amp;pages=413-428&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation" id="sref32">Stillhart C., Vu&#x0010d;i&#x00107;evi&#x00107; K., Augustijns P., Basit A.W., Batchelor H., Flanagan T.R. Impact of gastrointestinal physiology on drug absorption in special populations&#x02013;&#x02013;an ungap review. <span><span class="ref-journal">Eur J Pharmaceut Sci. </span>2020;<span class="ref-vol">147</span>:105280.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32109493" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmaceut+Sci&amp;title=Impact+of+gastrointestinal+physiology+on+drug+absorption+in+special+populations&#x02013;&#x02013;an+ungap+review&amp;author=C.+Stillhart&amp;author=K.+Vu&#x0010d;i&#x00107;evi&#x00107;&amp;author=P.+Augustijns&amp;author=A.W.+Basit&amp;author=H.+Batchelor&amp;volume=147&amp;publication_year=2020&amp;pages=105280&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation" id="sref33">Koziolek M., Grimm M., Becker D., Iordanov V., Zou H., Shimizu J. Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap&#x000ae; system. <span><span class="ref-journal">J Pharm Sci. </span>2015;<span class="ref-vol">104</span>:2855–2863.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25411065" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Investigation+of+pH+and+temperature+profiles+in+the+GI+tract+of+fasted+human+subjects+using+the+Intellicap&#x000ae;+system&amp;author=M.+Koziolek&amp;author=M.+Grimm&amp;author=D.+Becker&amp;author=V.+Iordanov&amp;author=H.+Zou&amp;volume=104&amp;publication_year=2015&amp;pages=2855-2863&amp;pmid=25411065&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation" id="sref34">Evans D.F., Pye G., Bramley R., Clark A.G., Dyson T.J., Hardcastle J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. <span><span class="ref-journal">Gut. </span>1988;<span class="ref-vol">29</span>:1035–1041.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1433896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3410329" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Measurement+of+gastrointestinal+pH+profiles+in+normal+ambulant+human+subjects&amp;author=D.F.+Evans&amp;author=G.+Pye&amp;author=R.+Bramley&amp;author=A.G.+Clark&amp;author=T.J.+Dyson&amp;volume=29&amp;publication_year=1988&amp;pages=1035-1041&amp;pmid=3410329&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation" id="sref35">Khan M.S., Roberts M.S. Challenges and innovations of drug delivery in older age. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2018;<span class="ref-vol">135</span>:3–38.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30217519" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Challenges+and+innovations+of+drug+delivery+in+older+age&amp;author=M.S.+Khan&amp;author=M.S.+Roberts&amp;volume=135&amp;publication_year=2018&amp;pages=3-38&amp;pmid=30217519&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation" id="sref36">Mooij M.G., de Koning B.A.E., Huijsman M.L., de Wildt S.N. Ontogeny of oral drug absorption processes in children. <span><span class="ref-journal">Expet Opin Drug Metabol Toxicol. </span>2012;<span class="ref-vol">8</span>:1293–1303.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22686526" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Metabol+Toxicol&amp;title=Ontogeny+of+oral+drug+absorption+processes+in+children&amp;author=M.G.+Mooij&amp;author=B.A.E.+de+Koning&amp;author=M.L.+Huijsman&amp;author=S.N.+de+Wildt&amp;volume=8&amp;publication_year=2012&amp;pages=1293-1303&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation" id="sref37">Deng J., Zhu X., Chen Z., Fan C.H., Kwan H.S., Wong C.H. A review of food&#x02013;drug interactions on oral drug absorption. <span><span class="ref-journal">Drugs. </span>2017;<span class="ref-vol">77</span>:1833–1855.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29076109" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=A+review+of+food&#x02013;drug+interactions+on+oral+drug+absorption&amp;author=J.+Deng&amp;author=X.+Zhu&amp;author=Z.+Chen&amp;author=C.H.+Fan&amp;author=H.S.+Kwan&amp;volume=77&amp;publication_year=2017&amp;pages=1833-1855&amp;pmid=29076109&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation" id="sref38">Sasaki Y., Hada R., Nakajima H., Fukuda S., Munakata A. Improved localizing method of radiopill in measurement of entire gastrointestinal ph profiles: colonic luminal pH in normal subjects and patients with Crohn's disease. <span><span class="ref-journal">Am J Gastroenterol. </span>1997;<span class="ref-vol">92</span>:114–118.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8995949" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=Improved+localizing+method+of+radiopill+in+measurement+of+entire+gastrointestinal+ph+profiles:+colonic+luminal+pH+in+normal+subjects+and+patients+with+Crohn's+disease&amp;author=Y.+Sasaki&amp;author=R.+Hada&amp;author=H.+Nakajima&amp;author=S.+Fukuda&amp;author=A.+Munakata&amp;volume=92&amp;publication_year=1997&amp;pages=114-118&amp;pmid=8995949&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation" id="sref39">Fallingborg J., Christensen L.A., Jacobsen B.A., Rasmussen SNr. Very low intraluminal colonic pH in patients with active ulcerative colitis. <span><span class="ref-journal">Dig Dis Sci. </span>1993;<span class="ref-vol">38</span>:1989–1993.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8223071" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig+Dis+Sci&amp;title=Very+low+intraluminal+colonic+pH+in+patients+with+active+ulcerative+colitis&amp;author=J.+Fallingborg&amp;author=L.A.+Christensen&amp;author=B.A.+Jacobsen&amp;author=SNr+Rasmussen&amp;volume=38&amp;publication_year=1993&amp;pages=1989-1993&amp;pmid=8223071&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation" id="sref40">Lu P.J. Gastric juice acidity in upper gastrointestinal diseases. <span><span class="ref-journal">World J Gastroenterol. </span>2010;<span class="ref-vol">16</span>:5496–5501.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2988245/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21086570" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Gastric+juice+acidity+in+upper+gastrointestinal+diseases&amp;author=P.J.+Lu&amp;volume=16&amp;publication_year=2010&amp;pages=5496-5501&amp;pmid=21086570&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation" id="sref41">Wei W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. <span><span class="ref-journal">Int J Pharm. </span>1999;<span class="ref-vol">185</span>:129–188.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10460913" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Instability,+stabilization,+and+formulation+of+liquid+protein+pharmaceuticals&amp;author=W.+Wei&amp;volume=185&amp;publication_year=1999&amp;pages=129-188&amp;pmid=10460913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation" id="sref42">Gracia R., Yus C., Abian O., Mendoza G., Irusta S., Sebastian V. Enzyme structure and function protection from gastrointestinal degradation using enteric coatings. <span><span class="ref-journal">Int J Biol Macromol. </span>2018;<span class="ref-vol">119</span>:413–422.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30048728" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Enzyme+structure+and+function+protection+from+gastrointestinal+degradation+using+enteric+coatings&amp;author=R.+Gracia&amp;author=C.+Yus&amp;author=O.+Abian&amp;author=G.+Mendoza&amp;author=S.+Irusta&amp;volume=119&amp;publication_year=2018&amp;pages=413-422&amp;pmid=30048728&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation" id="sref43">Zhang W., Li Y., Zou P., Wu M., Zhang Z., Zhang T. The effects of pharmaceutical excipients on gastrointestinal tract metabolic enzymes and transporters&#x02014;an update. <span><span class="ref-journal">AAPS J. </span>2016;<span class="ref-vol">18</span>:830–843.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27184579" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AAPS+J&amp;title=The+effects+of+pharmaceutical+excipients+on+gastrointestinal+tract+metabolic+enzymes+and+transporters&#x02014;an+update&amp;author=W.+Zhang&amp;author=Y.+Li&amp;author=P.+Zou&amp;author=M.+Wu&amp;author=Z.+Zhang&amp;volume=18&amp;publication_year=2016&amp;pages=830-843&amp;pmid=27184579&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation" id="sref44">Bernkop-Schn&#x000fc;rch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. <span><span class="ref-journal">J Control Release. </span>1998;<span class="ref-vol">52</span>:1–16.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9685931" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=The+use+of+inhibitory+agents+to+overcome+the+enzymatic+barrier+to+perorally+administered+therapeutic+peptides+and+proteins&amp;author=A.+Bernkop-Schn&#x000fc;rch&amp;volume=52&amp;publication_year=1998&amp;pages=1-16&amp;pmid=9685931&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation" id="sref45">Whitcomb D.C., Lowe M.E. Human pancreatic digestive enzymes. <span><span class="ref-journal">Dig Dis Sci. </span>2007;<span class="ref-vol">52</span>:1–17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17205399" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dig+Dis+Sci&amp;title=Human+pancreatic+digestive+enzymes&amp;author=D.C.+Whitcomb&amp;author=M.E.+Lowe&amp;volume=52&amp;publication_year=2007&amp;pages=1-17&amp;pmid=17205399&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib46">46. <span class="element-citation" id="sref46">Sanch&#x000f3;n J., Fern&#x000e1;ndez-Tom&#x000e9; S., Miralles B., Hern&#x000e1;ndez-Ledesma B., Tom&#x000e9; D., Gaudichon C. Protein degradation and peptide release from milk proteins in human jejunum: comparison with <em>in&#x000a0;vitro</em> gastrointestinal simulation. <span><span class="ref-journal">Food Chem. </span>2018;<span class="ref-vol">239</span>:486–494.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28873595" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Food+Chem&amp;title=Protein+degradation+and+peptide+release+from+milk+proteins+in+human+jejunum:+comparison+with+in&#x000a0;vitro+gastrointestinal+simulation&amp;author=J.+Sanch&#x000f3;n&amp;author=S.+Fern&#x000e1;ndez-Tom&#x000e9;&amp;author=B.+Miralles&amp;author=B.+Hern&#x000e1;ndez-Ledesma&amp;author=D.+Tom&#x000e9;&amp;volume=239&amp;publication_year=2018&amp;pages=486-494&amp;pmid=28873595&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib47">47. <span class="element-citation" id="sref47">Woodley J.F. Enzymatic barriers for GI peptide and protein delivery. <span><span class="ref-journal">Crit Rev Ther Drug Carrier Syst. </span>1994;<span class="ref-vol">11</span>:61–95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7600588" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Ther+Drug+Carrier+Syst&amp;title=Enzymatic+barriers+for+GI+peptide+and+protein+delivery&amp;author=J.F.+Woodley&amp;volume=11&amp;publication_year=1994&amp;pages=61-95&amp;pmid=7600588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib48">48. <span class="element-citation" id="sref48">Miner-Williams W.M., Stevens B.R., Moughan P.J. Are intact peptides absorbed from the healthy gut in the adult human?. <span><span class="ref-journal">Nutr Res Rev. </span>2015;<span class="ref-vol">27</span>:308–329.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25623084" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nutr+Res+Rev&amp;title=Are+intact+peptides+absorbed+from+the+healthy+gut+in+the+adult+human?.&amp;author=W.M.+Miner-Williams&amp;author=B.R.+Stevens&amp;author=P.J.+Moughan&amp;volume=27&amp;publication_year=2015&amp;pages=308-329&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib49">49. <span class="element-citation" id="sref49">Cui M., Wu W., Hovgaard L., Lu Y., Chen D., Qi J. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin. <span><span class="ref-journal">Int J Pharm. </span>2015;<span class="ref-vol">489</span>:277–284.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25957702" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Liposomes+containing+cholesterol+analogues+of+botanical+origin+as+drug+delivery+systems+to+enhance+the+oral+absorption+of+insulin&amp;author=M.+Cui&amp;author=W.+Wu&amp;author=L.+Hovgaard&amp;author=Y.+Lu&amp;author=D.+Chen&amp;volume=489&amp;publication_year=2015&amp;pages=277-284&amp;pmid=25957702&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib50">50. <span class="element-citation" id="sref50">He H., Lu Y., Qi J., Zhao W., Dong X., Wu W. Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin. <span><span class="ref-journal">Acta Pharm Sinica B. </span>2018;<span class="ref-vol">8</span>:97–105.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5985626/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29872626" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharm+Sinica+B&amp;title=Biomimetic+thiamine-+and+niacin-decorated+liposomes+for+enhanced+oral+delivery+of+insulin&amp;author=H.+He&amp;author=Y.+Lu&amp;author=J.+Qi&amp;author=W.+Zhao&amp;author=X.+Dong&amp;volume=8&amp;publication_year=2018&amp;pages=97-105&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib51">51. <span class="element-citation" id="sref51">Wang J., Yadav V., Smart A.L., Tajiri S., Basit A.W. Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs. <span><span class="ref-journal">Mol Pharm. </span>2015;<span class="ref-vol">12</span>:966–973.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25612507" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Toward+oral+delivery+of+biopharmaceuticals:+an+assessment+of+the+gastrointestinal+stability+of+17+peptide+drugs&amp;author=J.+Wang&amp;author=V.+Yadav&amp;author=A.L.+Smart&amp;author=S.+Tajiri&amp;author=A.W.+Basit&amp;volume=12&amp;publication_year=2015&amp;pages=966-973&amp;pmid=25612507&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib52">52. <span class="element-citation" id="sref52">Wu L., Shan W., Zhang Z., Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2018;<span class="ref-vol">124</span>:150–163.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28989056" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Engineering+nanomaterials+to+overcome+the+mucosal+barrier+by+modulating+surface+properties&amp;author=L.+Wu&amp;author=W.+Shan&amp;author=Z.+Zhang&amp;author=Y.+Huang&amp;volume=124&amp;publication_year=2018&amp;pages=150-163&amp;pmid=28989056&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib53">53. <span class="element-citation" id="sref53">Varum F.J., Veiga F., Sousa J.S., Basit A.W. Mucus thickness in the gastrointestinal tract of laboratory animals. <span><span class="ref-journal">J Pharm Pharmacol. </span>2012;<span class="ref-vol">64</span>:218–227.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22221097" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;title=Mucus+thickness+in+the+gastrointestinal+tract+of+laboratory+animals&amp;author=F.J.+Varum&amp;author=F.+Veiga&amp;author=J.S.+Sousa&amp;author=A.W.+Basit&amp;volume=64&amp;publication_year=2012&amp;pages=218-227&amp;pmid=22221097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib54">54. <span class="element-citation" id="sref54">Ensign L.M., Cone R., Hanes J. Oral drug delivery with polymeric nanoparticles:the gastrointestinal mucus barriers. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2012;<span class="ref-vol">2012</span>:557–570.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3322271/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22212900" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+drug+delivery+with+polymeric+nanoparticles:the+gastrointestinal+mucus+barriers&amp;author=L.M.+Ensign&amp;author=R.+Cone&amp;author=J.+Hanes&amp;volume=2012&amp;publication_year=2012&amp;pages=557-570&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib55">55. <span class="element-citation" id="sref55">Bansil R., Turner B.S. The biology of mucus: composition, synthesis and organization. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2018;<span class="ref-vol">124</span>:3–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28970050" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=The+biology+of+mucus:+composition,+synthesis+and+organization&amp;author=R.+Bansil&amp;author=B.S.+Turner&amp;volume=124&amp;publication_year=2018&amp;pages=3-15&amp;pmid=28970050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib56">56. <span class="element-citation" id="sref56">Corfield A.P., Carroll D., Myerscough N., Probert C. Mucins in the gastrointestinal tract in health and disease. <span><span class="ref-journal">Front Biosci. </span>2001;<span class="ref-vol">6</span>:D1321–D1357.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11578958" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Biosci&amp;title=Mucins+in+the+gastrointestinal+tract+in+health+and+disease&amp;author=A.P.+Corfield&amp;author=D.+Carroll&amp;author=N.+Myerscough&amp;author=C.+Probert&amp;volume=6&amp;publication_year=2001&amp;pages=D1321-D1357&amp;pmid=11578958&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib57">57. <span class="element-citation" id="sref57">Murty V., Sarosiek J., Slomiany A., Slomiany B. Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1984;<span class="ref-vol">121</span>:521–529.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6732822" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Effect+of+lipids+and+proteins+on+the+viscosity+of+gastric+mucus+glycoprotein&amp;author=V.+Murty&amp;author=J.+Sarosiek&amp;author=A.+Slomiany&amp;author=B.+Slomiany&amp;volume=121&amp;publication_year=1984&amp;pages=521-529&amp;pmid=6732822&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib58">58. <span class="element-citation" id="sref58">Demouveaux B., Gouyer V., Gottrand F., Narita T., Desseyn J.L. Gel-forming mucin interactome drives mucus viscoelasticity. <span><span class="ref-journal">Adv Colloid Interface Sci. </span>2018;<span class="ref-vol">252</span>:69–82.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29329667" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Colloid+Interface+Sci&amp;title=Gel-forming+mucin+interactome+drives+mucus+viscoelasticity&amp;author=B.+Demouveaux&amp;author=V.+Gouyer&amp;author=F.+Gottrand&amp;author=T.+Narita&amp;author=J.L.+Desseyn&amp;volume=252&amp;publication_year=2018&amp;pages=69-82&amp;pmid=29329667&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib59">59. <span class="element-citation" id="sref59">Lichtenberger L. The hydrophobic barrier properties of gastrointestinal mucus. <span><span class="ref-journal">Annu Rev Physiol. </span>1995;<span class="ref-vol">57</span>:565–583.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7778878" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Physiol&amp;title=The+hydrophobic+barrier+properties+of+gastrointestinal+mucus&amp;author=L.+Lichtenberger&amp;volume=57&amp;publication_year=1995&amp;pages=565-583&amp;pmid=7778878&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib60">60. <span class="element-citation" id="sref60">Homayun B., Lin X., Choi H.J. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. <span><span class="ref-journal">Pharmaceutics. </span>2019;<span class="ref-vol">11</span>:129.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6471246/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30893852" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Challenges+and+recent+progress+in+oral+drug+delivery+systems+for+biopharmaceuticals&amp;author=B.+Homayun&amp;author=X.+Lin&amp;author=H.J.+Choi&amp;volume=11&amp;publication_year=2019&amp;pages=129&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib61">61. <span class="element-citation" id="sref61">Boegh M., Nielsen H.M. Mucus as a barrier to drug delivery&#x02013;understanding and mimicking the barrier properties. <span><span class="ref-journal">Basic Clin Pharmacol Toxicol. </span>2015;<span class="ref-vol">116</span>:179–186.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25349046" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Basic+Clin+Pharmacol+Toxicol&amp;title=Mucus+as+a+barrier+to+drug+delivery&#x02013;understanding+and+mimicking+the+barrier+properties&amp;author=M.+Boegh&amp;author=H.M.+Nielsen&amp;volume=116&amp;publication_year=2015&amp;pages=179-186&amp;pmid=25349046&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib62">62. <span class="element-citation" id="sref62">Zhang X., Cheng H., Dong W., Zhang M., Liu Q., Wang X. Design and intestinal mucus penetration mechanism of core-shell nanocomplex. <span><span class="ref-journal">J Control Release. </span>2018;<span class="ref-vol">272</span>:29–38.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29305112" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Design+and+intestinal+mucus+penetration+mechanism+of+core-shell+nanocomplex&amp;author=X.+Zhang&amp;author=H.+Cheng&amp;author=W.+Dong&amp;author=M.+Zhang&amp;author=Q.+Liu&amp;volume=272&amp;publication_year=2018&amp;pages=29-38&amp;pmid=29305112&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib63">63. <span class="element-citation" id="sref63">Qi J., Zhuang J., Lv Y., Lu Y., Wu W. Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery. <span><span class="ref-journal">J Control Release. </span>2018;<span class="ref-vol">275</span>:92–106.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29454741" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Exploiting+or+overcoming+the+dome+trap+for+enhanced+oral+immunization+and+drug+delivery&amp;author=J.+Qi&amp;author=J.+Zhuang&amp;author=Y.+Lv&amp;author=Y.+Lu&amp;author=W.+Wu&amp;volume=275&amp;publication_year=2018&amp;pages=92-106&amp;pmid=29454741&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib64">64. <span class="element-citation" id="sref64">Cheng H., Leblond C. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine: unitarian theory of the origin of the four epithelial cell types. <span><span class="ref-journal">Am J Anat. </span>1974;<span class="ref-vol">141</span>:537–561.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4440635" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Anat&amp;title=Origin,+differentiation+and+renewal+of+the+four+main+epithelial+cell+types+in+the+mouse+small+intestine:+unitarian+theory+of+the+origin+of+the+four+epithelial+cell+types&amp;author=H.+Cheng&amp;author=C.+Leblond&amp;volume=141&amp;publication_year=1974&amp;pages=537-561&amp;pmid=4440635&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib65">65. <span class="element-citation" id="sref65">Capaldo C.T., Powell D.N., Kalman D. Layered defense: how mucus and tight junctions seal the intestinal barrier. <span><span class="ref-journal">J Mol Med. </span>2017;<span class="ref-vol">95</span>:927–934.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5548832/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28707083" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Med&amp;title=Layered+defense:+how+mucus+and+tight+junctions+seal+the+intestinal+barrier&amp;author=C.T.+Capaldo&amp;author=D.N.+Powell&amp;author=D.+Kalman&amp;volume=95&amp;publication_year=2017&amp;pages=927-934&amp;pmid=28707083&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib66">66. <span class="element-citation" id="sref66">Vancamelbeke M., Vermeire S. The intestinal barrier: a fundamental role in health and disease. <span><span class="ref-journal">Expet Rev Gastroenterol Hepatol. </span>2017;<span class="ref-vol">11</span>:821–834.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6104804/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28650209" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Rev+Gastroenterol+Hepatol&amp;title=The+intestinal+barrier:+a+fundamental+role+in+health+and+disease&amp;author=M.+Vancamelbeke&amp;author=S.+Vermeire&amp;volume=11&amp;publication_year=2017&amp;pages=821-834&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib67">67. <span class="element-citation" id="sref67">Odenwald M.A., Turner J.R. The intestinal epithelial barrier: a therapeutic target?. <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2017;<span class="ref-vol">14</span>:9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5554468/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27848962" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Gastroenterol+Hepatol&amp;title=The+intestinal+epithelial+barrier:+a+therapeutic+target?.&amp;author=M.A.+Odenwald&amp;author=J.R.+Turner&amp;volume=14&amp;publication_year=2017&amp;pages=9&amp;pmid=27848962&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib68">68. <span class="element-citation" id="sref68">Owen R.L., Jones A.L. Epithelial cell specialization within human peyer's patches: an ultrastructural study of intestinal lymphoid follicles. <span><span class="ref-journal">Gastroenterology. </span>1974;<span class="ref-vol">66</span>:189–203.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4810912" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Epithelial+cell+specialization+within+human+peyer's+patches:+an+ultrastructural+study+of+intestinal+lymphoid+follicles&amp;author=R.L.+Owen&amp;author=A.L.+Jones&amp;volume=66&amp;publication_year=1974&amp;pages=189-203&amp;pmid=4810912&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib69">69. <span class="element-citation" id="sref69">Jung C., Hugot J.P., Barreau F. Peyer's patches: the immune sensors of the intestine. <span><span class="ref-journal">Int J Inflamm. </span>2010;<span class="ref-vol">2010</span>:823710.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3004000/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21188221" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Inflamm&amp;title=Peyer's+patches:+the+immune+sensors+of+the+intestine&amp;author=C.+Jung&amp;author=J.P.+Hugot&amp;author=F.+Barreau&amp;volume=2010&amp;publication_year=2010&amp;pages=823710&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib70">70. <span class="element-citation" id="sref70">Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2001;<span class="ref-vol">46</span>:3–26.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11259830" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development&amp;author=C.A.+Lipinski&amp;author=F.+Lombardo&amp;author=B.W.+Dominy&amp;author=P.J.+Feeney&amp;volume=46&amp;publication_year=2001&amp;pages=3-26&amp;pmid=11259830&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib71">71. <span class="element-citation" id="sref71">Anderson J.M., Balda M.S., Fanning A.S. The structure and regulation of tight junctions. <span><span class="ref-journal">Curr Opin Cell Biol. </span>1993;<span class="ref-vol">5</span>:772–778.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8240820" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Cell+Biol&amp;title=The+structure+and+regulation+of+tight+junctions&amp;author=J.M.+Anderson&amp;author=M.S.+Balda&amp;author=A.S.+Fanning&amp;volume=5&amp;publication_year=1993&amp;pages=772-778&amp;pmid=8240820&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib72">72. <span class="element-citation" id="sref72">Anderson J., Van Itallie C. Tight junctions and the molecular basis for regulation of paracellular permeability. <span><span class="ref-journal">Am J Physiol-gastr L. </span>1995;<span class="ref-vol">269</span>:G467–G475.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7485497" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol-gastr+L&amp;title=Tight+junctions+and+the+molecular+basis+for+regulation+of+paracellular+permeability&amp;author=J.+Anderson&amp;author=C.+Van+Itallie&amp;volume=269&amp;publication_year=1995&amp;pages=G467-G475&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib73">73. <span class="element-citation" id="sref73">Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. <span><span class="ref-journal">Cell Mol Life Sci. </span>2013;<span class="ref-vol">70</span>:631–659.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22782113" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Life+Sci&amp;title=Regulation+of+intestinal+epithelial+permeability+by+tight+junctions&amp;author=T.+Suzuki&amp;volume=70&amp;publication_year=2013&amp;pages=631-659&amp;pmid=22782113&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib74">74. <span class="element-citation" id="sref74">Antosova Z., Mackova M., Kral V., Macek T. Therapeutic application of peptides and proteins: parenteral forever? <span><span class="ref-journal">Trends Biotechnol. </span>2009;<span class="ref-vol">27</span>:628–635.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19766335" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biotechnol&amp;title=Therapeutic+application+of+peptides+and+proteins:+parenteral+forever?&amp;author=Z.+Antosova&amp;author=M.+Mackova&amp;author=V.+Kral&amp;author=T.+Macek&amp;volume=27&amp;publication_year=2009&amp;pages=628-635&amp;pmid=19766335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib75">75. <span class="element-citation" id="sref75">Maher S., Brayden D.J. Overcoming poor permeability: translating permeation enhancers for oral peptide delivery. <span><span class="ref-journal">Drug Discov Today. </span>2012;<span class="ref-vol">9</span>:e113–e119.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Overcoming+poor+permeability:+translating+permeation+enhancers+for+oral+peptide+delivery&amp;author=S.+Maher&amp;author=D.J.+Brayden&amp;volume=9&amp;publication_year=2012&amp;pages=e113-e119&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib76">76. <span class="element-citation" id="sref76">Wolf J.L., Rubin D.H., Finberg R., Kauffman R.S., Sharpe A.H., Trier J.S. Intestinal M cells: a pathway for entry of reovirus into the host. <span><span class="ref-journal">Science. </span>1981;<span class="ref-vol">212</span>:471–472.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6259737" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Intestinal+M+cells:+a+pathway+for+entry+of+reovirus+into+the+host&amp;author=J.L.+Wolf&amp;author=D.H.+Rubin&amp;author=R.+Finberg&amp;author=R.S.+Kauffman&amp;author=A.H.+Sharpe&amp;volume=212&amp;publication_year=1981&amp;pages=471-472&amp;pmid=6259737&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib77">77. <span class="element-citation" id="sref77">Singh B., Maharjan S., Jiang T., Kang S.K., Choi Y.J., Cho C.S. Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine. <span><span class="ref-journal">Mol Pharm. </span>2015;<span class="ref-vol">12</span>:3816–3828.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26394158" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Combinatorial+approach+of+antigen+delivery+using+M+cell-homing+peptide+and+mucoadhesive+vehicle+to+enhance+the+efficacy+of+oral+vaccine&amp;author=B.+Singh&amp;author=S.+Maharjan&amp;author=T.+Jiang&amp;author=S.K.+Kang&amp;author=Y.J.+Choi&amp;volume=12&amp;publication_year=2015&amp;pages=3816-3828&amp;pmid=26394158&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib78">78. <span class="element-citation" id="sref78">M&#x000e9;nard S., Lebreton C., Schumann M., Matysiak-Budnik T., Dugave C., Bouhnik Y. Paracellular <em>versus</em> transcellular intestinal permeability to gliadin peptides in active celiac disease. <span><span class="ref-journal">Am J Pathol. </span>2012;<span class="ref-vol">180</span>:608–615.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22119716" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=Paracellular+versus+transcellular+intestinal+permeability+to+gliadin+peptides+in+active+celiac+disease&amp;author=S.+M&#x000e9;nard&amp;author=C.+Lebreton&amp;author=M.+Schumann&amp;author=T.+Matysiak-Budnik&amp;author=C.+Dugave&amp;volume=180&amp;publication_year=2012&amp;pages=608-615&amp;pmid=22119716&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib79">79. <span class="element-citation" id="sref79">Tyagi P., Pechenov S., Subramony J.A. Oral peptide delivery: translational challenges due to physiological effects. <span><span class="ref-journal">J Control Release. </span>2018;<span class="ref-vol">287</span>:167–176.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30145135" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Oral+peptide+delivery:+translational+challenges+due+to+physiological+effects&amp;author=P.+Tyagi&amp;author=S.+Pechenov&amp;author=J.A.+Subramony&amp;volume=287&amp;publication_year=2018&amp;pages=167-176&amp;pmid=30145135&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib80">80. <span class="element-citation" id="sref80">Boronikolos G.C., Menge B.A., Schenker N., Breuer T.G., Otte J.M., Heckermann S. Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance. <span><span class="ref-journal">Diabetologia. </span>2015;<span class="ref-vol">58</span>:1175–1182.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25725624" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Upper+gastrointestinal+motility+and+symptoms+in+individuals+with+diabetes,+prediabetes+and+normal+glucose+tolerance&amp;author=G.C.+Boronikolos&amp;author=B.A.+Menge&amp;author=N.+Schenker&amp;author=T.G.+Breuer&amp;author=J.M.+Otte&amp;volume=58&amp;publication_year=2015&amp;pages=1175-1182&amp;pmid=25725624&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib81">81. <span class="element-citation" id="sref81">Sugihara M., Takeuchi S., Sugita M., Higaki K., Kataoka M., Yamashita S. Analysis of intra- and inter- subject variability in oral drug absorption in human bioequivalence studies of 113 generic products. <span><span class="ref-journal">Mol Pharm. </span>2015;<span class="ref-vol">12</span>:4405–4413.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26568266" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Analysis+of+intra-+and+inter-+subject+variability+in+oral+drug+absorption+in+human+bioequivalence+studies+of+113+generic+products&amp;author=M.+Sugihara&amp;author=S.+Takeuchi&amp;author=M.+Sugita&amp;author=K.+Higaki&amp;author=M.+Kataoka&amp;volume=12&amp;publication_year=2015&amp;pages=4405-4413&amp;pmid=26568266&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib82">82. <span class="element-citation" id="sref82">Jamal Azam Y., Machavaram K.K., Rostami-Hodjegan A. The modulating effects of endogenous substances on drug metabolising enzymes and implications for inter-individual variability and quantitative prediction. <span><span class="ref-journal">Curr Drug Metabol. </span>2014;<span class="ref-vol">15</span>:599–619.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25255874" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Metabol&amp;title=The+modulating+effects+of+endogenous+substances+on+drug+metabolising+enzymes+and+implications+for+inter-individual+variability+and+quantitative+prediction&amp;author=Y.+Jamal+Azam&amp;author=K.K.+Machavaram&amp;author=A.+Rostami-Hodjegan&amp;volume=15&amp;publication_year=2014&amp;pages=599-619&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib83">83. <span class="element-citation" id="sref83">Bois F.Y., Jamei M., Clewell H.J. PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. <span><span class="ref-journal">Toxicology. </span>2010;<span class="ref-vol">278</span>:256–267.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20600548" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=PBPK+modelling+of+inter-individual+variability+in+the+pharmacokinetics+of+environmental+chemicals&amp;author=F.Y.+Bois&amp;author=M.+Jamei&amp;author=H.J.+Clewell&amp;volume=278&amp;publication_year=2010&amp;pages=256-267&amp;pmid=20600548&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib84">84. <span class="element-citation" id="sref84">Gervasi V., Agnol R.D., Cullen S., McCoy T., Vucen S., Crean A. Parenteral protein formulations: an overview of approved products within the European Union. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2018;<span class="ref-vol">131</span>:8–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30006246" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Parenteral+protein+formulations:+an+overview+of+approved+products+within+the+European+Union&amp;author=V.+Gervasi&amp;author=R.D.+Agnol&amp;author=S.+Cullen&amp;author=T.+McCoy&amp;author=S.+Vucen&amp;volume=131&amp;publication_year=2018&amp;pages=8-24&amp;pmid=30006246&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib85">85. <span class="element-citation" id="sref85">Krause M.E., Sahin E. Chemical and physical instabilities in manufacturing and storage of therapeutic proteins. <span><span class="ref-journal">Curr Opin Biotechnol. </span>2019;<span class="ref-vol">60</span>:159–167.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30861476" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Biotechnol&amp;title=Chemical+and+physical+instabilities+in+manufacturing+and+storage+of+therapeutic+proteins&amp;author=M.E.+Krause&amp;author=E.+Sahin&amp;volume=60&amp;publication_year=2019&amp;pages=159-167&amp;pmid=30861476&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib86">86. <span class="element-citation" id="sref86">Duerr C., Friess W. Antibody&#x02013;drug conjugates&#x02014;stability and formulation. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2019;<span class="ref-vol">139</span>:168–176.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30940541" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Antibody&#x02013;drug+conjugates&#x02014;stability+and+formulation&amp;author=C.+Duerr&amp;author=W.+Friess&amp;volume=139&amp;publication_year=2019&amp;pages=168-176&amp;pmid=30940541&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib87">87. <span class="element-citation" id="sref87">Wang W., Ohtake S. Science and art of protein formulation development. <span><span class="ref-journal">Int J Pharm. </span>2019;<span class="ref-vol">568</span>:118505.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31306712" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Science+and+art+of+protein+formulation+development&amp;author=W.+Wang&amp;author=S.+Ohtake&amp;volume=568&amp;publication_year=2019&amp;pages=118505&amp;pmid=31306712&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib88">88. <span class="element-citation" id="sref88">Pace C.N., Fu H., Fryar K.L., Landua J., Trevino S.R., Shirley B.A. Contribution of hydrophobic interactions to protein stability. <span><span class="ref-journal">J Mol Biol. </span>2011;<span class="ref-vol">408</span>:514–528.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3086625/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21377472" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Biol&amp;title=Contribution+of+hydrophobic+interactions+to+protein+stability&amp;author=C.N.+Pace&amp;author=H.+Fu&amp;author=K.L.+Fryar&amp;author=J.+Landua&amp;author=S.R.+Trevino&amp;volume=408&amp;publication_year=2011&amp;pages=514-528&amp;pmid=21377472&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib89">89. <span class="element-citation" id="sref89">Nick Pace C., Scholtz J.M., Grimsley G.R. Forces stabilizing proteins. <span><span class="ref-journal">FEBS Lett. </span>2014;<span class="ref-vol">588</span>:2177–2184.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4116631/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24846139" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Forces+stabilizing+proteins&amp;author=C.+Nick+Pace&amp;author=J.M.+Scholtz&amp;author=G.R.+Grimsley&amp;volume=588&amp;publication_year=2014&amp;pages=2177-2184&amp;pmid=24846139&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib90">90. <span class="element-citation" id="sref90">Oyetayo O.O., M&#x000e9;ndez-Lucio O., Bender A., Kiefer H. Diversity selection, screening and quantitative structure&#x02013;activity relationships of osmolyte-like additive effects on the thermal stability of a monoclonal antibody. <span><span class="ref-journal">Eur J Pharmaceut Sci. </span>2017;<span class="ref-vol">97</span>:151–157.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27866015" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmaceut+Sci&amp;title=Diversity+selection,+screening+and+quantitative+structure&#x02013;activity+relationships+of+osmolyte-like+additive+effects+on+the+thermal+stability+of+a+monoclonal+antibody&amp;author=O.O.+Oyetayo&amp;author=O.+M&#x000e9;ndez-Lucio&amp;author=A.+Bender&amp;author=H.+Kiefer&amp;volume=97&amp;publication_year=2017&amp;pages=151-157&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib91">91. <span class="element-citation" id="sref91">Singh S.N., Kumar S., Bondar V., Wang N., Forcino R., Colandene J. Unexplored benefits of controlled ice nucleation: lyophilization of a highly concentrated monoclonal antibody solution. <span><span class="ref-journal">Int J Pharm. </span>2018;<span class="ref-vol">552</span>:171–179.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30261214" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Unexplored+benefits+of+controlled+ice+nucleation:+lyophilization+of+a+highly+concentrated+monoclonal+antibody+solution&amp;author=S.N.+Singh&amp;author=S.+Kumar&amp;author=V.+Bondar&amp;author=N.+Wang&amp;author=R.+Forcino&amp;volume=552&amp;publication_year=2018&amp;pages=171-179&amp;pmid=30261214&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib92">92. <span class="element-citation" id="sref92">Qian J., Yearley E., Tian S., Jing L., Balsaraf A., Lo Surdo P. Non-enzymatic and site-specific glycan shedding: a novel protein degradation pathway observed in a stabilized form of RSV prefusion F protein. <span><span class="ref-journal">Anal Chem. </span>2018;<span class="ref-vol">90</span>:10897–10902.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30152690" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=Non-enzymatic+and+site-specific+glycan+shedding:+a+novel+protein+degradation+pathway+observed+in+a+stabilized+form+of+RSV+prefusion+F+protein&amp;author=J.+Qian&amp;author=E.+Yearley&amp;author=S.+Tian&amp;author=L.+Jing&amp;author=A.+Balsaraf&amp;volume=90&amp;publication_year=2018&amp;pages=10897-10902&amp;pmid=30152690&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib93">93. <span class="element-citation" id="sref93">Calero-Rubio C., Ghosh R., Saluja A., Roberts C.J. Predicting protein&#x02012;protein interactions of concentrated antibody solutions using dilute solution data and coarse-grained molecular models. <span><span class="ref-journal">J Pharm Sci. </span>2018;<span class="ref-vol">107</span>:1269–1281.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5916024/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29274822" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Predicting+protein&#x02012;protein+interactions+of+concentrated+antibody+solutions+using+dilute+solution+data+and+coarse-grained+molecular+models&amp;author=C.+Calero-Rubio&amp;author=R.+Ghosh&amp;author=A.+Saluja&amp;author=C.J.+Roberts&amp;volume=107&amp;publication_year=2018&amp;pages=1269-1281&amp;pmid=29274822&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib94">94. <span class="element-citation" id="sref94">Shi S., Hashemi V., Wang S.C., Yang J., Yang M., Semple A. Overcoming challenges with intravenous administration of an investigational protein therapeutic. <span><span class="ref-journal">J Pharm Sci. </span>2017;<span class="ref-vol">106</span>:3465–3473.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28778425" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Overcoming+challenges+with+intravenous+administration+of+an+investigational+protein+therapeutic&amp;author=S.+Shi&amp;author=V.+Hashemi&amp;author=S.C.+Wang&amp;author=J.+Yang&amp;author=M.+Yang&amp;volume=106&amp;publication_year=2017&amp;pages=3465-3473&amp;pmid=28778425&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib95">95. <span class="element-citation" id="sref95">Falconer R.J. Advances in liquid formulations of parenteral therapeutic proteins. <span><span class="ref-journal">Biotechnol Adv. </span>2019;<span class="ref-vol">37</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31254660" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biotechnol+Adv&amp;title=Advances+in+liquid+formulations+of+parenteral+therapeutic+proteins&amp;author=R.J.+Falconer&amp;volume=37&amp;publication_year=2019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib96">96. <span class="element-citation" id="sref96">Cirkovas A., Sereikaite J. Different effects of L-arginine on the heat-induced unfolding and aggregation of proteins. <span><span class="ref-journal">Biologicals. </span>2011;<span class="ref-vol">39</span>:181–188.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21550265" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biologicals&amp;title=Different+effects+of+L-arginine+on+the+heat-induced+unfolding+and+aggregation+of+proteins&amp;author=A.+Cirkovas&amp;author=J.+Sereikaite&amp;volume=39&amp;publication_year=2011&amp;pages=181-188&amp;pmid=21550265&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib97">97. <span class="element-citation" id="sref97">Geraldes D.C., Beraldo-de-Ara&#x000fa;jo V.L., Pardo B.O.P., Pessoa Junior A., Stephano M.A., de Oliveira-Nascimento L. Protein drug delivery: current dosage form profile and formulation strategies. <span><span class="ref-journal">J Drug Target. </span>2020;<span class="ref-vol">28</span>:339–355.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31575296" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Target&amp;title=Protein+drug+delivery:+current+dosage+form+profile+and+formulation+strategies&amp;author=D.C.+Geraldes&amp;author=V.L.+Beraldo-de-Ara&#x000fa;jo&amp;author=B.O.P.+Pardo&amp;author=A.+Pessoa+Junior&amp;author=M.A.+Stephano&amp;volume=28&amp;publication_year=2020&amp;pages=339-355&amp;pmid=31575296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib98">98. <span class="element-citation" id="sref98">Bane J., Mozziconacci O., Yi L., Wang Y.J., Sreedhara A., Sch&#x000f6;neich C. Photo-oxidation of IGG1 and model peptides: detection and analysis of triply oxidized his and trp side chain cleavage products. <span><span class="ref-journal">Pharm Res. </span>2017;<span class="ref-vol">34</span>:229–242.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27800571" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Photo-oxidation+of+IGG1+and+model+peptides:+detection+and+analysis+of+triply+oxidized+his+and+trp+side+chain+cleavage+products&amp;author=J.+Bane&amp;author=O.+Mozziconacci&amp;author=L.+Yi&amp;author=Y.J.+Wang&amp;author=A.+Sreedhara&amp;volume=34&amp;publication_year=2017&amp;pages=229-242&amp;pmid=27800571&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib99">99. <span class="element-citation" id="sref99">Kamerzell T.J., Esfandiary R., Joshi S.B., Middaugh C.R., Volkin D.B. Protein&#x02013;excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2011;<span class="ref-vol">63</span>:1118–1159.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21855584" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Protein&#x02013;excipient+interactions:+mechanisms+and+biophysical+characterization+applied+to+protein+formulation+development&amp;author=T.J.+Kamerzell&amp;author=R.+Esfandiary&amp;author=S.B.+Joshi&amp;author=C.R.+Middaugh&amp;author=D.B.+Volkin&amp;volume=63&amp;publication_year=2011&amp;pages=1118-1159&amp;pmid=21855584&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib100">100. <span class="element-citation" id="sref100">Forney-Stevens K.M., Bogner R.H., Pikal M.J. Addition of amino acids to further stabilize lyophilized sucrose-based protein formulations: I. screening of 15 amino acids in two model proteins. <span><span class="ref-journal">J Pharm Sci. </span>2016;<span class="ref-vol">105</span>:697–704.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26414114" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Addition+of+amino+acids+to+further+stabilize+lyophilized+sucrose-based+protein+formulations:+I.+screening+of+15+amino+acids+in+two+model+proteins&amp;author=K.M.+Forney-Stevens&amp;author=R.H.+Bogner&amp;author=M.J.+Pikal&amp;volume=105&amp;publication_year=2016&amp;pages=697-704&amp;pmid=26414114&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib101">101. <span class="element-citation" id="sref101">Bhatnagar B.S., Bogner R.H., Pikal M.J. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. <span><span class="ref-journal">Pharmaceut Dev Technol. </span>2007;<span class="ref-vol">12</span>:505–523.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17963151" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceut+Dev+Technol&amp;title=Protein+stability+during+freezing:+separation+of+stresses+and+mechanisms+of+protein+stabilization&amp;author=B.S.+Bhatnagar&amp;author=R.H.+Bogner&amp;author=M.J.+Pikal&amp;volume=12&amp;publication_year=2007&amp;pages=505-523&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib102">102. <span class="element-citation" id="sref102">Arsiccio A., Pisano R. Surfactants as stabilizers for biopharmaceuticals: an insight into the molecular mechanisms for inhibition of protein aggregation. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2018;<span class="ref-vol">128</span>:98–106.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29653178" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Surfactants+as+stabilizers+for+biopharmaceuticals:+an+insight+into+the+molecular+mechanisms+for+inhibition+of+protein+aggregation&amp;author=A.+Arsiccio&amp;author=R.+Pisano&amp;volume=128&amp;publication_year=2018&amp;pages=98-106&amp;pmid=29653178&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib103">103. <span class="element-citation" id="sref103">Semenyuk P., Muronetz V. Protein interaction with charged macromolecules: from model polymers to unfolded proteins and post-translational modifications. <span><span class="ref-journal">Int J Mol Sci. </span>2019;<span class="ref-vol">20</span>:1252.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6429204/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30871103" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&amp;title=Protein+interaction+with+charged+macromolecules:+from+model+polymers+to+unfolded+proteins+and+post-translational+modifications&amp;author=P.+Semenyuk&amp;author=V.+Muronetz&amp;volume=20&amp;publication_year=2019&amp;pages=1252&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib104">104. <span class="element-citation" id="sref104">Yahyaei M., Mehrnejad F., Naderi-Manesh H., Rezayan A.H. Protein adsorption onto polysaccharides: comparison of chitosan and chitin polymers. <span><span class="ref-journal">Carbohydr Polym. </span>2018;<span class="ref-vol">191</span>:191–197.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29661309" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carbohydr+Polym&amp;title=Protein+adsorption+onto+polysaccharides:+comparison+of+chitosan+and+chitin+polymers&amp;author=M.+Yahyaei&amp;author=F.+Mehrnejad&amp;author=H.+Naderi-Manesh&amp;author=A.H.+Rezayan&amp;volume=191&amp;publication_year=2018&amp;pages=191-197&amp;pmid=29661309&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib105">105. <span class="element-citation" id="sref105">Mat D.J.L., Cattenoz T., Souchon I., Michon C., Le Feunteun S. Monitoring protein hydrolysis by pepsin using pH-stat: <em>in&#x000a0;vitro</em> gastric digestions in static and dynamic ph conditions. <span><span class="ref-journal">Food Chem. </span>2018;<span class="ref-vol">239</span>:268–275.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28873569" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Food+Chem&amp;title=Monitoring+protein+hydrolysis+by+pepsin+using+pH-stat:+in&#x000a0;vitro+gastric+digestions+in+static+and+dynamic+ph+conditions&amp;author=D.J.L.+Mat&amp;author=T.+Cattenoz&amp;author=I.+Souchon&amp;author=C.+Michon&amp;author=S.+Le+Feunteun&amp;volume=239&amp;publication_year=2018&amp;pages=268-275&amp;pmid=28873569&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib106">106. <span class="element-citation" id="sref106">Xu B., Zhang W., Chen Y., Xu Y., Wang B., Zong L. Eudragit&#x000ae; L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. <span><span class="ref-journal">Int J Biol Macromol. </span>2018;<span class="ref-vol">113</span>:534–542.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29408613" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Eudragit&#x000ae;+L100-coated+mannosylated+chitosan+nanoparticles+for+oral+protein+vaccine+delivery&amp;author=B.+Xu&amp;author=W.+Zhang&amp;author=Y.+Chen&amp;author=Y.+Xu&amp;author=B.+Wang&amp;volume=113&amp;publication_year=2018&amp;pages=534-542&amp;pmid=29408613&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib107">107. <span class="element-citation" id="sref107">Schilling R.J., Mitra A.K. Degradation of insulin by trypsin and alpha-chymotrypsin. <span><span class="ref-journal">Pharm Res. </span>1991;<span class="ref-vol">8</span>:721–727.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2062801" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Degradation+of+insulin+by+trypsin+and+alpha-chymotrypsin&amp;author=R.J.+Schilling&amp;author=A.K.+Mitra&amp;volume=8&amp;publication_year=1991&amp;pages=721-727&amp;pmid=2062801&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib108">108. <span class="element-citation" id="sref108">Welling S.H., Hub&#x000e1;lek F., Jacobsen J., Brayden D.J., Rahbek U.L., Buckley S.T. The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2014;<span class="ref-vol">86</span>:544–551.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24384069" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=The+role+of+citric+acid+in+oral+peptide+and+protein+formulations:+relationship+between+calcium+chelation+and+proteolysis+inhibition&amp;author=S.H.+Welling&amp;author=F.+Hub&#x000e1;lek&amp;author=J.+Jacobsen&amp;author=D.J.+Brayden&amp;author=U.L.+Rahbek&amp;volume=86&amp;publication_year=2014&amp;pages=544-551&amp;pmid=24384069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib109">109. <span class="element-citation" id="sref109">Lee Y.H., Perry B.A., Labruno S., Lee H.S., Stern W., Falzone L.M. Impact of regional intestinal ph modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs. <span><span class="ref-journal">Pharm Res. </span>1999;<span class="ref-vol">16</span>:1233–1239.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10468025" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Impact+of+regional+intestinal+ph+modulation+on+absorption+of+peptide+drugs:+oral+absorption+studies+of+salmon+calcitonin+in+beagle+dogs&amp;author=Y.H.+Lee&amp;author=B.A.+Perry&amp;author=S.+Labruno&amp;author=H.S.+Lee&amp;author=W.+Stern&amp;volume=16&amp;publication_year=1999&amp;pages=1233-1239&amp;pmid=10468025&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib110">110. <span class="element-citation" id="sref110">Binkley N., Bolognese M., Sidorowicz-Bialynicka A., Vally T., Trout R., Miller C. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the oral calcitonin in postmenopausal osteoporosis (oracal) trial. <span><span class="ref-journal">J Bone Miner Res. </span>2012;<span class="ref-vol">27</span>:1821–1829.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22437792" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res&amp;title=A+phase+3+trial+of+the+efficacy+and+safety+of+oral+recombinant+calcitonin:+the+oral+calcitonin+in+postmenopausal+osteoporosis+(oracal)+trial&amp;author=N.+Binkley&amp;author=M.+Bolognese&amp;author=A.+Sidorowicz-Bialynicka&amp;author=T.+Vally&amp;author=R.+Trout&amp;volume=27&amp;publication_year=2012&amp;pages=1821-1829&amp;pmid=22437792&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib111">111. <span class="element-citation" id="sref111">Choonara B.F., Choonara Y.E., Kumar P., Bijukumar D., du Toit L.C., Pillay V. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. <span><span class="ref-journal">Biotechnol Adv. </span>2014;<span class="ref-vol">32</span>:1269–1282.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25099657" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biotechnol+Adv&amp;title=A+review+of+advanced+oral+drug+delivery+technologies+facilitating+the+protection+and+absorption+of+protein+and+peptide+molecules&amp;author=B.F.+Choonara&amp;author=Y.E.+Choonara&amp;author=P.+Kumar&amp;author=D.+Bijukumar&amp;author=L.C.+du+Toit&amp;volume=32&amp;publication_year=2014&amp;pages=1269-1282&amp;pmid=25099657&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib112">112. <span class="element-citation" id="sref112">Niu M., Lu Y., Hovgaard L., Wu W. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, <em>in&#x000a0;vitro</em> characterization, and improved protection against enzymatic degradation. <span><span class="ref-journal">Int J Nanomed. </span>2011;<span class="ref-vol">6</span>:1155.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3148843/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21822379" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Nanomed&amp;title=Liposomes+containing+glycocholate+as+potential+oral+insulin+delivery+systems:+preparation,+in&#x000a0;vitro+characterization,+and+improved+protection+against+enzymatic+degradation&amp;author=M.+Niu&amp;author=Y.+Lu&amp;author=L.+Hovgaard&amp;author=W.+Wu&amp;volume=6&amp;publication_year=2011&amp;pages=1155&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib113">113. <span class="element-citation" id="sref113">Agrwal V., Reddy I.K., Khan M.A. Oral delivery of proteins: effect of chicken and duck ovomucoid on the stability of insulin in the presence of <em>&#x003b1;</em>-chymotrypsin and trypsin. <span><span class="ref-journal">Pharm Pharmcol Commun. </span>2000;<span class="ref-vol">6</span>:223–227.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Pharmcol+Commun&amp;title=Oral+delivery+of+proteins:+effect+of+chicken+and+duck+ovomucoid+on+the+stability+of+insulin+in+the+presence+of+&#x003b1;-chymotrypsin+and+trypsin&amp;author=V.+Agrwal&amp;author=I.K.+Reddy&amp;author=M.A.+Khan&amp;volume=6&amp;publication_year=2000&amp;pages=223-227&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib114">114. <span class="element-citation" id="sref114">Arbit E., Kidron M. Oral insulin delivery in a physiologic context. <span><span class="ref-journal">J Diabetes Sci Technol. </span>2017;<span class="ref-vol">11</span>:825–832.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5588830/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28654313" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Sci+Technol&amp;title=Oral+insulin+delivery+in+a+physiologic+context&amp;author=E.+Arbit&amp;author=M.+Kidron&amp;volume=11&amp;publication_year=2017&amp;pages=825-832&amp;pmid=28654313&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib115">115. <span class="element-citation" id="sref115">Del Curto M.D., Maroni A., Palugan L., Zema L., Gazzaniga A., Sangalli M.E. Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds. <span><span class="ref-journal">J Pharm Sci. </span>2011;<span class="ref-vol">100</span>:3251–3259.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21465487" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Oral+delivery+system+for+two-pulse+colonic+release+of+protein+drugs+and+protease+inhibitor/absorption+enhancer+compounds&amp;author=M.D.+Del+Curto&amp;author=A.+Maroni&amp;author=L.+Palugan&amp;author=L.+Zema&amp;author=A.+Gazzaniga&amp;volume=100&amp;publication_year=2011&amp;pages=3251-3259&amp;pmid=21465487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib116">116. <span class="element-citation" id="sref116">Maderuelo C., Lanao J.M., Zarzuelo A. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. <span><span class="ref-journal">Eur J Pharmaceut Sci. </span>2019;<span class="ref-vol">138</span>:105019.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31374253" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmaceut+Sci&amp;title=Enteric+coating+of+oral+solid+dosage+forms+as+a+tool+to+improve+drug+bioavailability&amp;author=C.+Maderuelo&amp;author=J.M.+Lanao&amp;author=A.+Zarzuelo&amp;volume=138&amp;publication_year=2019&amp;pages=105019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib117">117. <span class="element-citation" id="sref117">Nikam V.K., Kotade K., Gaware V., Dolas R., Dhamak K., Somwanshi S. Eudragit a versatile polymer: a review. <span><span class="ref-journal">Pharmacologyonline. </span>2011;<span class="ref-vol">1</span>:152–164.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacologyonline&amp;title=Eudragit+a+versatile+polymer:+a+review&amp;author=V.K.+Nikam&amp;author=K.+Kotade&amp;author=V.+Gaware&amp;author=R.+Dolas&amp;author=K.+Dhamak&amp;volume=1&amp;publication_year=2011&amp;pages=152-164&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib118">118. <span class="element-citation" id="sref118">Werle M., Makhlof A., Takeuchi H. Oral protein delivery: a patent review of academic and industrial approaches. <span><span class="ref-journal">Recent Pat Drug Deliv Formulation. </span>2009;<span class="ref-vol">3</span>:94–104.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19519570" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Recent+Pat+Drug+Deliv+Formulation&amp;title=Oral+protein+delivery:+a+patent+review+of+academic+and+industrial+approaches&amp;author=M.+Werle&amp;author=A.+Makhlof&amp;author=H.+Takeuchi&amp;volume=3&amp;publication_year=2009&amp;pages=94-104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib119">119. <span class="element-citation" id="sref119">Li P., Tan A., Prestidge C.A., Nielsen H.M., M&#x000fc;llertz A. Self-nanoemulsifying drug delivery systems for oral insulin delivery: <em>in&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> evaluations of enteric coating and drug loading. <span><span class="ref-journal">Int J Pharm. </span>2014;<span class="ref-vol">477</span>:390–398.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25455781" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Self-nanoemulsifying+drug+delivery+systems+for+oral+insulin+delivery:+in&#x000a0;vitro+and+in&#x000a0;vivo+evaluations+of+enteric+coating+and+drug+loading&amp;author=P.+Li&amp;author=A.+Tan&amp;author=C.A.+Prestidge&amp;author=H.M.+Nielsen&amp;author=A.+M&#x000fc;llertz&amp;volume=477&amp;publication_year=2014&amp;pages=390-398&amp;pmid=25455781&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib120">120. <span class="element-citation" id="sref120">Sonaje K., Chen Y.J., Chen H.L., Wey S.P., Juang J.H., Nguyen H.N. Enteric-coated capsules filled with freeze-dried chitosan/poly(<em>&#x003b3;</em>-glutamic acid) nanoparticles for oral insulin delivery. <span><span class="ref-journal">Biomaterials. </span>2010;<span class="ref-vol">31</span>:3384–3394.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20149435" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Enteric-coated+capsules+filled+with+freeze-dried+chitosan/poly(&#x003b3;-glutamic+acid)+nanoparticles+for+oral+insulin+delivery&amp;author=K.+Sonaje&amp;author=Y.J.+Chen&amp;author=H.L.+Chen&amp;author=S.P.+Wey&amp;author=J.H.+Juang&amp;volume=31&amp;publication_year=2010&amp;pages=3384-3394&amp;pmid=20149435&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib121">121. <span class="element-citation" id="sref121">Makhlof A., Tozuka Y., Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. <span><span class="ref-journal">Eur J Pharmaceut Sci. </span>2011;<span class="ref-vol">42</span>:445–451.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21182939" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmaceut+Sci&amp;title=Design+and+evaluation+of+novel+pH-sensitive+chitosan+nanoparticles+for+oral+insulin+delivery&amp;author=A.+Makhlof&amp;author=Y.+Tozuka&amp;author=H.+Takeuchi&amp;volume=42&amp;publication_year=2011&amp;pages=445-451&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib122">122. <span class="element-citation" id="sref122">Sinha V.R., Singh A., Kumar R.V., Singh S., Kumria R., Bhinge J. Oral colon-specific drug delivery of protein and peptide drugs. <span><span class="ref-journal">Crit Rev Ther Drug. </span>2007;<span class="ref-vol">24</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17430100" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Ther+Drug&amp;title=Oral+colon-specific+drug+delivery+of+protein+and+peptide+drugs&amp;author=V.R.+Sinha&amp;author=A.+Singh&amp;author=R.V.+Kumar&amp;author=S.+Singh&amp;author=R.+Kumria&amp;volume=24&amp;publication_year=2007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib123">123. <span class="element-citation" id="sref123">Patel M.M., Shah T., Amin A. Therapeutic opportunities in colon-specific drug-delivery systems. <span><span class="ref-journal">Crit Rev Ther Drug. </span>2007;<span class="ref-vol">24</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17725524" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Ther+Drug&amp;title=Therapeutic+opportunities+in+colon-specific+drug-delivery+systems&amp;author=M.M.+Patel&amp;author=T.+Shah&amp;author=A.+Amin&amp;volume=24&amp;publication_year=2007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib124">124. <span class="element-citation" id="sref124">Chen S., Guo F., Deng T., Zhu S., Liu W., Zhong H. Eudragit S100-coated chitosan nanoparticles co-loading TAT for enhanced oral colon absorption of insulin. <span><span class="ref-journal">AAPS PharmSciTech. </span>2017;<span class="ref-vol">18</span>:1277–1287.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27480441" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AAPS+PharmSciTech&amp;title=Eudragit+S100-coated+chitosan+nanoparticles+co-loading+TAT+for+enhanced+oral+colon+absorption+of+insulin&amp;author=S.+Chen&amp;author=F.+Guo&amp;author=T.+Deng&amp;author=S.+Zhu&amp;author=W.+Liu&amp;volume=18&amp;publication_year=2017&amp;pages=1277-1287&amp;pmid=27480441&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib125">125. <span class="element-citation" id="sref125">Zhang Y., Chi C., Huang X., Zou Q., Li X., Chen L. Starch-based nanocapsules fabricated through layer-by-layer assembly for oral delivery of protein to lower gastrointestinal tract. <span><span class="ref-journal">Carbohydr Polym. </span>2017;<span class="ref-vol">171</span>:242–251.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28578960" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carbohydr+Polym&amp;title=Starch-based+nanocapsules+fabricated+through+layer-by-layer+assembly+for+oral+delivery+of+protein+to+lower+gastrointestinal+tract&amp;author=Y.+Zhang&amp;author=C.+Chi&amp;author=X.+Huang&amp;author=Q.+Zou&amp;author=X.+Li&amp;volume=171&amp;publication_year=2017&amp;pages=242-251&amp;pmid=28578960&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib126">126. <span class="element-citation" id="sref126">Meneguin A.B., Beyssac E., Garrait G., Hsein H., Cury B.S. Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: a technological platform for protection against enzymatic degradation and improvement of intestinal permeability. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2018;<span class="ref-vol">123</span>:84–94.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29175551" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Retrograded+starch/pectin+coated+gellan+gum-microparticles+for+oral+administration+of+insulin:+a+technological+platform+for+protection+against+enzymatic+degradation+and+improvement+of+intestinal+permeability&amp;author=A.B.+Meneguin&amp;author=E.+Beyssac&amp;author=G.+Garrait&amp;author=H.+Hsein&amp;author=B.S.+Cury&amp;volume=123&amp;publication_year=2018&amp;pages=84-94&amp;pmid=29175551&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib127">127. <span class="element-citation" id="sref127">Kumar K.V., Sivakumar T., Mani T.T. Colon targeting drug delivery system: a review on recent approaches. <span><span class="ref-journal">Int J Pharma Bio Sci. </span>2011;<span class="ref-vol">2</span>:11–19.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharma+Bio+Sci&amp;title=Colon+targeting+drug+delivery+system:+a+review+on+recent+approaches&amp;author=K.V.+Kumar&amp;author=T.+Sivakumar&amp;author=T.T.+Mani&amp;volume=2&amp;publication_year=2011&amp;pages=11-19&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib128">128. <span class="element-citation" id="sref128">Ye C., Chi H. A review of recent progress in drug and protein encapsulation: approaches, applications and challenges. <span><span class="ref-journal">Mater Sci Eng C. </span>2018;<span class="ref-vol">83</span>:233–246.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29208283" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mater+Sci+Eng+C&amp;title=A+review+of+recent+progress+in+drug+and+protein+encapsulation:+approaches,+applications+and+challenges&amp;author=C.+Ye&amp;author=H.+Chi&amp;volume=83&amp;publication_year=2018&amp;pages=233-246&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib129">129. <span class="element-citation" id="sref129">Onuigbo E., Iseghohimhen J., Chah K., Gyang M., Attama A. Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: innate and acquired immunity. <span><span class="ref-journal">Vaccine. </span>2018;<span class="ref-vol">36</span>:4973–4978.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30017142" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Chitosan/alginate+microparticles+for+the+oral+delivery+of+fowl+typhoid+vaccine:+innate+and+acquired+immunity&amp;author=E.+Onuigbo&amp;author=J.+Iseghohimhen&amp;author=K.+Chah&amp;author=M.+Gyang&amp;author=A.+Attama&amp;volume=36&amp;publication_year=2018&amp;pages=4973-4978&amp;pmid=30017142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib130">130. <span class="element-citation" id="sref130">Li D., Zhuang J., He H., Jiang S., Banerjee A., Lu Y. Influence of particle geometry on gastrointestinal transit and absorption following oral administration. <span><span class="ref-journal">ACS Appl Mater Interfaces. </span>2017;<span class="ref-vol">9</span>:42492–42502.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29148702" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Appl+Mater+Interfaces&amp;title=Influence+of+particle+geometry+on+gastrointestinal+transit+and+absorption+following+oral+administration&amp;author=D.+Li&amp;author=J.+Zhuang&amp;author=H.+He&amp;author=S.+Jiang&amp;author=A.+Banerjee&amp;volume=9&amp;publication_year=2017&amp;pages=42492-42502&amp;pmid=29148702&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib131">131. <span class="element-citation" id="sref131">Banerjee A., Qi J., Gogoi R., Wong J., Mitragotri S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. <span><span class="ref-journal">J Control Release. </span>2016;<span class="ref-vol">238</span>:176–185.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5289391/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27480450" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Role+of+nanoparticle+size,+shape+and+surface+chemistry+in+oral+drug+delivery&amp;author=A.+Banerjee&amp;author=J.+Qi&amp;author=R.+Gogoi&amp;author=J.+Wong&amp;author=S.+Mitragotri&amp;volume=238&amp;publication_year=2016&amp;pages=176-185&amp;pmid=27480450&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib132">132. <span class="element-citation" id="sref132">Roberts M., Bentley M., Harris J. Chemistry for peptide and protein pegylation. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2002;<span class="ref-vol">54</span>:459–476.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12052709" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Chemistry+for+peptide+and+protein+pegylation&amp;author=M.+Roberts&amp;author=M.+Bentley&amp;author=J.+Harris&amp;volume=54&amp;publication_year=2002&amp;pages=459-476&amp;pmid=12052709&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib133">133. <span class="element-citation" id="sref133">Aguirre T.A., Teijeiro-Osorio D., Rosa M., Coulter I., Alonso M., Brayden D. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">106</span>:223–241.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26921819" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Current+status+of+selected+oral+peptide+technologies+in+advanced+preclinical+development+and+in+clinical+trials&amp;author=T.A.+Aguirre&amp;author=D.+Teijeiro-Osorio&amp;author=M.+Rosa&amp;author=I.+Coulter&amp;author=M.+Alonso&amp;volume=106&amp;publication_year=2016&amp;pages=223-241&amp;pmid=26921819&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib134">134. <span class="element-citation" id="sref134">Nojima Y., Suzuki Y., Iguchi K., Shiga T., Iwata A., Fujimoto T. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration. <span><span class="ref-journal">Bioconjugate Chem. </span>2008;<span class="ref-vol">19</span>:2253–2259.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18834167" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjugate+Chem&amp;title=Development+of+poly(ethylene+glycol)+conjugated+lactoferrin+for+oral+administration&amp;author=Y.+Nojima&amp;author=Y.+Suzuki&amp;author=K.+Iguchi&amp;author=T.+Shiga&amp;author=A.+Iwata&amp;volume=19&amp;publication_year=2008&amp;pages=2253-2259&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib135">135. <span class="element-citation" id="sref135">Ryan S.M., Wang X., Mantovani G., Sayers C.T., Haddleton D.M., Brayden D.J. Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly (ethylene glycol)methyl ether methacrylate) yields a bioactive stable conjugate. <span><span class="ref-journal">J Control Release. </span>2009;<span class="ref-vol">135</span>:51–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19168100" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Conjugation+of+salmon+calcitonin+to+a+combed-shaped+end+functionalized+poly(poly+(ethylene+glycol)methyl+ether+methacrylate)+yields+a+bioactive+stable+conjugate&amp;author=S.M.+Ryan&amp;author=X.+Wang&amp;author=G.+Mantovani&amp;author=C.T.+Sayers&amp;author=D.M.+Haddleton&amp;volume=135&amp;publication_year=2009&amp;pages=51-59&amp;pmid=19168100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib136">136. <span class="element-citation" id="sref136">Gentilucci L., De Marco R., Cerisoli L. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. <span><span class="ref-journal">Curr Pharmaceut Des. </span>2010;<span class="ref-vol">16</span>:3185–3203.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20687878" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharmaceut+Des&amp;title=Chemical+modifications+designed+to+improve+peptide+stability:+incorporation+of+non-natural+amino+acids,+pseudo-peptide+bonds,+and+cyclization&amp;author=L.+Gentilucci&amp;author=R.+De+Marco&amp;author=L.+Cerisoli&amp;volume=16&amp;publication_year=2010&amp;pages=3185-3203&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib137">137. <span class="element-citation" id="sref137">Conibear A.C., Chaousis S., Durek T., Johan Rosengren K., Craik D.J., Schroeder C.I. Approaches to the stabilization of bioactive epitopes by grafting and peptide cyclization. <span><span class="ref-journal">Pept Sci. </span>2016;<span class="ref-vol">106</span>:89–100.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26566734" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pept+Sci&amp;title=Approaches+to+the+stabilization+of+bioactive+epitopes+by+grafting+and+peptide+cyclization&amp;author=A.C.+Conibear&amp;author=S.+Chaousis&amp;author=T.+Durek&amp;author=K.+Johan+Rosengren&amp;author=D.J.+Craik&amp;volume=106&amp;publication_year=2016&amp;pages=89-100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib138">138. <span class="element-citation" id="sref138">Zhang R.Y., Thapa P., Espiritu M.J., Menon V., Bingham J.P. From nature to creation: going around in circles, the art of peptide cyclization. <span><span class="ref-journal">Bioorg Med Chem. </span>2018;<span class="ref-vol">26</span>:1135–1150.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29295762" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem&amp;title=From+nature+to+creation:+going+around+in+circles,+the+art+of+peptide+cyclization&amp;author=R.Y.+Zhang&amp;author=P.+Thapa&amp;author=M.J.+Espiritu&amp;author=V.+Menon&amp;author=J.P.+Bingham&amp;volume=26&amp;publication_year=2018&amp;pages=1135-1150&amp;pmid=29295762&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib139">139. <span class="element-citation" id="sref139">Matsui K., Kimura T., Ota K., Iitake K., Shoji M., Inoue M. Resistance of 1-deamino[8-<span class="small-caps">d</span>-argininei]-vasopressin to <em>in&#x000a0;vitro</em> degradation as compared with arginine vasopressin. <span><span class="ref-journal">Endocrinol Jpn. </span>1985;<span class="ref-vol">32</span>:547–557.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3936702" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinol+Jpn&amp;title=Resistance+of+1-deamino[8-d-argininei]-vasopressin+to+in&#x000a0;vitro+degradation+as+compared+with+arginine+vasopressin&amp;author=K.+Matsui&amp;author=T.+Kimura&amp;author=K.+Ota&amp;author=K.+Iitake&amp;author=M.+Shoji&amp;volume=32&amp;publication_year=1985&amp;pages=547-557&amp;pmid=3936702&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib140">140. <span class="element-citation" id="sref140">White C.J., Yudin A.K. Contemporary strategies for peptide macrocyclization. <span><span class="ref-journal">Nat Chem. </span>2011;<span class="ref-vol">3</span>:509.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21697871" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem&amp;title=Contemporary+strategies+for+peptide+macrocyclization&amp;author=C.J.+White&amp;author=A.K.+Yudin&amp;volume=3&amp;publication_year=2011&amp;pages=509&amp;pmid=21697871&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib141">141. <span class="element-citation" id="sref141">Bogdanowich-Knipp S.J., Chakrabarti S., Siahaan T.J., Williams T.D., Dillman R.K. Solution stability of linear vs. cyclic RGD peptides. <span><span class="ref-journal">J Pept Res. </span>1999;<span class="ref-vol">53</span>:530–541.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10424348" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pept+Res&amp;title=Solution+stability+of+linear+vs.+cyclic+RGD+peptides&amp;author=S.J.+Bogdanowich-Knipp&amp;author=S.+Chakrabarti&amp;author=T.J.+Siahaan&amp;author=T.D.+Williams&amp;author=R.K.+Dillman&amp;volume=53&amp;publication_year=1999&amp;pages=530-541&amp;pmid=10424348&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib142">142. <span class="element-citation" id="sref142">Nielsen D.S., Shepherd N.E., Xu W., Lucke A.J., Stoermer M.J., Fairlie D.P. Orally absorbed cyclic peptides. <span><span class="ref-journal">Chem Rev. </span>2017;<span class="ref-vol">117</span>:8094–8128.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28541045" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Rev&amp;title=Orally+absorbed+cyclic+peptides&amp;author=D.S.+Nielsen&amp;author=N.E.+Shepherd&amp;author=W.+Xu&amp;author=A.J.+Lucke&amp;author=M.J.+Stoermer&amp;volume=117&amp;publication_year=2017&amp;pages=8094-8128&amp;pmid=28541045&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib143">143. <span class="element-citation" id="sref143">Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2009;<span class="ref-vol">61</span>:158–171.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2667119/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19133304" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Mucus-penetrating+nanoparticles+for+drug+and+gene+delivery+to+mucosal+tissues&amp;author=S.K.+Lai&amp;author=Y.Y.+Wang&amp;author=J.+Hanes&amp;volume=61&amp;publication_year=2009&amp;pages=158-171&amp;pmid=19133304&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib144">144. <span class="element-citation" id="sref144">Ensign L.M., Schneider C., Suk J.S., Cone R., Hanes J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. <span><span class="ref-journal">Adv Mater. </span>2012;<span class="ref-vol">24</span>:3887–3894.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3710133/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22988559" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Mater&amp;title=Mucus+penetrating+nanoparticles:+biophysical+tool+and+method+of+drug+and+gene+delivery&amp;author=L.M.+Ensign&amp;author=C.+Schneider&amp;author=J.S.+Suk&amp;author=R.+Cone&amp;author=J.+Hanes&amp;volume=24&amp;publication_year=2012&amp;pages=3887-3894&amp;pmid=22988559&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib145">145. <span class="element-citation" id="sref145">Yu T., Chisholm J., Choi W.J., Anonuevo A., Pulicare S., Zhong W. Mucus-penetrating nanosuspensions for enhanced delivery of poorly soluble drugs to mucosal surfaces. <span><span class="ref-journal">Adv Healthc Mater. </span>2016;<span class="ref-vol">5</span>:2745–2750.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5586074/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27717163" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Healthc+Mater&amp;title=Mucus-penetrating+nanosuspensions+for+enhanced+delivery+of+poorly+soluble+drugs+to+mucosal+surfaces&amp;author=T.+Yu&amp;author=J.+Chisholm&amp;author=W.J.+Choi&amp;author=A.+Anonuevo&amp;author=S.+Pulicare&amp;volume=5&amp;publication_year=2016&amp;pages=2745-2750&amp;pmid=27717163&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib146">146. <span class="element-citation" id="sref146">Suk J.S., Lai S.K., Boylan N.J., Dawson M.R., Boyle M.P., Hanes J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with <em>N</em>-acetyl cysteine. <span><span class="ref-journal">Nanomedicine. </span>2011;<span class="ref-vol">6</span>:365–375.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3102009/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21385138" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Rapid+transport+of+muco-inert+nanoparticles+in+cystic+fibrosis+sputum+treated+with+N-acetyl+cysteine&amp;author=J.S.+Suk&amp;author=S.K.+Lai&amp;author=N.J.+Boylan&amp;author=M.R.+Dawson&amp;author=M.P.+Boyle&amp;volume=6&amp;publication_year=2011&amp;pages=365-375&amp;pmid=21385138&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib147">147. <span class="element-citation" id="sref147">Khan J., Iiboshi Y., Cui L., Wasa M., Okada A. Role of intestinal mucus on the uptake of latex beads by peyer's patches and on their transport to mesenteric lymph nodes in rats. <span><span class="ref-journal">Jpen-parenter Enter. </span>1999;<span class="ref-vol">23</span>:19–23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9888413" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Jpen-parenter+Enter&amp;title=Role+of+intestinal+mucus+on+the+uptake+of+latex+beads+by+peyer's+patches+and+on+their+transport+to+mesenteric+lymph+nodes+in+rats&amp;author=J.+Khan&amp;author=Y.+Iiboshi&amp;author=L.+Cui&amp;author=M.+Wasa&amp;author=A.+Okada&amp;volume=23&amp;publication_year=1999&amp;pages=19-23&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib148">148. <span class="element-citation" id="sref148">Ensign L.M., Cone R., Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2012;<span class="ref-vol">64</span>:557–570.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3322271/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22212900" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+drug+delivery+with+polymeric+nanoparticles:+the+gastrointestinal+mucus+barriers&amp;author=L.M.+Ensign&amp;author=R.+Cone&amp;author=J.+Hanes&amp;volume=64&amp;publication_year=2012&amp;pages=557-570&amp;pmid=22212900&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib149">149. <span class="element-citation" id="sref149">Maisel K., Ensign L., Reddy M., Cone R., Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. <span><span class="ref-journal">J Control Release. </span>2015;<span class="ref-vol">197</span>:48–57.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4272879/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25449804" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Effect+of+surface+chemistry+on+nanoparticle+interaction+with+gastrointestinal+mucus+and+distribution+in+the+gastrointestinal+tract+following+oral+and+rectal+administration+in+the+mouse&amp;author=K.+Maisel&amp;author=L.+Ensign&amp;author=M.+Reddy&amp;author=R.+Cone&amp;author=J.+Hanes&amp;volume=197&amp;publication_year=2015&amp;pages=48-57&amp;pmid=25449804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib150">150. <span class="element-citation" id="sref150">Huckaby J.T., Lai S.K. Pegylation for enhancing nanoparticle diffusion in mucus. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2018;<span class="ref-vol">124</span>:125–139.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28882703" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Pegylation+for+enhancing+nanoparticle+diffusion+in+mucus&amp;author=J.T.+Huckaby&amp;author=S.K.+Lai&amp;volume=124&amp;publication_year=2018&amp;pages=125-139&amp;pmid=28882703&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib151">151. <span class="element-citation" id="sref151">Popov A., Enlow E., Bourassa J., Chen H. Mucus-penetrating nanoparticles made with &#x0201c;mucoadhesive&#x0201d; poly(vinyl alcohol) <span><span class="ref-journal">Nanomedicine. </span>2016;<span class="ref-vol">12</span>:1863–1871.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27112308" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Mucus-penetrating+nanoparticles+made+with+&#x0201c;mucoadhesive&#x0201d;+poly(vinyl+alcohol)&amp;author=A.+Popov&amp;author=E.+Enlow&amp;author=J.+Bourassa&amp;author=H.+Chen&amp;volume=12&amp;publication_year=2016&amp;pages=1863-1871&amp;pmid=27112308&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib152">152. <span class="element-citation" id="sref152">Shan W., Zhu X., Liu M., Li L., Zhong J., Sun W. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. <span><span class="ref-journal">ACS Nano. </span>2015;<span class="ref-vol">9</span>:2345–2356.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25658958" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Nano&amp;title=Overcoming+the+diffusion+barrier+of+mucus+and+absorption+barrier+of+epithelium+by+self-assembled+nanoparticles+for+oral+delivery+of+insulin&amp;author=W.+Shan&amp;author=X.+Zhu&amp;author=M.+Liu&amp;author=L.+Li&amp;author=J.+Zhong&amp;volume=9&amp;publication_year=2015&amp;pages=2345-2356&amp;pmid=25658958&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib153">153. <span class="element-citation" id="sref153">Wang A., Yang T., Fan W., Yang Y., Zhu Q., Guo S. Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers. <span><span class="ref-journal">Adv Healthc Mater. </span>2019;<span class="ref-vol">8</span>:1801123.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30485708" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Healthc+Mater&amp;title=Protein+corona+liposomes+achieve+efficient+oral+insulin+delivery+by+overcoming+mucus+and+epithelial+barriers&amp;author=A.+Wang&amp;author=T.+Yang&amp;author=W.+Fan&amp;author=Y.+Yang&amp;author=Q.+Zhu&amp;volume=8&amp;publication_year=2019&amp;pages=1801123&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib154">154. <span class="element-citation" id="sref154">Wu J., Zheng Y., Liu M., Shan W., Zhang Z., Huang Y. Biomimetic virus like and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. <span><span class="ref-journal">ACS Appl Mater Interfaces. </span>2018;<span class="ref-vol">10</span>:9916–9928.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29504398" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Appl+Mater+Interfaces&amp;title=Biomimetic+virus+like+and+charge+reversible+nanoparticles+to+sequentially+overcome+mucus+and+epithelial+barriers+for+oral+insulin+delivery&amp;author=J.+Wu&amp;author=Y.+Zheng&amp;author=M.+Liu&amp;author=W.+Shan&amp;author=Z.+Zhang&amp;volume=10&amp;publication_year=2018&amp;pages=9916-9928&amp;pmid=29504398&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib155">155. <span class="element-citation" id="sref155">Guo M., Wei M., Li W., Guo M., Guo C., Ma M. Impacts of particle shapes on the oral delivery of drug nanocrystals: mucus permeation, transepithelial transport and bioavailability. <span><span class="ref-journal">J Control Release. </span>2019;<span class="ref-vol">307</span>:64–75.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31207275" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Impacts+of+particle+shapes+on+the+oral+delivery+of+drug+nanocrystals:+mucus+permeation,+transepithelial+transport+and+bioavailability&amp;author=M.+Guo&amp;author=M.+Wei&amp;author=W.+Li&amp;author=M.+Guo&amp;author=C.+Guo&amp;volume=307&amp;publication_year=2019&amp;pages=64-75&amp;pmid=31207275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib156">156. <span class="element-citation" id="sref156">Yu M., Wang J., Yang Y., Zhu C., Su Q., Guo S. Rotation-facilitated rapid transport of nanorods in mucosal tissues. <span><span class="ref-journal">Nano Lett. </span>2016;<span class="ref-vol">16</span>:7176–7182.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27700115" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nano+Lett&amp;title=Rotation-facilitated+rapid+transport+of+nanorods+in+mucosal+tissues&amp;author=M.+Yu&amp;author=J.+Wang&amp;author=Y.+Yang&amp;author=C.+Zhu&amp;author=Q.+Su&amp;volume=16&amp;publication_year=2016&amp;pages=7176-7182&amp;pmid=27700115&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib157">157. <span class="element-citation" id="sref157">D&#x000fc;nnhaupt S., Kammona O., Waldner C., Kiparissides C., Bernkop-Schn&#x000fc;rch A. Nano-carrier systems: strategies to overcome the mucus gel barrier. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2015;<span class="ref-vol">96</span>:447–453.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25712487" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Nano-carrier+systems:+strategies+to+overcome+the+mucus+gel+barrier&amp;author=S.+D&#x000fc;nnhaupt&amp;author=O.+Kammona&amp;author=C.+Waldner&amp;author=C.+Kiparissides&amp;author=A.+Bernkop-Schn&#x000fc;rch&amp;volume=96&amp;publication_year=2015&amp;pages=447-453&amp;pmid=25712487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib158">158. <span class="element-citation" id="sref158">Zupan&#x0010d;i&#x0010d; O., Grie&#x003b2;inger J.A., Rohrer J., de Sousa I.P., Danninger L., Partenhauser A. Development, <em>in&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> evaluation of a self-emulsifying drug delivery system (sedds) for oral enoxaparin administration. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2016;<span class="ref-vol">109</span>:113–121.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27693677" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Development,+in&#x000a0;vitro+and+in&#x000a0;vivo+evaluation+of+a+self-emulsifying+drug+delivery+system+(sedds)+for+oral+enoxaparin+administration&amp;author=O.+Zupan&#x0010d;i&#x0010d;&amp;author=J.A.+Grie&#x003b2;inger&amp;author=J.+Rohrer&amp;author=I.P.+de+Sousa&amp;author=L.+Danninger&amp;volume=109&amp;publication_year=2016&amp;pages=113-121&amp;pmid=27693677&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib159">159. <span class="element-citation" id="sref159">Florey H.W. Secretion and function of intestinal mucus. <span><span class="ref-journal">Gastroenterology. </span>1962;<span class="ref-vol">43</span>:326–329.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/13893646" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Secretion+and+function+of+intestinal+mucus&amp;author=H.W.+Florey&amp;volume=43&amp;publication_year=1962&amp;pages=326-329&amp;pmid=13893646&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib160">160. <span class="element-citation" id="sref160">Chickering D., Iii, Jacob J., Desai T., Harrison M., Harris W., Morrell C. Bioadhesive microspheres: III. an <em>in&#x000a0;vivo</em> transit and bioavailability study of drug-loaded alginate and poly(fumaric<em>-co-</em>sebacic anhydride) microspheres. <span><span class="ref-journal">J Control Release. </span>1997;<span class="ref-vol">48</span>:35–46.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Bioadhesive+microspheres:+III.+an+in&#x000a0;vivo+transit+and+bioavailability+study+of+drug-loaded+alginate+and+poly(fumaric-co-sebacic+anhydride)+microspheres&amp;author=D.+Chickering&amp;author=J.+Jacob&amp;author=T.+Desai&amp;author=M.+Harrison&amp;author=W.+Harris&amp;volume=48&amp;publication_year=1997&amp;pages=35-46&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib161">161. <span class="element-citation" id="sref161">Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. <span><span class="ref-journal">J Control Release. </span>1990;<span class="ref-vol">11</span>:205–214.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Controlled+vaccine+release+in+the+gut-associated+lymphoid+tissues.+I.+Orally+administered+biodegradable+microspheres+target+the+peyer's+patches&amp;author=J.H.+Eldridge&amp;author=C.J.+Hammond&amp;author=J.A.+Meulbroek&amp;author=J.K.+Staas&amp;author=R.M.+Gilley&amp;volume=11&amp;publication_year=1990&amp;pages=205-214&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib162">162. <span class="element-citation" id="sref162">Chen F., Zhang Z.R., Yuan F., Qin X., Wang M., Huang Y. <em>In&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> study of <em>n</em>-trimethyl chitosan nanoparticles for oral protein delivery. <span><span class="ref-journal">Int J Pharm. </span>2008;<span class="ref-vol">349</span>:226–233.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17825506" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=In&#x000a0;vitro+and+in&#x000a0;vivo+study+of+n-trimethyl+chitosan+nanoparticles+for+oral+protein+delivery&amp;author=F.+Chen&amp;author=Z.R.+Zhang&amp;author=F.+Yuan&amp;author=X.+Qin&amp;author=M.+Wang&amp;volume=349&amp;publication_year=2008&amp;pages=226-233&amp;pmid=17825506&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib163">163. <span class="element-citation" id="sref163">Bernkop-Schn&#x000fc;rch A. Thiomers: a new generation of mucoadhesive polymers. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2005;<span class="ref-vol">57</span>:1569–1582.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16176846" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Thiomers:+a+new+generation+of+mucoadhesive+polymers&amp;author=A.+Bernkop-Schn&#x000fc;rch&amp;volume=57&amp;publication_year=2005&amp;pages=1569-1582&amp;pmid=16176846&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib164">164. <span class="element-citation" id="sref164">Bernkop-Schn&#x000fc;rch A., Hornof M., Zoidl T. Thiolated polymers&#x02014;thiomers: synthesis and <em>in&#x000a0;vitro</em> evaluation of chitosan&#x02013;2-iminothiolane conjugates. <span><span class="ref-journal">Int J Pharm. </span>2003;<span class="ref-vol">260</span>:229–237.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12842342" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Thiolated+polymers&#x02014;thiomers:+synthesis+and+in&#x000a0;vitro+evaluation+of+chitosan&#x02013;2-iminothiolane+conjugates&amp;author=A.+Bernkop-Schn&#x000fc;rch&amp;author=M.+Hornof&amp;author=T.+Zoidl&amp;volume=260&amp;publication_year=2003&amp;pages=229-237&amp;pmid=12842342&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib165">165. <span class="element-citation" id="sref165">Yin L., Ding J., He C., Cui L., Tang C., Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. <span><span class="ref-journal">Biomaterials. </span>2009;<span class="ref-vol">30</span>:5691–5700.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19615735" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Drug+permeability+and+mucoadhesion+properties+of+thiolated+trimethyl+chitosan+nanoparticles+in+oral+insulin+delivery&amp;author=L.+Yin&amp;author=J.+Ding&amp;author=C.+He&amp;author=L.+Cui&amp;author=C.+Tang&amp;volume=30&amp;publication_year=2009&amp;pages=5691-5700&amp;pmid=19615735&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib166">166. <span class="element-citation" id="sref166">Lehr C.M. Lectin-mediated drug delivery: the second generation of bioadhesives. <span><span class="ref-journal">J Control Release. </span>2000;<span class="ref-vol">65</span>:19–29.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10699266" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Lectin-mediated+drug+delivery:+the+second+generation+of+bioadhesives&amp;author=C.M.+Lehr&amp;volume=65&amp;publication_year=2000&amp;pages=19-29&amp;pmid=10699266&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib167">167. <span class="element-citation" id="sref167">Leong K.H., Chung L.Y., Noordin M.I., Onuki Y., Morishita M., Takayama K. Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery. <span><span class="ref-journal">Carbohydr Polym. </span>2011;<span class="ref-vol">86</span>:555–565.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carbohydr+Polym&amp;title=Lectin-functionalized+carboxymethylated+kappa-carrageenan+microparticles+for+oral+insulin+delivery&amp;author=K.H.+Leong&amp;author=L.Y.+Chung&amp;author=M.I.+Noordin&amp;author=Y.+Onuki&amp;author=M.+Morishita&amp;volume=86&amp;publication_year=2011&amp;pages=555-565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib168">168. <span class="element-citation" id="sref168">Zhang N., Ping Q., Huang G., Xu W., Cheng Y., Han X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. <span><span class="ref-journal">Int J Pharm. </span>2006;<span class="ref-vol">327</span>:153–159.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16935443" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Lectin-modified+solid+lipid+nanoparticles+as+carriers+for+oral+administration+of+insulin&amp;author=N.+Zhang&amp;author=Q.+Ping&amp;author=G.+Huang&amp;author=W.+Xu&amp;author=Y.+Cheng&amp;volume=327&amp;publication_year=2006&amp;pages=153-159&amp;pmid=16935443&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib169">169. <span class="element-citation" id="sref169">Teutonico D., Ponchel G. Patches for improving gastrointestinal absorption: an overview. <span><span class="ref-journal">Drug Discov Today. </span>2011;<span class="ref-vol">16</span>:991–997.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21683153" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Patches+for+improving+gastrointestinal+absorption:+an+overview&amp;author=D.+Teutonico&amp;author=G.+Ponchel&amp;volume=16&amp;publication_year=2011&amp;pages=991-997&amp;pmid=21683153&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib170">170. <span class="element-citation" id="sref170">Banerjee A., Mitragotri S. Intestinal patch systems for oral drug delivery. <span><span class="ref-journal">Curr Opin Pharmacol. </span>2017;<span class="ref-vol">36</span>:58–65.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28850875" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pharmacol&amp;title=Intestinal+patch+systems+for+oral+drug+delivery&amp;author=A.+Banerjee&amp;author=S.+Mitragotri&amp;volume=36&amp;publication_year=2017&amp;pages=58-65&amp;pmid=28850875&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib171">171. <span class="element-citation" id="sref171">Shen Z., Mitragotri S. Intestinal patches for oral drug delivery. <span><span class="ref-journal">Pharm Res. </span>2002;<span class="ref-vol">19</span>:391–395.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12033369" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Intestinal+patches+for+oral+drug+delivery&amp;author=Z.+Shen&amp;author=S.+Mitragotri&amp;volume=19&amp;publication_year=2002&amp;pages=391-395&amp;pmid=12033369&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib172">172. <span class="element-citation" id="sref172">Gupta V., Hwang B.H., Lee J., Anselmo A.C., Doshi N., Mitragotri S. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. <span><span class="ref-journal">J Control Release. </span>2013;<span class="ref-vol">172</span>:753–762.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24035976" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Mucoadhesive+intestinal+devices+for+oral+delivery+of+salmon+calcitonin&amp;author=V.+Gupta&amp;author=B.H.+Hwang&amp;author=J.+Lee&amp;author=A.C.+Anselmo&amp;author=N.+Doshi&amp;volume=172&amp;publication_year=2013&amp;pages=753-762&amp;pmid=24035976&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib173">173. <span class="element-citation" id="sref173">Whitehead K., Shen Z., Mitragotri S. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. <span><span class="ref-journal">J Control Release. </span>2004;<span class="ref-vol">98</span>:37–45.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15245887" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Oral+delivery+of+macromolecules+using+intestinal+patches:+applications+for+insulin+delivery&amp;author=K.+Whitehead&amp;author=Z.+Shen&amp;author=S.+Mitragotri&amp;volume=98&amp;publication_year=2004&amp;pages=37-45&amp;pmid=15245887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib174">174. <span class="element-citation" id="sref174">Banerjee A., Wong J., Gogoi R., Brown T., Mitragotri S. Intestinal micropatches for oral insulin delivery. <span><span class="ref-journal">J Drug Target. </span>2017;<span class="ref-vol">25</span>:608–615.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28266884" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Target&amp;title=Intestinal+micropatches+for+oral+insulin+delivery&amp;author=A.+Banerjee&amp;author=J.+Wong&amp;author=R.+Gogoi&amp;author=T.+Brown&amp;author=S.+Mitragotri&amp;volume=25&amp;publication_year=2017&amp;pages=608-615&amp;pmid=28266884&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib175">175. <span class="element-citation" id="sref175">Toorisaka E., Watanabe K., Ono H., Hirata M., Kamiya N., Goto M. Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery. <span><span class="ref-journal">Acta Biomater. </span>2012;<span class="ref-vol">8</span>:653–658.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21982846" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Biomater&amp;title=Intestinal+patches+with+an+immobilized+solid-in-oil+formulation+for+oral+protein+delivery&amp;author=E.+Toorisaka&amp;author=K.+Watanabe&amp;author=H.+Ono&amp;author=M.+Hirata&amp;author=N.+Kamiya&amp;volume=8&amp;publication_year=2012&amp;pages=653-658&amp;pmid=21982846&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib176">176. <span class="element-citation" id="sref176">Gupta V., Hwang B.H., Doshi N., Banerjee A., Anselmo A.C., Mitragotri S. Delivery of exenatide and insulin using mucoadhesive intestinal devices. <span><span class="ref-journal">Ann Biomed Eng. </span>2016;<span class="ref-vol">44</span>:1993–2007.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26864536" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Biomed+Eng&amp;title=Delivery+of+exenatide+and+insulin+using+mucoadhesive+intestinal+devices&amp;author=V.+Gupta&amp;author=B.H.+Hwang&amp;author=N.+Doshi&amp;author=A.+Banerjee&amp;author=A.C.+Anselmo&amp;volume=44&amp;publication_year=2016&amp;pages=1993-2007&amp;pmid=26864536&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib177">177. <span class="element-citation" id="sref177">Peppas N.A., Wood K.M., Blanchette J.O. Hydrogels for oral delivery of therapeutic proteins. <span><span class="ref-journal">Expet Opin Biol Ther. </span>2004;<span class="ref-vol">4</span>:881–887.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15174970" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Biol+Ther&amp;title=Hydrogels+for+oral+delivery+of+therapeutic+proteins&amp;author=N.A.+Peppas&amp;author=K.M.+Wood&amp;author=J.O.+Blanchette&amp;volume=4&amp;publication_year=2004&amp;pages=881-887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib178">178. <span class="element-citation" id="sref178">Kamei N., Morishita M., Chiba H., Kavimandan N.J., Peppas N.A., Takayama K. Complexation hydrogels for intestinal delivery of interferon <em>&#x003b2;</em> and calcitonin. <span><span class="ref-journal">J Control Release. </span>2009;<span class="ref-vol">134</span>:98–102.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3042132/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19095021" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Complexation+hydrogels+for+intestinal+delivery+of+interferon+&#x003b2;+and+calcitonin&amp;author=N.+Kamei&amp;author=M.+Morishita&amp;author=H.+Chiba&amp;author=N.J.+Kavimandan&amp;author=N.A.+Peppas&amp;volume=134&amp;publication_year=2009&amp;pages=98-102&amp;pmid=19095021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib179">179. <span class="element-citation" id="sref179">Nakamura K., Murray R.J., Joseph J.I., Peppas N.A., Morishita M., Lowman A.M. Oral insulin delivery using p(MAA<em>-g-</em>EG) hydrogels: effects of network morphology on insulin delivery characteristics. <span><span class="ref-journal">J Control Release. </span>2004;<span class="ref-vol">95</span>:589–599.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15023469" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Oral+insulin+delivery+using+p(MAA-g-EG)+hydrogels:+effects+of+network+morphology+on+insulin+delivery+characteristics&amp;author=K.+Nakamura&amp;author=R.J.+Murray&amp;author=J.I.+Joseph&amp;author=N.A.+Peppas&amp;author=M.+Morishita&amp;volume=95&amp;publication_year=2004&amp;pages=589-599&amp;pmid=15023469&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib180">180. <span class="element-citation" id="sref180">Dorkoosh F., Verhoef J.C., Borchard G., Rafiee-Tehrani M., Verheijden J., Junginger H. Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers. <span><span class="ref-journal">Int J Pharm. </span>2002;<span class="ref-vol">247</span>:47–55.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12429484" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Intestinal+absorption+of+human+insulin+in+pigs+using+delivery+systems+based+on+superporous+hydrogel+polymers&amp;author=F.+Dorkoosh&amp;author=J.C.+Verhoef&amp;author=G.+Borchard&amp;author=M.+Rafiee-Tehrani&amp;author=J.+Verheijden&amp;volume=247&amp;publication_year=2002&amp;pages=47-55&amp;pmid=12429484&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib181">181. <span class="element-citation" id="sref181">Yin L., Fei L., Cui F., Tang C., Yin C. Superporous hydrogels containing poly(acrylic acid<em>-co-</em>acrylamide)/<em>O</em>-carboxymethyl chitosan interpenetrating polymer networks. <span><span class="ref-journal">Biomaterials. </span>2007;<span class="ref-vol">28</span>:1258–1266.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17118443" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Superporous+hydrogels+containing+poly(acrylic+acid-co-acrylamide)/O-carboxymethyl+chitosan+interpenetrating+polymer+networks&amp;author=L.+Yin&amp;author=L.+Fei&amp;author=F.+Cui&amp;author=C.+Tang&amp;author=C.+Yin&amp;volume=28&amp;publication_year=2007&amp;pages=1258-1266&amp;pmid=17118443&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib182">182. <span class="element-citation" id="sref182">Yin L., Ding J., Zhang J., He C., Tang C., Yin C. Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin. <span><span class="ref-journal">Biomaterials. </span>2010;<span class="ref-vol">31</span>:3347–3356.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20116843" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Polymer+integrity+related+absorption+mechanism+of+superporous+hydrogel+containing+interpenetrating+polymer+networks+for+oral+delivery+of+insulin&amp;author=L.+Yin&amp;author=J.+Ding&amp;author=J.+Zhang&amp;author=C.+He&amp;author=C.+Tang&amp;volume=31&amp;publication_year=2010&amp;pages=3347-3356&amp;pmid=20116843&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib183">183. <span class="element-citation" id="sref183">Pauletti G.M., Gangwar S., Siahaan T.J., Jeffrey A., Borchardt R T. Improvement of oral peptide bioavailability: peptidomimetics and prodrug strategies. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>1997;<span class="ref-vol">27</span>:235–256.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10837560" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Improvement+of+oral+peptide+bioavailability:+peptidomimetics+and+prodrug+strategies&amp;author=G.M.+Pauletti&amp;author=S.+Gangwar&amp;author=T.J.+Siahaan&amp;author=A.+Jeffrey&amp;author=T.+Borchardt+R&amp;volume=27&amp;publication_year=1997&amp;pages=235-256&amp;pmid=10837560&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib184">184. <span class="element-citation" id="sref184">Borchardt R.T. Optimizing oral absorption of peptides using prodrug strategies. <span><span class="ref-journal">J Control Release. </span>1999;<span class="ref-vol">62</span>:231–238.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10518655" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Optimizing+oral+absorption+of+peptides+using+prodrug+strategies&amp;author=R.T.+Borchardt&amp;volume=62&amp;publication_year=1999&amp;pages=231-238&amp;pmid=10518655&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib185">185. <span class="element-citation" id="sref185">Hashizume M., Douen T., Murakami M., Yamamoto A., Takada K., Muranishi S. Improvement of large intestinal absorption of insulin by chemical modification with palmitic acid in rats. <span><span class="ref-journal">J Pharm Pharmacol. </span>1992;<span class="ref-vol">44</span>:555–559.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1357133" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;title=Improvement+of+large+intestinal+absorption+of+insulin+by+chemical+modification+with+palmitic+acid+in+rats&amp;author=M.+Hashizume&amp;author=T.+Douen&amp;author=M.+Murakami&amp;author=A.+Yamamoto&amp;author=K.+Takada&amp;volume=44&amp;publication_year=1992&amp;pages=555-559&amp;pmid=1357133&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib186">186. <span class="element-citation" id="sref186">Shen W.C. Oral peptide and protein delivery: unfulfilled promises? <span><span class="ref-journal">Drug Discov Today. </span>2003;<span class="ref-vol">8</span>:607–608.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12867138" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Oral+peptide+and+protein+delivery:+unfulfilled+promises?&amp;author=W.C.+Shen&amp;volume=8&amp;publication_year=2003&amp;pages=607-608&amp;pmid=12867138&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib187">187. <span class="element-citation" id="sref187">Ekrami H.M., Kennedy A.R., Shen W.C. Water-soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides. <span><span class="ref-journal">FEBS Lett. </span>1995;<span class="ref-vol">371</span>:283–286.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7556611" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Water-soluble+fatty+acid+derivatives+as+acylating+agents+for+reversible+lipidization+of+polypeptides&amp;author=H.M.+Ekrami&amp;author=A.R.+Kennedy&amp;author=W.C.+Shen&amp;volume=371&amp;publication_year=1995&amp;pages=283-286&amp;pmid=7556611&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib188">188. <span class="element-citation" id="sref188">Wang J., Chow D., Heiati H., Shen W.C. Reversible lipidization for the&#x000a0;oral delivery of salmon calcitonin. <span><span class="ref-journal">J Control Release. </span>2003;<span class="ref-vol">88</span>:369–380.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12644363" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Reversible+lipidization+for+the&#x000a0;oral+delivery+of+salmon+calcitonin&amp;author=J.+Wang&amp;author=D.+Chow&amp;author=H.+Heiati&amp;author=W.C.+Shen&amp;volume=88&amp;publication_year=2003&amp;pages=369-380&amp;pmid=12644363&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib189">189. <span class="element-citation" id="sref189">Vadlapudi A.D., Vadlapatla R.K., Kwatra D., Earla R., Samanta S.K., Pal D. Targeted lipid based drug conjugates: a novel strategy for drug delivery. <span><span class="ref-journal">Int J Pharm. </span>2012;<span class="ref-vol">434</span>:315–324.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3401275/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22692074" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Targeted+lipid+based+drug+conjugates:+a+novel+strategy+for+drug+delivery&amp;author=A.D.+Vadlapudi&amp;author=R.K.+Vadlapatla&amp;author=D.+Kwatra&amp;author=R.+Earla&amp;author=S.K.+Samanta&amp;volume=434&amp;publication_year=2012&amp;pages=315-324&amp;pmid=22692074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib190">190. <span class="element-citation" id="sref190">Windsor E., Cronheim G.E. Gastro-intestinal absorption of heparin and synthetic heparinoids. <span><span class="ref-journal">Nature. </span>1961;<span class="ref-vol">190</span>:263–264.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/13785784" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Gastro-intestinal+absorption+of+heparin+and+synthetic+heparinoids&amp;author=E.+Windsor&amp;author=G.E.+Cronheim&amp;volume=190&amp;publication_year=1961&amp;pages=263-264&amp;pmid=13785784&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib191">191. <span class="element-citation" id="sref191">Su F.Y., Lin K.J., Sonaje K., Wey S.P., Yen T.C., Ho Y.C. Protease&#x000a0;inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. <span><span class="ref-journal">Biomaterials. </span>2012;<span class="ref-vol">33</span>:2801–2811.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22243802" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Protease&#x000a0;inhibition+and+absorption+enhancement+by+functional+nanoparticles+for+effective+oral+insulin+delivery&amp;author=F.Y.+Su&amp;author=K.J.+Lin&amp;author=K.+Sonaje&amp;author=S.P.+Wey&amp;author=T.C.+Yen&amp;volume=33&amp;publication_year=2012&amp;pages=2801-2811&amp;pmid=22243802&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib192">192. <span class="element-citation" id="sref192">Niu M., Tan Y.N., Guan P., Hovgaard L., Lu Y., Qi J. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. <span><span class="ref-journal">Int J Pharm. </span>2014;<span class="ref-vol">460</span>:119–130.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24275447" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Enhanced+oral+absorption+of+insulin-loaded+liposomes+containing+bile+salts:+a+mechanistic+study&amp;author=M.+Niu&amp;author=Y.N.+Tan&amp;author=P.+Guan&amp;author=L.+Hovgaard&amp;author=Y.+Lu&amp;volume=460&amp;publication_year=2014&amp;pages=119-130&amp;pmid=24275447&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib193">193. <span class="element-citation" id="sref193">Hu S., Niu M., Hu F., Lu Y., Qi J., Yin Z., Wu W. Integrity and stability of oral liposomes containing bile salts studied in simulated and <em>ex&#x000a0;vivo</em> gastrointestinal media. <span><span class="ref-journal">Int J Pharm. </span>2013;<span class="ref-vol">441</span>:693–700.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23089580" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Integrity+and+stability+of+oral+liposomes+containing+bile+salts+studied+in+simulated+and+ex&#x000a0;vivo+gastrointestinal+media&amp;author=S.+Hu&amp;author=M.+Niu&amp;author=F.+Hu&amp;author=Y.+Lu&amp;author=J.+Qi&amp;volume=441&amp;publication_year=2013&amp;pages=693-700&amp;pmid=23089580&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib194">194. <span class="element-citation" id="sref194">Niu M., Lu Y., Hovgaard L., Guan P., Tan Y., Lian R. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2012;<span class="ref-vol">81</span>:265–272.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22369880" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Hypoglycemic+activity+and+oral+bioavailability+of+insulin-loaded+liposomes+containing+bile+salts+in+rats:+the+effect+of+cholate+type,+particle+size+and+administered+dose&amp;author=M.+Niu&amp;author=Y.+Lu&amp;author=L.+Hovgaard&amp;author=P.+Guan&amp;author=Y.+Tan&amp;volume=81&amp;publication_year=2012&amp;pages=265-272&amp;pmid=22369880&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib195">195. <span class="element-citation" id="sref195">Malkov D., Angelo R., Wang H.Z., Flanders E., Tang H., Gomez-Orellana I. Oral delivery of insulin with the eligen&#x000ae; technology: mechanistic studies. <span><span class="ref-journal">Curr Drug Deliv. </span>2005;<span class="ref-vol">2</span>:191–197.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16305420" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Deliv&amp;title=Oral+delivery+of+insulin+with+the+eligen&#x000ae;+technology:+mechanistic+studies&amp;author=D.+Malkov&amp;author=R.+Angelo&amp;author=H.Z.+Wang&amp;author=E.+Flanders&amp;author=H.+Tang&amp;volume=2&amp;publication_year=2005&amp;pages=191-197&amp;pmid=16305420&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib196">196. <span class="element-citation" id="sref196">Rivera T.M., Leone-Bay A., Paton D.R., Leipold H.R., Baughman R.A. Oral delivery of heparin in combination with sodium <em>N</em>-[8-(2-hydroxybenzoyl) amino] caprylate: pharmacological considerations. <span><span class="ref-journal">Pharm Res. </span>1997;<span class="ref-vol">14</span>:1830.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9453076" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Oral+delivery+of+heparin+in+combination+with+sodium+N-[8-(2-hydroxybenzoyl)+amino]+caprylate:+pharmacological+considerations&amp;author=T.M.+Rivera&amp;author=A.+Leone-Bay&amp;author=D.R.+Paton&amp;author=H.R.+Leipold&amp;author=R.A.+Baughman&amp;volume=14&amp;publication_year=1997&amp;pages=1830&amp;pmid=9453076&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib197">197. <span class="element-citation" id="sref197">Twarog C., Fattah S., Heade J., Maher S., Fattal E., Brayden D.J. Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10) <span><span class="ref-journal">Pharmaceutics. </span>2019;<span class="ref-vol">11</span>:78.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6410172/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30781867" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Intestinal+permeation+enhancers+for+oral+delivery+of+macromolecules:+a+comparison+between+salcaprozate+sodium+(SNAC)+and+sodium+caprate+(C10)&amp;author=C.+Twarog&amp;author=S.+Fattah&amp;author=J.+Heade&amp;author=S.+Maher&amp;author=E.+Fattal&amp;volume=11&amp;publication_year=2019&amp;pages=78&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib198">198. <span class="element-citation" id="sref198">McGavigan A.K., Murphy K.G. Gut hormones: the future of obesity treatment?. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2012;<span class="ref-vol">74</span>:911–919.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3522804/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22452339" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;title=Gut+hormones:+the+future+of+obesity+treatment?.&amp;author=A.K.+McGavigan&amp;author=K.G.+Murphy&amp;volume=74&amp;publication_year=2012&amp;pages=911-919&amp;pmid=22452339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib199">199. <span class="element-citation" id="sref199">Bucheit J.D., Pamulapati L.G., Carter N., Malloy K., Dixon D.L., Sisson E.M. Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist. <span><span class="ref-journal">Diabetes Technol Therapeut. </span>2020;<span class="ref-vol">22</span>:10–18.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31436480" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Technol+Therapeut&amp;title=Oral+semaglutide:+a+review+of+the+first+oral+glucagon-like+peptide+1+receptor+agonist&amp;author=J.D.+Bucheit&amp;author=L.G.+Pamulapati&amp;author=N.+Carter&amp;author=K.+Malloy&amp;author=D.L.+Dixon&amp;volume=22&amp;publication_year=2020&amp;pages=10-18&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib200">200. <span class="element-citation" id="sref200">Brayden D., Creed E., O'connell A., Leipold H., Agarwal R., Leone-Bay A. Heparin absorption across the intestine: effects of sodium <em>N</em>-[8-(2-hydroxybenzoyl) amino] caprylate in rat <em>in situ</em> intestinal instillations and in Caco-2 monolayers. <span><span class="ref-journal">Pharm Res. </span>1997;<span class="ref-vol">14</span>:1772–1779.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9453067" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Heparin+absorption+across+the+intestine:+effects+of+sodium+N-[8-(2-hydroxybenzoyl)+amino]+caprylate+in+rat+in+situ+intestinal+instillations+and+in+Caco-2+monolayers&amp;author=D.+Brayden&amp;author=E.+Creed&amp;author=A.+O'connell&amp;author=H.+Leipold&amp;author=R.+Agarwal&amp;volume=14&amp;publication_year=1997&amp;pages=1772-1779&amp;pmid=9453067&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib201">201. <span class="element-citation" id="sref201">Arbit E., Goldberg M., Gomez-Orellana I., Majuru S. Oral heparin: status review. <span><span class="ref-journal">Thromb J. </span>2006;<span class="ref-vol">4</span>:6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1526416/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16686945" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thromb+J&amp;title=Oral+heparin:+status+review&amp;author=E.+Arbit&amp;author=M.+Goldberg&amp;author=I.+Gomez-Orellana&amp;author=S.+Majuru&amp;volume=4&amp;publication_year=2006&amp;pages=6&amp;pmid=16686945&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib202">202. <span class="element-citation" id="sref202">Fasano A., Nataro J.P. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2004;<span class="ref-vol">56</span>:795–807.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15063590" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Intestinal+epithelial+tight+junctions+as+targets+for+enteric+bacteria-derived+toxins&amp;author=A.+Fasano&amp;author=J.P.+Nataro&amp;volume=56&amp;publication_year=2004&amp;pages=795-807&amp;pmid=15063590&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib203">203. <span class="element-citation" id="sref203">Fasano A., Fiorentini C., Donelli G., Uzzau S., Kaper J.B., Margaretten K. Zonula occludens toxin modulates tight junctions through protein kinase c-dependent actin reorganization, <em>in&#x000a0;vitro</em>. <span><span class="ref-journal">J Clin Invest. </span>1995;<span class="ref-vol">96</span>:710–720.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC185254/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7635964" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Zonula+occludens+toxin+modulates+tight+junctions+through+protein+kinase+c-dependent+actin+reorganization,+in&#x000a0;vitro&amp;author=A.+Fasano&amp;author=C.+Fiorentini&amp;author=G.+Donelli&amp;author=S.+Uzzau&amp;author=J.B.+Kaper&amp;volume=96&amp;publication_year=1995&amp;pages=710-720&amp;pmid=7635964&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib204">204. <span class="element-citation" id="sref204">Di Pierro M., Lu R., Uzzau S., Wang W., Margaretten K., Pazzani C. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:19160–19165.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11278543" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Zonula+occludens+toxin+structure-function+analysis.+Identification+of+the+fragment+biologically+active+on+tight+junctions+and+of+the+zonulin+receptor+binding+domain&amp;author=M.+Di+Pierro&amp;author=R.+Lu&amp;author=S.+Uzzau&amp;author=W.+Wang&amp;author=K.+Margaretten&amp;volume=276&amp;publication_year=2001&amp;pages=19160-19165&amp;pmid=11278543&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib205">205. <span class="element-citation" id="sref205">Gopalakrishnan S., Pandey N., Tamiz A.P., Vere J., Carrasco R., Somerville R. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. <span><span class="ref-journal">Int J Pharm. </span>2009;<span class="ref-vol">365</span>:121–130.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18832018" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Mechanism+of+action+of+ZOT-derived+peptide+AT-1002,+a+tight+junction+regulator+and+absorption+enhancer&amp;author=S.+Gopalakrishnan&amp;author=N.+Pandey&amp;author=A.P.+Tamiz&amp;author=J.+Vere&amp;author=R.+Carrasco&amp;volume=365&amp;publication_year=2009&amp;pages=121-130&amp;pmid=18832018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib206">206. <span class="element-citation" id="sref206">Kelly C.P., Green P.H.R., Murray J.A., DiMarino A., Colatrella A., Leffler D.A. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>2013;<span class="ref-vol">37</span>:252–262.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23163616" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;title=Larazotide+acetate+in+patients+with+coeliac+disease+undergoing+a+gluten+challenge:+a+randomised+placebo-controlled+study&amp;author=C.P.+Kelly&amp;author=P.H.R.+Green&amp;author=J.A.+Murray&amp;author=A.+DiMarino&amp;author=A.+Colatrella&amp;volume=37&amp;publication_year=2013&amp;pages=252-262&amp;pmid=23163616&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib207">207. <span class="element-citation" id="sref207">Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I., Artursson P. A new principle for tight junction modulation based on occludin peptides. <span><span class="ref-journal">Mol Pharmacol. </span>2003;<span class="ref-vol">64</span>:1530–1540.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14645684" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=A+new+principle+for+tight+junction+modulation+based+on+occludin+peptides&amp;author=S.+Tavelin&amp;author=K.+Hashimoto&amp;author=J.+Malkinson&amp;author=L.+Lazorova&amp;author=I.+Toth&amp;volume=64&amp;publication_year=2003&amp;pages=1530-1540&amp;pmid=14645684&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib208">208. <span class="element-citation" id="sref208">Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. <span><span class="ref-journal">J Cell Biol. </span>1999;<span class="ref-vol">147</span>:195–204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2164970/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10508866" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Clostridium+perfringens+enterotoxin+fragment+removes+specific+claudins+from+tight+junction+strands:+evidence+for+direct+involvement+of+claudins+in+tight+junction+barrier&amp;author=N.+Sonoda&amp;author=M.+Furuse&amp;author=H.+Sasaki&amp;author=S.+Yonemura&amp;author=J.+Katahira&amp;volume=147&amp;publication_year=1999&amp;pages=195-204&amp;pmid=10508866&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib209">209. <span class="element-citation" id="sref209">B&#x000f6;hmov&#x000e1; E., Machov&#x000e1; D., Pechar M., Pola R., Vencl&#x000ed;kov&#x000e1; K., Janou&#x00161;kov&#x000e1; O. Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells. <span><span class="ref-journal">Physiol Res. </span>2018;<span class="ref-vol">67</span>:S267–S279.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30379549" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Res&amp;title=Cell-penetrating+peptides:+a+useful+tool+for+the+delivery+of+various+cargoes+into+cells&amp;author=E.+B&#x000f6;hmov&#x000e1;&amp;author=D.+Machov&#x000e1;&amp;author=M.+Pechar&amp;author=R.+Pola&amp;author=K.+Vencl&#x000ed;kov&#x000e1;&amp;volume=67&amp;publication_year=2018&amp;pages=S267-S279&amp;pmid=30379549&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib210">210. <span class="element-citation" id="sref210">Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the antennapedia homeodomain translocates through biological membranes. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:10444–10450.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8144628" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+third+helix+of+the+antennapedia+homeodomain+translocates+through+biological+membranes&amp;author=D.+Derossi&amp;author=A.H.+Joliot&amp;author=G.+Chassaing&amp;author=A.+Prochiantz&amp;volume=269&amp;publication_year=1994&amp;pages=10444-10450&amp;pmid=8144628&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib211">211. <span class="element-citation" id="sref211">S&#x000e1;nchez-Navarro M., Garcia J., Giralt E., Teixid&#x000f3; M. Using peptides to increase transport across the intestinal barrier. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">106</span>:355–366.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27155131" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Using+peptides+to+increase+transport+across+the+intestinal+barrier&amp;author=M.+S&#x000e1;nchez-Navarro&amp;author=J.+Garcia&amp;author=E.+Giralt&amp;author=M.+Teixid&#x000f3;&amp;volume=106&amp;publication_year=2016&amp;pages=355-366&amp;pmid=27155131&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib212">212. <span class="element-citation" id="sref212">Danielsen E.M., Hansen G.H. Impact of cell-penetrating peptides (CPPs) melittin and HIV-1 TAT on the enterocyte brush border using a mucosal explant system. <span><span class="ref-journal">Biochim Biophys Acta-Biomembranes. </span>2018;<span class="ref-vol">1860</span>:1589–1599.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29856994" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta-Biomembranes&amp;title=Impact+of+cell-penetrating+peptides+(CPPs)+melittin+and+HIV-1+TAT+on+the+enterocyte+brush+border+using+a+mucosal+explant+system&amp;author=E.M.+Danielsen&amp;author=G.H.+Hansen&amp;volume=1860&amp;publication_year=2018&amp;pages=1589-1599&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib213">213. <span class="element-citation" id="sref213">Zhang L., Shi Y., Song Y., Sun X., Zhang X., Sun K. The use of low molecular weight protamine to enhance oral absorption of exenatide. <span><span class="ref-journal">Int J Pharm. </span>2018;<span class="ref-vol">547</span>:265–273.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29800739" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=The+use+of+low+molecular+weight+protamine+to+enhance+oral+absorption+of+exenatide&amp;author=L.+Zhang&amp;author=Y.+Shi&amp;author=Y.+Song&amp;author=X.+Sun&amp;author=X.+Zhang&amp;volume=547&amp;publication_year=2018&amp;pages=265-273&amp;pmid=29800739&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib214">214. <span class="element-citation" id="sref214">Kamei N., Shigei C., Hasegawa R., Takeda-Morishita M. Exploration of the key factors for optimizing the <em>in&#x000a0;vivo</em> oral delivery of insulin by using a noncovalent strategy with cell-penetrating peptides. <span><span class="ref-journal">Biol Pharm Bull. </span>2018;<span class="ref-vol">41</span>:239–246.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29386483" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biol+Pharm+Bull&amp;title=Exploration+of+the+key+factors+for+optimizing+the+in&#x000a0;vivo+oral+delivery+of+insulin+by+using+a+noncovalent+strategy+with+cell-penetrating+peptides&amp;author=N.+Kamei&amp;author=C.+Shigei&amp;author=R.+Hasegawa&amp;author=M.+Takeda-Morishita&amp;volume=41&amp;publication_year=2018&amp;pages=239-246&amp;pmid=29386483&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib215">215. <span class="element-citation" id="sref215">Zhang X., Wu W. Ligand-mediated active targeting for enhanced oral absorption. <span><span class="ref-journal">Drug Discov Today. </span>2014;<span class="ref-vol">19</span>:898–904.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24631680" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Ligand-mediated+active+targeting+for+enhanced+oral+absorption&amp;author=X.+Zhang&amp;author=W.+Wu&amp;volume=19&amp;publication_year=2014&amp;pages=898-904&amp;pmid=24631680&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib216">216. <span class="element-citation" id="sref216">Jain S., Rathi V.V., Jain A.K., Das M., Godugu C. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. <span><span class="ref-journal">Nanomedicine. </span>2012;<span class="ref-vol">7</span>:1311–1337.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22583576" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Folate-decorated+PLGA+nanoparticles+as+a+rationally+designed+vehicle+for+the+oral+delivery+of+insulin&amp;author=S.+Jain&amp;author=V.V.+Rathi&amp;author=A.K.+Jain&amp;author=M.+Das&amp;author=C.+Godugu&amp;volume=7&amp;publication_year=2012&amp;pages=1311-1337&amp;pmid=22583576&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib217">217. <span class="element-citation" id="sref217">Zhang X., Qi J., Lu Y., He W., Li X., Wu W. Biotinylated liposomes as potential carriers for the oral delivery of insulin. <span><span class="ref-journal">Nanomedicine. </span>2014;<span class="ref-vol">10</span>:167–176.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23891617" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Biotinylated+liposomes+as+potential+carriers+for+the+oral+delivery+of+insulin&amp;author=X.+Zhang&amp;author=J.+Qi&amp;author=Y.+Lu&amp;author=W.+He&amp;author=X.+Li&amp;volume=10&amp;publication_year=2014&amp;pages=167-176&amp;pmid=23891617&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib218">218. <span class="element-citation" id="sref218">Chalasani K.B., Russell-Jones G.J., Jain A.K., Diwan P.V., Jain S.K. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. <span><span class="ref-journal">J Control Release. </span>2007;<span class="ref-vol">122</span>:141–150.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17707540" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Effective+oral+delivery+of+insulin+in+animal+models+using+vitamin+B12-coated+dextran+nanoparticles&amp;author=K.B.+Chalasani&amp;author=G.J.+Russell-Jones&amp;author=A.K.+Jain&amp;author=P.V.+Diwan&amp;author=S.K.+Jain&amp;volume=122&amp;publication_year=2007&amp;pages=141-150&amp;pmid=17707540&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib219">219. <span class="element-citation" id="sref219">Verma A., Sharma S., Gupta P.K., Singh A., Teja B.V., Dwivedi P. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and ph responsive carrier for improved oral delivery of insulin. <span><span class="ref-journal">Acta Biomater. </span>2016;<span class="ref-vol">31</span>:288–300.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26685755" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Biomater&amp;title=Vitamin+B12+functionalized+layer+by+layer+calcium+phosphate+nanoparticles:+a+mucoadhesive+and+ph+responsive+carrier+for+improved+oral+delivery+of+insulin&amp;author=A.+Verma&amp;author=S.+Sharma&amp;author=P.K.+Gupta&amp;author=A.+Singh&amp;author=B.V.+Teja&amp;volume=31&amp;publication_year=2016&amp;pages=288-300&amp;pmid=26685755&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib220">220. <span class="element-citation" id="sref220">Zhang J., Tang C., Yin C. Galactosylated trimethyl chitosan&#x02013;cysteine nanoparticles loaded with <em>MAP4k4</em> siRNA for targeting activated macrophages. <span><span class="ref-journal">Biomaterials. </span>2013;<span class="ref-vol">34</span>:3667–3677.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23419643" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Galactosylated+trimethyl+chitosan&#x02013;cysteine+nanoparticles+loaded+with+MAP4k4+siRNA+for+targeting+activated+macrophages&amp;author=J.+Zhang&amp;author=C.+Tang&amp;author=C.+Yin&amp;volume=34&amp;publication_year=2013&amp;pages=3667-3677&amp;pmid=23419643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib221">221. <span class="element-citation" id="sref221">Byeon J.C., Lee S.E., Kim H., Ahn J.B., Kim D.H., Choi J.S. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability. <span><span class="ref-journal">Drug Deliv. </span>2019;<span class="ref-vol">26</span>:216–225.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6407602/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30843439" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Deliv&amp;title=Design+of+novel+proliposome+formulation+for+antioxidant+peptide,+glutathione+with+enhanced+oral+bioavailability+and+stability&amp;author=J.C.+Byeon&amp;author=S.E.+Lee&amp;author=H.+Kim&amp;author=J.B.+Ahn&amp;author=D.H.+Kim&amp;volume=26&amp;publication_year=2019&amp;pages=216-225&amp;pmid=30843439&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib222">222. <span class="element-citation" id="sref222">East L., Isacke C.M. The mannose receptor family. <span><span class="ref-journal">Biochim Biophys Acta Gen Subj. </span>2002;<span class="ref-vol">1572</span>:364–386.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12223280" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta+Gen+Subj&amp;title=The+mannose+receptor+family&amp;author=L.+East&amp;author=C.M.+Isacke&amp;volume=1572&amp;publication_year=2002&amp;pages=364-386&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib223">223. <span class="element-citation" id="sref223">Liu D., Jiang G., Yu W., Li L., Tong Z., Kong X. Oral delivery of insulin using CaCO<sub>3</sub>-based composite nanocarriers with hyaluronic acid coatings. <span><span class="ref-journal">Mater Lett. </span>2017;<span class="ref-vol">188</span>:263–266.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mater+Lett&amp;title=Oral+delivery+of+insulin+using+CaCO3-based+composite+nanocarriers+with+hyaluronic+acid+coatings&amp;author=D.+Liu&amp;author=G.+Jiang&amp;author=W.+Yu&amp;author=L.+Li&amp;author=Z.+Tong&amp;volume=188&amp;publication_year=2017&amp;pages=263-266&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib224">224. <span class="element-citation" id="sref224">Amet N., Wang W., Shen W.C. Human growth hormone&#x02013;transferrin fusion protein for oral delivery in hypophysectomized rats. <span><span class="ref-journal">J Control Release. </span>2010;<span class="ref-vol">141</span>:177–182.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2815093/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19761807" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Human+growth+hormone&#x02013;transferrin+fusion+protein+for+oral+delivery+in+hypophysectomized+rats&amp;author=N.+Amet&amp;author=W.+Wang&amp;author=W.C.+Shen&amp;volume=141&amp;publication_year=2010&amp;pages=177-182&amp;pmid=19761807&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib225">225. <span class="element-citation" id="sref225">Pridgen E.M., Alexis F., Kuo T.T., Levy-Nissenbaum E., Karnik R., Blumberg R.S. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery. <span><span class="ref-journal">Sci Transl Med. </span>2013;<span class="ref-vol">5</span>:213ra167.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4023672/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24285486" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Transepithelial+transport+of+Fc-targeted+nanoparticles+by+the+neonatal+Fc+receptor+for+oral+delivery&amp;author=E.M.+Pridgen&amp;author=F.+Alexis&amp;author=T.T.+Kuo&amp;author=E.+Levy-Nissenbaum&amp;author=R.+Karnik&amp;volume=5&amp;publication_year=2013&amp;pages=213ra167&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib226">226. <span class="element-citation" id="sref226">Zhang N., Ping Q.N., Huang G.H., Xu W.F. Investigation of lectin-modified insulin liposomes as carriers for oral administration. <span><span class="ref-journal">Int J Pharm. </span>2005;<span class="ref-vol">294</span>:247–259.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15814248" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Investigation+of+lectin-modified+insulin+liposomes+as+carriers+for+oral+administration&amp;author=N.+Zhang&amp;author=Q.N.+Ping&amp;author=G.H.+Huang&amp;author=W.F.+Xu&amp;volume=294&amp;publication_year=2005&amp;pages=247-259&amp;pmid=15814248&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib227">227. <span class="element-citation" id="sref227">Liu C., Shan W., Liu M., Zhu X., Xu J., Xu Y. A novel ligand conjugated nanoparticles for oral insulin delivery. <span><span class="ref-journal">Drug Deliv. </span>2016;<span class="ref-vol">23</span>:2015–2025.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26203690" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Deliv&amp;title=A+novel+ligand+conjugated+nanoparticles+for+oral+insulin+delivery&amp;author=C.+Liu&amp;author=W.+Shan&amp;author=M.+Liu&amp;author=X.+Zhu&amp;author=J.+Xu&amp;volume=23&amp;publication_year=2016&amp;pages=2015-2025&amp;pmid=26203690&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib228">228. <span class="element-citation" id="sref228">Jin Y., Song Y., Zhu X., Zhou D., Chen C., Zhang Z. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. <span><span class="ref-journal">Biomaterials. </span>2012;<span class="ref-vol">33</span>:1573–1582.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22093292" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Goblet+cell-targeting+nanoparticles+for+oral+insulin+delivery+and+the+influence+of+mucus+on+insulin+transport&amp;author=Y.+Jin&amp;author=Y.+Song&amp;author=X.+Zhu&amp;author=D.+Zhou&amp;author=C.+Chen&amp;volume=33&amp;publication_year=2012&amp;pages=1573-1582&amp;pmid=22093292&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib229">229. <span class="element-citation" id="sref229">Russell-Jones G. Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities. <span><span class="ref-journal">Ther Deliv. </span>2011;<span class="ref-vol">2</span>:1575–1593.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22833983" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ther+Deliv&amp;title=Intestinal+receptor+targeting+for+peptide+delivery:+an+expert's+personal+perspective+on+reasons+for+failure+and+new+opportunities&amp;author=G.+Russell-Jones&amp;volume=2&amp;publication_year=2011&amp;pages=1575-1593&amp;pmid=22833983&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib230">230. <span class="element-citation" id="sref230">Hamman J.H., Demana P.H., Olivier E.I. Targeting receptors, transporters and site of absorption to improve oral drug delivery. <span><span class="ref-journal">Drug Target Insights. </span>2007;<span class="ref-vol">2</span>:71–81.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3155234/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21901064" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Target+Insights&amp;title=Targeting+receptors,+transporters+and+site+of+absorption+to+improve+oral+drug+delivery&amp;author=J.H.+Hamman&amp;author=P.H.+Demana&amp;author=E.I.+Olivier&amp;volume=2&amp;publication_year=2007&amp;pages=71-81&amp;pmid=21901064&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib231">231. <span class="element-citation" id="sref231">Xie S., Gong Y.C., Xiong X.Y., Li Z.L., Luo Y.Y., Li Y.P. Targeted folate-conjugated pluronic P85/poly(lactide<em>-co-</em>glycolide) polymersome for the oral delivery of insulin. <span><span class="ref-journal">Nanomedicine. </span>2018;<span class="ref-vol">13</span>:2527–2544.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30338724" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Targeted+folate-conjugated+pluronic+P85/poly(lactide-co-glycolide)+polymersome+for+the+oral+delivery+of+insulin&amp;author=S.+Xie&amp;author=Y.C.+Gong&amp;author=X.Y.+Xiong&amp;author=Z.L.+Li&amp;author=Y.Y.+Luo&amp;volume=13&amp;publication_year=2018&amp;pages=2527-2544&amp;pmid=30338724&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib232">232. <span class="element-citation" id="sref232">Kokrashvili Z., Mosinger B., Margolskee R.F. Taste signaling elements expressed in gut enteroendocrine cells regulate nutrient-responsive secretion of gut hormones. <span><span class="ref-journal">Am J Clin Nutr. </span>2009;<span class="ref-vol">90</span></span> 822s-5s. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3136008/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19571229" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;title=Taste+signaling+elements+expressed+in+gut+enteroendocrine+cells+regulate+nutrient-responsive+secretion+of+gut+hormones&amp;author=Z.+Kokrashvili&amp;author=B.+Mosinger&amp;author=R.F.+Margolskee&amp;volume=90&amp;publication_year=2009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib233">233. <span class="element-citation" id="sref233">Li Y., Yang B., Zhang X. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. <span><span class="ref-journal">Int J Pharm. </span>2019;<span class="ref-vol">568</span>:118508.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31299337" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Oral+delivery+of+imatinib+through+galactosylated+polymeric+nanoparticles+to+explore+the+contribution+of+a+saccharide+ligand+to+absorption&amp;author=Y.+Li&amp;author=B.+Yang&amp;author=X.+Zhang&amp;volume=568&amp;publication_year=2019&amp;pages=118508&amp;pmid=31299337&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib234">234. <span class="element-citation" id="sref234">Fievez V., Plapied L., des Rieux A., Pourcelle V., Freichels H., Wascotte V. Targeting nanoparticles to m cells with non-peptidic ligands for oral vaccination. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2009;<span class="ref-vol">73</span>:16–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19409989" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Targeting+nanoparticles+to+m+cells+with+non-peptidic+ligands+for+oral+vaccination&amp;author=V.+Fievez&amp;author=L.+Plapied&amp;author=A.+des+Rieux&amp;author=V.+Pourcelle&amp;author=H.+Freichels&amp;volume=73&amp;publication_year=2009&amp;pages=16-24&amp;pmid=19409989&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib235">235. <span class="element-citation" id="sref235">Ganugula R., Arora M., Guada M., Saini P., Kumar M.N.V.R. Noncompetitive active transport exploiting intestinal transferrin receptors for oral delivery of proteins by tunable nanoplatform. <span><span class="ref-journal">ACS Macro Lett. </span>2017;<span class="ref-vol">6</span>:161–164.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Macro+Lett&amp;title=Noncompetitive+active+transport+exploiting+intestinal+transferrin+receptors+for+oral+delivery+of+proteins+by+tunable+nanoplatform&amp;author=R.+Ganugula&amp;author=M.+Arora&amp;author=M.+Guada&amp;author=P.+Saini&amp;author=M.N.V.R.+Kumar&amp;volume=6&amp;publication_year=2017&amp;pages=161-164&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib236">236. <span class="element-citation" id="sref236">Yong J.M., Mantaj J., Cheng Y., Vllasaliu D. Delivery of nanoparticles across the intestinal epithelium <em>via</em> the transferrin transport pathway. <span><span class="ref-journal">Pharmaceutics. </span>2019;<span class="ref-vol">11</span>:298.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6680486/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31248025" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Delivery+of+nanoparticles+across+the+intestinal+epithelium+via+the+transferrin+transport+pathway&amp;author=J.M.+Yong&amp;author=J.+Mantaj&amp;author=Y.+Cheng&amp;author=D.+Vllasaliu&amp;volume=11&amp;publication_year=2019&amp;pages=298&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib237">237. <span class="element-citation" id="sref237">Kang T., Jiang M., Jiang D., Feng X., Yao J., Song Q. Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex. <span><span class="ref-journal">Mol Pharm. </span>2015;<span class="ref-vol">12</span>:2947–2961.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26149889" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Enhancing+glioblastoma-specific+penetration+by+functionalization+of+nanoparticles+with+an+iron-mimic+peptide+targeting+transferrin/transferrin+receptor+complex&amp;author=T.+Kang&amp;author=M.+Jiang&amp;author=D.+Jiang&amp;author=X.+Feng&amp;author=J.+Yao&amp;volume=12&amp;publication_year=2015&amp;pages=2947-2961&amp;pmid=26149889&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib238">238. <span class="element-citation" id="sref238">Liu M., Wu L., Shan W., Cui Y., Huang Y. Iron-mimic peptide converts transferrin from foe to friend for orally targeting insulin delivery. <span><span class="ref-journal">J Mater Chem B. </span>2018;<span class="ref-vol">6</span>:593–601.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32254488" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mater+Chem+B&amp;title=Iron-mimic+peptide+converts+transferrin+from+foe+to+friend+for+orally+targeting+insulin+delivery&amp;author=M.+Liu&amp;author=L.+Wu&amp;author=W.+Shan&amp;author=Y.+Cui&amp;author=Y.+Huang&amp;volume=6&amp;publication_year=2018&amp;pages=593-601&amp;pmid=32254488&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib239">239. <span class="element-citation" id="sref239">Azevedo C., Nilsen J., Grevys A., Nunes R., Andersen J.T., Sarmento B. Engineered albumin-functionalized nanoparticles for improved fcrn binding enhance oral delivery of insulin. <span><span class="ref-journal">J Control Release. </span>2020;<span class="ref-vol">327</span>:161–173.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32771477" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Engineered+albumin-functionalized+nanoparticles+for+improved+fcrn+binding+enhance+oral+delivery+of+insulin&amp;author=C.+Azevedo&amp;author=J.+Nilsen&amp;author=A.+Grevys&amp;author=R.+Nunes&amp;author=J.T.+Andersen&amp;volume=327&amp;publication_year=2020&amp;pages=161-173&amp;pmid=32771477&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib240">240. <span class="element-citation" id="sref240">Martins J., Liu D., Fontana F., Ferreira M., Correia A., Valentino S. Microfluidic nanoassembly of bioengineered chitosan-modified FcRn-targeted porous silicon nanoparticles @ hypromellose acetate succinate for oral delivery of anti-diabetic peptides. <span><span class="ref-journal">ACS Appl Mater Interfaces. </span>2018;<span class="ref-vol">10</span>:44354–44367.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30525379" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Appl+Mater+Interfaces&amp;title=Microfluidic+nanoassembly+of+bioengineered+chitosan-modified+FcRn-targeted+porous+silicon+nanoparticles+@+hypromellose+acetate+succinate+for+oral+delivery+of+anti-diabetic+peptides&amp;author=J.+Martins&amp;author=D.+Liu&amp;author=F.+Fontana&amp;author=M.+Ferreira&amp;author=A.+Correia&amp;volume=10&amp;publication_year=2018&amp;pages=44354-44367&amp;pmid=30525379&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib241">241. <span class="element-citation" id="sref241">Sun A.Q., Zhu L., Luo Y., Xu S., Suchy F.J. Human organic solute transporter (host): protein interaction and membrane sorting process. <span><span class="ref-journal">Int J Biochem Mol Biol. </span>2012;<span class="ref-vol">3</span>:290–301.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3476788/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23097745" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biochem+Mol+Biol&amp;title=Human+organic+solute+transporter+(host):+protein+interaction+and+membrane+sorting+process&amp;author=A.Q.+Sun&amp;author=L.+Zhu&amp;author=Y.+Luo&amp;author=S.+Xu&amp;author=F.J.+Suchy&amp;volume=3&amp;publication_year=2012&amp;pages=290-301&amp;pmid=23097745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib242">242. <span class="element-citation" id="sref242">Varghese Gupta S., Gupta D., Sun J., Dahan A., Tsume Y., Hilfinger J. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach. <span><span class="ref-journal">Mol Pharm. </span>2011;<span class="ref-vol">8</span>:2358–2367.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3304100/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21905667" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Enhancing+the+intestinal+membrane+permeability+of+zanamivir:+a+carrier+mediated+prodrug+approach&amp;author=S.+Varghese+Gupta&amp;author=D.+Gupta&amp;author=J.+Sun&amp;author=A.+Dahan&amp;author=Y.+Tsume&amp;volume=8&amp;publication_year=2011&amp;pages=2358-2367&amp;pmid=21905667&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib243">243. <span class="element-citation" id="sref243">Fan W., Xia D., Zhu Q., Li X., He S., Zhu C. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. <span><span class="ref-journal">Biomaterials. </span>2017;<span class="ref-vol">151</span>:13–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29055774" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Functional+nanoparticles+exploit+the+bile+acid+pathway+to+overcome+multiple+barriers+of+the+intestinal+epithelium+for+oral+insulin+delivery&amp;author=W.+Fan&amp;author=D.+Xia&amp;author=Q.+Zhu&amp;author=X.+Li&amp;author=S.+He&amp;volume=151&amp;publication_year=2017&amp;pages=13-22&amp;pmid=29055774&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib244">244. <span class="element-citation" id="sref244">Wu L., Liu M., Shan W., Zhu X., Li L., Zhang Z. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. <span><span class="ref-journal">J Control Release. </span>2017;<span class="ref-vol">262</span>:273–283.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28774842" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Bioinspired+butyrate-functionalized+nanovehicles+for+targeted+oral+delivery+of+biomacromolecular+drugs&amp;author=L.+Wu&amp;author=M.+Liu&amp;author=W.+Shan&amp;author=X.+Zhu&amp;author=L.+Li&amp;volume=262&amp;publication_year=2017&amp;pages=273-283&amp;pmid=28774842&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib245">245. <span class="element-citation" id="sref245">Kunisawa J., Kurashima Y., Kiyono H. Gut-associated lymphoid tissues for the development of oral vaccines. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2012;<span class="ref-vol">64</span>:523–530.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21827802" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Gut-associated+lymphoid+tissues+for+the+development+of+oral+vaccines&amp;author=J.+Kunisawa&amp;author=Y.+Kurashima&amp;author=H.+Kiyono&amp;volume=64&amp;publication_year=2012&amp;pages=523-530&amp;pmid=21827802&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib246">246. <span class="element-citation" id="sref246">Brayden D.J., Jepson M.A., Baird A.W. Intestinal peyer's patch m cells and oral vaccine targeting. <span><span class="ref-journal">Drug Discov Today. </span>2005;<span class="ref-vol">10</span>:1145–1157.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16182207" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Intestinal+peyer's+patch+m+cells+and+oral+vaccine+targeting&amp;author=D.J.+Brayden&amp;author=M.A.+Jepson&amp;author=A.W.+Baird&amp;volume=10&amp;publication_year=2005&amp;pages=1145-1157&amp;pmid=16182207&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib247">247. <span class="element-citation" id="sref247">Clark M.A., Blair H., Liang L., Brey R.N., Brayden D., Hirst B.H. Targeting polymerised liposome vaccine carriers to intestinal M cells. <span><span class="ref-journal">Vaccine. </span>2001;<span class="ref-vol">20</span>:208–217.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11567766" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Targeting+polymerised+liposome+vaccine+carriers+to+intestinal+M+cells&amp;author=M.A.+Clark&amp;author=H.+Blair&amp;author=L.+Liang&amp;author=R.N.+Brey&amp;author=D.+Brayden&amp;volume=20&amp;publication_year=2001&amp;pages=208-217&amp;pmid=11567766&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib248">248. <span class="element-citation" id="sref248">Kim B.Y., Jeong J.H., Park K., Kim J.D. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system. <span><span class="ref-journal">J Control Release. </span>2005;<span class="ref-vol">102</span>:525–538.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15681076" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Bioadhesive+interaction+and+hypoglycemic+effect+of+insulin-loaded+lectin-microparticle+conjugates+in+oral+insulin+delivery+system&amp;author=B.Y.+Kim&amp;author=J.H.+Jeong&amp;author=K.+Park&amp;author=J.D.+Kim&amp;volume=102&amp;publication_year=2005&amp;pages=525-538&amp;pmid=15681076&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib249">249. <span class="element-citation" id="sref249">Yoo M.K., Kang S.K., Choi J.H., Park I.K., Na H.S., Lee H.C. Targeted delivery of chitosan nanoparticles to peyer's patch using M cell-homing peptide selected by phage display technique. <span><span class="ref-journal">Biomaterials. </span>2010;<span class="ref-vol">31</span>:7738–7747.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20656343" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Targeted+delivery+of+chitosan+nanoparticles+to+peyer's+patch+using+M+cell-homing+peptide+selected+by+phage+display+technique&amp;author=M.K.+Yoo&amp;author=S.K.+Kang&amp;author=J.H.+Choi&amp;author=I.K.+Park&amp;author=H.S.+Na&amp;volume=31&amp;publication_year=2010&amp;pages=7738-7747&amp;pmid=20656343&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib250">250. <span class="element-citation" id="sref250">Zhang P., Xu Y., Zhu X., Huang Y. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin. <span><span class="ref-journal">Int J Pharm. </span>2015;<span class="ref-vol">496</span>:993–1005.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26541299" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Goblet+cell+targeting+nanoparticle+containing+drug-loaded+micelle+cores+for+oral+delivery+of+insulin&amp;author=P.+Zhang&amp;author=Y.+Xu&amp;author=X.+Zhu&amp;author=Y.+Huang&amp;volume=496&amp;publication_year=2015&amp;pages=993-1005&amp;pmid=26541299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib251">251. <span class="element-citation" id="sref251">Mohamadzadeh M., Duong T., Sandwick S.J., Hoover T., Klaenhammer T.R. Dendritic cell targeting of bacillus anthracis protective antigen expressed by lactobacillus acidophilus protects mice from lethal challenge. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:4331–4336.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2647975/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19246373" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Dendritic+cell+targeting+of+bacillus+anthracis+protective+antigen+expressed+by+lactobacillus+acidophilus+protects+mice+from+lethal+challenge&amp;author=M.+Mohamadzadeh&amp;author=T.+Duong&amp;author=S.J.+Sandwick&amp;author=T.+Hoover&amp;author=T.R.+Klaenhammer&amp;volume=106&amp;publication_year=2009&amp;pages=4331-4336&amp;pmid=19246373&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib252">252. <span class="element-citation" id="sref252">Kathania M., Zadeh M., Lightfoot Y.L., Roman R.M., Sahay B., Abbott J.R. Colonic immune stimulation by targeted oral vaccine. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3559436/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23383086" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Colonic+immune+stimulation+by+targeted+oral+vaccine&amp;author=M.+Kathania&amp;author=M.+Zadeh&amp;author=Y.L.+Lightfoot&amp;author=R.M.+Roman&amp;author=B.+Sahay&amp;volume=8&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib253">253. <span class="element-citation" id="sref253">Ryan G.M., Kaminskas L.M., Porter C.J. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. <span><span class="ref-journal">J Control Release. </span>2014;<span class="ref-vol">193</span>:241–256.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24801249" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Nano-chemotherapeutics:+maximising+lymphatic+drug+exposure+to+improve+the+treatment+of+lymph-metastatic+cancers&amp;author=G.M.+Ryan&amp;author=L.M.+Kaminskas&amp;author=C.J.+Porter&amp;volume=193&amp;publication_year=2014&amp;pages=241-256&amp;pmid=24801249&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib254">254. <span class="element-citation" id="sref254">Supersaxo A., Hein W.R., Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. <span><span class="ref-journal">Pharm Res. </span>1990;<span class="ref-vol">7</span>:167–169.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2137911" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Effect+of+molecular+weight+on+the+lymphatic+absorption+of+water-soluble+compounds+following+subcutaneous+administration&amp;author=A.+Supersaxo&amp;author=W.R.+Hein&amp;author=H.+Steffen&amp;volume=7&amp;publication_year=1990&amp;pages=167-169&amp;pmid=2137911&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib255">255. <span class="element-citation" id="sref255">Oussoren C., Zuidema J., Crommelin D., Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: II. influence of liposomal size, lipid composition and lipid dose. <span><span class="ref-journal">Biochim Biophys Acta Biomembr. </span>1997;<span class="ref-vol">1328</span>:261–272.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9315622" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta+Biomembr&amp;title=Lymphatic+uptake+and+biodistribution+of+liposomes+after+subcutaneous+injection:+II.+influence+of+liposomal+size,+lipid+composition+and+lipid+dose&amp;author=C.+Oussoren&amp;author=J.+Zuidema&amp;author=D.+Crommelin&amp;author=G.+Storm&amp;volume=1328&amp;publication_year=1997&amp;pages=261-272&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib256">256. <span class="element-citation" id="sref256">Reddy S.T., Van Der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. <span><span class="ref-journal">Nat Biotechnol. </span>2007;<span class="ref-vol">25</span>:1159–1164.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17873867" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Exploiting+lymphatic+transport+and+complement+activation+in+nanoparticle+vaccines&amp;author=S.T.+Reddy&amp;author=A.J.+Van+Der+Vlies&amp;author=E.+Simeoni&amp;author=V.+Angeli&amp;author=G.J.+Randolph&amp;volume=25&amp;publication_year=2007&amp;pages=1159-1164&amp;pmid=17873867&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib257">257. <span class="element-citation" id="sref257">Ke X., Howard G.P., Tang H., Cheng B., Saung M.T., Santos J.L. Physical and chemical profiles of nanoparticles for lymphatic targeting. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2019;<span class="ref-vol">151</span>:72–93.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31626825" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Physical+and+chemical+profiles+of+nanoparticles+for+lymphatic+targeting&amp;author=X.+Ke&amp;author=G.P.+Howard&amp;author=H.+Tang&amp;author=B.+Cheng&amp;author=M.T.+Saung&amp;volume=151&amp;publication_year=2019&amp;pages=72-93&amp;pmid=31626825&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib258">258. <span class="element-citation" id="sref258">Managuli R.S., Raut S.Y., Reddy M.S., Mutalik S. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2018;<span class="ref-vol">15</span>:787–804.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30025212" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Targeting+the+intestinal+lymphatic+system:+a+versatile+path+for+enhanced+oral+bioavailability+of+drugs&amp;author=R.S.+Managuli&amp;author=S.Y.+Raut&amp;author=M.S.+Reddy&amp;author=S.+Mutalik&amp;volume=15&amp;publication_year=2018&amp;pages=787-804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib259">259. <span class="element-citation" id="sref259">Trevaskis N.L., Kaminskas L.M., Porter C.J.H. From sewer to saviour&#x02014;targeting the lymphatic system to promote drug exposure and activity. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2015;<span class="ref-vol">14</span>:781–803.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26471369" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=From+sewer+to+saviour&#x02014;targeting+the+lymphatic+system+to+promote+drug+exposure+and+activity&amp;author=N.L.+Trevaskis&amp;author=L.M.+Kaminskas&amp;author=C.J.H.+Porter&amp;volume=14&amp;publication_year=2015&amp;pages=781-803&amp;pmid=26471369&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib260">260. <span class="element-citation" id="sref260">Trotta M., Carlotti M.E., Gallarate M., Zara G.P., Muntoni E., Battaglia L. Insulin-loaded SLN prepared with the emulsion dilution technique: <em>in&#x000a0;vivo</em> tracking of nanoparticles after oral administration to rats. <span><span class="ref-journal">J Dispersion Sci Technol. </span>2011;<span class="ref-vol">32</span>:1041–1045.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Dispersion+Sci+Technol&amp;title=Insulin-loaded+SLN+prepared+with+the+emulsion+dilution+technique:+in&#x000a0;vivo+tracking+of+nanoparticles+after+oral+administration+to+rats&amp;author=M.+Trotta&amp;author=M.E.+Carlotti&amp;author=M.+Gallarate&amp;author=G.P.+Zara&amp;author=E.+Muntoni&amp;volume=32&amp;publication_year=2011&amp;pages=1041-1045&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib261">261. <span class="element-citation" id="sref261">Hackett M.J., Zaro J.L., Shen W.C., Guley P.C., Cho M.J. Fatty acids as therapeutic auxiliaries for oral and parenteral formulations. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2013;<span class="ref-vol">65</span>:1331–1339.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3537895/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22921839" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Fatty+acids+as+therapeutic+auxiliaries+for+oral+and+parenteral+formulations&amp;author=M.J.+Hackett&amp;author=J.L.+Zaro&amp;author=W.C.+Shen&amp;author=P.C.+Guley&amp;author=M.J.+Cho&amp;volume=65&amp;publication_year=2013&amp;pages=1331-1339&amp;pmid=22921839&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib262">262. <span class="element-citation" id="sref262">Florence A.T. Nanoparticle uptake by the oral route: fulfilling its potential? <span><span class="ref-journal">Drug Discov Today. </span>2005;<span class="ref-vol">2</span>:75–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24981758" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Nanoparticle+uptake+by+the+oral+route:+fulfilling+its+potential?&amp;author=A.T.+Florence&amp;volume=2&amp;publication_year=2005&amp;pages=75-81&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib263">263. <span class="element-citation" id="sref263">Xie Y., Jiang S., Xia F., Hu X., He H., Yin Z. Glucan microparticles thickened with thermosensitive gels as potential carriers for oral delivery of insulin. <span><span class="ref-journal">J Mater Chem B. </span>2016;<span class="ref-vol">4</span>:4040–4048.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32263103" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mater+Chem+B&amp;title=Glucan+microparticles+thickened+with+thermosensitive+gels+as+potential+carriers+for+oral+delivery+of+insulin&amp;author=Y.+Xie&amp;author=S.+Jiang&amp;author=F.+Xia&amp;author=X.+Hu&amp;author=H.+He&amp;volume=4&amp;publication_year=2016&amp;pages=4040-4048&amp;pmid=32263103&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib264">264. <span class="element-citation" id="sref264">Xie Y., Hu X., He H., Xia F., Ma Y., Qi J. Tracking translocation of glucan microparticles targeting m cells: implications for oral drug delivery. <span><span class="ref-journal">J Mater Chem B. </span>2016;<span class="ref-vol">4</span>:2864–2873.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32262964" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mater+Chem+B&amp;title=Tracking+translocation+of+glucan+microparticles+targeting+m+cells:+implications+for+oral+drug+delivery&amp;author=Y.+Xie&amp;author=X.+Hu&amp;author=H.+He&amp;author=F.+Xia&amp;author=Y.+Ma&amp;volume=4&amp;publication_year=2016&amp;pages=2864-2873&amp;pmid=32262964&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib265">265. <span class="element-citation" id="sref265">Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. <span><span class="ref-journal">Pharm Res. </span>1996;<span class="ref-vol">13</span>:1838–1845.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8987081" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Gastrointestinal+uptake+of+biodegradable+microparticles:+effect+of+particle+size&amp;author=M.P.+Desai&amp;author=V.+Labhasetwar&amp;author=G.L.+Amidon&amp;author=R.J.+Levy&amp;volume=13&amp;publication_year=1996&amp;pages=1838-1845&amp;pmid=8987081&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib266">266. <span class="element-citation" id="sref266">Jani P., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. <span><span class="ref-journal">J Pharm Pharmacol. </span>1990;<span class="ref-vol">42</span>:821–826.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1983142" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;title=Nanoparticle+uptake+by+the+rat+gastrointestinal+mucosa:+quantitation+and+particle+size+dependency&amp;author=P.+Jani&amp;author=G.W.+Halbert&amp;author=J.+Langridge&amp;author=A.T.+Florence&amp;volume=42&amp;publication_year=1990&amp;pages=821-826&amp;pmid=1983142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib267">267. <span class="element-citation" id="sref267">Tacket C.O., Reid R.H., Boedeker E.C., Losonsky G., Nataro J.P., Bhagat H. Enteral immunization and challenge of volunteers given enterotoxigenic <em>E. coli</em> CFA/II encapsulated in biodegradable microspheres. <span><span class="ref-journal">Vaccine. </span>1994;<span class="ref-vol">12</span>:1270–1274.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7856290" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Enteral+immunization+and+challenge+of+volunteers+given+enterotoxigenic+E.+coli+CFA/II+encapsulated+in+biodegradable+microspheres&amp;author=C.O.+Tacket&amp;author=R.H.+Reid&amp;author=E.C.+Boedeker&amp;author=G.+Losonsky&amp;author=J.P.+Nataro&amp;volume=12&amp;publication_year=1994&amp;pages=1270-1274&amp;pmid=7856290&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib268">268. <span class="element-citation" id="sref268">Katz D.E., DeLorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., Van Hamont J.E. Oral immunization of adult volunteers with microencapsulated enterotoxigenic <em>Escherichia coli</em> (ETEC) CS6 antigen. <span><span class="ref-journal">Vaccine. </span>2003;<span class="ref-vol">21</span>:341–346.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12531630" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Oral+immunization+of+adult+volunteers+with+microencapsulated+enterotoxigenic+Escherichia+coli+(ETEC)+CS6+antigen&amp;author=D.E.+Katz&amp;author=A.J.+DeLorimier&amp;author=M.K.+Wolf&amp;author=E.R.+Hall&amp;author=F.J.+Cassels&amp;volume=21&amp;publication_year=2003&amp;pages=341-346&amp;pmid=12531630&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib269">269. <span class="element-citation" id="sref269">Lei Z., Chen B., Koo Y.M., MacFarlane D.R. Introduction: ionic liquids. <span><span class="ref-journal">Chem Rev. </span>2017;<span class="ref-vol">117</span>:6633–6635.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28535681" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Rev&amp;title=Introduction:+ionic+liquids&amp;author=Z.+Lei&amp;author=B.+Chen&amp;author=Y.M.+Koo&amp;author=D.R.+MacFarlane&amp;volume=117&amp;publication_year=2017&amp;pages=6633-6635&amp;pmid=28535681&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib270">270. <span class="element-citation" id="sref270">Wu X., Yu Q., Wu J., Li T., Ding N., Wu W. Ionic liquids containing ketoconazole improving topical treatment of <em>T. Interdigitale</em> infection by synergistic action. <span><span class="ref-journal">Int J Pharm. </span>2020;<span class="ref-vol">589</span>:119842.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32890655" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Ionic+liquids+containing+ketoconazole+improving+topical+treatment+of+T.+Interdigitale+infection+by+synergistic+action&amp;author=X.+Wu&amp;author=Q.+Yu&amp;author=J.+Wu&amp;author=T.+Li&amp;author=N.+Ding&amp;volume=589&amp;publication_year=2020&amp;pages=119842&amp;pmid=32890655&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib271">271. <span class="element-citation" id="sref271">Wu X., Chen Z., Li Y., Yu Q., Lu Y., Zhu Q. Improving dermal delivery of hydrophilic macromolecules by biocompatible ionic liquid based on choline and malic acid. <span><span class="ref-journal">Int J Pharm. </span>2019;<span class="ref-vol">558</span>:380–387.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30664995" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Improving+dermal+delivery+of+hydrophilic+macromolecules+by+biocompatible+ionic+liquid+based+on+choline+and+malic+acid&amp;author=X.+Wu&amp;author=Z.+Chen&amp;author=Y.+Li&amp;author=Q.+Yu&amp;author=Y.+Lu&amp;volume=558&amp;publication_year=2019&amp;pages=380-387&amp;pmid=30664995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib272">272. <span class="element-citation" id="sref272">Wu X., Zhang H., He S., Yu Q., Lu Y., Wu W. Improving dermal delivery of hyaluronic acid by ionic liquids for attenuating skin dehydration. <span><span class="ref-journal">Int J Biol Macromol. </span>2020;<span class="ref-vol">150</span>:528–535.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32057854" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Improving+dermal+delivery+of+hyaluronic+acid+by+ionic+liquids+for+attenuating+skin+dehydration&amp;author=X.+Wu&amp;author=H.+Zhang&amp;author=S.+He&amp;author=Q.+Yu&amp;author=Y.+Lu&amp;volume=150&amp;publication_year=2020&amp;pages=528-535&amp;pmid=32057854&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib273">273. <span class="element-citation" id="sref273">Egorova K.S., Gordeev E.G., Ananikov V.P. Biological activity of ionic liquids and their application in pharmaceutics and medicine. <span><span class="ref-journal">Chem Rev. </span>2017;<span class="ref-vol">117</span>:7132–7189.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28125212" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Rev&amp;title=Biological+activity+of+ionic+liquids+and+their+application+in+pharmaceutics+and+medicine&amp;author=K.S.+Egorova&amp;author=E.G.+Gordeev&amp;author=V.P.+Ananikov&amp;volume=117&amp;publication_year=2017&amp;pages=7132-7189&amp;pmid=28125212&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib274">274. <span class="element-citation" id="sref274">Zakrewsky M., Lovejoy K.S., Kern T.L., Miller T.E., Le V., Nagy A. Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2014;<span class="ref-vol">111</span>:13313–13318.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4169946/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25157174" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Ionic+liquids+as+a+class+of+materials+for+transdermal+delivery+and+pathogen+neutralization&amp;author=M.+Zakrewsky&amp;author=K.S.+Lovejoy&amp;author=T.L.+Kern&amp;author=T.E.+Miller&amp;author=V.+Le&amp;volume=111&amp;publication_year=2014&amp;pages=13313-13318&amp;pmid=25157174&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib275">275. <span class="element-citation" id="sref275">Banerjee A., Ibsen K., Iwao Y., Zakrewsky M., Mitragotri S. Transdermal protein delivery using choline and geranate (CAGE) deep eutectic solvent. <span><span class="ref-journal">Adv Healthc Mater. </span>2017;<span class="ref-vol">6</span>:1601411.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28337858" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Healthc+Mater&amp;title=Transdermal+protein+delivery+using+choline+and+geranate+(CAGE)+deep+eutectic+solvent&amp;author=A.+Banerjee&amp;author=K.+Ibsen&amp;author=Y.+Iwao&amp;author=M.+Zakrewsky&amp;author=S.+Mitragotri&amp;volume=6&amp;publication_year=2017&amp;pages=1601411&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib276">276. <span class="element-citation" id="sref276">Banerjee A., Ibsen K., Brown T., Chen R., Agatemor C., Mitragotri S. Ionic liquids for oral insulin delivery. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2018;<span class="ref-vol">115</span>:7296–7301.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6048483/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29941553" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Ionic+liquids+for+oral+insulin+delivery&amp;author=A.+Banerjee&amp;author=K.+Ibsen&amp;author=T.+Brown&amp;author=R.+Chen&amp;author=C.+Agatemor&amp;volume=115&amp;publication_year=2018&amp;pages=7296-7301&amp;pmid=29941553&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib277">277. <span class="element-citation" id="sref277">Shi Y., Zhao Z., Gao Y., Pan D.C., Salinas A.K., Tanner E.E. Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes. <span><span class="ref-journal">J Control Release. </span>2020;<span class="ref-vol">322</span>:602–609.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32201308" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Oral+delivery+of+sorafenib+through+spontaneous+formation+of+ionic+liquid+nanocomplexes&amp;author=Y.+Shi&amp;author=Z.+Zhao&amp;author=Y.+Gao&amp;author=D.C.+Pan&amp;author=A.K.+Salinas&amp;volume=322&amp;publication_year=2020&amp;pages=602-609&amp;pmid=32201308&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib278">278. <span class="element-citation" id="sref278">Angsantikul P., Peng K., Curreri A.M., Chua Y., Chen K.Z., Ehondor J. Ionic liquids and deep eutectic solvents for enhanced delivery of antibodies in the gastrointestinal tract. <span><span class="ref-journal">Adv Funct Mater. </span>2020;<span class="ref-vol">n/a</span>:2002912.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Funct+Mater&amp;title=Ionic+liquids+and+deep+eutectic+solvents+for+enhanced+delivery+of+antibodies+in+the+gastrointestinal+tract&amp;author=P.+Angsantikul&amp;author=K.+Peng&amp;author=A.M.+Curreri&amp;author=Y.+Chua&amp;author=K.Z.+Chen&amp;volume=n/a&amp;publication_year=2020&amp;pages=2002912&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib279">279. <span class="element-citation" id="sref279">Li Y., Wu X., Zhu Q., Chen Z., Lu Y., Qi J. Improving the hypoglycemic effect of insulin <em>via</em> the nasal administration of deep eutectic solvents. <span><span class="ref-journal">Int J Pharm. </span>2019;<span class="ref-vol">569</span>:118584.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31376466" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Improving+the+hypoglycemic+effect+of+insulin+via+the+nasal+administration+of+deep+eutectic+solvents&amp;author=Y.+Li&amp;author=X.+Wu&amp;author=Q.+Zhu&amp;author=Z.+Chen&amp;author=Y.+Lu&amp;volume=569&amp;publication_year=2019&amp;pages=118584&amp;pmid=31376466&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib280">280. <span class="element-citation" id="sref280">Peng K., Shi Y., LaBarbiera A., Mitragotri S. Mucoadhesive ionic liquid gel patches for oral delivery. <span><span class="ref-journal">ACS Biomater Sci Eng. </span>2020 doi: 10.1021/acsbiomaterials.0c01024.</span> Available from:  [<a href="//doi.org/10.1021%2Facsbiomaterials.0c01024" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Biomater+Sci+Eng&amp;title=Mucoadhesive+ionic+liquid+gel+patches+for+oral+delivery&amp;author=K.+Peng&amp;author=Y.+Shi&amp;author=A.+LaBarbiera&amp;author=S.+Mitragotri&amp;publication_year=2020&amp;doi=10.1021/acsbiomaterials.0c01024&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib281">281. <span class="element-citation" id="sref281">Tanner E.E., Piston K.M., Ma H., Ibsen K.N., Nangia S., Mitragotri S. The influence of water on choline-based ionic liquids. <span><span class="ref-journal">ACS Biomater Sci Eng. </span>2019;<span class="ref-vol">5</span>:3645–3653.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33405745" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Biomater+Sci+Eng&amp;title=The+influence+of+water+on+choline-based+ionic+liquids&amp;author=E.E.+Tanner&amp;author=K.M.+Piston&amp;author=H.+Ma&amp;author=K.N.+Ibsen&amp;author=S.+Nangia&amp;volume=5&amp;publication_year=2019&amp;pages=3645-3653&amp;pmid=33405745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib282">282. <span class="element-citation" id="sref282">Rzhevskiy A.S., Singh T.R.R., Donnelly R.F., Anissimov Y.G. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues. <span><span class="ref-journal">J Control Release. </span>2018;<span class="ref-vol">270</span>:184–202.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29203415" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Microneedles+as+the+technique+of+drug+delivery+enhancement+in+diverse+organs+and+tissues&amp;author=A.S.+Rzhevskiy&amp;author=T.R.R.+Singh&amp;author=R.F.+Donnelly&amp;author=Y.G.+Anissimov&amp;volume=270&amp;publication_year=2018&amp;pages=184-202&amp;pmid=29203415&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib283">283. <span class="element-citation" id="sref283">Lee K., Goudie M.J., Tebon P., Sun W., Luo Z., Lee J. Non-transdermal microneedles for advanced drug delivery. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2019;<span class="ref-vol">165&#x02013;166</span>:41–59.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7295684/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31837356" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Non-transdermal+microneedles+for+advanced+drug+delivery&amp;author=K.+Lee&amp;author=M.J.+Goudie&amp;author=P.+Tebon&amp;author=W.+Sun&amp;author=Z.+Luo&amp;volume=165&#x02013;166&amp;publication_year=2019&amp;pages=41-59&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib284">284. <span class="element-citation" id="sref284">Lee J.W., Prausnitz M.R. Drug delivery using microneedle patches: not just for skin. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2018;<span class="ref-vol">15</span>:541–543.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29708770" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Drug+delivery+using+microneedle+patches:+not+just+for+skin&amp;author=J.W.+Lee&amp;author=M.R.+Prausnitz&amp;volume=15&amp;publication_year=2018&amp;pages=541-543&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib285">285. <span class="element-citation" id="sref285">Traverso G., Schoellhammer C.M., Schroeder A., Maa R., Lauwers G.Y., Polat B.E. Microneedles for drug delivery <em>via</em> the gastrointestinal tract. <span><span class="ref-journal">J Pharm Sci. </span>2015;<span class="ref-vol">104</span>:362–367.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4349565/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25250829" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Microneedles+for+drug+delivery+via+the+gastrointestinal+tract&amp;author=G.+Traverso&amp;author=C.M.+Schoellhammer&amp;author=A.+Schroeder&amp;author=R.+Maa&amp;author=G.Y.+Lauwers&amp;volume=104&amp;publication_year=2015&amp;pages=362-367&amp;pmid=25250829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib286">286. <span class="element-citation" id="sref286">Abramson A., Caffarel-Salvador E., Soares V., Minahan D., Tian R.Y., Lu X. A luminal unfolding microneedle injector for oral delivery of macromolecules. <span><span class="ref-journal">Nat Med. </span>2019;<span class="ref-vol">25</span>:1512–1518.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7218658/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31591601" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=A+luminal+unfolding+microneedle+injector+for+oral+delivery+of+macromolecules&amp;author=A.+Abramson&amp;author=E.+Caffarel-Salvador&amp;author=V.+Soares&amp;author=D.+Minahan&amp;author=R.Y.+Tian&amp;volume=25&amp;publication_year=2019&amp;pages=1512-1518&amp;pmid=31591601&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib287">287. <span class="element-citation" id="sref287">Prausnitz M.R., Gomaa Y., Li W. Microneedle patch drug delivery in the gut. <span><span class="ref-journal">Nat Med. </span>2019;<span class="ref-vol">25</span>:1471–1472.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31591600" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Microneedle+patch+drug+delivery+in+the+gut&amp;author=M.R.+Prausnitz&amp;author=Y.+Gomaa&amp;author=W.+Li&amp;volume=25&amp;publication_year=2019&amp;pages=1471-1472&amp;pmid=31591600&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib288">288. <span class="element-citation" id="sref288">Abramson A., Caffarel-Salvador E., Khang M., Dellal D., Silverstein D., Gao Y. An ingestible self-orienting system for oral delivery of macromolecules. <span><span class="ref-journal">Science. </span>2019;<span class="ref-vol">363</span>:611–615.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6430586/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30733413" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=An+ingestible+self-orienting+system+for+oral+delivery+of+macromolecules&amp;author=A.+Abramson&amp;author=E.+Caffarel-Salvador&amp;author=M.+Khang&amp;author=D.+Dellal&amp;author=D.+Silverstein&amp;volume=363&amp;publication_year=2019&amp;pages=611-615&amp;pmid=30733413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib289">289. <span class="element-citation" id="sref289">Aran K., Chooljian M., Paredes J., Rafi M., Lee K., Kim A.Y. An oral microjet vaccination system elicits antibody production in rabbits. <span><span class="ref-journal">Sci Transl Med. </span>2017;<span class="ref-vol">9</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28275153" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=An+oral+microjet+vaccination+system+elicits+antibody+production+in+rabbits&amp;author=K.+Aran&amp;author=M.+Chooljian&amp;author=J.+Paredes&amp;author=M.+Rafi&amp;author=K.+Lee&amp;volume=9&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib290">290. <span class="element-citation" id="sref290">Sheng J., Han L., Qin J., Ru G., Li R., Wu L. <em>N-</em>Trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. <span><span class="ref-journal">ACS Appl Mater Interfaces. </span>2015;<span class="ref-vol">7</span>:15430–15441.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26111015" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Appl+Mater+Interfaces&amp;title=N-Trimethyl+chitosan+chloride-coated+PLGA+nanoparticles+overcoming+multiple+barriers+to+oral+insulin+absorption&amp;author=J.+Sheng&amp;author=L.+Han&amp;author=J.+Qin&amp;author=G.+Ru&amp;author=R.+Li&amp;volume=7&amp;publication_year=2015&amp;pages=15430-15441&amp;pmid=26111015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib291">291. <span class="element-citation" id="sref291">Yin Y., Chen D., Qiao M., Lu Z., Hu H. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. <span><span class="ref-journal">J Control Release. </span>2006;<span class="ref-vol">116</span>:337–345.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17097180" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Preparation+and+evaluation+of+lectin-conjugated+PLGA+nanoparticles+for+oral+delivery+of+thymopentin&amp;author=Y.+Yin&amp;author=D.+Chen&amp;author=M.+Qiao&amp;author=Z.+Lu&amp;author=H.+Hu&amp;volume=116&amp;publication_year=2006&amp;pages=337-345&amp;pmid=17097180&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib292">292. <span class="element-citation" id="sref292">Garinot M., Fi&#x000e9;vez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L. Pegylated PLGA-based nanoparticles targeting M cells for oral vaccination. <span><span class="ref-journal">J Control Release. </span>2007;<span class="ref-vol">120</span>:195–204.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17586081" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Pegylated+PLGA-based+nanoparticles+targeting+M+cells+for+oral+vaccination&amp;author=M.+Garinot&amp;author=V.+Fi&#x000e9;vez&amp;author=V.+Pourcelle&amp;author=F.+Stoffelbach&amp;author=A.+des+Rieux&amp;volume=120&amp;publication_year=2007&amp;pages=195-204&amp;pmid=17586081&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib293">293. <span class="element-citation" id="sref293">Kostadinova A.I., Middelburg J., Ciulla M., Garssen J., Hennink W.E., Knippels L.M.J. PLGA nanoparticles loaded with beta-lactoglobulin-derived peptides modulate mucosal immunity and may facilitate cow's milk allergy prevention. <span><span class="ref-journal">Eur J Pharmacol. </span>2018;<span class="ref-vol">818</span>:211–220.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29079360" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;title=PLGA+nanoparticles+loaded+with+beta-lactoglobulin-derived+peptides+modulate+mucosal+immunity+and+may+facilitate+cow's+milk+allergy+prevention&amp;author=A.I.+Kostadinova&amp;author=J.+Middelburg&amp;author=M.+Ciulla&amp;author=J.+Garssen&amp;author=W.E.+Hennink&amp;volume=818&amp;publication_year=2018&amp;pages=211-220&amp;pmid=29079360&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib294">294. <span class="element-citation" id="sref294">Narayanan D., Anitha A., Jayakumar R., Chennazhi K.P. <em>In&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> evaluation of osteoporosis therapeutic peptide PTH 1&#x02013;34 loaded pegylated chitosan nanoparticles. <span><span class="ref-journal">Mol Pharm. </span>2013;<span class="ref-vol">10</span>:4159–4167.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24006937" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=In&#x000a0;vitro+and+in&#x000a0;vivo+evaluation+of+osteoporosis+therapeutic+peptide+PTH+1&#x02013;34+loaded+pegylated+chitosan+nanoparticles&amp;author=D.+Narayanan&amp;author=A.+Anitha&amp;author=R.+Jayakumar&amp;author=K.P.+Chennazhi&amp;volume=10&amp;publication_year=2013&amp;pages=4159-4167&amp;pmid=24006937&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib295">295. <span class="element-citation" id="sref295">Marasini N., Giddam A.K., Khalil Z.G., Hussein W.M., Capon R.J., Batzloff M.R. Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery. <span><span class="ref-journal">Nanomedicine. </span>2016;<span class="ref-vol">11</span>:3223–3235.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27830630" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Double+adjuvanting+strategy+for+peptide-based+vaccines:+trimethyl+chitosan+nanoparticles+for+lipopeptide+delivery&amp;author=N.+Marasini&amp;author=A.K.+Giddam&amp;author=Z.G.+Khalil&amp;author=W.M.+Hussein&amp;author=R.J.+Capon&amp;volume=11&amp;publication_year=2016&amp;pages=3223-3235&amp;pmid=27830630&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib296">296. <span class="element-citation" id="sref296">Zeng Z., Qi D., Yang L., Liu J., Tang Y., Chen H. Stimuli-responsive self-assembled dendrimers for oral protein delivery. <span><span class="ref-journal">J Control Release. </span>2019;<span class="ref-vol">315</span>:206–213.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31672623" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Stimuli-responsive+self-assembled+dendrimers+for+oral+protein+delivery&amp;author=Z.+Zeng&amp;author=D.+Qi&amp;author=L.+Yang&amp;author=J.+Liu&amp;author=Y.+Tang&amp;volume=315&amp;publication_year=2019&amp;pages=206-213&amp;pmid=31672623&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib297">297. <span class="element-citation" id="sref297">Makhlof A., Fujimoto S., Tozuka Y., Takeuchi H. <em>In&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> evaluation of WGA&#x02013;carbopol modified liposomes as carriers for oral peptide delivery. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2011;<span class="ref-vol">77</span>:216–224.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21147220" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=In&#x000a0;vitro+and+in&#x000a0;vivo+evaluation+of+WGA&#x02013;carbopol+modified+liposomes+as+carriers+for+oral+peptide+delivery&amp;author=A.+Makhlof&amp;author=S.+Fujimoto&amp;author=Y.+Tozuka&amp;author=H.+Takeuchi&amp;volume=77&amp;publication_year=2011&amp;pages=216-224&amp;pmid=21147220&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib298">298. <span class="element-citation" id="sref298">Parmentier J., Hofhaus G., Thomas S., Cuesta L.C., Gropp F., Schr&#x000f6;der R. Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole. <span><span class="ref-journal">J Pharm Sci. </span>2014;<span class="ref-vol">103</span>:3985–3993.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25332052" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Improved+oral+bioavailability+of+human+growth+hormone+by+a+combination+of+liposomes+containing+bio-enhancers+and+tetraether+lipids+and+omeprazole&amp;author=J.+Parmentier&amp;author=G.+Hofhaus&amp;author=S.+Thomas&amp;author=L.C.+Cuesta&amp;author=F.+Gropp&amp;volume=103&amp;publication_year=2014&amp;pages=3985-3993&amp;pmid=25332052&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib299">299. <span class="element-citation" id="sref299">Li Z., Zhang L., Sun W., Ding Q., Hou Y., Xu Y. Archaeosomes with encapsulated antigens for oral vaccine delivery. <span><span class="ref-journal">Vaccine. </span>2011;<span class="ref-vol">29</span>:5260–5266.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21609747" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Archaeosomes+with+encapsulated+antigens+for+oral+vaccine+delivery&amp;author=Z.+Li&amp;author=L.+Zhang&amp;author=W.+Sun&amp;author=Q.+Ding&amp;author=Y.+Hou&amp;volume=29&amp;publication_year=2011&amp;pages=5260-5266&amp;pmid=21609747&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib300">300. <span class="element-citation" id="sref300">Wang N., Wang T., Zhang M., Chen R., Niu R., Deng Y. Mannose derivative and lipid a dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2014;<span class="ref-vol">88</span>:194–206.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24769065" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Mannose+derivative+and+lipid+a+dually+decorated+cationic+liposomes+as+an+effective+cold+chain+free+oral+mucosal+vaccine+adjuvant-delivery+system&amp;author=N.+Wang&amp;author=T.+Wang&amp;author=M.+Zhang&amp;author=R.+Chen&amp;author=R.+Niu&amp;volume=88&amp;publication_year=2014&amp;pages=194-206&amp;pmid=24769065&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib301">301. <span class="element-citation" id="sref301">Gupta P.N., Vyas S.P. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. <span><span class="ref-journal">Colloids Surf, B. </span>2011;<span class="ref-vol">82</span>:118–125.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20843665" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Colloids+Surf,+B&amp;title=Investigation+of+lectinized+liposomes+as+M-cell+targeted+carrier-adjuvant+for+mucosal+immunization&amp;author=P.N.+Gupta&amp;author=S.P.+Vyas&amp;volume=82&amp;publication_year=2011&amp;pages=118-125&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib302">302. <span class="element-citation" id="sref302">Hecq J., Amighi K., Goole J. Development and evaluation of insulin-loaded cationic solid lipid nanoparticles for oral delivery. <span><span class="ref-journal">J Drug Deliv Sci Technol. </span>2016;<span class="ref-vol">36</span>:192–200.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Deliv+Sci+Technol&amp;title=Development+and+evaluation+of+insulin-loaded+cationic+solid+lipid+nanoparticles+for+oral+delivery&amp;author=J.+Hecq&amp;author=K.+Amighi&amp;author=J.+Goole&amp;volume=36&amp;publication_year=2016&amp;pages=192-200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib303">303. <span class="element-citation" id="sref303">Fan T., Chen C., Guo H., Xu J., Zhang J., Zhu X. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2014;<span class="ref-vol">88</span>:518–528.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24968819" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Design+and+evaluation+of+solid+lipid+nanoparticles+modified+with+peptide+ligand+for+oral+delivery+of+protein+drugs&amp;author=T.+Fan&amp;author=C.+Chen&amp;author=H.+Guo&amp;author=J.+Xu&amp;author=J.+Zhang&amp;volume=88&amp;publication_year=2014&amp;pages=518-528&amp;pmid=24968819&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib304">304. <span class="element-citation" id="sref304">Li X., Qi J., Xie Y., Zhang X., Hu S., Xu Y. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats. <span><span class="ref-journal">Int J Nanomed. </span>2013;<span class="ref-vol">8</span>:23–32.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3534302/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23293517" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Nanomed&amp;title=Nanoemulsions+coated+with+alginate/chitosan+as+oral+insulin+delivery+systems:+preparation,+characterization,+and+hypoglycemic+effect+in+rats&amp;author=X.+Li&amp;author=J.+Qi&amp;author=Y.+Xie&amp;author=X.+Zhang&amp;author=S.+Hu&amp;volume=8&amp;publication_year=2013&amp;pages=23-32&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib305">305. <span class="element-citation" id="sref305">Lin P.Y., Chen K.H., Miao Y.B., Chen H.L., Lin K.J., Chen C.T. Phase-changeable nanoemulsions for oral delivery of a therapeutic peptide: toward targeting the pancreas for antidiabetic treatments using lymphatic transport. <span><span class="ref-journal">Adv Funct Mater. </span>2019;<span class="ref-vol">29</span>:1809015.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Funct+Mater&amp;title=Phase-changeable+nanoemulsions+for+oral+delivery+of+a+therapeutic+peptide:+toward+targeting+the+pancreas+for+antidiabetic+treatments+using+lymphatic+transport&amp;author=P.Y.+Lin&amp;author=K.H.+Chen&amp;author=Y.B.+Miao&amp;author=H.L.+Chen&amp;author=K.J.+Lin&amp;volume=29&amp;publication_year=2019&amp;pages=1809015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib306">306. <span class="element-citation" id="sref306">Abeer M.M., Meka A.K., Pujara N., Kumeria T., Strounina E., Nunes R. Rationally designed dendritic silica nanoparticles for oral delivery of exenatide. <span><span class="ref-journal">Pharmaceutics. </span>2019;<span class="ref-vol">11</span>:418.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6723263/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31430872" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Rationally+designed+dendritic+silica+nanoparticles+for+oral+delivery+of+exenatide&amp;author=M.M.+Abeer&amp;author=A.K.+Meka&amp;author=N.+Pujara&amp;author=T.+Kumeria&amp;author=E.+Strounina&amp;volume=11&amp;publication_year=2019&amp;pages=418&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib307">307. <span class="element-citation" id="sref307">Tan X., Zhang Y., Wang Q., Ren T., Gou J., Guo W. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides. <span><span class="ref-journal">Biomater Sci. </span>2019;<span class="ref-vol">7</span>:2934–2950.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31094367" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomater+Sci&amp;title=Cell-penetrating+peptide+together+with+PEG-modified+mesostructured+silica+nanoparticles+promotes+mucous+permeation+and+oral+delivery+of+therapeutic+proteins+and+peptides&amp;author=X.+Tan&amp;author=Y.+Zhang&amp;author=Q.+Wang&amp;author=T.+Ren&amp;author=J.+Gou&amp;volume=7&amp;publication_year=2019&amp;pages=2934-2950&amp;pmid=31094367&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib308">308. <span class="element-citation" id="sref308">Lamson N.G., Berger A., Fein K.C., Whitehead K.A. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. <span><span class="ref-journal">Nat Biomed Eng. </span>2020;<span class="ref-vol">4</span>:84–96.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7461704/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31686002" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biomed+Eng&amp;title=Anionic+nanoparticles+enable+the+oral+delivery+of+proteins+by+enhancing+intestinal+permeability&amp;author=N.G.+Lamson&amp;author=A.+Berger&amp;author=K.C.+Fein&amp;author=K.A.+Whitehead&amp;volume=4&amp;publication_year=2020&amp;pages=84-96&amp;pmid=31686002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib309">309. <span class="element-citation" id="sref309">Scaramuzzi K., Tanaka G.D., Neto F.M., Garcia P.R.A.F., Gabrili J.J.M., Oliveira D.C.A. Nanostructured SBA-15 silica: an effective protective vehicle to oral hepatitis B vaccine immunization. <span><span class="ref-journal">Nanomedicine. </span>2016;<span class="ref-vol">12</span>:2241–2250.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27339784" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Nanostructured+SBA-15+silica:+an+effective+protective+vehicle+to+oral+hepatitis+B+vaccine+immunization&amp;author=K.+Scaramuzzi&amp;author=G.D.+Tanaka&amp;author=F.M.+Neto&amp;author=P.R.A.F.+Garcia&amp;author=J.J.M.+Gabrili&amp;volume=12&amp;publication_year=2016&amp;pages=2241-2250&amp;pmid=27339784&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib310">310. <span class="element-citation" id="sref310">Cao P., Han F.Y., Gr&#x000f8;ndahl L., Xu Z.P., Li L. Enhanced oral vaccine efficacy of polysaccharide-coated calcium phosphate nanoparticles. <span><span class="ref-journal">ACS Omega. </span>2020;<span class="ref-vol">5</span>:18185–18197.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7392379/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32743193" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Omega&amp;title=Enhanced+oral+vaccine+efficacy+of+polysaccharide-coated+calcium+phosphate+nanoparticles&amp;author=P.+Cao&amp;author=F.Y.+Han&amp;author=L.+Gr&#x000f8;ndahl&amp;author=Z.P.+Xu&amp;author=L.+Li&amp;volume=5&amp;publication_year=2020&amp;pages=18185-18197&amp;pmid=32743193&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib311">311. <span class="element-citation" id="sref311">Cho H.J., Oh J., Choo M.K., Ha J.I., Park Y., Maeng H.J. Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin. <span><span class="ref-journal">Int J Biol Macromol. </span>2014;<span class="ref-vol">63</span>:15–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24444886" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Chondroitin+sulfate-capped+gold+nanoparticles+for+the+oral+delivery+of+insulin&amp;author=H.J.+Cho&amp;author=J.+Oh&amp;author=M.K.+Choo&amp;author=J.I.+Ha&amp;author=Y.+Park&amp;volume=63&amp;publication_year=2014&amp;pages=15-20&amp;pmid=24444886&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib312">312. <span class="element-citation" id="sref312">Lundquist P., Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2016;<span class="ref-vol">106</span>:256–276.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27496705" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+absorption+of+peptides+and+nanoparticles+across+the+human+intestine:+opportunities,+limitations+and+studies+in+human+tissues&amp;author=P.+Lundquist&amp;author=P.+Artursson&amp;volume=106&amp;publication_year=2016&amp;pages=256-276&amp;pmid=27496705&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib313">313. <span class="element-citation" id="sref313">Sonaje K., Chuang E.Y., Lin K.J., Yen T.C., Su F.Y., Tseng M.T. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. <span><span class="ref-journal">Mol Pharm. </span>2012;<span class="ref-vol">9</span>:1271–1279.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22462641" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Opening+of+epithelial+tight+junctions+and+enhancement+of+paracellular+permeation+by+chitosan:+microscopic,+ultrastructural,+and+computed-tomographic+observations&amp;author=K.+Sonaje&amp;author=E.Y.+Chuang&amp;author=K.J.+Lin&amp;author=T.C.+Yen&amp;author=F.Y.+Su&amp;volume=9&amp;publication_year=2012&amp;pages=1271-1279&amp;pmid=22462641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib314">314. <span class="element-citation" id="sref314">Yu Z., Ma L., Ye S., Li G., Zhang M. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress. <span><span class="ref-journal">Carbohydr Polym. </span>2020;<span class="ref-vol">236</span>:115972.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32172827" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carbohydr+Polym&amp;title=Construction+of+an+environmentally+friendly+octenylsuccinic+anhydride+modified+pH-sensitive+chitosan+nanoparticle+drug+delivery+system+to+alleviate+inflammation+and+oxidative+stress&amp;author=Z.+Yu&amp;author=L.+Ma&amp;author=S.+Ye&amp;author=G.+Li&amp;author=M.+Zhang&amp;volume=236&amp;publication_year=2020&amp;pages=115972&amp;pmid=32172827&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib315">315. <span class="element-citation" id="sref315">Thanou M., Nihot M., Jansen M., Verhoef J.C., Junginger H. Mono-<em>n</em>-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia <em>in&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em>. <span><span class="ref-journal">J Pharm Sci. </span>2001;<span class="ref-vol">90</span>:38–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11064377" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Mono-n-carboxymethyl+chitosan+(MCC),+a+polyampholytic+chitosan+derivative,+enhances+the+intestinal+absorption+of+low+molecular+weight+heparin+across+intestinal+epithelia+in&#x000a0;vitro+and+in&#x000a0;vivo&amp;author=M.+Thanou&amp;author=M.+Nihot&amp;author=M.+Jansen&amp;author=J.C.+Verhoef&amp;author=H.+Junginger&amp;volume=90&amp;publication_year=2001&amp;pages=38-46&amp;pmid=11064377&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib316">316. <span class="element-citation" id="sref316">Gradauer K., Barthelmes J., Vonach C., Almer G., Mangge H., Teubl B. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. <span><span class="ref-journal">J Control Release. </span>2013;<span class="ref-vol">172</span>:872–878.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3913890/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24140721" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Liposomes+coated+with+thiolated+chitosan+enhance+oral+peptide+delivery+to+rats&amp;author=K.+Gradauer&amp;author=J.+Barthelmes&amp;author=C.+Vonach&amp;author=G.+Almer&amp;author=H.+Mangge&amp;volume=172&amp;publication_year=2013&amp;pages=872-878&amp;pmid=24140721&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib317">317. <span class="element-citation" id="sref317">Sonaje K., Lin K.J., Wang J.J., Mi F.L., Chen C.T., Juang J.H. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. <span><span class="ref-journal">Adv Funct Mater. </span>2010;<span class="ref-vol">20</span>:3695–3700.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Funct+Mater&amp;title=Self-assembled+pH-sensitive+nanoparticles:+a+platform+for+oral+delivery+of+protein+drugs&amp;author=K.+Sonaje&amp;author=K.J.+Lin&amp;author=J.J.+Wang&amp;author=F.L.+Mi&amp;author=C.T.+Chen&amp;volume=20&amp;publication_year=2010&amp;pages=3695-3700&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib318">318. <span class="element-citation" id="sref318">Sarmento B., Ribeiro A., Veiga F., Sampaio P., Neufeld R., Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. <span><span class="ref-journal">Pharm Res. </span>2007;<span class="ref-vol">24</span>:2198–2206.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17577641" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Alginate/chitosan+nanoparticles+are+effective+for+oral+insulin+delivery&amp;author=B.+Sarmento&amp;author=A.+Ribeiro&amp;author=F.+Veiga&amp;author=P.+Sampaio&amp;author=R.+Neufeld&amp;volume=24&amp;publication_year=2007&amp;pages=2198-2206&amp;pmid=17577641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib319">319. <span class="element-citation" id="sref319">Thanou M., Florea B.I., Langeme&#x000ff;er M.W.E., Verhoef J.C., Junginger H.E. <em>N-</em>Trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin <em>in&#x000a0;vitro</em> (Caco-2 cells) and <em>in&#x000a0;vivo</em> (rats) <span><span class="ref-journal">Pharm Res. </span>2000;<span class="ref-vol">17</span>:27–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10714604" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=N-Trimethylated+chitosan+chloride+(TMC)+improves+the+intestinal+permeation+of+the+peptide+drug+buserelin+in&#x000a0;vitro+(Caco-2+cells)+and+in&#x000a0;vivo+(rats)&amp;author=M.+Thanou&amp;author=B.I.+Florea&amp;author=M.W.E.+Langeme&#x000ff;er&amp;author=J.C.+Verhoef&amp;author=H.E.+Junginger&amp;volume=17&amp;publication_year=2000&amp;pages=27-31&amp;pmid=10714604&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib320">320. <span class="element-citation" id="sref320">Moghassemi S., Parnian E., Hakamivala A., Darzianiazizi M., Vardanjani M.M., Kashanian S. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. <span><span class="ref-journal">Mater Sci Eng C. </span>2015;<span class="ref-vol">46</span>:333–340.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25491995" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mater+Sci+Eng+C&amp;title=Uptake+and+transport+of+insulin+across+intestinal+membrane+model+using+trimethyl+chitosan+coated+insulin+niosomes&amp;author=S.+Moghassemi&amp;author=E.+Parnian&amp;author=A.+Hakamivala&amp;author=M.+Darzianiazizi&amp;author=M.M.+Vardanjani&amp;volume=46&amp;publication_year=2015&amp;pages=333-340&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib321">321. <span class="element-citation" id="sref321">Tsai L.C., Chen C.H., Lin C.W., Ho Y.C., Mi F.L. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin. <span><span class="ref-journal">Int J Biol Macromol. </span>2019;<span class="ref-vol">126</span>:141–150.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30586591" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Development+of+mutlifunctional+nanoparticles+self-assembled+from+trimethyl+chitosan+and+fucoidan+for+enhanced+oral+delivery+of+insulin&amp;author=L.C.+Tsai&amp;author=C.H.+Chen&amp;author=C.W.+Lin&amp;author=Y.C.+Ho&amp;author=F.L.+Mi&amp;volume=126&amp;publication_year=2019&amp;pages=141-150&amp;pmid=30586591&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib322">322. <span class="element-citation" id="sref322">Zhang H., Huang X., Sun Y., Xing J., Yamamoto A., Gao Y. Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin. <span><span class="ref-journal">Drug Deliv. </span>2016;<span class="ref-vol">23</span>:2419–2427.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25594571" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Deliv&amp;title=Absorption-improving+effects+of+chitosan+oligomers+based+on+their+mucoadhesive+properties:+a+comparative+study+on+the+oral+and+pulmonary+delivery+of+calcitonin&amp;author=H.+Zhang&amp;author=X.+Huang&amp;author=Y.+Sun&amp;author=J.+Xing&amp;author=A.+Yamamoto&amp;volume=23&amp;publication_year=2016&amp;pages=2419-2427&amp;pmid=25594571&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib323">323. <span class="element-citation" id="sref323">Zhang X., Sun M., Zheng A., Cao D., Bi Y., Sun J. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. <span><span class="ref-journal">Eur J Pharmaceut Sci. </span>2012;<span class="ref-vol">45</span>:632–638.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22248882" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmaceut+Sci&amp;title=Preparation+and+characterization+of+insulin-loaded+bioadhesive+PLGA+nanoparticles+for+oral+administration&amp;author=X.+Zhang&amp;author=M.+Sun&amp;author=A.+Zheng&amp;author=D.+Cao&amp;author=Y.+Bi&amp;volume=45&amp;publication_year=2012&amp;pages=632-638&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib324">324. <span class="element-citation" id="sref324">Paul P.K., Nopparat J., Nuanplub M., Treetong A., Suedee R. Improvement in insulin absorption into gastrointestinal epithelial cells by using molecularly imprinted polymer nanoparticles: microscopic evaluation and ultrastructure. <span><span class="ref-journal">Int J Pharm. </span>2017;<span class="ref-vol">530</span>:279–290.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28764982" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Improvement+in+insulin+absorption+into+gastrointestinal+epithelial+cells+by+using+molecularly+imprinted+polymer+nanoparticles:+microscopic+evaluation+and+ultrastructure&amp;author=P.K.+Paul&amp;author=J.+Nopparat&amp;author=M.+Nuanplub&amp;author=A.+Treetong&amp;author=R.+Suedee&amp;volume=530&amp;publication_year=2017&amp;pages=279-290&amp;pmid=28764982&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib325">325. <span class="element-citation" id="sref325">Paul P.K., Treetong A., Suedee R. Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system. <span><span class="ref-journal">Acta Pharm. </span>2017;<span class="ref-vol">67</span>:149–168.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28590908" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharm&amp;title=Biomimetic+insulin-imprinted+polymer+nanoparticles+as+a+potential+oral+drug+delivery+system&amp;author=P.K.+Paul&amp;author=A.+Treetong&amp;author=R.+Suedee&amp;volume=67&amp;publication_year=2017&amp;pages=149-168&amp;pmid=28590908&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib326">326. <span class="element-citation" id="sref326">Martins S., Sarmento B., Ferreira D.C., Souto E.B. Lipid-based colloidal carriers for peptide and protein delivery&#x02013;liposomes <em>versus</em> lipid nanoparticles. <span><span class="ref-journal">Int J Nanomed. </span>2007;<span class="ref-vol">2</span>:595.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2676808/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18203427" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Nanomed&amp;title=Lipid-based+colloidal+carriers+for+peptide+and+protein+delivery&#x02013;liposomes+versus+lipid+nanoparticles&amp;author=S.+Martins&amp;author=B.+Sarmento&amp;author=D.C.+Ferreira&amp;author=E.B.+Souto&amp;volume=2&amp;publication_year=2007&amp;pages=595&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib327">327. <span class="element-citation" id="sref327">Li P., Nielsen H.M., M&#x000fc;llertz A. Oral delivery of peptides and proteins using lipid-based drug delivery systems. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2012;<span class="ref-vol">9</span>:1289–1304.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22897647" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Oral+delivery+of+peptides+and+proteins+using+lipid-based+drug+delivery+systems&amp;author=P.+Li&amp;author=H.M.+Nielsen&amp;author=A.+M&#x000fc;llertz&amp;volume=9&amp;publication_year=2012&amp;pages=1289-1304&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib328">328. <span class="element-citation" id="sref328">Qi J., Zhuang J., Lu Y., Dong X., Zhao W., Wu W. <em>In</em> vivo fate of lipid-based nanoparticles. <span><span class="ref-journal">Drug Discov Today. </span>2017;<span class="ref-vol">22</span>:166–172.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27713035" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=In+vivo+fate+of+lipid-based+nanoparticles&amp;author=J.+Qi&amp;author=J.+Zhuang&amp;author=Y.+Lu&amp;author=X.+Dong&amp;author=W.+Zhao&amp;volume=22&amp;publication_year=2017&amp;pages=166-172&amp;pmid=27713035&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib329">329. <span class="element-citation" id="sref329">Zhang X., Yi Y., Qi J., Lu Y., Tian Z., Xie Y. Controlled release of cyclosporine a self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. <span><span class="ref-journal">Int J Pharm. </span>2013;<span class="ref-vol">452</span>:233–240.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23688622" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Controlled+release+of+cyclosporine+a+self-nanoemulsifying+systems+from+osmotic+pump+tablets:+near+zero-order+release+and+pharmacokinetics+in+dogs&amp;author=X.+Zhang&amp;author=Y.+Yi&amp;author=J.+Qi&amp;author=Y.+Lu&amp;author=Z.+Tian&amp;volume=452&amp;publication_year=2013&amp;pages=233-240&amp;pmid=23688622&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib330">330. <span class="element-citation" id="sref330">Li Y., Yokoyama W., Xu S., Zhu S., Ma J., Zhong F. Formation and stability of w/o microemulsion formed by food grade ingredients and its oral delivery of insulin in mice. <span><span class="ref-journal">J Func Food. </span>2017;<span class="ref-vol">30</span>:134–141.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Func+Food&amp;title=Formation+and+stability+of+w/o+microemulsion+formed+by+food+grade+ingredients+and+its+oral+delivery+of+insulin+in+mice&amp;author=Y.+Li&amp;author=W.+Yokoyama&amp;author=S.+Xu&amp;author=S.+Zhu&amp;author=J.+Ma&amp;volume=30&amp;publication_year=2017&amp;pages=134-141&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib331">331. <span class="element-citation" id="sref331">Sharma G., Wilson K., van der Walle C.F., Sattar N., Petrie J.R., Ravi Kumar M.N.V. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. <span><span class="ref-journal">Eur J Pharm Biopharm. </span>2010;<span class="ref-vol">76</span>:159–169.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20655382" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Biopharm&amp;title=Microemulsions+for+oral+delivery+of+insulin:+design,+development+and+evaluation+in+streptozotocin+induced+diabetic+rats&amp;author=G.+Sharma&amp;author=K.+Wilson&amp;author=C.F.+van+der+Walle&amp;author=N.+Sattar&amp;author=J.R.+Petrie&amp;volume=76&amp;publication_year=2010&amp;pages=159-169&amp;pmid=20655382&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib332">332. <span class="element-citation" id="sref332">Cheng M.B., Wang J.C., Li Y.H., Liu X.Y., Zhang X., Chen D.W. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. <span><span class="ref-journal">J Control Release. </span>2008;<span class="ref-vol">129</span>:41–48.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18474405" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Control+Release&amp;title=Characterization+of+water-in-oil+microemulsion+for+oral+delivery+of+earthworm+fibrinolytic+enzyme&amp;author=M.B.+Cheng&amp;author=J.C.+Wang&amp;author=Y.H.+Li&amp;author=X.Y.+Liu&amp;author=X.+Zhang&amp;volume=129&amp;publication_year=2008&amp;pages=41-48&amp;pmid=18474405&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib333">333. <span class="element-citation" id="sref333">He H., Lu Y., Qi J., Zhu Q., Chen Z., Wu W. Adapting liposomes for oral drug delivery. <span><span class="ref-journal">Acta Pharm Sinica B. </span>2019;<span class="ref-vol">9</span>:36–48.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6362257/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30766776" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharm+Sinica+B&amp;title=Adapting+liposomes+for+oral+drug+delivery&amp;author=H.+He&amp;author=Y.+Lu&amp;author=J.+Qi&amp;author=Q.+Zhu&amp;author=Z.+Chen&amp;volume=9&amp;publication_year=2019&amp;pages=36-48&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib334">334. <span class="element-citation" id="sref334">Patel H.M., Ryman B.E. Oral administration of insulin by encapsulation within liposomes. <span><span class="ref-journal">FEBS Lett. </span>1976;<span class="ref-vol">62</span>:60–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/129340" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Oral+administration+of+insulin+by+encapsulation+within+liposomes&amp;author=H.M.+Patel&amp;author=B.E.+Ryman&amp;volume=62&amp;publication_year=1976&amp;pages=60-63&amp;pmid=129340&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib335">335. <span class="element-citation" id="sref335">Dapergolas G., Gregoriadis G. Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. <span><span class="ref-journal">Lancet. </span>1976;<span class="ref-vol">308</span>:824–827.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/61498" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Hypoglycaemic+effect+of+liposome-entrapped+insulin+administered+intragastrically+into+rats&amp;author=G.+Dapergolas&amp;author=G.+Gregoriadis&amp;volume=308&amp;publication_year=1976&amp;pages=824-827&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib336">336. <span class="element-citation" id="sref336">Arrieta-Molero J.F., Aleck K., Sinha M.K., Brownscheidle C.M., Shapiro L.J., Sperling M.A. Orally administered liposome-entrapped insulin in diabetic animals. <span><span class="ref-journal">Hormone Res Paedia. </span>1982;<span class="ref-vol">16</span>:249–256.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6751980" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hormone+Res+Paedia&amp;title=Orally+administered+liposome-entrapped+insulin+in+diabetic+animals&amp;author=J.F.+Arrieta-Molero&amp;author=K.+Aleck&amp;author=M.K.+Sinha&amp;author=C.M.+Brownscheidle&amp;author=L.J.+Shapiro&amp;volume=16&amp;publication_year=1982&amp;pages=249-256&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib337">337. <span class="element-citation" id="sref337">Liu W., Li D., Dong Z., Liu K., He H., Lu Y. Insight into the <em>in&#x000a0;vivo</em> translocation of oral liposomes by fluorescence resonance energy transfer effect. <span><span class="ref-journal">Int J Pharm. </span>2020;<span class="ref-vol">587</span>:119682.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32717284" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Insight+into+the+in&#x000a0;vivo+translocation+of+oral+liposomes+by+fluorescence+resonance+energy+transfer+effect&amp;author=W.+Liu&amp;author=D.+Li&amp;author=Z.+Dong&amp;author=K.+Liu&amp;author=H.+He&amp;volume=587&amp;publication_year=2020&amp;pages=119682&amp;pmid=32717284&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib338">338. <span class="element-citation" id="sref338">Shukla A., Khatri K., Gupta P.N., Goyal A.K., Mehta A., Vyas S.P. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes) <span><span class="ref-journal">J Pharm Pharmaceut Sci. </span>2008;<span class="ref-vol">11</span>:59–66.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18445364" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmaceut+Sci&amp;title=Oral+immunization+against+hepatitis+B+using+bile+salt+stabilized+vesicles+(bilosomes)&amp;author=A.+Shukla&amp;author=K.+Khatri&amp;author=P.N.+Gupta&amp;author=A.K.+Goyal&amp;author=A.+Mehta&amp;volume=11&amp;publication_year=2008&amp;pages=59-66&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib339">339. <span class="element-citation" id="sref339">Wilkhu J.S., McNeil S.E., Anderson D.E., Perrie Y. Characterization and optimization of bilosomes for oral vaccine delivery. <span><span class="ref-journal">J Drug Target. </span>2013;<span class="ref-vol">21</span>:291–299.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30952177" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Drug+Target&amp;title=Characterization+and+optimization+of+bilosomes+for+oral+vaccine+delivery&amp;author=J.S.+Wilkhu&amp;author=S.E.+McNeil&amp;author=D.E.+Anderson&amp;author=Y.+Perrie&amp;volume=21&amp;publication_year=2013&amp;pages=291-299&amp;pmid=30952177&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib340">340. <span class="element-citation" id="sref340">Qi J., Lu Y., Wu W. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. <span><span class="ref-journal">Curr Drug Metabol. </span>2012;<span class="ref-vol">13</span>:418–428.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22443536" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Metabol&amp;title=Absorption,+disposition+and+pharmacokinetics+of+solid+lipid+nanoparticles&amp;author=J.+Qi&amp;author=Y.+Lu&amp;author=W.+Wu&amp;volume=13&amp;publication_year=2012&amp;pages=418-428&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib341">341. <span class="element-citation" id="sref341">Almeida A.J., Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2007;<span class="ref-vol">59</span>:478–490.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17543416" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Solid+lipid+nanoparticles+as+a+drug+delivery+system+for+peptides+and+proteins&amp;author=A.J.+Almeida&amp;author=E.+Souto&amp;volume=59&amp;publication_year=2007&amp;pages=478-490&amp;pmid=17543416&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib342">342. <span class="element-citation" id="sref342">Yoon G., Jin W.P., Yoon I.S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. <span><span class="ref-journal">J Pharm Invest. </span>2013;<span class="ref-vol">43</span>:353–362.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Invest&amp;title=Solid+lipid+nanoparticles+(SLNs)+and+nanostructured+lipid+carriers+(NLCs):+recent+advances+in+drug+delivery&amp;author=G.+Yoon&amp;author=W.P.+Jin&amp;author=I.S.+Yoon&amp;volume=43&amp;publication_year=2013&amp;pages=353-362&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib343">343. <span class="element-citation" id="sref343">Sarmento B., Martins S., Ferreira D., Souto E.B. Oral insulin delivery by means of solid lipid nanoparticles. <span><span class="ref-journal">Int J Nanomed. </span>2007;<span class="ref-vol">2</span>:743–749.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2676823/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18203440" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Nanomed&amp;title=Oral+insulin+delivery+by+means+of+solid+lipid+nanoparticles&amp;author=B.+Sarmento&amp;author=S.+Martins&amp;author=D.+Ferreira&amp;author=E.B.+Souto&amp;volume=2&amp;publication_year=2007&amp;pages=743-749&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib344">344. <span class="element-citation" id="sref344">Sarmento B., Mazzaglia D., Bonferoni M.C., Neto A.P., do C&#x000e9;u, Monteiro M., Seabra V. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system. <span><span class="ref-journal">Carbohydr Polym. </span>2011;<span class="ref-vol">84</span>:919–925.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carbohydr+Polym&amp;title=Effect+of+chitosan+coating+in+overcoming+the+phagocytosis+of+insulin+loaded+solid+lipid+nanoparticles+by+mononuclear+phagocyte+system&amp;author=B.+Sarmento&amp;author=D.+Mazzaglia&amp;author=M.C.+Bonferoni&amp;author=A.P.+Neto&amp;author=C&#x000e9;u+do&amp;volume=84&amp;publication_year=2011&amp;pages=919-925&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib345">345. <span class="element-citation" id="sref345">Zhang Z.H., Zhang Y.L., Zhou J.P., Lv H.X. Solid lipid nanoparticles modified with stearic acid&#x02013;octaarginine for oral administration of insulin. <span><span class="ref-journal">Int J Nanomed. </span>2012;<span class="ref-vol">7</span>:3333.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3405896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22848162" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Nanomed&amp;title=Solid+lipid+nanoparticles+modified+with+stearic+acid&#x02013;octaarginine+for+oral+administration+of+insulin&amp;author=Z.H.+Zhang&amp;author=Y.L.+Zhang&amp;author=J.P.+Zhou&amp;author=H.X.+Lv&amp;volume=7&amp;publication_year=2012&amp;pages=3333&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib346">346. <span class="element-citation" id="sref346">Yu Z., Fan W., Wang L., Qi J., Lu Y., Wu W. Effect of surface charges on oral absorption of intact solid lipid nanoparticles. <span><span class="ref-journal">Mol Pharm. </span>2019;<span class="ref-vol">16</span>:5013–5024.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31638827" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=Effect+of+surface+charges+on+oral+absorption+of+intact+solid+lipid+nanoparticles&amp;author=Z.+Yu&amp;author=W.+Fan&amp;author=L.+Wang&amp;author=J.+Qi&amp;author=Y.+Lu&amp;volume=16&amp;publication_year=2019&amp;pages=5013-5024&amp;pmid=31638827&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib347">347. <span class="element-citation" id="sref347">Mor&#x000e7;&#x000f6;l T., Nagappan P., Nerenbaum L., Mitchell A., Bell S. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. <span><span class="ref-journal">Int J Pharm. </span>2004;<span class="ref-vol">277</span>:91–97.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15158972" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Calcium+phosphate-PEG-insulin-casein+(CAPIC)+particles+as+oral+delivery+systems+for+insulin&amp;author=T.+Mor&#x000e7;&#x000f6;l&amp;author=P.+Nagappan&amp;author=L.+Nerenbaum&amp;author=A.+Mitchell&amp;author=S.+Bell&amp;volume=277&amp;publication_year=2004&amp;pages=91-97&amp;pmid=15158972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib348">348. <span class="element-citation" id="sref348">Florek J., Caillard R., Kleitz F. Evaluation of mesoporous silica nanoparticles for oral drug delivery&#x02014;current status and perspective of msns drug carriers. <span><span class="ref-journal">Nanoscale. </span>2017;<span class="ref-vol">9</span>:15252–15277.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28984885" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Evaluation+of+mesoporous+silica+nanoparticles+for+oral+drug+delivery&#x02014;current+status+and+perspective+of+msns+drug+carriers&amp;author=J.+Florek&amp;author=R.+Caillard&amp;author=F.+Kleitz&amp;volume=9&amp;publication_year=2017&amp;pages=15252-15277&amp;pmid=28984885&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib349">349. <span class="element-citation" id="sref349">Andreani T., de Souza A.L.R., Kiill C.P., Lorenz&#x000f3;n E.N., Fangueiro J.F., Calpena A.C. Preparation and characterization of peg-coated silica nanoparticles for oral insulin delivery. <span><span class="ref-journal">Int J Pharm. </span>2014;<span class="ref-vol">473</span>:627–635.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25089510" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Pharm&amp;title=Preparation+and+characterization+of+peg-coated+silica+nanoparticles+for+oral+insulin+delivery&amp;author=T.+Andreani&amp;author=A.L.R.+de+Souza&amp;author=C.P.+Kiill&amp;author=E.N.+Lorenz&#x000f3;n&amp;author=J.F.+Fangueiro&amp;volume=473&amp;publication_year=2014&amp;pages=627-635&amp;pmid=25089510&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib350">350. <span class="element-citation" id="sref350">Choi S.R., Jang D.-J., Kim S., An S., Lee J., Oh E. Polymer-coated spherical mesoporous silica for pH-controlled delivery of insulin. <span><span class="ref-journal">J Mater Chem B. </span>2014;<span class="ref-vol">2</span>:616–619.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32261277" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mater+Chem+B&amp;title=Polymer-coated+spherical+mesoporous+silica+for+pH-controlled+delivery+of+insulin&amp;author=S.R.+Choi&amp;author=D.-J.+Jang&amp;author=S.+Kim&amp;author=S.+An&amp;author=J.+Lee&amp;volume=2&amp;publication_year=2014&amp;pages=616-619&amp;pmid=32261277&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib351">351. <span class="element-citation" id="sref351">Rasmussen M.K., Kardjilov N., Oliveira C.L., Watts B., Villanova J., Botosso V.F. 3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15. <span><span class="ref-journal">Sci Rep. </span>2019;<span class="ref-vol">9</span>:1–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6465313/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30988384" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=3D+visualisation+of+hepatitis+B+vaccine+in+the+oral+delivery+vehicle+SBA-15&amp;author=M.K.+Rasmussen&amp;author=N.+Kardjilov&amp;author=C.L.+Oliveira&amp;author=B.+Watts&amp;author=J.+Villanova&amp;volume=9&amp;publication_year=2019&amp;pages=1-8&amp;pmid=30626917&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib352">352. <span class="element-citation" id="sref352">Sharma S., Verma A., Teja B.V., Pandey G., Mittapelly N., Trivedi R. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: trends and transitions. <span><span class="ref-journal">Colloids Surf, B. </span>2015;<span class="ref-vol">133</span>:120–139.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26094145" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Colloids+Surf,+B&amp;title=An+insight+into+functionalized+calcium+based+inorganic+nanomaterials+in+biomedicine:+trends+and+transitions&amp;author=S.+Sharma&amp;author=A.+Verma&amp;author=B.V.+Teja&amp;author=G.+Pandey&amp;author=N.+Mittapelly&amp;volume=133&amp;publication_year=2015&amp;pages=120-139&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib353">353. <span class="element-citation" id="sref353">Ramachandran R., Paul W., Sharma C.P. Synthesis and characterization of pegylated calcium phosphate nanoparticles for oral insulin delivery. <span><span class="ref-journal">J Biomed Mater Res B. </span>2009;<span class="ref-vol">88</span>:41–48.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18946870" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomed+Mater+Res+B&amp;title=Synthesis+and+characterization+of+pegylated+calcium+phosphate+nanoparticles+for+oral+insulin+delivery&amp;author=R.+Ramachandran&amp;author=W.+Paul&amp;author=C.P.+Sharma&amp;volume=88&amp;publication_year=2009&amp;pages=41-48&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib354">354. <span class="element-citation" id="sref354">Kumari Y., Singh S.K., Kumar R., Kumar B., Kaur G., Gulati M. Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin. <span><span class="ref-journal">Int J Biol Macromol. </span>2020;<span class="ref-vol">149</span>:976–988.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32018009" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Biol+Macromol&amp;title=Modified+apple+polysaccharide+capped+gold+nanoparticles+for+oral+delivery+of+insulin&amp;author=Y.+Kumari&amp;author=S.K.+Singh&amp;author=R.+Kumar&amp;author=B.+Kumar&amp;author=G.+Kaur&amp;volume=149&amp;publication_year=2020&amp;pages=976-988&amp;pmid=32018009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib355">355. <span class="element-citation" id="sref355">Safari M., Kamari Y., Ghiaci M., Sadeghi-Aliabadi H., Mirian M. Synthesis and characterization of insulin/zirconium phosphate@ TiO<sub>2</sub> hybrid composites for enhanced oral insulin delivery applications. <span><span class="ref-journal">Drug Dev Ind Pharm. </span>2017;<span class="ref-vol">43</span>:862–870.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27489129" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Dev+Ind+Pharm&amp;title=Synthesis+and+characterization+of+insulin/zirconium+phosphate@+TiO2+hybrid+composites+for+enhanced+oral+insulin+delivery+applications&amp;author=M.+Safari&amp;author=Y.+Kamari&amp;author=M.+Ghiaci&amp;author=H.+Sadeghi-Aliabadi&amp;author=M.+Mirian&amp;volume=43&amp;publication_year=2017&amp;pages=862-870&amp;pmid=27489129&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib356">356. <span class="element-citation" id="sref356">Hofmann-Amtenbrink M., Grainger D.W., Hofmann H. Nanoparticles in medicine: current challenges facing inorganic nanoparticle toxicity assessments and standardizations. <span><span class="ref-journal">Nanomedicine. </span>2015;<span class="ref-vol">11</span>:1689–1694.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26051651" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Nanoparticles+in+medicine:+current+challenges+facing+inorganic+nanoparticle+toxicity+assessments+and+standardizations&amp;author=M.+Hofmann-Amtenbrink&amp;author=D.W.+Grainger&amp;author=H.+Hofmann&amp;volume=11&amp;publication_year=2015&amp;pages=1689-1694&amp;pmid=26051651&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib357">357. <span class="element-citation" id="sref357">Yang G., Phua S.Z.F., Bindra A.K., Zhao Y. Degradability and clearance of inorganic nanoparticles for biomedical applications. <span><span class="ref-journal">Adv Mater. </span>2019;<span class="ref-vol">31</span>:1805730.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30614561" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Mater&amp;title=Degradability+and+clearance+of+inorganic+nanoparticles+for+biomedical+applications&amp;author=G.+Yang&amp;author=S.Z.F.+Phua&amp;author=A.K.+Bindra&amp;author=Y.+Zhao&amp;volume=31&amp;publication_year=2019&amp;pages=1805730&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib358">358. <span class="element-citation" id="sref358">Lopes M., Sim&#x000f5;es S., Veiga F., Sei&#x000e7;a R., Ribeiro A. Why most oral insulin formulations do not reach clinical trials. <span><span class="ref-journal">Ther Deliv. </span>2015;<span class="ref-vol">6</span>:973–987.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26272222" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ther+Deliv&amp;title=Why+most+oral+insulin+formulations+do+not+reach+clinical+trials&amp;author=M.+Lopes&amp;author=S.+Sim&#x000f5;es&amp;author=F.+Veiga&amp;author=R.+Sei&#x000e7;a&amp;author=A.+Ribeiro&amp;volume=6&amp;publication_year=2015&amp;pages=973-987&amp;pmid=26272222&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib359">359. <span class="element-citation" id="sref359">Hauss D.J. Oral lipid-based formulations. <span><span class="ref-journal">Adv Drug Deliv Rev. </span>2007;<span class="ref-vol">59</span>:667–676.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17618704" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Drug+Deliv+Rev&amp;title=Oral+lipid-based+formulations&amp;author=D.J.+Hauss&amp;volume=59&amp;publication_year=2007&amp;pages=667-676&amp;pmid=17618704&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib360">360. <span class="element-citation" id="sref360">Kovarik J.M., Mueller E.A., Kutz K., Van Bree J.B., Tetzloff W. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. <span><span class="ref-journal">J Pharm Sci. </span>1994;<span class="ref-vol">83</span>:444–446.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8207699" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Reduced+inter-+and+intraindividual+variability+in+cyclosporine+pharmacokinetics+from+a+microemulsion+formulation&amp;author=J.M.+Kovarik&amp;author=E.A.+Mueller&amp;author=K.+Kutz&amp;author=J.B.+Van+Bree&amp;author=W.+Tetzloff&amp;volume=83&amp;publication_year=1994&amp;pages=444-446&amp;pmid=8207699&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib361">361. <span class="element-citation" id="sref361">Zaoral M. DDAVP (desmopressin) and solid phase peptide synthesis. <span><span class="ref-journal">Pept Sci. </span>2008;<span class="ref-vol">90</span>:213.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18428153" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pept+Sci&amp;title=DDAVP+(desmopressin)+and+solid+phase+peptide+synthesis&amp;author=M.+Zaoral&amp;volume=90&amp;publication_year=2008&amp;pages=213&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib362">362. <span class="element-citation" id="sref362">F. Pharmaceuticals  . 2010. Minirin&#x000ae; Tablets&#x02014;New Zealand data sheet.<a href="http://www.medsafe.govt.nz/profs/datasheet/m/Minirintab.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.medsafe.govt.nz/profs/datasheet/m/Minirintab.pdf</a> Available from: <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=F.+Pharmaceuticals+Minirin&#x000ae;+Tablets&#x02014;New+Zealand+data+sheet+2010+Available+from:+http://www.medsafe.govt.nz/profs/datasheet/m/Minirintab.pdf+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib363">363. <span class="element-citation" id="sref363">Pohl E., Heine A., Sheldrick G.M., Dauter Z., Wilson K.S., Kallen J. Structure of octreotide, a somatostatin analogue. <span><span class="ref-journal">Acta Crystallogr D. </span>1995;<span class="ref-vol">51</span>:48–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15299335" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr+D&amp;title=Structure+of+octreotide,+a+somatostatin+analogue&amp;author=E.+Pohl&amp;author=A.+Heine&amp;author=G.M.+Sheldrick&amp;author=Z.+Dauter&amp;author=K.S.+Wilson&amp;volume=51&amp;publication_year=1995&amp;pages=48-59&amp;pmid=15299335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib364">364. <span class="element-citation" id="sref364">Tuvia S., Atsmon J., Teichman S.L., Katz S., Salama P., Pelled D. Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:2362–2369.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22539587" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Oral+octreotide+absorption+in+human+subjects:+comparable+pharmacokinetics+to+parenteral+octreotide+and+effective+growth+hormone+suppression&amp;author=S.+Tuvia&amp;author=J.+Atsmon&amp;author=S.L.+Teichman&amp;author=S.+Katz&amp;author=P.+Salama&amp;volume=97&amp;publication_year=2012&amp;pages=2362-2369&amp;pmid=22539587&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib365">365. <span class="mixed-citation" id="sref365">https://www.clinicaltrials.gov/ct2/show/results/<a id="__tag_985713722" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01923181" ref="reftype=extlink-clinical-trial&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01923181","term_id":"NCT01923181"}}</span>NCT01923181</a>?term=oral+semaglutide&#x00026;phase=1&#x00026;draw=2&#x00026;rank=1.</span></div><div class="ref-cit-blk half_rhythm" id="bib366">366. <span class="element-citation" id="sref366">Busby R.W., Bryant A.P., Bartolini W.P., Cordero E.A., Hannig G., Kessler M.M. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. <span><span class="ref-journal">Eur J Pharmacol. </span>2010;<span class="ref-vol">649</span>:328–335.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20863829" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;title=Linaclotide,+through+activation+of+guanylate+cyclase+C,+acts+locally+in+the+gastrointestinal+tract+to+elicit+enhanced+intestinal+secretion+and+transit&amp;author=R.W.+Busby&amp;author=A.P.+Bryant&amp;author=W.P.+Bartolini&amp;author=E.A.+Cordero&amp;author=G.+Hannig&amp;volume=649&amp;publication_year=2010&amp;pages=328-335&amp;pmid=20863829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib367">367. <span class="element-citation" id="sref367">Rao S., Kupfer Y., Pagala M., Chapnick E., Tessler S. Systemic absorption of oral vancomycin in patients with clostridium difficile infection. <span><span class="ref-journal">Scand J Infect Dis. </span>2011;<span class="ref-vol">43</span>:386–388.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21198337" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Infect+Dis&amp;title=Systemic+absorption+of+oral+vancomycin+in+patients+with+clostridium+difficile+infection&amp;author=S.+Rao&amp;author=Y.+Kupfer&amp;author=M.+Pagala&amp;author=E.+Chapnick&amp;author=S.+Tessler&amp;volume=43&amp;publication_year=2011&amp;pages=386-388&amp;pmid=21198337&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib368">368. <span class="element-citation" id="sref368">Fuhrmann G., Leroux J.-C. Improving the stability and activity of oral therapeutic enzymes&#x02014;recent advances and perspectives. <span><span class="ref-journal">Pharm Res. </span>2014;<span class="ref-vol">31</span>:1099–1105.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24185592" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Improving+the+stability+and+activity+of+oral+therapeutic+enzymes&#x02014;recent+advances+and+perspectives&amp;author=G.+Fuhrmann&amp;author=J.-C.+Leroux&amp;volume=31&amp;publication_year=2014&amp;pages=1099-1105&amp;pmid=24185592&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib369">369. <span class="mixed-citation" id="sref369">Company Announcement: financial report for the period 1 January 2015 to 30 June 2015. Novo Nordisk. Available from: <a href="https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2015/20150806_finanical%20report_Q2%202015_UK.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2015/20150806_finanical%20report_Q2%202015_UK.pdf</a> [Accessed August 12, 2019].</span></div><div class="ref-cit-blk half_rhythm" id="bib370">370. <span class="element-citation" id="sref370">Li J., Wang Y., Han L., Sun X., Yu H., Yu Y. Time&#x02013;action profile of an oral enteric insulin formulation in healthy Chinese volunteers. <span><span class="ref-journal">Clin Therapeut. </span>2012;<span class="ref-vol">34</span>:2333–2338.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23195963" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Therapeut&amp;title=Time&#x02013;action+profile+of+an+oral+enteric+insulin+formulation+in+healthy+Chinese+volunteers&amp;author=J.+Li&amp;author=Y.+Wang&amp;author=L.+Han&amp;author=X.+Sun&amp;author=H.+Yu&amp;volume=34&amp;publication_year=2012&amp;pages=2333-2338&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib371">371. <span class="element-citation" id="sref371">Eldor R., Arbit E., Corcos A., Kidron M. Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3622027/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23593142" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Glucose-reducing+effect+of+the+ORMD-0801+oral+insulin+preparation+in+patients+with+uncontrolled+type+1+diabetes:+a+pilot+study&amp;author=R.+Eldor&amp;author=E.+Arbit&amp;author=A.+Corcos&amp;author=M.+Kidron&amp;volume=8&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib372">372. <span class="element-citation" id="sref372">Zijlstra E., Heinemann L., Plum-M&#x000f6;rschel L. Oral insulin reloaded: a structured approach. <span><span class="ref-journal">J Diabetes Sci Technol. </span>2014;<span class="ref-vol">8</span>:458–465.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4455450/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24876606" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Sci+Technol&amp;title=Oral+insulin+reloaded:+a+structured+approach&amp;author=E.+Zijlstra&amp;author=L.+Heinemann&amp;author=L.+Plum-M&#x000f6;rschel&amp;volume=8&amp;publication_year=2014&amp;pages=458-465&amp;pmid=24876606&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib373">373. <span class="element-citation" id="sref373">Khedkar A., Lebovitz H., Fleming A., Cherrington A., Jose V., Athalye S.N. Impact of insulin tregopil and its permeation enhancer on pharmacokinetics of metformin in healthy volunteers: randomized, open-label, placebo-controlled, crossover study. <span><span class="ref-journal">Clin Transl Sci. </span>2019;<span class="ref-vol">12</span>:276–282.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6510383/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30592549" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Sci&amp;title=Impact+of+insulin+tregopil+and+its+permeation+enhancer+on+pharmacokinetics+of+metformin+in+healthy+volunteers:+randomized,+open-label,+placebo-controlled,+crossover+study&amp;author=A.+Khedkar&amp;author=H.+Lebovitz&amp;author=A.+Fleming&amp;author=A.+Cherrington&amp;author=V.+Jose&amp;volume=12&amp;publication_year=2019&amp;pages=276-282&amp;pmid=30592549&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib374">374. <span class="element-citation" id="sref374">Khedkar A., Lebovitz H., Fleming A., Cherrington A., Jose V., Athalye S.N. Pharmacokinetics and pharmacodynamics of insulin tregopil in relation to premeal dosing time, between meal interval, and meal composition in patients with type 2 diabetes mellitus. <span><span class="ref-journal">Clin Pharmacol Drug Develop. </span>2020;<span class="ref-vol">9</span>:74–86.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7004075/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31392840" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Drug+Develop&amp;title=Pharmacokinetics+and+pharmacodynamics+of+insulin+tregopil+in+relation+to+premeal+dosing+time,+between+meal+interval,+and+meal+composition+in+patients+with+type+2+diabetes+mellitus&amp;author=A.+Khedkar&amp;author=H.+Lebovitz&amp;author=A.+Fleming&amp;author=A.+Cherrington&amp;author=V.+Jose&amp;volume=9&amp;publication_year=2020&amp;pages=74-86&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib375">375. <span class="element-citation" id="sref375">Geho W.B., Geho H.C., Lau J.R., Gana T.J. Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation. <span><span class="ref-journal">J Diabetes Sci Technol. </span>2009;<span class="ref-vol">3</span>:1451–1459.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2787047/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20144401" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Sci+Technol&amp;title=Hepatic-directed+vesicle+insulin:+a+review+of+formulation+development+and+preclinical+evaluation&amp;author=W.B.+Geho&amp;author=H.C.+Geho&amp;author=J.R.+Lau&amp;author=T.J.+Gana&amp;volume=3&amp;publication_year=2009&amp;pages=1451-1459&amp;pmid=20144401&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib376">376. <span class="element-citation" id="sref376">Geho W.B., Rosenberg L.N., Schwartz S.L., Lau J.R., Gana T.J. A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitus. <span><span class="ref-journal">J Diabetes Sci Technol. </span>2014;<span class="ref-vol">8</span>:551–559.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4455427/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24876619" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Sci+Technol&amp;title=A+single-blind,+placebo-controlled,+dose-ranging+trial+of+oral+hepatic-directed+vesicle+insulin+add-on+to+oral+antidiabetic+treatment+in+patients+with+type+2+diabetes+mellitus&amp;author=W.B.+Geho&amp;author=L.N.+Rosenberg&amp;author=S.L.+Schwartz&amp;author=J.R.+Lau&amp;author=T.J.+Gana&amp;volume=8&amp;publication_year=2014&amp;pages=551-559&amp;pmid=24876619&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib377">377. <span class="element-citation" id="sref377">Karsdal M.A., Byrjalsen I., Henriksen K., Riis B.J., Lau E.M., Arnold M. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. <span><span class="ref-journal">Osteoarthr Cartilage. </span>2010;<span class="ref-vol">18</span>:150–159.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19747581" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Osteoarthr+Cartilage&amp;title=The+effect+of+oral+salmon+calcitonin+delivered+with+5-CNAC+on+bone+and+cartilage+degradation+in+osteoarthritic+patients:+a+14-day+randomized+study&amp;author=M.A.+Karsdal&amp;author=I.+Byrjalsen&amp;author=K.+Henriksen&amp;author=B.J.+Riis&amp;author=E.M.+Lau&amp;volume=18&amp;publication_year=2010&amp;pages=150-159&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib378">378. <span class="mixed-citation" id="sref378"><a href="https://www.protagonist-inc.com/pipeline/product-candidates/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.protagonist-inc.com/pipeline/product-candidates/</a>.</span></div><div class="ref-cit-blk half_rhythm" id="bib379">379. <span class="mixed-citation" id="sref379"><a href="http://avaxiabiologics.com/programs/avx-470.php" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://avaxiabiologics.com/programs/avx-470.php</a>.</span></div><div class="ref-cit-blk half_rhythm" id="bib380">380. <span class="mixed-citation" id="sref380"><a href="http://protalix.com/pipeline/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://protalix.com/pipeline/</a>.</span></div><div class="ref-cit-blk half_rhythm" id="bib381">381. <span class="mixed-citation" id="sref381">Sung HW, Liao ZX, Peng SF, Tu H, inventors; GP Medical, Inc., National Tsing Hua University, assignee. Nanoparticles for protein drug delivery. United States patent US No. 8283317B1. 2012 Oct 9.</span></div><div class="ref-cit-blk half_rhythm" id="bib382">382. <span class="mixed-citation" id="sref382">Transgene reports excellent results from TrabiOralTM oral insulin studies, Available from: <a href="http://www.transgenebiotek.com/images/inner/news/press_release_120521_tbl_trabioral_insulin_efficacy_studies.pdf2012" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.transgenebiotek.com/images/inner/news/press_release_120521_tbl_trabioral_insulin_efficacy_studies.pdf2012</a> [Accessed 7 December, 2015].</span></div><div class="ref-cit-blk half_rhythm" id="bib383">383. <span class="element-citation" id="sref383">Thwala L.N., Pr&#x000e9;at V., Csaba N.S. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes. <span><span class="ref-journal">Expet Opin Drug Deliv. </span>2017;<span class="ref-vol">14</span>:23–36.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27351299" ref="reftype=pubmed&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expet+Opin+Drug+Deliv&amp;title=Emerging+delivery+platforms+for+mucosal+administration+of+biopharmaceuticals:+a+critical+update+on+nasal,+pulmonary+and+oral+routes&amp;author=L.N.+Thwala&amp;author=V.+Pr&#x000e9;at&amp;author=N.S.+Csaba&amp;volume=14&amp;publication_year=2017&amp;pages=23-36&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib384">384. <span class="mixed-citation" id="sref384"><a href="https://emisphere.com/technology/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://emisphere.com/technology/</a>.</span></div><div class="ref-cit-blk half_rhythm" id="bib385">385. <span class="element-citation" id="sref385">Maggio E.T. Novel formulations for non-invasive delivery &#x00026; stabilization of peptides. <span><span class="ref-journal">Biopolymers. </span>2013;<span class="ref-vol">13</span>:68–75.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biopolymers&amp;title=Novel+formulations+for+non-invasive+delivery+&#x00026;+stabilization+of+peptides&amp;author=E.T.+Maggio&amp;volume=13&amp;publication_year=2013&amp;pages=68-75&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8424290&amp;issue-id=389664&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Acta Pharmaceutica Sinica. B</span> are provided here courtesy of <strong>Elsevier</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8424290/pdf/main.pdf" class="int-view">PDF (4.6M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8424290/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8424290/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8424290" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="qIMFynVeF4sBPSW1uECGDKHihzByzoNqZ3koBK60J04D7WmhESNivSfhc9t9O7uf">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F&amp;text=Oral%20delivery%20of%20proteins%20and%20peptides%3A%20Challenges%2C%20status%20quo%20and%20future%20perspectives" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8424290%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424290/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34522593/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34522593/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8424290/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8424290/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8424290/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
